t i
t h
i n
a n
r e
e n
e r
e d</w>
o f</w>
o n
th e</w>
o n</w>
r o
an d</w>
a ti
a t
i n</w>
i t
a r
a l</w>
o r
s t
a l
e s</w>
s i
d i
a s
a c
e c
e l
i c
in g</w>
e r</w>
t o</w>
o m
o r</w>
u l
o l
u r
ati on</w>
a s</w>
t s</w>
e s
re s
p ro
o s
t r
d e
en t</w>
u n
T h
it h</w>
w ith</w>
i s</w>
v e</w>
l y</w>
c on
p l
a t</w>
ti on</w>
a p
a n</w>
c h
a m
i l
i m
u c
er e</w>
e m
i s
t er
e x
a g
i d
u s
at ed</w>
f or</w>
p h
a b
e n</w>
o c
i c</w>
w as</w>
c om
f f
e t
Th e</w>
p er
it y</w>
o u
w ere</w>
on s</w>
c e</w>
e v
en ts</w>
c l
o t
o g
s u
i g
q u
o p
a d
o w
th at</w>
m e
b y</w>
at e</w>
p ati
st r
v i
i f
a r</w>
w h
u m
re n
l e</w>
p res
as e</w>
t ed</w>
si s</w>
u d
d uc
s e
l e
n e
ar e</w>
s p
ti n
re d</w>
in e</w>
c el
t e
c o
si on</w>
ic al</w>
h a
f or
m o
pati ents</w>
i b
ro m</w>
ac ti
f rom</w>
re c
n o
g en
m ent</w>
ti c</w>
s h
p o
p a
e p
p re
i r
an t</w>
m a
s y
v er
ur e</w>
0 .
u t
p ar
e en</w>
ig h
th e
l o
g n
en t
e ff
ro u
b e</w>
as s
i z
ti ve</w>
p or
r a
en ce</w>
ati ons</w>
h e
ti c
r i
u s</w>
c re
m on
re l
en ti
v el
si gn
al ly</w>
t re
h y
t ro
ol og
t er</w>
o b
ti m
l s</w>
ar y</w>
u m</w>
on al</w>
for m
s c
b et
a in
en d
tin g</w>
ul ar</w>
th er</w>
e ar
sp ec
in f
an g
s er
if ic
d er
l i
di c
di ff
ag e</w>
ou s</w>
tr an
st ud
res p
as ed</w>
eff ec
e ren
th is</w>
es e</w>
an c
f ac
t h</w>
o d</w>
I n</w>
al y
on e</w>
i d</w>
an ti
stud y</w>
ati ve</w>
i al</w>
re g
es s</w>
an ce</w>
v ed</w>
c or
in ter
no t</w>
o x
m or
or s</w>
o d
cel ls</w>
th er
l ow
s ur
i es</w>
su b
a f
m in
g rou
e -
in cre
y p
acti v
d ing</w>
diff eren
sign ific
ab le</w>
pro te
p os
er s</w>
ar i
es s
ic h</w>
o un
di s
or y</w>
b i
an aly
w een</w>
u re
v e
res ul
oc i
y l
bet ween</w>
s e</w>
st e
wh ich</w>
an t
ha ve</w>
m ic
en c
i a</w>
in g
al l</w>
c ar
tre at
t ec
ap os
& apos
in v
un c
f i
us e</w>
y m
al u
l ev
ti ons</w>
as es</w>
y t
at es</w>
th an</w>
af ter</w>
i r</w>
l u
os e</w>
u t</w>
duc ed</w>
treat ment</w>
us ed</w>
es t</w>
W e</w>
ati n
a y
resp on
a y</w>
i t</w>
ass oci
e st
en tr
cel l</w>
tran s
r an
it s</w>
me th
al s</w>
el s</w>
com pl
m un
i th
il ity</w>
h igh
b e
0 0
ul ation</w>
p r
v ari
t w
ar g
us ing</w>
d s</w>
v id
con tro
ro m
ur ing</w>
pres sion</w>
u di
th ese</w>
& #
d er</w>
c ur
i ti
&# 9
di se
h ib
ot h</w>
Th is</w>
h as</w>
f unc
b een</w>
c a
el ec
O N
atin g</w>
cl in
j ec
b l
ou t</w>
sh ow
w e</w>
vel y</w>
b ut</w>
f ol
b in
de vel
fac t
em ent</w>
g l
s o</w>
ther ap
st udi
cl ud
o l</w>
r ap
t a
grou p</w>
mor e</w>
am in
ac ter
igh t</w>
i p
d ec
c ol
I n
resul ts</w>
v er</w>
ma y</w>
m an
t en
m at
w e
N A</w>
str uc
oun d</w>
1 .
per i
a st
activ ity</w>
the ir</w>
el y</w>
as t</w>
r u
i st
p ol
devel op
ure s</w>
ha d</w>
er al</w>
os t</w>
og en
re e</w>
c an</w>
vi r
t ;</w>
d at
e d
s t</w>
tr ac
s ec
on -
d uring</w>
mic ro
al so</w>
iz ed</w>
prote in</w>
olog ical</w>
associ ated</w>
ou r</w>
tw o</w>
a v
b oth</w>
m al
f in
con c
m et
me di
ul d</w>
ch ang
t yp
re qu
c r
es ti
analy sis</w>
S I
in hib
p e
re por
sy n
pro c
r is
pa red</w>
dise ase</w>
t ain
g g
me as
ant ly</w>
im mun
g h</w>
em b
w ith
el l
t u
c ul
de p
ch em
in clud
lo w</w>
l in
he al
ab ility</w>
w or
clin ical</w>
id e</w>
g r
h um
ti onal</w>
si ve</w>
si st
R E
s uc
e l</w>
n or
su gg
t om
iz ation</w>
on g</w>
1 0</w>
ec h
pa th
po si
t o
y ear
dat a</w>
anc er</w>
d e</w>
o ther</w>
m ul
un der
k e</w>
s am
t um
C L
ay s</w>
f ic
al l
f r
ev er</w>
om e</w>
de ter
n i
lev els</w>
ac h</w>
incre ased</w>
rap h
p ot
pl e</w>
id enti
ex pression</w>
d om
f ir
signific antly</w>
an ts</w>
T S</w>
ob ser
duc tion</w>
rel ated</w>
s en
ati c</w>
effec ts</w>
f ound</w>
ev alu
ep t
it e</w>
fol low
pres s
on g
in s</w>
M E
g ro
d ro
v en
signific ant</w>
therap y</w>
effec t</w>
com pared</w>
l oc
di ag
t ure</w>
ig h</w>
dep end
0. 0
e t</w>
S U
per form
ent al</w>
studi es</w>
e i
com p
se qu
o per
ch ar
pl as
tim e</w>
ti vely</w>
inf ec
s ev
&apos ;</w>
ac h
tr a
c ancer</w>
n o</w>
ap pro
e re
il e</w>
m al</w>
p s</w>
ow ever</w>
ste m</w>
differen t</w>
su p
m s</w>
al ity</w>
d u
in dic
ris k</w>
og raph
b le</w>
hum an</w>
l t;</w>
& lt;</w>
show ed</w>
ou t
esti g
year s</w>
qu ot
& quot
&quot ;</w>
D S</w>
&apos ;
h igh</w>
vi e
il l
sur g
A l
b ased</w>
mo d
in duced</w>
contro l</w>
s es</w>
ti s
sh o
por t
C ON
f e
T H
olog y</w>
r ate</w>
inv estig
an is
h o
conc entr
ti es</w>
u ro
ac tion</w>
U SI
- 1
CL USI
CON CLUSI
pl ic
m ost</w>
enti al</w>
fi ed</w>
k ing</w>
v al
po st
in to</w>
&apos; s</w>
on ic</w>
k n
k s</w>
2 .
at er</w>
m il
c es</w>
SU L
om a</w>
m ar
f u
a ff
k in
RE SUL
2 0
form ation</w>
ac c
o ph
b lo
RESUL TS</w>
de tec
b o
y -
pati ent</w>
c y
if ic</w>
il d
id ence</w>
m a</w>
it ed</w>
dec re
Th ese</w>
A C
y n
ra di
pres ent</w>
enc y</w>
os ph
c yt
el l</w>
pro vid
c al
c h</w>
tic al</w>
vi v
s ol
ut e</w>
ur al</w>
rec ept
cl e</w>
a in</w>
d es
g re
m ech
u al</w>
char acter
ol ec
a -
e g
e tic</w>
c ases</w>
e ar</w>
grou ps</w>
T I
um b
im pro
func tion</w>
u tion</w>
u p
spec ific</w>
TH O
si ons</w>
on ly</w>
resp ec
ME THO
high er</w>
con tr
o f
uc le
- 1</w>
v alu
gen e</w>
de l</w>
1 ;</w>
&#9 1;</w>
respon se</w>
en z
an s</w>
ti v
m ents</w>
hy dro
a il
obser ved</w>
oc yt
tis su
3 ;</w>
&#9 3;</w>
ec ted</w>
y si
an d
ro s
mul ti
gro w
ing s</w>
gen er
com m
s ti
l if
typ e</w>
reg i
1 9
er g
m p
blo od</w>
im port
en g
de mon
demon str
mo del</w>
v ing</w>
f l
p op
1 0
METHO DS</w>
a th
d ru
suc h</w>
at ory</w>
wh o</w>
sy stem</w>
nor mal</w>
in c
y s
ot al</w>
o re
h ist
tec h
s tim
N D</w>
ro le</w>
a d</w>
par tic
fact ors</w>
w ell</w>
tic s</w>
at ure</w>
wh en</w>
depend ent</w>
b r
hy per
C h
ph osph
ren t</w>
f lu
c are</w>
D NA</w>
ch ild
e th
H owever</w>
th rou
m ut
v as
m y
com bin
z ed</w>
ic i
kn ow
pr im
heal th</w>
at s</w>
con di
ent ly</w>
th ree</w>
d el
ex amin
n on-
pro g
th ose</w>
tre ated</w>
ac t</w>
i um</w>
inv ol
chang es</w>
m olec
tain ed</w>
o ver</w>
in al</w>
for e</w>
ph ysi
pro duc
ass ess
n umb
mech anis
ver y</w>
con t
s ul
st em
di vid
R O
it r
u p</w>
lev el</w>
m is
3 .
incre ase</w>
t otal</w>
ab l
per im
cl u
re n</w>
er y</w>
T o</w>
ac id</w>
no sis</w>
m emb
I I</w>
r ang
ad di
ar d</w>
5 0</w>
si ble</w>
m us
c ular</w>
re vie
l arg
deter min
x im
ab ol
f ib
tr i
as s</w>
l ess</w>
2 -
p it
ati onal</w>
or g
respec tively</w>
car di
meth od</w>
develop ment</w>
a re
l im
is h
o ver
ep ti
fir st</w>
pre dic
co un
ter n
f er
b od
o sis</w>
ag es</w>
th s</w>
ne uro
ne w</w>
perform ed</w>
grow th</w>
R NA</w>
E C
m ac
a i
od s</w>
o -
am ong</w>
pl ac
out com
2 0</w>
o ur
co uld</w>
me dic
w om
pot ential</w>
acti ve</w>
ic ally</w>
t em
child ren</w>
s elec
O N</w>
cr ib
sen si
bod y</w>
p er</w>
i v
9 5</w>
di rec
l ong
sub jec
m i
c in
p at
h or
en ted</w>
ma in
y ing</w>
g en</w>
ph en
o us
al ph
l am
tum or</w>
f requ
i ed</w>
an e
c ap
S t
me an</w>
5 -
ter s</w>
en s
k ed</w>
con si
1 2</w>
d ed</w>
numb er</w>
ri p
low er</w>
si mil
in -
C on
import ant</w>
sy stem
0. 00
repor ted</w>
m g</w>
reg ul
ex perim
h em
th ou
throu gh</w>
includ ing</w>
b re
with in</w>
g u
d ings</w>
te st
is ol
b ra
di sc
id s</w>
u r</w>
om e
bin ding</w>
iti es</w>
n on
p ec
rel ati
ad e</w>
os pit
4 .
we e
ti l
A T
a si
re ve
ex pos
n ucle
v ol
wom en</w>
n ec
ON S</w>
with out</w>
cel l
n os
A n
y c
posi tive</w>
fact or</w>
com par
r ats</w>
ear ly</w>
res s</w>
N A
u b
mon ths</w>
I t</w>
l ym
prote ins</w>
ti on
met abol
di d</w>
y l</w>
ot yp
identi fied</w>
C D
mic e</w>
ag ing</w>
col l
e ther</w>
c ase</w>
m it
v es</w>
d ays</w>
ni qu
on d
e x</w>
des crib
t ly</w>
ap p
ograph y</w>
ar ter
it er
t arg
g o
ha vi
u red</w>
the sis</w>
ol d</w>
e ach</w>
t est</w>
recept or</w>
e u
am ine</w>
bi o
ch rom
tissu e</w>
min i
s ed</w>
tiv ity</w>
1 -
i red</w>
du e</w>
re s</w>
th ere</w>
in divid
sugg est</w>
memb ran
ch r
ogen e
tech niqu
sc op
s ing
g h
inhib it
c al</w>
pl es</w>
hy po
C I</w>
ma j
diag nosis</w>
per c
CONCLUSI ONS</w>
re sist
c at
d o
an n
t ures</w>
t y</w>
oper ative</w>
fac e</w>
enz ym
fin dings</w>
sy mp
ic e</w>
wor k</w>
thou gh</w>
3 -
or der</w>
oc cur
ti s</w>
ar di
in t
inf lu
s k
fu l</w>
acti ons</w>
ous ly</w>
fic ation</w>
infec tion</w>
be havi
o id</w>
s it
5 .
sur viv
1 5</w>
i p</w>
z e</w>
a x
pres ence</w>
ur ther</w>
in iti
C om
l l
or al</w>
b ec
ad ul
wh ile</w>
al e</w>
3 0</w>
vas cular</w>
prim ary</w>
diag nos
P ro
m ot
p ri
ati s
P C
surg ery</w>
for m</w>
f t</w>
ex pl
a sis</w>
L -
et y</w>
w ay</w>
l ab
re duced</w>
simil ar</w>
l at
is e</w>
ox id
en h
ser um</w>
differen ces</w>
bra in</w>
f em
ex trac
ent ation</w>
activ ation</w>
ad mini
r ati
al ed</w>
know n</w>
or e</w>
pol y
a ut
vir us</w>
inf lam
h ospit
mor ph
ear ch</w>
ob tained</w>
sup por
at ely</w>
b acter
ac y</w>
il l</w>
pre vi
6 .
gen es</w>
studi ed</w>
ab out</w>
revie w</w>
stim ul
f am
differen ti
plas ma</w>
rec ei
decre ased</w>
v is
s ing</w>
er i
spec ies</w>
s ome</w>
i l</w>
en e
sy ch
l ine</w>
meas ured</w>
in j
condi tions</w>
ro ph
p ul
is m</w>
Th ere</w>
K G
ish ed</w>
e qu
B AC
C A
g s</w>
symp tom
ev idence</w>
4 -
cl es</w>
m ental</w>
un der</w>
ne ur
7 .
n er
p an
P A
t al</w>
RO U
d ay</w>
follow ing</w>
ter m</w>
pop ulation</w>
BAC KG
BACKG ROU
k ers</w>
lym ph
BACKGROU ND</w>
p ur
sho uld</w>
comm on</w>
am e
s el
ar ti
compl et
as si
v enti
concentr ations</w>
addi tion</w>
a z
ec t</w>
gl uc
develop ed</w>
dru g</w>
li ver</w>
R es
ac ute</w>
s -
l ac
tran sc
re duc
repor t</w>
reve aled</w>
d es</w>
im pl
ic s</w>
j u
rang e</w>
cor rel
a di
peri od</w>
in te
ex c
chem ical</w>
subjec ts</w>
he ar
o st
surviv al</w>
on sh
d ose</w>
E x
v ement</w>
f il
elec tro
the y</w>
f ul
ain s</w>
ne g
an im
investig ated</w>
demonstr ated</w>
o di
di ab
character is
elec tr
ch ol
itr o</w>
chang e</w>
ig n
sho w</w>
concentr ation</w>
d rom
c op
1 4</w>
inj ur
effec tive</w>
in tr
di str
compl ic
chr onic</w>
b one</w>
F -
ag ement</w>
proc ed
est er
ven tion</w>
2 5</w>
g e</w>
v itro</w>
ocyt es</w>
ei ther</w>
anc ed</w>
m ine</w>
enc es</w>
includ ed</w>
pr acti
p sych
m en
ad v
st ate</w>
es ting</w>
press ed</w>
res earch</w>
a u
res sion</w>
f o
sam ples</w>
CONCLUSI ON</w>
t ox
c er
relati onsh
m all</w>
k e
re si
sugg est
maj or</w>
yn am
heal th
O B
r ates</w>
di st
examin ed</w>
P -
func tional</w>
an y</w>
molec ular</w>
car cin
a c</w>
t -
compl ex</w>
eff ici
y ear</w>
c ir
press ure</w>
we ight</w>
lo b
J EC
un d</w>
ain st</w>
H I
ox y
on d</w>
evalu ated</w>
oc c
1 1</w>
proc ess
pa in</w>
struc ture</w>
M e
ab s
determin ed</w>
W h
con tin
meth ods</w>
E R
8 .
pro duction</w>
f our</w>
1 6</w>
ag ainst</w>
appro ach</w>
b ility</w>
i tion</w>
der s</w>
par ti
O ur</w>
pro b
d os
deter mine</w>
em ia</w>
TI V
2 4</w>
ve l</w>
sur face</w>
ren al</w>
syn drom
f urther</w>
s mall</w>
transc rip
p u
partic ip
se t</w>
pro per
a e</w>
l os
st and
or t</w>
b as
es tim
l un
im p
OB JEC
A c
vir on
n ess</w>
OBJEC TIV
us es</w>
disc us
qu anti
membran e</w>
ap plic
s ch
k g</w>
anti -
be fore</w>
re le
A d
cur rent</w>
distr ib
valu es</w>
con duc
er c
d r
g t;</w>
& gt;</w>
ar ly</w>
ph ase</w>
D i
op ath
ta ke</w>
qu ality</w>
S C
ome tr
in formation</w>
tain ing</w>
larg e</w>
0 0</w>
symptom s</w>
el d</w>
w ater</w>
po in
al -
r at</w>
gre ater</w>
sam e</w>
f -
g ra
2 00
ic ity</w>
4 0</w>
g a
1 8</w>
1 3</w>
mus cle</w>
li ke</w>
ain ing</w>
ver se</w>
en ing</w>
mo di
posi tion</w>
sing le</w>
proc ess</w>
ver s
wh ether</w>
str ation</w>
f ail
w ill</w>
de m
en viron
contr ib
vari ous</w>
a use</w>
provid e</w>
show n</w>
under st
spec tive</w>
f y</w>
n ing</w>
t ality</w>
in jec
at us</w>
as ing</w>
ane ous</w>
f oc
m in</w>
str at
neg ative</w>
o therapy</w>
respon ses</w>
av ail
man agement</w>
con sist
alph a</w>
ex peri
is t</w>
ta in</w>
h om
- up</w>
ell ular</w>
expos ure</w>
p epti
en s</w>
S T
comp on
surg ical</w>
de fic
detec ted</w>
st er
ul es</w>
olog ic</w>
tic ally</w>
rati o</w>
el ial</w>
ur ation</w>
si ze</w>
f ree</w>
v al</w>
mechanis ms</w>
invol ved</w>
pres ented</w>
f low</w>
syndrom e</w>
wh ere
pos sible</w>
f eren
0.0 5</w>
wee ks</w>
suc c
o th
e al</w>
cyt o
st ress</w>
sev eral</w>
no vel</w>
mor tality</w>
ol e</w>
proper ties</w>
rec ur
om ic</w>
clu sion</w>
contin u
tin al</w>
m uc
N -
b il
si de</w>
pro tec
outcom es</w>
T w
com mun
at ures</w>
og ni
high -
ag ed</w>
ren ce</w>
de fin
t ur
6 0</w>
differen ce</w>
im aging</w>
lun g</w>
li p
perform ance</w>
therap eu
multi ple</w>
de red</w>
ll ed</w>
meas ure
un d
assess ed</w>
M A
man y</w>
bo di
car b
s cre
medic al</w>
n an
lif e</w>
resist ance</w>
rec or
org an
associ ation</w>
at r
tom y</w>
re duction</w>
strat eg
contro ls</w>
con fir
s al
O n
mod els</w>
regi on</w>
10 0</w>
le u
hear t</w>
n al</w>
t en</w>
6 -
where as</w>
viv o</w>
T -
mechanis m</w>
y st
est abl
et es</w>
c entr
sti tu
par ame
E n
ar mac
al ized</w>
de f
los s</w>
m ed</w>
pre gn
in duc
lif er
ad en
h el
isol ated</w>
gr ad
m ag
N e
i ly</w>
injur y</w>
at or</w>
typ es</w>
bodi es</w>
C -
C O
c ros
medi ated</w>
P ati
ec tion</w>
mat ory</w>
c an
at h</w>
pos e</w>
p ap
ac et
a ro
ogene sis</w>
en e</w>
I N
I m
sev ere</w>
1 7</w>
ograph ic</w>
ang i
ran dom
a ir
H e
oc ardi
anc es</w>
gr am
tu b
et al</w>
in sul
pro lifer
y r
yl ation</w>
y ro
o ch
enzym e</w>
analy zed</w>
bl oc
at al</w>
em ents</w>
com po
le -
anc y</w>
am p
v entr
sequ ence</w>
immun e</w>
res c
be ing</w>
b ac
cy cl
m ass</w>
sensi tivity</w>
c i
evalu ate</w>
tran sp
c ere
a ver
t ural</w>
us e
techniqu e</w>
val ence</w>
ach i
li k
t or</w>
em s</w>
ic es</w>
inhib ition</w>
mon ary</w>
therapeu tic</w>
ass ay</w>
follow -up</w>
s mo
reg ulation</w>
0 -
suppor t</w>
P re
pos ed</w>
is h</w>
st age</w>
s us
iz e</w>
characteris tics</w>
d ys
C T</w>
ph ot
9 .
A n</w>
relationsh ip</w>
s ite</w>
der i
dise ases</w>
A M
valu e</w>
l og
it al</w>
are a</w>
tem per
gen etic</w>
iti s</w>
ag on
vi a</w>
A L
t end
cl assi
pe a
sec re
ter min
individ u
ogen ic</w>
fu sion</w>
frequ ency</w>
al ization</w>
e p</w>
ic ular</w>
in ten
inflam matory</w>
vol um
w a
su s</w>
l ight</w>
fam ily</w>
Al l</w>
w ays</w>
st atis
parame ters</w>
decre ase</w>
R e
le sions</w>
con struc
ec ts</w>
met ast
ex p
Al though</w>
pu bl
outcom e</w>
detec tion</w>
ic h
combin ation</w>
S -
ser v
al ing</w>
health y</w>
a m</w>
in ary</w>
contr ast</w>
n it
ic ul
A -
de x</w>
inc idence</w>
ma in</w>
mis sion</w>
ab il
ain ed</w>
admini stration</w>
flu o
pro f
con taining</w>
A s</w>
is on</w>
cell ular</w>
me tr
re tro
s af
0.00 1</w>
trans pl
es c
e ding</w>
indic ate</w>
2 1</w>
ist s</w>
U n
oc ial</w>
l as
ca used</w>
re action</w>
st atus</w>
system s</w>
et er</w>
th rom
hospit al</w>
M R
os om
h owever</w>
requ ired</w>
e ph
vi ties</w>
describ ed</w>
ic acy</w>
ab ly</w>
deri ved</w>
ad ing</w>
he pati
a k
bre ast</w>
b ene
cal c
mal e</w>
ac cur
consi dered</w>
an ding</w>
rele ase</w>
le ft</w>
long -
or ig
cardi ac</w>
sit es</w>
test ed</w>
erg y</w>
per s
l ig
S A</w>
evalu ation</w>
it ation</w>
distrib ution</w>
i de
i on</w>
the si
i di
inte gr
tum ors</w>
g e
d ens
or ders</w>
op tim
C R
si m
o t</w>
recept ors</w>
si g
ca use</w>
ten sion</w>
or ing</w>
spec ific
sel f-
ag g
previ ously</w>
s oci
avail able</w>
A f
follow ed</w>
8 0</w>
st s</w>
high ly</w>
anim als</w>
gluc ose</w>
mar k
R ec
syn thesis</w>
ph armac
ul ts</w>
A B
dis tin
resul t</w>
el i
P O
b ro
l iter
th ro
carcin oma</w>
F or</w>
fi ve</w>
identi fy</w>
conduc ted</w>
M S</w>
H ere</w>
pro duced</w>
in es</w>
correl ation</w>
investig ate</w>
o ff
pro mot
A ND</w>
ti n</w>
OBJECTIV E</w>
e ts</w>
scop y</w>
m er
el ev
complic ations</w>
Pati ents</w>
if ied</w>
ex hib
ai m</w>
recei ved</w>
ap pl
experim ental</w>
on ary</w>
leu k
l es</w>
bec ause</w>
del i
m RNA</w>
bet a-
p tion</w>
targ et</w>
defic i
in ation</w>
ma xim
bet a</w>
Af ter</w>
o ste
ass ess</w>
influ ence</w>
ex pressed</w>
co ur
dru gs</w>
C a
direc t</w>
all eng
ot ox
otyp e</w>
A I
ep ith
fe atures</w>
imp act</w>
atr ic</w>
res t</w>
n at
O R</w>
eff icacy</w>
op to
anti bodies</w>
en d</w>
impro ved</w>
gl yc
mat er
E ff
r h
s y</w>
tran si
assess ment</w>
tin e</w>
u ted</w>
gen eral</w>
bet ter</w>
car ri
le d
t oc
ho w</w>
I C
d ynam
ri al</w>
int es
con f
s in
he ter
o s</w>
de ath</w>
su ff
pre valence</w>
i f</w>
el ine</w>
in trac
aly sis</w>
individu als</w>
d am
stim ulation</w>
c ri
str ic
stand ard</w>
d ow
iv en</w>
hydro x
on es</w>
m l</w>
mon it
Res ults</w>
diab etes</w>
1 9</w>
- induced</w>
I g
aff ected</w>
hor mon
kin ase</w>
un i
ch alleng
D E
gener ation</w>
fail ure</w>
ap opto
e y
lik ely</w>
h al
h er
i ally</w>
l eng
the tic</w>
path way</w>
adul t</w>
A s
at ten
im pa
volum e</w>
tim es</w>
9 0</w>
pl o
m m</w>
sub st
H C
si onal</w>
pol ym
ro sis</w>
t ors</w>
re co
arter y</w>
ol ic</w>
acti vities</w>
sur ve
fr ac
as e-
g am
t le</w>
physi cal</w>
ant ation</w>
ol y
sk in</w>
un ds</w>
sam ple</w>
inv a
ul ations</w>
cont ent</w>
pl at
th en</w>
pat tern
ul e</w>
si mul
S E</w>
u til
1 2
liter ature</w>
incre asing</w>
a im
sec ond</w>
id ity</w>
A r
tissu es</w>
over all</w>
w o
sensi tive</w>
in dependent</w>
indic ated</w>
s l
y s</w>
fi eld</w>
A D
app ear
pul monary</w>
trans f
par t</w>
dis orders</w>
r y
u e</w>
8 -
dom in
rel ative</w>
pl ay</w>
ad ju
m en</w>
s .</w>
inter action</w>
analy ses</w>
v acc
o red</w>
ev en</w>
inter vention</w>
R NA
meth yl
wh ere</w>
w ent</w>
neur ons</w>
ol s</w>
in tra
ra m</w>
feren ce</w>
in dex</w>
y oun
cor related</w>
post -
cal cul
mal ign
ol ution</w>
of ten</w>
individ ual</w>
sequ ences</w>
o ti
t ation</w>
ne ed</w>
or b
is ed</w>
at ors</w>
character ized</w>
r ing</w>
mo use</w>
ter n</w>
fem ale</w>
sig n</w>
m ade</w>
sec ond
led ge</w>
complet e</w>
P s</w>
contro lled</w>
h ep
immun o
impro ve</w>
00 0</w>
under went</w>
7 0</w>
br al</w>
appro xim
at eral</w>
n et
I L-
B M
en ergy</w>
proced ure</w>
s our
o p</w>
dens ity</w>
b ri
le ast</w>
vir al</w>
iz ing</w>
sc ore</w>
particip ants</w>
tu red</w>
the re
aver age</w>
am oun
N o</w>
2 2</w>
diagnos tic</w>
o m</w>
o tic</w>
ro p
amin o</w>
R -
s co
str ains</w>
pat tern</w>
V -
ocyt e</w>
G F
pattern s</w>
demonstr ate</w>
anti body</w>
b or
se par
p rec
ud e</w>
u sion</w>
radi ation</w>
bi ological</w>
initi al</w>
ste red</w>
enh anced</w>
pa ren
ob jec
b ur
si x</w>
ati n</w>
ke y</w>
ven ess</w>
D -
ad he
ox ide</w>
te red</w>
techniqu es</w>
enc ed</w>
regi ons</w>
succ ess
obser v
i an</w>
ati vely</w>
reg ar
gh t</w>
or -
ver sus</w>
occur red</w>
cor ding</w>
g iven</w>
it es</w>
cl os
m ight</w>
test s</w>
pot enti
i .
ir atory</w>
temper ature</w>
ag ents</w>
co h
appl ied</w>
phosph or
insul in</w>
om as</w>
si l
abl es</w>
re mo
id ne
combin ed</w>
mo der
end oth
rel i
cor onary</w>
adul ts</w>
19 9
ur ther
centr al</w>
A t</w>
P h
u ally</w>
al es</w>
S E
ev ed</w>
1 3
urther more</w>
poin t</w>
al low
mi x
are as</w>
an ds</w>
ev ents</w>
ful ly</w>
P E
long- term</w>
cul ture</w>
ros s</w>
ex erc
P ar
su m
on t
min im
activ ated</w>
t ol
low -
sh or
s ocial</w>
m id
tr ial</w>
gre es</w>
er -
re pe
inhib ited</w>
e duc
th al
d -
process es</w>
gu id
n er</w>
behavi or</w>
struc tural</w>
sign aling</w>
b ir
loc al</w>
pap er</w>
se en</w>
leng th</w>
ut es</w>
P T
oc y
coll ected</w>
str y</w>
know ledge</w>
discus sed</w>
infec ted</w>
och ond
v s.</w>
spec tr
lim ited</w>
lin es</w>
struc tures</w>
de grees</w>
F urthermore</w>
the m</w>
peri ph
S D</w>
s em
prolifer ation</w>
w id
spec tro
I II</w>
l y
ventr icular</w>
er ing</w>
erg ic</w>
di men
l it
k en</w>
par t
inhibit or</w>
compo unds</w>
wo uld</w>
ne ed
1 ,
de sign
compar ison</w>
in e
ch arg
rec ent</w>
resul ted</w>
use ful</w>
cor rec
P A</w>
th yro
su per
ay ed</w>
practi ce</w>
inter actions</w>
se g
t op
qu e</w>
D is
w ide</w>
ast ro
U sing</w>
re main
reg ression</w>
k idne
go od</w>
un it</w>
oph ag
form s</w>
confir med</w>
revie w
il d</w>
cros s-
cr iter
A R
suggest ed</w>
tech n
co hor
or ption</w>
ut ure</w>
au th
intes tinal</w>
fol d</w>
tr aining</w>
s w
ch ain</w>
hist ory</w>
d uration</w>
incre ases</w>
ec tomy</w>
defin ed</w>
mag ne
nor mal
bacter ial</w>
tri als</w>
m ig
de v
re pres
m el
r ight</w>
c ogni
1 4
n ur
meas ures</w>
is tic</w>
tr as
o vascular</w>
plas m
2 8</w>
medi an</w>
st re
2 3</w>
7 -
underst anding</w>
injec tion</w>
an al
c ou
pan cre
applic ation</w>
ac ross</w>
suggest s</w>
m ation</w>
D e
bas eline</w>
ch o
P L
experim ents</w>
sco res</w>
t ow
scre ening</w>
selec ted</w>
p H</w>
nec ess
ul ated</w>
ati on-
- old</w>
ner ve</w>
al coh
l ay
o v
3 5</w>
pepti de</w>
0.0 1</w>
S ur
establ ished</w>
ar ds</w>
e red</w>
ur ine</w>
re comm
at a</w>
im plic
approxim ately</w>
Tw o</w>
o in
d ra
os cop
pro posed</w>
PC R</w>
ur s</w>
sub sequ
acc um
h ar
d oc
previ ous</w>
metabol ism</w>
bi om
5 3</w>
sugg esting</w>
Th us</w>
om y</w>
7 5</w>
ter i
func tions</w>
consi der
I L
fluo resc
n u
pro por
p ow
st ro
dam age</w>
esti on
s o
r im
emb ry
C o
ra y</w>
ex t</w>
ep t</w>
second ary</w>
mut ations</w>
vers ity</w>
He al
my ocardi
diagnos ed</w>
id es</w>
gl ut
ch ed</w>
pa ir</w>
cap ac
s et
con clud
str ain</w>
periph eral</w>
ad ap
al tern
measure ments</w>
examin ation</w>
quanti t
P D</w>
is chem
E S</w>
gl y
i sion</w>
dis order</w>
C lin
p i
differenti ation</w>
fib r
rel ev
pop ulations</w>
form ed</w>
C T
pro gram
l l</w>
l or
post operative</w>
st able</w>
es pec
y i
o z
metabol ic</w>
ac ids</w>
ess ential</w>
sc ale</w>
or i
espec ially</w>
Th e
d ou
al one</w>
ic ro
d on
p ite</w>
arti cle</w>
mit ochond
provid es</w>
compon ents</w>
0 1</w>
ga str
compl ex
ai ly</w>
distin c
infec tions</w>
r are</w>
v it
mo l</w>
do es</w>
venti onal</w>
cri tical</w>
alph a-
sub str
vis ual</w>
Wh en</w>
- based</w>
T R
apopto sis</w>
pregn ancy</w>
exerc ise</w>
H -
b u
an e</w>
B i
ar c
t esting</w>
th us</w>
cir c
b asis</w>
bi op
1 5
de sign</w>
requ i
cour se</w>
a or
d o</w>
th i
pro bl
4 5</w>
fac il
enc ing</w>
b al
th re
le ar
HI V</w>
fr ag
st ar
resi du
ac cording</w>
sti ll</w>
ul arly</w>
ad s</w>
sol ution</w>
1 6
experi ence</w>
effici ent</w>
S P
tra um
re fl
criter ia</w>
el ing</w>
ho urs</w>
calc ium</w>
le ad</w>
resist ant</w>
sen s
anti gen</w>
ser ies</w>
On e</w>
aff ect</w>
2 7</w>
dic al</w>
dom ain</w>
Q u
strateg ies</w>
impro vement</w>
4 8</w>
am pl
2 6</w>
T N
st ability</w>
on set</w>
cor respon
diff icul
addi tional</w>
g lob
ent er</w>
estion n
in si
m es
l ong</w>
di g
s ex
de g
ut aneous</w>
og n
sc i
appro pri
path ways</w>
cogni tive</w>
resp iratory</w>
medi ate</w>
em plo
re ma
cl er
or ity</w>
to -
e b
rap id</w>
rema ins</w>
3 1</w>
ol der</w>
d aily</w>
M eth
ve red</w>
chol ester
cl ear</w>
scop ic</w>
inhibit ors</w>
up take</w>
eri or</w>
describ e</w>
cohor t</w>
r ine</w>
o ple</w>
P S</w>
lab or
M D
3 2</w>
d ri
f uture</w>
reduc e</w>
3 6</w>
str ong
tol er
t ent</w>
kidne y</w>
abs ence</w>
1 8
cy cle</w>
oxy gen</w>
us t</w>
deli very</w>
pro mis
g i
ific ation</w>
st ed</w>
I F
ne l</w>
ten sive</w>
gr ade</w>
my el
al though</w>
con ver
produc ts</w>
molec ules</w>
dos es</w>
sol u
m am
plac ement</w>
lin ked</w>
sp inal</w>
consist ent</w>
t as
provid ed</w>
ant agon
recomm end
O f</w>
transcrip tion</w>
ach es</w>
ther s</w>
o si
b ar
W ith</w>
ac coun
I I
in duction</w>
de grad
U R
import ance</w>
random ized</w>
is su
prog ression</w>
om er
s pl
expos ed</w>
po or</w>
im ens</w>
proced ures</w>
al g
chem otherapy</w>
b ial</w>
t y-
ol esc
admini stered</w>
er y
inter val</w>
lip id</w>
v s</w>
wee k</w>
ogen ous</w>
g ran
deg ree</w>
flu id</w>
C s</w>
s le
lin ear</w>
conc er
th ir
hyper tension</w>
en ting</w>
youn g</w>
l ying</w>
og ether</w>
regul ated</w>
resul ting</w>
de pression</w>
n ot
og en</w>
pri or</w>
plat el
B oth</w>
en co
M R</w>
Ch in
nucle ar</w>
ren g
P D
ul tras
elev ated</w>
physi ological</w>
environ ment</w>
Heal th</w>
probl ems</w>
capac ity</w>
mar kers</w>
u ter
in tro
l ation</w>
O n</w>
3 7</w>
f at
reco very</w>
pre par
condi tion</w>
transp ort</w>
compon ent</w>
fo od</w>
ib le</w>
G en
electr on</w>
G F</w>
nat ural</w>
mech an
hep at
anti gen
e ds</w>
ac e</w>
C S
trans fer
T ran
sign al</w>
pos si
pe ople</w>
i ting</w>
In ter
il s</w>
in e-
hepati c</w>
Th ere
3 8</w>
at t
it on
3 4</w>
M ore
achi eved</w>
R A
- 2</w>
pre v
O S</w>
er ity</w>
se x</w>
ta ken</w>
r ib
d en
suff ici
epith elial</w>
defici ency</w>
More over</w>
w ell
al ter
pre -
secre tion</w>
di et</w>
a er
arter ial</w>
tox icity</w>
en ter
gro und</w>
MR I</w>
partic ularly</w>
cat aly
inva sive</w>
r ation</w>
in ity</w>
ast s</w>
inflam mation</w>
ne w
3 3</w>
S er
s om
ne um
medi um</w>
x i
cr yst
chrom at
pur pose</w>
2 9</w>
p ut</w>
st reng
l ed</w>
sup pl
am ide</w>
id ine</w>
al k
fic ial</w>
ann ing</w>
saf ety</w>
magne tic</w>
fam il
fi x
vari ables</w>
tr ig
gastr ic</w>
system ic</w>
o ids</w>
mut ation</w>
cardi ovascular</w>
necess ary</w>
myocardi al</w>
mac roph
6 5</w>
0. 9
c epti
stimul ated</w>
ip s</w>
val ent</w>
endoth elial</w>
modi fied</w>
con ventional</w>
ad verse</w>
termin al</w>
teri or</w>
polym er
appropri ate</w>
co -
si a</w>
ex amine</w>
or ies</w>
o id
cere bral</w>
G rou
yl -
b ul
RNA s</w>
anti bio
re ver
t able</w>
coun tr
e tics</w>
f un
de n</w>
e .</w>
need ed</w>
specific ity</w>
pro toc
statis tically</w>
org anis
There fore</w>
C H
transpl antation</w>
su mp
odi um</w>
St ud
vie w</w>
p al
am eter</w>
transf er</w>
stro ke</w>
cl ass</w>
m em
recor ded</w>
selec tive</w>
re stric
quantit ative</w>
et ed</w>
eri als</w>
loc ation</w>
ill ary</w>
poly morph
on ucle
prog ram</w>
b enz
T re
year -old</w>
am in</w>
ca uses</w>
P R
mod ul
lac k</w>
mot or</w>
j unc
F in
ati c
col i</w>
ol ar</w>
includ e</w>
cl e
monit oring</w>
is o
e tion</w>
ti veness</w>
val id
direc tly</w>
ic an</w>
os ome</w>
ab dom
vari ation</w>
em entation</w>
j oin
eph al
aim ed</w>
opath y</w>
d ate</w>
ad olesc
intr av
carri ed</w>
e ight</w>
l -
fe w</w>
ent -
un its</w>
sev erity</w>
calcul ated</w>
sus cepti
venti ons</w>
hormon e</w>
as p
tem por
high est</w>
diab etic</w>
partic ular</w>
t a</w>
p ig
up on</w>
fi t</w>
there fore</w>
b el
og lob
devel op</w>
S .</w>
regar ding</w>
TI ON</w>
t e</w>
ur b
rec ogn
om y
19 8
identi fication</w>
2 ,
distinc t</w>
st -
ac qu
lat eral</w>
1 7
I -
o w</w>
tre m
estim ated</w>
B P</w>
l ast</w>
on omic</w>
L D
bacter ia</w>
cor por
ic ation</w>
C .</w>
dow n
4 2</w>
l a
meas ure</w>
inf ants</w>
sim ple</w>
malign ant</w>
h ost</w>
B -
ad d
li qu
ch lor
V E
tion ing</w>
z ation</w>
Ca 2</w>
under lying</w>
phosph ate</w>
er gen
fib ro
res on
re pair</w>
amoun t</w>
physi ci
res sive</w>
or d
tion ally</w>
ar r
ter ms</w>
otyp es</w>
an terior</w>
te x</w>
throm b
qu estionn
A mon
ir e</w>
0. 8
ar ch</w>
anim al</w>
N C
t ogether</w>
a qu
relev ant</w>
cholester ol</w>
r ab
res h
d op
environ mental</w>
ho od</w>
A D</w>
appro aches</w>
treat ments</w>
H y
in ated</w>
pl ant</w>
D uring</w>
enzym es</w>
ag e-
pl ing</w>
dys function</w>
as pec
cur ren
l ec
ne o
g li
ometr ic</w>
C N
4 4</w>
se p
th ic
oper ation</w>
ac ts</w>
str ong</w>
Amon g</w>
0. 5</w>
A T</w>
M ul
rec tal</w>
mon th</w>
ha ving</w>
p neum
rel ation</w>
review ed</w>
osom al</w>
ag ent</w>
c m</w>
ip p
develop ing</w>
relati vely</w>
mut ant</w>
ad ren
occ ur</w>
i. e.</w>
commun ity</w>
S ev
surve y</w>
arti cles</w>
p en
n g</w>
ri x</w>
muc h</w>
plic ation</w>
intrac ellular</w>
maxim um</w>
all el
ri tis</w>
exhib ited</w>
on e-
i stry</w>
H R</w>
indic ating</w>
m an</w>
yc in</w>
ar ch
measure ment</w>
accur acy</w>
per fusion</w>
pre vention</w>
appear s</w>
A P
metr y</w>
sev en</w>
X -
con st
S ub
design ed</w>
sul f
ph yl
process ing</w>
Clin ical</w>
inter ventions</w>
v ical</w>
strateg y</w>
c rip
stud ents</w>
comp are</w>
S H</w>
s atis
ab normal
subsequ ent</w>
mal es</w>
C l
s odium</w>
emplo y
he ad</w>
p ac
le ading</w>
frequ ently</w>
en sive</w>
altern ative</w>
pre ven
at e-
s ity</w>
vie w
micro scopy</w>
sump tion</w>
facil it
o od</w>
M M
educ ation</w>
di atric</w>
invol vement</w>
re x
nit ro
E D</w>
fem ales</w>
hy bri
contrib ute</w>
s pati
Grou p</w>
ometr y</w>
in take</w>
effec tiveness</w>
main ly</w>
dimen sional</w>
l ate</w>
adv anced</w>
v en</w>
thesi zed</w>
G -
um -
al ong</w>
labor atory</w>
sp e
os a</w>
gener ated</w>
tr ation</w>
c y</w>
enc ies</w>
pro spective</w>
rec ently</w>
ru p
me ans</w>
accum ulation</w>
m L</w>
inf arc
impa ir
ner v
lit tle</w>
ep tion</w>
ex tent</w>
me -
pea k</w>
O R
bir th</w>
R eg
a de
P er
perc ent
es ophag
A mer
inhibit ory</w>
vi sion</w>
ne u
der iv
air e</w>
ro w</w>
f at</w>
sh if
fr action</w>
ax is</w>
n s</w>
SI G
re construc
b le
olog ically</w>
poin ts</w>
b est</w>
g astro
v ar
conf idence</w>
on tal</w>
at tr
P UR
G F-
sle ep</w>
e ting</w>
4 3</w>
hel p</w>
auth ors</w>
s per
s of
tw o-
inten sity</w>
to ol</w>
an es
PUR PO
asi c</w>
sour ce</w>
lear ning</w>
vari ate</w>
go ing</w>
A u
th em
net work</w>
sh ap
mel an
pa rent</w>
ur inary</w>
coll ag
op o
pro p
objec tive</w>
oph il
PURPO SE</w>
ot rop
im ages</w>
rou s</w>
mater ial</w>
subst anti
ol ig
in corpor
A p
c anc
a k</w>
A b
effici ency</w>
inc ub
D ata</w>
selec tion</w>
e ti
alcoh ol</w>
adv ant
as th
og s</w>
com mon
per sist
hist o
re tin
5 5</w>
gn os
well -
regul atory</w>
C ol
sy m
bac k</w>
throu gh
vari able</w>
com position</w>
tu al</w>
le m</w>
ar b
sh ort</w>
mit ted</w>
B y</w>
et ary</w>
sin ce</w>
L I
ell a</w>
am e</w>
mem ory</w>
cor tex</w>
ass ays</w>
moder ate</w>
aff inity</w>
no w</w>
S i
re st
s qu
mat ure</w>
show s</w>
mat rix</w>
hypo thesis</w>
in d
res ection</w>
t y
cul tures</w>
w ar
inter nal</w>
7 2</w>
pro fil
hydrox y
or ph
repor ts</w>
id -
mitochond rial</w>
charg e</w>
kn ess</w>
oc l
ne on
isol ates</w>
f av
u tive</w>
um er
k er</w>
ade qu
reson ance</w>
w all</w>
Stud y</w>
re produc
es tion</w>
predic ted</w>
ha em
trac t</w>
correspon ding</w>
applic ations</w>
op en</w>
remain ed</w>
el ed</w>
oti de</w>
N or
col on
investig ation</w>
sing le-
i e
hem at
oxid ative</w>
it ary</w>
le sion</w>
C or
phosphor ylation</w>
k ground</w>
p yr
ic a</w>
fat ty</w>
thyro id</w>
f etal</w>
em ic</w>
se ud
Mul ti
protec tive</w>
syn ap
res olution</w>
optim al</w>
trans mission</w>
mor b
ig n</w>
prob lem</w>
U S</w>
dem ic</w>
re actions</w>
ati ves</w>
I V</w>
c -
ar th
l ater</w>
carb on</w>
con nec
aor tic</w>
S M
mechan ical</w>
ar ity</w>
sp ont
cat eg
asi a</w>
ab o
9 -
r al</w>
st ages</w>
s mal
O 2</w>
ex trem
pro xim
or ation</w>
C a</w>
G l
wor l
dat ab
an ol</w>
en ous</w>
lac t
ER I
ing ly</w>
h and</w>
an at
S S</w>
exp ected</w>
uni que</w>
nu tri
al b
prog nosis</w>
C I
3 9</w>
i -
Tre at
abdom inal</w>
ch ing</w>
mus t</w>
organ ic</w>
el etal</w>
vari ety</w>
oc k</w>
T A
com e</w>
recur rence</w>
complex es</w>
i on
hy th
plas tic</w>
b ound</w>
gam ma</w>
gnos tic</w>
ap pe
de ta
em ergen
clin ically</w>
g -
un known</w>
gen ic</w>
T r
pl ants</w>
cer vical</w>
respon sible</w>
p h</w>
pro st
induc e</w>
ad der</w>
sch o
2. 5</w>
prof es
larg er</w>
ar yn
der ly</w>
l igh
B ased</w>
retro spective</w>
prof ile</w>
spec imens</w>
aut o
as ym
lay er</w>
um in
c ost</w>
tend ed</w>
y g
publ ic</w>
4 1</w>
ch an
t ory</w>
l ys
ap pea
fun g
appea red</w>
streng th</w>
f ying</w>
pres sive</w>
enh anc
ari ly</w>
thir d</w>
re as
li po
degrad ation</w>
agg reg
er ro
S T</w>
H B
serv ices</w>
ou th</w>
ste p</w>
cyt otox
vit amin</w>
perc ent</w>
smo king</w>
parti al</w>
substr ate</w>
dynam ics</w>
tom ography</w>
s at
c u
cul tured</w>
strong ly</w>
l ap
tro ph
gen ome</w>
ro w
eth yl
wh ole</w>
success ful</w>
extrac ellular</w>
atten tion</w>
st aining</w>
F or
re ad
P P
C M
lo ro
ch ild</w>
m entation</w>
6 7</w>
propor tion</w>
g el</w>
M AT
percent age</w>
ester n</w>
under going</w>
common ly</w>
maj ority</w>
recei ving</w>
ne ural</w>
al lo
i ous</w>
C A</w>
SIG N</w>
An ti
produc t</w>
re ference</w>
Di ff
di sp
con sumption</w>
loc ated</w>
liqu id</w>
countr ies</w>
signific ance</w>
es ity</w>
o vari
L e
4 6</w>
tern al</w>
publ ished</w>
pro state</w>
in ce</w>
P M
or rh
- type</w>
on ch
cer tain</w>
biop sy</w>
produc e</w>
simul t
- related</w>
em o
DE SIGN</w>
OBJECTIV ES</w>
ven ous</w>
ra ther</w>
mo tion</w>
a b</w>
z ing</w>
0. 7
di tional</w>
em erg
Treat ment</w>
M o
4 9</w>
F urther</w>
an xi
d y
oxid ation</w>
t ren
pre domin
S A
ex am
chem istry</w>
pl ays</w>
remo val</w>
dynam ic</w>
k er
Com par
mig ration</w>
e ve</w>
doc um
M et
al tered</w>
lymph ocytes</w>
as c
ide mi
S im
pl ast
An alysis</w>
ul in</w>
ec ting</w>
ti t
a w
we igh
resi d
divid ed</w>
E M
The y</w>
ob struc
p on
O b
f ish</w>
mat erials</w>
residu es</w>
Th ree</w>
mater nal</w>
atten u
D es
gly co
continu ous</w>
pepti des</w>
pre pared</w>
Meth ods</w>
press ing</w>
5 6</w>
e m</w>
pl asia</w>
S pec
ane ously</w>
re active</w>
cor tical</w>
th or
5 2</w>
cor e</w>
spec i
hepati tis</w>
abo ve</w>
S y
S O
st ained</w>
b en
prev ent</w>
occur s</w>
bl adder</w>
H g</w>
man if
neuro log
long er</w>
C P
pro jec
el derly</w>
post erior</w>
rec ip
a ir</w>
up per</w>
neur onal</w>
st er</w>
H R
con trac
E N
morb idity</w>
rec ru
4 7</w>
ogni tion</w>
M y
e .
H D
om es</w>
v ation</w>
id al</w>
abnormal ities</w>
inf usion</w>
bas al</w>
foc us</w>
pl ed</w>
pur ified</w>
os yn
b ase</w>
hum ans</w>
A N
tempor al</w>
k es</w>
S p
tub er
MAT ERI
ver s</w>
chan nel</w>
ti co
pancre atic</w>
invol ving</w>
emb er</w>
re combin
ob ic</w>
ap h
pow er</w>
ar cin
ol ip
fl ex
n ational</w>
oc k
gen ital</w>
C B
Im mun
mark er</w>
B ac
potenti ally</w>
ag re
mat ched</w>
H L
pro gnostic</w>
s ph
eb o</w>
y et</w>
chrom osome</w>
micro M</w>
tem p
th resh
or ith
membran es</w>
con sec
cler osis</w>
acet yl
ti al</w>
Wh ile</w>
an th
fer red</w>
H P
si vely</w>
pr inc
5 4</w>
plasm ic</w>
ju g
g er</w>
el ines</w>
aspec ts</w>
heter ogene
complet ed</w>
man ner</w>
phen otype</w>
ab normal</w>
bar ri
sub stitu
path ogenesis</w>
cell -
system atic</w>
r am
inter pre
res our
n ature</w>
ve si
promot er</w>
d enti
fluoresc ence</w>
plast y</w>
differenti al</w>
M I
it able</w>
6 4</w>
ro les</w>
cont act</w>
v ul
6 2</w>
O -
in ser
plac ebo</w>
S N
F rom</w>
reduc ing</w>
g est
abs orption</w>
relationsh ips</w>
, 000</w>
B e
alter ations</w>
bec ome</w>
qu al
n ed</w>
throm bo
v ements</w>
ach ed</w>
spati al</w>
implic ations</w>
od ynam
os ine</w>
ar com
us ually</w>
frequ ent</w>
. 00
20 0</w>
dis co
fe eding</w>
cor d</w>
1. 5</w>
kin etics</w>
V I
join t</w>
h ere</w>
as al</w>
mil d</w>
di etary</w>
e f</w>
suffici ent</w>
for ce</w>
pro long
5 1</w>
ser ved</w>
til ity</w>
arth ritis</w>
appe ar</w>
de -
ery thro
nucle us</w>
op e</w>
attr ib
s in</w>
ass es</w>
g .</w>
sec tion</w>
re -
alg orith
M ost</w>
om en
las er</w>
us al</w>
determin ation</w>
curren tly</w>
questionn aire</w>
predic tive</w>
biom ar
challeng e</w>
im age</w>
chang ed</w>
pre h
con clusion</w>
1. 0
bene fit</w>
character ization</w>
te en</w>
o ve
O ver
fibro bl
conclud e</w>
ev id
v ec
is ting</w>
classi fication</w>
tas k</w>
L i
S C</w>
protoc ol</w>
AL S</w>
ep id
ed -
plac e</w>
collag en</w>
orig in</w>
chromat ography</w>
str um
osom es</w>
con stitu
A S</w>
s on</w>
detec t</w>
inte rest</w>
ell ing</w>
app ing</w>
ipp oc
ac char
wid ely</w>
id ly</w>
em ph
& amp
&amp ;</w>
n ine</w>
parti cles</w>
it ud
ir on</w>
ar s</w>
ne ut
olog ies</w>
olog ous</w>
ob esity</w>
psych i
medic ine</w>
H D</w>
sec tional</w>
difficul t</w>
P G
pol ar
d or
P K
li ving</w>
is ing</w>
acc ess</w>
str i
g raph
promis ing</w>
metast asis</w>
sex ual</w>
glob al</w>
IN T
v ity</w>
if or
lym ph</w>
E uro
6 3</w>
f ed</w>
end oscop
ev ol
plac ed</w>
co ag
p -
l yc
ippoc amp
D ec
st abil
as h
w ard</w>
su peri
tiv es</w>
de x
traum a</w>
pot ent</w>
t on</w>
el ements</w>
tr yp
m M</w>
10 -
protec tion</w>
P I
t el
si on
6 8</w>
n umer
ent y-
macroph ages</w>
at temp
platel et</w>
or th
th ym
5 8</w>
tow ard</w>
en ro
ne ph
0. 1</w>
ev olution</w>
molec ule</w>
impa ired</w>
rec ognition</w>
s ess
success fully</w>
S L
g er
t ob
le ads</w>
wor ks</w>
impair ment</w>
transi tion</w>
sp ace</w>
U C
complet ely</w>
adju sted</w>
acc ept
d ogs</w>
consec utive</w>
sti t
do m</w>
ovari an</w>
spec tively</w>
polymer ase</w>
ach ing</w>
neu tr
behavi oral</w>
. 0
di ameter</w>
ar m</w>
ex ternal</w>
β -
recur rent</w>
e f
b ut
M T
predic t</w>
occ us</w>
ey e</w>
thesi a</w>
aro und</w>
vas cul
A fr
tum our</w>
mar row</w>
dos e-
it y-
gra ft</w>
medi a</w>
sus p
vir uses</w>
requi res</w>
A P</w>
ap s</w>
5 7</w>
lo ad</w>
y cl
ep il
occur rence</w>
wh ite</w>
ti l</w>
nan op
U ni
can di
pos ite</w>
h ex
comp an
recombin ant</w>
yi el
e. g.</w>
n m</w>
Diff eren
ma king</w>
pa ir
comp ut
Des pite</w>
8 5</w>
memb ers</w>
statis tical</w>
gra f
c utaneous</w>
pl us</w>
P C</w>
on c
f al
ec onomic</w>
i i</w>
dom ains</w>
gen ase</w>
kin es</w>
gener ally</w>
dow n</w>
el ium</w>
b ile</w>
S R
ver te
5 9</w>
sh e
Ne w</w>
iton eal</w>
g in
est ro
M icro
h ippocamp
op en
ul a</w>
compar able</w>
N a</w>
rap idly</w>
S tr
sequ encing</w>
infarc tion</w>
l and
D M</w>
through out</w>
clu sions</w>
gen der</w>
const ant</w>
Fin ally</w>
k ne
E .</w>
6 6</w>
set ting</w>
el im
cont ext</w>
kin etic</w>
p y
H ospit
e ous</w>
SC s</w>
bio chemical</w>
in strum
ac r
o ked</w>
ad j
ac ting</w>
Eff ects</w>
psych ological</w>
stre am</w>
sign s</w>
ic le</w>
vacc ine</w>
mod eling</w>
re main</w>
in d</w>
fac es</w>
spectr um</w>
ent ary</w>
disc rim
O r
lu o
profil es</w>
metast atic</w>
IL -1
antigen s</w>
v ag
ne eds</w>
canc ers</w>
P hy
n itr
compo und</w>
saf e</w>
adequ ate</w>
solu ble</w>
c enter</w>
injur ies</w>
i si
AT P</w>
associ ations</w>
asth ma</w>
expl ore</w>
dra w
N O</w>
od ds</w>
el ic
m ia</w>
targ ets</w>
dou b
h ol
accur ate</w>
an -
ex isting</w>
ocl onal</w>
ran ial</w>
i ons</w>
respec t</w>
ib r
ol -
r he
anxi ety</w>
chr on
oc ular</w>
C C</w>
br onch
pe diatric</w>
um in</w>
form ing</w>
guid elines</w>
develop mental</w>
il i
diff er</w>
ed ly</w>
p tom
st ates</w>
mix ed</w>
S yn
tuber cul
m as
thal am
ra z
K -
cl on
characteris tic</w>
ey es</w>
dev ice</w>
mar ked</w>
anc ies</w>
re tinal</w>
P r
f its</w>
vari ability</w>
hypo x
st res
Eff ect</w>
thor ac
qu in
def ects</w>
s es
org an</w>
experi enced</w>
B ec
fac ial</w>
C an
famil ies</w>
yl ated</w>
frac ture</w>
re present</w>
r s</w>
organis ms</w>
comp uted</w>
E R</w>
ischem ic</w>
ultras ound</w>
D a</w>
pneum on
wh at</w>
ep is
ac u
w ild
ble eding</w>
l er</w>
lab eled</w>
o rectal</w>
targ eted</w>
program s</w>
tic ular</w>
al ine</w>
st en
co sts</w>
min utes</w>
sign als</w>
not ed</w>
an other</w>
acti n</w>
manif est
D I
al low</w>
therap ies</w>
ro ti
met al</w>
ch ic
nec k</w>
T L
leuk emia</w>
pres entation</w>
aryn g
allow s</w>
b on
dist al</w>
path ological</w>
specific ally</w>
toler ance</w>
N S
E -
7 3</w>
nec rosis</w>
intrav enous</w>
phen omen
ex tr
com pe
thic kness</w>
al most</w>
ch ann
h ab
6 1</w>
d ental</w>
S ince</w>
superi or</w>
nerv ous</w>
spont aneous</w>
com preh
fin ding</w>
L .</w>
inhib it</w>
ich ia</w>
gram s</w>
di an</w>
b asic</w>
extrac tion</w>
phot o
morph ology</w>
pres er
n ic
prob ably</w>
syn th
observ ations</w>
sub unit</w>
employ ed</w>
adhe sion</w>
suscepti bility</w>
p ast</w>
S h
con jug
oxid ase</w>
ab und
lap aro
rati os</w>
r ich
con tained</w>
c ed</w>
recommend ed</w>
p ut
soci ation</w>
ap parent</w>
J ap
wor k
int act</w>
numb ers</w>
transp or
oxid ant</w>
mid d
rang ed</w>
tic ip
bi t</w>
cir cul
6 9</w>
at er
ob l
prepar ation</w>
k ine</w>
accoun t</w>
tain s</w>
cont amin
ab or
b eli
C D</w>
ar y
ch loro
pres s</w>
com pr
bor n</w>
oc arcin
hal f</w>
s ha
C l</w>
ane ur
sit u</w>
n am
transfer ase</w>
ogen etic</w>
M P
gre at
uc id
il ed</w>
y lo
hy dr
tow ards</w>
a ther
at rial</w>
ep idemi
adolesc ents</w>
7 8</w>
3 ,
indic ates</w>
ove rex
R A</w>
end ogenous</w>
pol ic
C F
fib rosis</w>
atic ally</w>
aneur ys
- 0.
t un
em ented</w>
P .</w>
enc ephal
ec tive</w>
Chin ese</w>
cel er
epil ep
ph ore
3 0
di versity</w>
H um
as sist
in stitu
Amer ican</w>
mam m
discus s</w>
mo vement</w>
ro ot</w>
bal ance</w>
ther mal</w>
vol un
des pite</w>
ther n</w>
meth od
sour ces</w>
per me
s on
tra ditional</w>
succ ess</w>
bo v
metr ic</w>
oly tic</w>
g on
sit u
se arch</w>
op tical</w>
reconstruc tion</w>
glut am
t or
yi eld</w>
underst and</w>
loc alization</w>
A .</w>
techn ology</w>
depend ently</w>
e str
fin al</w>
ty ros
- specific</w>
op i
esophag eal</w>
recogn ized</w>
5 0
vari ants</w>
c all
the ory</w>
un til</w>
B C</w>
1 0.
prolong ed</w>
m ing</w>
n -
mo de</w>
R ev
M -
thre e-
ch ym
E sch
radi o
CD 4</w>
en si
ph il
pre operative</w>
immun os
oph ysi
E p
Ad di
cr uc
cyt es</w>
mon oclonal</w>
emergen cy</w>
c en
Esch er
C S</w>
chann els</w>
gl and</w>
physici ans</w>
e di
requ ire</w>
nur sing</w>
estim ate</w>
r e</w>
wa ve</w>
E D
Escher ichia</w>
ac k</w>
ti me-
V A</w>
AM P</w>
defici ent</w>
7 1</w>
i ve</w>
oc om
ma ke</w>
k Da</w>
analy sed</w>
syn thesized</w>
st ep
random ly</w>
issu es</w>
par as
medic ation</w>
immuno histo
tr im
em is
ang li
or ts</w>
p el
bene fits</w>
extrac t</w>
bloc k</w>
neut roph
maxim al</w>
olec ular</w>
fr ame
des crip
ischem ia</w>
7 4</w>
of f</w>
targ eting</w>
an tim
ten ance</w>
H A</w>
P F
frac tures</w>
our s</w>
Hospit al</w>
enh ance</w>
of -
im en</w>
Un ited</w>
ar thro
1 1
C ancer</w>
oc or
ac compan
an ted</w>
T E
y e
inter fer
proxim al</w>
tox ic</w>
sch iz
end ing</w>
A A</w>
regi onal</w>
A L</w>
experim ent</w>
Th ir
Over all</w>
CS F</w>
appear ance</w>
J an
F ol
cross- sectional</w>
hem orrh
f re
re placement</w>
as sign
8 8</w>
k et
recur s
f ore
B r
g al
T B
pl ayed</w>
bil ateral</w>
complic ation</w>
inva sion</w>
fin d</w>
ei ved</w>
oph ren
distin gu
wh ose</w>
1 1.
us ual</w>
gen omic</w>
se iz
spectro scopy</w>
stimul i</w>
cal e</w>
requi re
ac celer
9 6</w>
ex pan
id en
ang u
cl ose</w>
no d
kne e</w>
R el
classi fied</w>
es tions</w>
MATERI ALS</w>
ap hy
ul ate</w>
syn thetic</w>
az ole</w>
se ems</w>
on in</w>
d one</w>
ve in</w>
mut ants</w>
cho ice</w>
ic in</w>
avail ability</w>
met a-
mo bil
7 6</w>
le t</w>
m ic</w>
foc al</w>
doub le-
prote in
so il</w>
del ayed</w>
R T</w>
al le
p recurs
depend ence</w>
F e
sk eletal</w>
N ational</w>
agre ement</w>
antagon ist</w>
injec ted</w>
psychi atric</w>
in ate</w>
ex cre
jec tion</w>
typ ical</w>
provid ing</w>
rel ap
P las
an a
S P</w>
co ord
hy p
equ i
P ost
ear li
ass emb
anal og
ev ery</w>
reli able</w>
cur ve</w>
possi bility</w>
itud inal</w>
Bec ause</w>
st or
O H</w>
F ac
ca th
os al</w>
initi ation</w>
neon atal</w>
a ine</w>
wild -type</w>
cyt os
end oc
ben ign</w>
U T
oglob in</w>
av age</w>
aut om
am b
E lec
g as</w>
prog ressive</w>
av es</w>
S ign
re plication</w>
a p</w>
u ary</w>
el ucid
path ology</w>
8 6</w>
7 7</w>
7 9</w>
lig and</w>
oper atively</w>
cell ent</w>
transi ent</w>
don or</w>
pregn ant</w>
conclud ed</w>
rel ax
k -
acti c</w>
ang le</w>
su itable</w>
grow ing</w>
recip i
micro grams</w>
ad ded</w>
metabol ites</w>
co ding</w>
Rec ent</w>
g radi
rou tine</w>
uc h</w>
main tenance</w>
ell ar</w>
s ou
on ate</w>
s al</w>
G T
k ary
pres enting</w>
en ic</w>
shor t-
D M
re f
inf il
is ation</w>
mil k</w>
H C</w>
h und
o il</w>
ex tensive</w>
un clear</w>
electro phore
mark edly</w>
it us</w>
v als</w>
z es</w>
ex ist
epis od
pro s
dist ance</w>
ex change</w>
a vi
ti ous</w>
lymph oma</w>
V -1</w>
fail ed</w>
cl ear
gran ul
transcrip tional</w>
se ts</w>
enro lled</w>
it ative</w>
en ed</w>
v ess
e ase</w>
l and</w>
R ep
re ly</w>
3 H</w>
observ ation</w>
no de</w>
gre at</w>
BM I</w>
thresh old</w>
n or</w>
ex ten
ill ness</w>
abil ities</w>
c ent
Ig G</w>
ha z
D ev
ot omy</w>
ir radiation</w>
vari ed</w>
ari a</w>
vi si
bov ine</w>
st ly</w>
r ich</w>
path y</w>
transpl ant</w>
ac t
sol id</w>
tin gs</w>
fac tion</w>
9 3</w>
to m</w>
prim arily</w>
eth anol</w>
oly sis</w>
hospit als</w>
phosph olip
enco ding</w>
port un
loc alized</w>
multi -
og ra
ver sion</w>
D O
gastro intestinal</w>
ogen s</w>
dis charge</w>
wor king</w>
vess els</w>
inter mediate</w>
compe ti
predic tion</w>
ex cellent</w>
Jan uary</w>
re tur
ch es</w>
pro mo
a rom
h ome</w>
nucle otide</w>
al is</w>
occur ring</w>
arcom a</w>
pol yp
antibio tic</w>
iden tical</w>
show ing</w>
S D
ar -
peri ods</w>
E C</w>
w al
gen e
synap tic</w>
C ur
sh ock</w>
C P</w>
b ly</w>
schiz ophren
col orectal</w>
metast ases</w>
u tions</w>
fib ers</w>
F A</w>
smal ler</w>
repe ated</w>
sens ory</w>
r ac
h ip</w>
commun ication</w>
he at</w>
induc es</w>
parti ally</w>
aim s</w>
challeng es</w>
vi ous</w>
pro pose</w>
de hydro
main tained</w>
A C</w>
cyto kines</w>
col on</w>
trans l
chol ine</w>
amoun ts</w>
ful l</w>
p seud
to ols</w>
minim al</w>
cycl ic</w>
phosph at
dev ices</w>
fol l
heal ing</w>
Pro te
Hum an</w>
cou pled</w>
vel oc
acqu ired</w>
H T</w>
g ain</w>
o thers</w>
1 3.
inter vals</w>
On ly</w>
r ho
8 4</w>
under g
val ve</w>
fluo ro
C R</w>
m urine</w>
0.00 01</w>
odynam ic</w>
promot e</w>
S ec
In cre
mal ian</w>
deriv atives</w>
M .</w>
C Y
ati on
behavi ors</w>
Me dic
sup pression</w>
1 2-
impl ementation</w>
h abil
us -
ris e</w>
smo oth</w>
Th er
g angli
ra dical</w>
exc ept</w>
TN F-
view s</w>
child hood</w>
er ic</w>
dist urb
p 53</w>
er r
chem o
conver sion</w>
contro ll
l ing</w>
roti d</w>
incub ation</w>
H igh
t ase</w>
nanop articles</w>
hist ological</w>
8 3</w>
extrac ted</w>
frame work</w>
in oc
fact ory</w>
serv ice</w>
shif t</w>
w ise</w>
8 2</w>
re al</w>
ad s
or ly</w>
tre at</w>
tubercul osis</w>
epid er
wor kers</w>
it ory</w>
sur ro
ri a</w>
9 8</w>
w ound</w>
St ates</w>
hy d
ar ies</w>
bel ow</w>
cor ne
ly sis</w>
a ud
mus cles</w>
adju v
W estern</w>
de pl
pro be</w>
es sive</w>
9 2</w>
dr in
Sev eral</w>
op portun
asp ir
b ular</w>
C r
emb ol
t ment</w>
datab ase</w>
recor ds</w>
9 9</w>
res ol
5 00</w>
en rich
an ine</w>
3 D</w>
pers on
in du
E valu
subjec t</w>
health care</w>
tyros ine</w>
U D
si an</w>
he re
di ed</w>
yl ase</w>
Ne uro
em p
inc id
m m
il ls</w>
oz yg
ul tra
foc used</w>
X- ray</w>
clos ely</w>
direc ted</w>
1. 0</w>
inten sive</w>
m arg
f ast</w>
p in
veloc ity</w>
produc ing</w>
ati tis</w>
dop amine</w>
st om
vari ations</w>
S I</w>
Chin a</w>
arter ies</w>
ill us</w>
E E
O F</w>
ear ing</w>
lat ter</w>
pers ons</w>
Con tro
achi eve</w>
n ative</w>
ocy tic</w>
est er</w>
- -
paren ts</w>
scho ol</w>
ex pressing</w>
ser ious</w>
o k</w>
impl antation</w>
tic ul
mat ter</w>
equ al</w>
vi ol
hybri di
trans formation</w>
an a</w>
analy ze</w>
2 50</w>
hyper tensive</w>
decre ases</w>
ser a</w>
extrac ts</w>
t al
air way</w>
in dependently</w>
ne ar</w>
D NA
c ent</w>
phen yl
compar ing</w>
nur ses</w>
if y</w>
ath s</w>
mam malian</w>
organ ization</w>
the ore
Ex perim
con genital</w>
anti oxidant</w>
pl ate</w>
st ers</w>
ad mission</w>
1 00
M an
influ enced</w>
comm erc
igh tly</w>
radi otherapy</w>
practi ces</w>
e a</w>
rab bit</w>
ow el</w>
ma -
hydro gen</w>
1 2.
ent ally</w>
ten tion</w>
C al
ar in</w>
b s</w>
seg ment</w>
b and</w>
perc eived</w>
G S</w>
as tic</w>
shap e</w>
uter ine</w>
remain ing</w>
rec tomy</w>
H ist
o ts</w>
9 4</w>
Sur g
E B
expl ored</w>
iz es</w>
N O
ocarcin oma</w>
aff ecting</w>
larg ely</w>
net works</w>
pl ex</w>
neurolog ical</w>
hund red</w>
op a
no v
morph ological</w>
om al
issu e</w>
In f
def ect</w>
mag nit
ex clud
P E</w>
cy s
lim b</w>
algorith m</w>
e- based</w>
as ting</w>
modi fication</w>
ev ent</w>
c is
8 9</w>
prote in-
gl omer
habil itation</w>
res er
melan oma</w>
solu tions</w>
impro ving</w>
compreh ensive</w>
alle l</w>
n a
IF N-
pro ved</w>
dem ographic</w>
cruc ial</w>
underst ood</w>
con tains</w>
A t
exhib it</w>
e de
sam pling</w>
4 ,
H z</w>
differenti ated</w>
tr iti
chlor ide</w>
m ol
it ations</w>
s ting</w>
fe ed
F our</w>
8 1</w>
il lu
sum mar
f ill
di verse</w>
wh om</w>
ad op
p p
8 7</w>
A R</w>
repres ents</w>
domin ant</w>
behavi our</w>
otyp ic</w>
Fol low
ris ks</w>
Tran s
ow n</w>
earli er</w>
fem oral</w>
res ting</w>
ye ast</w>
S ome</w>
stit ute</w>
enhanc ement</w>
circ um
surg e
substanti al</w>
F L
chrom e</w>
D R
N I
ab r
col um
antibio tics</w>
h ome
n ia</w>
sl ightly</w>
c ut
ran dom</w>
Com pared</w>
fr ontal</w>
sci enti
conc ept</w>
S cale</w>
electr onic</w>
- like</w>
con tain</w>
t ac
ob ese</w>
establ ish</w>
Me an</w>
predic tors</w>
pre g
om at
sec tions</w>
high ligh
Con clusion</w>
i od
N H
meas uring</w>
le th
satis faction</w>
stor age</w>
mod ulation</w>
con served</w>
meth ylation</w>
B .</w>
contrib ution</w>
osyn thesis</w>
ac in</w>
vis u
p il
posi tively</w>
de ep</w>
glyc er
ad es</w>
fi el
G AB
meth yl</w>
detec table</w>
Me dical</w>
reve al</w>
us ers</w>
ca re
9 7</w>
Uni versity</w>
c ad
expl ained</w>
bene ficial</w>
mi R-
sp re
1 4.
ex er
olog ists</w>
u es</w>
20 14</w>
E LI
ac ter</w>
enti a</w>
immun ity</w>
E T
RO D
and ed</w>
accompan ied</w>
dec line</w>
20 15</w>
an ese</w>
N a
i b</w>
M E</w>
ste re
add ress</w>
add res
fib er</w>
di ver
diff usion</w>
H 2
stand ardi
c DNA</w>
aff ects</w>
St udi
m er</w>
de part
worl d</w>
PA R
em bl
eng ine
C C
log istic</w>
f ar</w>
de hy
describ es</w>
fibrobl asts</w>
T yp
0. 2</w>
regul ate</w>
el op
k age</w>
spectro metry</w>
h am
org ans</w>
sup pressed</w>
can not</w>
O c
Ch ar
oc clusion</w>
clear ance</w>
ROD UC
con sequences</w>
sc anning</w>
immun ore
traum atic</w>
sy st
E 2</w>
bet a
alb umin</w>
se l</w>
new ly</w>
icro bial</w>
I CA
Ch ild
influ enz
INT RODUC
i pl
re activity</w>
9 1</w>
electr ical</w>
d a</w>
ac ted</w>
pul se</w>
consist ed</w>
F unc
im er</w>
INTRODUC TION</w>
multi variate</w>
allow ed</w>
lim it</w>
long itudinal</w>
e tr
vari ant</w>
integr ated</w>
it ude</w>
S al
effec tively</w>
epti de</w>
re verse</w>
Dev elop
oph osph
ar ray</w>
ath i
P ol
ost er
ster oid</w>
r ig
oun d
par allel</w>
f a
de vi
sten osis</w>
adjuv ant</w>
al ities</w>
ch est</w>
I s</w>
otrop ic</w>
respon si
fr actions</w>
adhe rence</w>
coun t</w>
roph y</w>
persist ent</w>
estim ates</w>
co ver
- dependent</w>
su stained</w>
N G</w>
ex tended</w>
gh ts</w>
M P</w>
bur den</w>
Bac kground</w>
magnit ude</w>
nor m
HC C</w>
az ol
Studi es</w>
assemb ly</w>
pro phyl
f it
3 00</w>
sel f</w>
an dro
ob tain</w>
ici ans</w>
se as
fix ation</w>
biomar kers</w>
cl early</w>
m ell
po orly</w>
ast er</w>
In te
advant ages</w>
yl ate</w>
Tw enty-
par ts</w>
ib ility</w>
st ay</w>
pl an
inhib its</w>
pl e
gen otype</w>
electr ic</w>
de si
rang ing</w>
f our
ap er
out put</w>
fac t</w>
substr ates</w>
suppor ted</w>
D el
P l
frag ment</w>
Addi tionally</w>
O ut
al dehy
separ ation</w>
ore s</w>
qu estions</w>
pres ents</w>
con serv
pit u
gener ative</w>
re al-
P ase</w>
c os
volun te
a wa
com it
dou ble</w>
press or</w>
expl ain</w>
x -
exam ple</w>
pair s</w>
rhe um
A g
20 16</w>
polymorph ism</w>
valid ated</w>
ampl itude</w>
infec tious</w>
dec ision</w>
ev oked</w>
h our</w>
ri um</w>
D A</w>
midd le</w>
assign ed</w>
is es</w>
a emia</w>
ex pec
ost asis</w>
l angu
n asal</w>
cap able</w>
ede ma</w>
pers onal</w>
fix ed</w>
z in
P B
docum ented</w>
func tioning</w>
determin ing</w>
le ts</w>
Sim il
As sess
nutri tion</w>
medi ately</w>
G A</w>
sh ip</w>
ather os
luo resc
4 0
mac ro
C V
ol ds</w>
ill ance</w>
thorac ic</w>
acet ate</w>
b owel</w>
S ch
pel v
princ i
A F
stimul us</w>
facilit ate</w>
mo ti
residu al</w>
mo thers</w>
W or
junc tion</w>
orig inal</w>
micro bial</w>
ot ens
N P</w>
impl ant</w>
cor d
Euro pe
per itoneal</w>
dep th</w>
intro duced</w>
end -
f et
C ell</w>
sensi ti
k ill
ul monary</w>
prolifer ative</w>
S S
al ve
epith elium</w>
embry onic</w>
anal ge
R S</w>
continu ed</w>
reproduc tive</w>
P V
O p
sur faces</w>
si c</w>
restric ted</w>
Compar ison</w>
ir ing</w>
assist ed</w>
min or</w>
Par ticip
b yp
de aths</w>
correl ations</w>
agon ist</w>
meta- analysis</w>
sal ine</w>
ul c
clin ic</w>
T 1</w>
u preg
coun ter
N F-
ca rotid</w>
car r
resour ces</w>
illu str
confir m</w>
at tit
ph ag
en al</w>
syst olic</w>
el ement</w>
pharmac o
reg ular</w>
pol ar</w>
circul ating</w>
20 -
is ms</w>
re habilitation</w>
S u
Ch ang
R adi
20 13</w>
sen se</w>
aryng eal</w>
h is</w>
dis played</w>
Ser um</w>
P I</w>
conc ep
subst ance</w>
sof t</w>
call ed</w>
cyto kine</w>
a id</w>
he ad
1 5.
Phy si
s low</w>
frag ments</w>
au g
emis sion</w>
reli ability</w>
anes thesia</w>
aer obic</w>
erro r</w>
mell itus</w>
7. 5</w>
insi c</w>
Au str
cl im
youn ger</w>
ad mitted</w>
vol t
m im
thou ght</w>
Evalu ation</w>
tox in</w>
G L
endoc rine</w>
flu x</w>
del etion</w>
0. 3</w>
GF R</w>
t on
M a
ser ve</w>
si es</w>
val idity</w>
regul ating</w>
susp ected</w>
B 1</w>
medi al</w>
al ign
car bo
IL- 6</w>
I N</w>
fung al</w>
symptom atic</w>
excre tion</w>
d yl
pl anning</w>
alph a
ach ment</w>
sol v
set tings</w>
ur ia</w>
Al z
ma x</w>
estro gen</w>
l ar
investig ations</w>
f und
pig s</w>
am ous</w>
gener ate</w>
G H</w>
g ir
cataly tic</w>
car til
emo tional</w>
o virus</w>
chym al</w>
eti ology</w>
cryst al</w>
util ization</w>
endoscop ic</w>
co efficient</w>
possi bly</w>
ech ocardi
recommend ations</w>
es sel</w>
ocyt osis</w>
repres ent
sper m</w>
C O</w>
R R</w>
h r</w>
B et
trac he
ta king</w>
av oid
remo ved</w>
P 1</w>
cytotox ic</w>
tren d</w>
en -
P rim
end ed</w>
posi tions</w>
ELI SA</w>
ne t</w>
Alz he
HC V</w>
1. 2</w>
hybridi zation</w>
iz ations</w>
I T
bi ology</w>
di a</w>
z one</w>
A 1</w>
cor tico
ys acchar
Europe an</w>
st anding</w>
loc us</w>
di alysis</w>
per f
muc osal</w>
ot or</w>
A S
AC T</w>
plas m</w>
go al</w>
dem entia</w>
I M
cre atin
tre ating</w>
m u
aden osine</w>
character ize</w>
hear ing</w>
on e
phosphat ase</w>
sw it
carb ox
con form
at ter
deta iled</w>
mic r
qual itative</w>
og ram</w>
schizophren ia</w>
rever sible</w>
Alzhe imer</w>
re tention</w>
2 5
F r
hist opath
neph ro
controll ing</w>
yt o
r hyth
fic ations</w>
M on
umb ar</w>
il ateral</w>
he ight</w>
pre feren
angi ography</w>
isol ation</w>
A V
vacc ination</w>
le a
no ise</w>
av y</w>
recei ve</w>
subjec ted</w>
sol ute</w>
ec al</w>
prog res
h and
pharmac ological</w>
frequ encies</w>
PE T</w>
symp tom</w>
bacter ium</w>
bloc ked</w>
in clusion</w>
nitro gen</w>
no des</w>
HI V-
demonstr ates</w>
d ents</w>
A 2</w>
H igh</w>
op ic</w>
per form</w>
1 20</w>
e asi
d end
ev er
aqu eous</w>
consider able</w>
simult aneously</w>
electrophore sis</w>
correc t</w>
p ic
vers ely</w>
im mediately</w>
separ ate</w>
potenti als</w>
pl er</w>
var ying</w>
o ic</w>
fibr ill
sp i
pr in
Sign ific
fav or
D op
gen it
c um
in sec
lymph ocyte</w>
re ached</w>
1 6.
elec tive</w>
dehydro genase</w>
integr ation</w>
allel e</w>
tu be</w>
vari ance</w>
n ar
u tion
am ph
0.0 2</w>
Res earch</w>
T- cell</w>
3 0-
el ess</w>
obstruc tion</w>
experi ences</w>
L PS</w>
venti lation</w>
hybri d</w>
assess ing</w>
b its</w>
P R</w>
em entary</w>
del ay</w>
muc osa</w>
er b
su ic
am ent</w>
speci al
pres crib
opath ic</w>
blo t</w>
wom an</w>
cyto chrome</w>
2 4-
B lo
sc an</w>
vec tor</w>
cryst all
ptom atic</w>
u ting</w>
reduc es</w>
barri er</w>
bl ind</w>
Ex pression</w>
G u
C ardi
compar ative</w>
g ent</w>
dri ven</w>
embry os</w>
bac kground</w>
af f</w>
f ru
ac ent</w>
L ong
numer ous</w>
T GF-
clu ster</w>
V ari
de oxy
spec ial</w>
ul f
lu tion</w>
ud es</w>
P e
di ast
om ical</w>
fe ature</w>
nucle i</w>
synth ase</w>
ish ing</w>
perc eption</w>
spectr a</w>
byp ass</w>
bu ff
r in
N K</w>
path ophysi
spe ed</w>
inf ant</w>
In hib
fir st-
I V
C E
cy cles</w>
M ore</w>
seg ments</w>
p um
ex ist</w>
ro t
feed back</w>
gra m</w>
m ented</w>
urb an</w>
bi as</w>
arr hyth
os in</w>
tum ours</w>
includ es</w>
hypo thalam
exist ence</w>
r ural</w>
retro spectively</w>
P K</w>
equi valent</w>
wh e
invol ves</w>
il ib
tion ed</w>
men ing
A K
antim icrobial</w>
langu age</w>
N MR</w>
phenomen on</w>
os in
mix ture</w>
M any</w>
apopto tic</w>
v ate</w>
ch ec
st ment</w>
prepar ations</w>
R s</w>
heterogene ity</w>
b ond</w>
I denti
p ed</w>
rele ased</w>
prob ability</w>
de generation</w>
cycl o
leu kin
complic ated</w>
I R</w>
preven ted</w>
er a</w>
α -
R T-
comp et
duc t</w>
20 12</w>
vi ability</w>
subsequ ently</w>
sk ills</w>
ca using</w>
fluoresc ent</w>
program m
nitr ic</w>
el ls</w>
Me as
aggreg ation</w>
tiv ation</w>
s .
n e</w>
P a
T 3</w>
HI V-1</w>
cou pling</w>
prog ress</w>
repor ting</w>
ast oma</w>
U l
g et
gradi ent</w>
b earing</w>
et h</w>
H .</w>
intra -
Dis ease</w>
Austr al
sal iv
attenu ated</w>
AI M</w>
u bi
D ep
an omal
0. 4</w>
theore tical</w>
fiel ds</w>
D L
ul l
Particip ants</w>
triti onal</w>
I B
cys tic</w>
angi otens
A U
adj acent</w>
H S
m os
p ing</w>
implic ated</w>
cyto plasmic</w>
circ ulation</w>
c oc
perc ep
sil ic
om on
ic -
lo ading</w>
dor sal</w>
si des</w>
v o
ro om</w>
ro b
P S
ar d
A F</w>
f ic</w>
del ta</w>
identi fying</w>
T A</w>
v essel</w>
r s
.00 1</w>
reg ard</w>
hyper troph
a x</w>
low est</w>
od on
e- specific</w>
Dec ember</w>
CY P
eff orts</w>
lin e
in a</w>
cor tis
b ran
respec tive</w>
distrib uted</w>
parti cle</w>
Di ag
pi g</w>
man ip
am ylo
cath eter</w>
restric tion</w>
te tra
recru ited</w>
un treated</w>
aden ocarcinoma</w>
volunte ers</w>
LD L</w>
di min
et ro
M L
m 2</w>
initi ally</w>
lim itations</w>
aphy loc
tra its</w>
dis ability</w>
ster oids</w>
micro g</w>
es tive</w>
eth n
ec h</w>
re ferred</w>
cere b
c ess
w in
vesi cles</w>
w at
hemorrh age</w>
pol y</w>
Con clusions</w>
o plasty</w>
immun oglob
v e-
f ever</w>
construc ted</w>
oxy gen
minim um</w>
l um
In v
st rom
D N
sim ulation</w>
step s</w>
alve olar</w>
ex per
adap tation</w>
st aff</w>
com posed</w>
ure -
D s</w>
al ter</w>
tic ity</w>
enti re</w>
achi ev
rou gh</w>
rab bits</w>
G R
cir rho
tin g
M in
bin d</w>
monit ored</w>
op tic</w>
res ear
phosph ati
kn ock
assi um</w>
k le</w>
ati gu
200 0</w>
3. 5</w>
dis per
profes sional</w>
arg in
dis cre
mon o
concer ning</w>
ar rang
disc ipl
cen ters</w>
sat ur
p ene
sin us</w>
2 -</w>
a ure
b ic
4 00</w>
direc tion</w>
k in</w>
evalu ating</w>
sequ ently</w>
elev ation</w>
he avy</w>
lipo protein</w>
struc tured</w>
com posite</w>
asi bility</w>
um ab</w>
t am
squ amous</w>
ta x
1. 4</w>
H E
le p
Char acter
sal t</w>
laparo scopic</w>
con comit
w er</w>
put ative</w>
coll ection</w>
auto immune</w>
predomin antly</w>
smo kers</w>
s chem
bec ame</w>
f ing
d ase</w>
simult aneous</w>
re perfusion</w>
adv ances</w>
expan sion</w>
ast om
1. 3</w>
standardi zed</w>
de pressive</w>
zin c</w>
ste ine</w>
there by</w>
consi sting</w>
G er
injec tions</w>
it ment</w>
1. 1</w>
T B</w>
Ac ute</w>
respon sive</w>
influenz a</w>
E arly</w>
om ics</w>
r it
recipi ents</w>
SE T
polic y</w>
cartil age</w>
overex pression</w>
athi one</w>
si on-
sulf ate</w>
2. 0</w>
shor ter</w>
ph ases</w>
me t</w>
R is
Ch r
spl een</w>
reg imen</w>
N L
surro un
suscepti ble</w>
carcin omas</w>
le g
Typ e</w>
H M
I P
br id
ad ed</w>
inser tion</w>
k ly</w>
i ance</w>
pitu itary</w>
ti on-
depend ing</w>
acc o</w>
G C</w>
don ors</w>
be d
exc it
E ach</w>
G E</w>
ad renal</w>
fr acti
TI NG</w>
lig ands</w>
A m
F ir
glutam ate</w>
relax ation</w>
gam ma-
epilep sy</w>
chol in
v ic
im mediate</w>
mo bility</w>
cle avage</w>
mi R
p ass
depend s</w>
episod es</w>
ex tension</w>
end ometr
0. 6</w>
arter i
extrem ely</w>
diast olic</w>
neg atively</w>
fl av
p us</w>
ST R
pre treatment</w>
v in
oscop y</w>
practi cal</w>
glyc os
ai l</w>
cl asses</w>
as ingly</w>
oster one</w>
p ine</w>
M ar
ill in</w>
util ized</w>
am mon
ep it
0. 8</w>
F ive</w>
ca vity</w>
esc ence</w>
Follow ing</w>
tas ks</w>
polymorph isms</w>
ren ess</w>
physici an</w>
inf ra
m apping</w>
b is
ser ot
path ogens</w>
cytotox icity</w>
C G</w>
idi c</w>
ing -
grow n</w>
reco vered</w>
allow ing</w>
oc ellular</w>
G I
def ine</w>
p ly</w>
re t
contrac tion</w>
cur ves</w>
f lo
clos ure</w>
3. 3</w>
I f</w>
F if
path ogenic</w>
S uch</w>
util ity</w>
o g</w>
consi der</w>
surve illance</w>
d wide</w>
coun ts</w>
l amin
man di
valid ation</w>
read y</w>
mat uration</w>
de position</w>
incorpor ation</w>
emph asi
Child ren</w>
al ways</w>
E V
O x
asym ptomatic</w>
S outh</w>
insi ghts</w>
re generation</w>
re plic
sp ine</w>
guid ed</w>
ul l</w>
sub units</w>
mitochond ria</w>
refl ect</w>
trans genic</w>
l ess
separ ated</w>
s ome
os por
r un
K 1</w>
me d
p yl
cardi omy
hypox ia</w>
polym er</w>
As sociation</w>
pot assium</w>
enzym atic</w>
lay ers</w>
ch ains</w>
sc ales</w>
oper ating</w>
favor able</w>
si c
ol e
dru g-
pre lim
METHO D</w>
or i</w>
short- term</w>
mo stly</w>
se -
correc tion</w>
temper atures</w>
t an
onucle ar</w>
P H</w>
thrombo sis</w>
ab use</w>
os c
Blo od</w>
Prim ary</w>
candi date</w>
Assess ment</w>
incre asingly</w>
Ther ap
S B
E m
ST UD
1 8.
STUD Y</w>
immunos up
M C
om eg
resid ents</w>
pl ex
drin king</w>
AT Pase</w>
in st
H T
i onic</w>
atigu e</w>
ru ption</w>
en se</w>
coag ulation</w>
tw are</w>
st atic</w>
requ iring</w>
of il
ubi qu
du od
precurs or</w>
P ur
dr am
ed ed</w>
sp ring</w>
o ro
suppl ementation</w>
vascul ar
ana es
valu able</w>
1. 6</w>
ot ting</w>
dec i
str ati
inter face</w>
Sy stem
H O
vir ul
defic its</w>
predic ting</w>
i ent</w>
in direct</w>
i etic</w>
or adi
main tain</w>
pa thetic</w>
aldehy de</w>
agg ressive</w>
y le</w>
1 5-
vers al</w>
20 17</w>
cell ul
polar ization</w>
l umbar</w>
adap tive</w>
commun ities</w>
g over
gi ve</w>
2 5-
si ties</w>
bro ad</w>
on dro
-1 -
HL A-
te eth</w>
L L
profes sion
m ach
pos t</w>
EE G</w>
en coun
ep tive</w>
attrib uted</w>
con sen
indic es</w>
categ ories</w>
C ar
worl dwide</w>
pos es</w>
aure us</w>
inf erior</w>
Str uc
in ner</w>
qu estion</w>
scienti fic</w>
om s</w>
e w
L V</w>
par ameter</w>
ne arly</w>
T ra
C u</w>
pr on
im e</w>
influ ences</w>
ene sis</w>
fact or-
ig ible</w>
Pre vious</w>
g ut</w>
ac e
1. 8</w>
in form
pa ired</w>
co st-
dec om
up -
perme ability</w>
methyl -
impl ants</w>
ro se</w>
ec tin</w>
su g
se e
h i
erro rs</w>
le x</w>
require ments</w>
real- time</w>
2 3
ri tic</w>
oti des</w>
mo vements</w>
predic tor</w>
cl ones</w>
manifest ations</w>
ar rest</w>
m mol</w>
emerg ing</w>
M D</w>
Ob jec
regul ates</w>
cl ar
op tions</w>
bi osynthesis</w>
T .</w>
A g</w>
unc er
4. 5</w>
loc ations</w>
PA TI
The ir</w>
ve h
ester one</w>
oper ated</w>
impro vements</w>
nu tritional</w>
b lu
oc al</w>
CO 2</w>
b p</w>
dr y</w>
estr adi
ilib rium</w>
t ations</w>
comp ens
prelim inary</w>
exc ess</w>
SET TING</w>
anti- inflammatory</w>
glut athione</w>
0. 9</w>
C M</w>
ori entation</w>
1. 7</w>
om ers</w>
spre ad</w>
F 1</w>
ari ties</w>
PATI EN
it ol</w>
abl ation</w>
fi st
on ce</w>
mm Hg</w>
re mission</w>
ag land
nic o
hem oglobin</w>
con sum
CN S</w>
corne al</w>
opi oid</w>
s clerosis</w>
advant age</w>
pelv ic</w>
1 50</w>
S V
ud g
c AMP</w>
in ating</w>
luoresc ence</w>
ag ne
is ons</w>
6 0
fe asibility</w>
pneumon ia</w>
Sur ve
lin ed</w>
p ren
great ly</w>
sub -
struc tion</w>
ex press</w>
ell ed</w>
pl ay
estim ation</w>
acqu isi
test osterone</w>
pati onal</w>
resi due</w>
sof tware</w>
hydro ph
es es</w>
vi de
inter leukin
Jap anese</w>
lim its</w>
easi ly</w>
L T
w ild</w>
CD 8</w>
simul ations</w>
n M</w>
intr insic</w>
M od
bu il
tw ice</w>
E vid
decre asing</w>
su med</w>
omon as</w>
lac king</w>
stimul ating</w>
all ergic</w>
colum n</w>
col or</w>
f abr
re ticul
ere s</w>
lo op</w>
promo ting</w>
ol e-
aneurys m</w>
I R
reas ons</w>
i ther</w>
ifor m</w>
U se</w>
rheum at
tren ds</w>
occ u
fund am
p s
clu sters</w>
off er</w>
hippocamp al</w>
li on</w>
A ut
evol ution
F s</w>
intro duction</w>
M olecular</w>
c ann
lip ids</w>
opo ietic</w>
n ers</w>
induc ing</w>
aud itory</w>
N T
hom ogene
opa usal</w>
- 3</w>
educ ational</w>
ga p</w>
ste ad
repe at</w>
scop e</w>
h er</w>
ab solute</w>
with draw
sch ed
T ri
trig lyc
p as
depart ment</w>
C K
plasm id</w>
f ro
inter views</w>
activ ating</w>
2. 2</w>
un usual</w>
hab it
id osis</w>
R h
gu ine
antagon ists</w>
or ial</w>
examin ations</w>
dis rup
compl ement</w>
vag inal</w>
Chang es</w>
th -
se di
Afr ican</w>
loc i</w>
medic ations</w>
ul ative</w>
hormon es</w>
Hy per
method ology</w>
ep i
Ris k</w>
home ostasis</w>
cere bro
per spective</w>
H F</w>
clos ed</w>
spectr al</w>
D et
p ent
c asp
o side</w>
AI DS</w>
s plic
osc ill
we ak</w>
tob acco</w>
ve get
re frac
deli vered</w>
indic ators</w>
fl ic
r icul
correl ate</w>
micro bi
M I</w>
ol i
ob acter
Chr onic</w>
tro p
sep sis</w>
trans lation</w>
barri ers</w>
seiz ures</w>
resol ved</w>
lact ate</w>
PL C</w>
challeng ing</w>
phen otypes</w>
gest ation</w>
dra in
ful ness</w>
Develop ment</w>
et -
M A</w>
20 10</w>
ax ial</w>
hypo thesized</w>
N OS</w>
entr y</w>
end o
F e</w>
sp ac
ow s</w>
pres su
S e
rob ust</w>
datab ases</w>
gu ide</w>
under taken</w>
-1 9
malign ancy</w>
c ephal
ain ts</w>
Al so</w>
Dop pler</w>
activ ator</w>
anat omical</w>
lin k</w>
dose- dependent</w>
func tion
cap sul
il e
adren ergic</w>
D C</w>
ti le</w>
ca the
intr am
fe a
Plas ma</w>
carbo hyd
relap se</w>
all ing</w>
re mark
hal f-
yiel ded</w>
ip al</w>
G 1</w>
are t
Rev ie
RT- PCR</w>
dis section</w>
Or g
ch ers</w>
N on
biop sies</w>
ra ised</w>
prec ip
gre en</w>
top ic</w>
dist ress</w>
le uc
subst ances</w>
analy tical</w>
classi cal</w>
haz ard</w>
bre ak
commerc ial</w>
T H</w>
n one</w>
0. 7</w>
v .</w>
ti d
2. 1</w>
2 D</w>
fe wer</w>
particip ation</w>
1 7.
t es
high- risk</w>
i tive</w>
ga ve</w>
en erg
IC U</w>
in activation</w>
graf ts</w>
P seud
ig aret
diff ered</w>
p toc
P ath
Rec ently</w>
amin o
al ready</w>
pop ul
prote ase</w>
micro scopic</w>
acquisi tion</w>
en chymal</w>
profession als</w>
disco very</w>
di arr
heterogene ous</w>
initi ated</w>
Par kin
arti ficial</w>
lab eling</w>
us h
ozyg ous</w>
compl iance</w>
evid ent</w>
prog esterone</w>
m -
S R</w>
re in
m ary</w>
H em
charg ed</w>
g old</w>
be y
contrib utes</w>
0.0 3</w>
N E
ant um</w>
it ems</w>
environ ments</w>
cyt e</w>
typ ically</w>
pro -
M O
I r
three- dimensional</w>
in come</w>
en sis</w>
otox in</w>
od -
it ec
N o
reve als</w>
li ve</w>
in os
fl ap</w>
men opausal</w>
D R</w>
bro ad
insi ght</w>
cap illary</w>
al izing</w>
B R
n atal</w>
og lyc
CL C</w>
fo ot</w>
D P</w>
insul in-
us cular</w>
provid ers</w>
dis play</w>
re fer
In tern
f atigue</w>
practi tion
cont ents</w>
cros s
concomit ant</w>
conf ig
T um
ca regi
bey ond</w>
adju stment</w>
de generative</w>
se em</w>
D F
awa reness</w>
4 50</w>
N TS</w>
sc aff
protoc ols</w>
coag ul
mut ag
ethyl ene</w>
L H</w>
RNA -
ophil a</w>
respon d</w>
2. 3</w>
ren e</w>
os e-
mul tic
20 11</w>
aut ophag
review s</w>
at um</w>
dis m</w>
tr ue</w>
ex tra
m ent
responsi veness</w>
soci o
con sul
glyco protein</w>
neutr al</w>
pl atin</w>
I ts</w>
os y
M S
m atic</w>
b ot
P res
G s</w>
SC C</w>
se d
em por
C ase</w>
bac k
high light</w>
paren tal</w>
d yst
interpre tation</w>
MD A</w>
comput er</w>
ne ither</w>
determin ants</w>
detec ting</w>
te tr
weigh ted</w>
tr ained</w>
exc e
am s</w>
an astom
circ u
C are</w>
depl etion</w>
S tre
F I
ampl ification</w>
W e
O ther</w>
a que</w>
l ibr
roph ic</w>
d ox
inhib iting</w>
AB STR
sh ar
electro de</w>
acc es
p .</w>
G y</w>
en abl
clin icians</w>
Multi ple</w>
P eri
platel ets</w>
og ly
re tri
gest ational</w>
at yp
Qu anti
relev ance</w>
incub ated</w>
it self</w>
modi fications</w>
HP V</w>
ram s</w>
hippocamp us</w>
ABSTR ACT</w>
impro ves</w>
di l
pre valent</w>
m ess
por tion</w>
immuno deficiency</w>
pol l
AI MS</w>
at -
W OR
S ing
underg o</w>
hospit alization</w>
un t</w>
M T</w>
ast -
in put</w>
d ates</w>
ch ondro
intro duc
syn erg
C L</w>
5 7
ogra ft</w>
epider mal</w>
macroph age</w>
I O
im id
r in</w>
z e
consen sus</w>
chrom atin</w>
M B
preven ting</w>
Si x</w>
she ep</w>
prost agland
le y</w>
cr y
ads orption</w>
N Ps</w>
ub er
S te
atic s</w>
2 4
N an
av oid</w>
recept or-
pro ven</w>
fol low</w>
RO S</w>
D ru
sou ght</w>
scre ened</w>
2. 4</w>
PATIEN TS</w>
ex clu
prec ise</w>
ig en
W ith
H S</w>
co ated</w>
L O
ma x
clon ed</w>
eph rine</w>
lu tin
attit udes</w>
hydro lysis</w>
oc cal</w>
2 7
S oci
flu or
fibr in
19 .
b al</w>
gon ad
G B
un ilateral</w>
enrich ed</w>
inf er
Si x
en able</w>
L ev
arch itec
rec i
al anine</w>
estradi ol</w>
Pati ent</w>
mal aria</w>
U NC
com pression</w>
L A
simil arity</w>
9 9
P P</w>
ou ter</w>
op tion</w>
C entr
refrac tory</w>
B raz
l ost</w>
s ar
diff use</w>
adi ly</w>
ocor tico
L 1</w>
AT ED</w>
per for
re ading</w>
f low
S up
perc utaneous</w>
ra ys</w>
c am
G 2</w>
com pati
ex ogenous</w>
dig ital</w>
correl ates</w>
O A</w>
tend ing</w>
tr ic
exclud ed</w>
sub types</w>
li pos
agon ists</w>
combin ations</w>
x en
N S</w>
ful l-
ic ans</w>
im mobil
yl ic</w>
observ ational</w>
plic ations</w>
creatin ine</w>
dat as
s a
memb er</w>
D 1</w>
μ g</w>
transcrip ts</w>
ME A
impl emented</w>
medi ates</w>
P oly
co he
M ech
sp ir
bil i
is ot
ic les</w>
P 2</w>
ysacchar ide</w>
ot a</w>
vis its</w>
ar ach
inter -
Evid ence</w>
off ers</w>
hom ologous</w>
abund ance</w>
identi ty</w>
argin ine</w>
ch amb
C ells</w>
T otal</w>
amin es</w>
le aves</w>
techn ical</w>
VE GF</w>
norm ally</w>
os es</w>
trans location</w>
P sych
lu te
z o
inter sti
t ant</w>
I C</w>
promot es</w>
ha ir</w>
gen otypes</w>
k ade</w>
WOR DS</w>
pro min
MEA SU
M at
port al</w>
lim iting</w>
com es</w>
abs orb
ex ac
con stric
- 6</w>
obstruc tive</w>
l ens</w>
fundam ental</w>
c it
pro genit
ster one</w>
secre tory</w>
ste ad</w>
auth or</w>
fil tration</w>
re presented</w>
B ar
an ing</w>
en sion</w>
e j
subjec tive</w>
c igaret
ur y</w>
e osin
G a
h is
surviv ors</w>
path ogen</w>
ti ary</w>
Signific ant</w>
dimen sions</w>
5. 5</w>
du al</w>
lo be</w>
cortis ol</w>
cop per</w>
ai res</w>
chang ing</w>
embry o</w>
consist s</w>
V ir
contr acti
cover age</w>
un changed</w>
pre ad</w>
substanti ally</w>
surroun ding</w>
suppor ting</w>
di ets</w>
t ance</w>
suppor ts</w>
por t</w>
ex ists</w>
I A</w>
miR -1
all -
col d</w>
n ose</w>
ure a</w>
si zes</w>
fil m</w>
om er</w>
pres um
-1 2</w>
ath yro
J un
prob es</w>
pres sions</w>
d ar
reduc tase</w>
qu ad
n oc
1. 9</w>
consist ently</w>
cre ated</w>
bel ong
bre a
TR UNC
TRUNC ATED</w>
accept able</w>
Com bin
th in</w>
M ut
Contro l</w>
itr al</w>
pil ot</w>
ou gh</w>
att achment</w>
N on-
ac a
ul t</w>
exc ision</w>
dise ase-
concer n</w>
T T
sub set</w>
elic ited</w>
Bi o
bacter i
dos age</w>
simul ated</w>
Ar ab
immunoglob ulin</w>
trans duction</w>
1 000</w>
2. 6</w>
c ase-
H A
indic ations</w>
emp ir
concer ns</w>
particip ated</w>
pres crip
U V</w>
fibrill ation</w>
w estern</w>
Res pon
S el
pati ent-
Parkin son</w>
agg lutin
op es</w>
enter ic</w>
te -
phosphati dyl
evolution ary</w>
app ed</w>
Fir st</w>
NC E</w>
ra rely</w>
L E
chrom osomal</w>
angiotens in</w>
2 6
satur ated</w>
for c
thromb in</w>
pron oun
agne tic</w>
ati le</w>
adolesc ent</w>
cirrho sis</w>
epidemi ological</w>
es pread</w>
sper mat
oper ations</w>
be am</w>
Thir ty-
pre term</w>
rever sed</w>
need le</w>
f all</w>
ur ity</w>
activ ate</w>
odi c</w>
occu pational</w>
trans formed</w>
reg imens</w>
s or
p ure</w>
be gin
fea sible</w>
gli al</w>
intrac ranial</w>
rheumat oid</w>
o ing</w>
H F
devi ation</w>
c ine</w>
sc ans</w>
a uc
-1 9</w>
syn chron
ne a</w>
on ing</w>
ym e</w>
equ ilibrium</w>
Ph armac
som at
eth yl</w>
l y-
inter national</w>
enco ded</w>
phil ic</w>
2. 8</w>
U S
complex ity</w>
elim ination</w>
eff lu
categ or
metabol ite</w>
2. 7</w>
chem ically</w>
intes tine</w>
N F
triglyc er
C F</w>
ting ly</w>
ti zed</w>
d ay
3. 0</w>
correc ted</w>
gir ls</w>
f ar
con str
infil tration</w>
ent y</w>
oph thal
th eses</w>
ec ological</w>
tox ic
re jection</w>
lea f</w>
5 ,
al ize</w>
abs ent</w>
in ess</w>
eli hood</w>
allel es</w>
dec ades</w>
ogen icity</w>
projec t</w>
pronoun ced</w>
t es</w>
mo tility</w>
per man
sym pathetic</w>
Cur rent</w>
om ycin</w>
down -
i dism</w>
an emia</w>
is ch
in stability</w>
pro t
all oc
carri ers</w>
down stream</w>
I GF
D .</w>
occ up
enti ally</w>
con n
Revie w</w>
techn ologies</w>
M al
A b</w>
sub cutaneous</w>
indic ator</w>
C H</w>
st ent</w>
deci sions</w>
bin ds</w>
DNA -
ab err
ann ual</w>
per in
phen yl</w>
sup ply</w>
hepat ocellular</w>
gen us</w>
T e
ir radi
prophyl axis</w>
.0 5</w>
K ore
sci ence</w>
out patient</w>
G re
A G</w>
St aphyloc
os ocial</w>
J .</w>
vul ner
star ting</w>
ra dic
s low
vacc ines</w>
g el
pyl ori</w>
spe ech</w>
lo aded</w>
situ ation</w>
mes enchymal</w>
res tingly</w>
te aching</w>
atin gs</w>
tim ing</w>
difficul ties</w>
begin ning</w>
v ary</w>
3 -</w>
as cular</w>
S W
1 8-
oun ds</w>
f asting</w>
6. 5</w>
Sy stem</w>
Intern ational</w>
p es
lif e-
2 8
an tic
I D
nam ely</w>
aor ta</w>
W om
bili ary</w>
Identi fication</w>
chrom osomes</w>
comp uter
r ated</w>
pow er
cy an
N P
attemp t</w>
ran e</w>
od e</w>
min eral</w>
inter n
wid espread</w>
inter act</w>
CO PD</w>
S F
ation- based</w>
der mal</w>
ast er
c ally</w>
ser ine</w>
discrim ination</w>
alk aline</w>
Func tional</w>
P o
discipl inary</w>
vis ed</w>
ol ol</w>
diagnos es</w>
5. 0</w>
pl aque</w>
te am</w>
trans fusion</w>
Pre dic
pl ane</w>
om orph
lik elihood</w>
b ed</w>
li es</w>
tur n</w>
atheros clerosis</w>
m T
ultras on
bre ath
j udg
et e</w>
monit or</w>
Incre ased</w>
d less</w>
resear chers</w>
Surg ical</w>
ph y
-1 00</w>
HB V</w>
ess es</w>
sp .</w>
dep ri
adi g
bloc kade</w>
neutroph ils</w>
D ros
trans mit
man aged</w>
re ach</w>
star t</w>
T C</w>
cyt ometry</w>
form ations</w>
3. 2</w>
tu ally</w>
tac hy
respon dents</w>
7 0
regar dless</w>
hepat ocytes</w>
Bet ween</w>
AC E</w>
intersti tial</w>
k eletal</w>
My co
N- terminal</w>
Un der</w>
engine ering</w>
modul ate</w>
selec tively</w>
su pr
be g
verte bral</w>
on to</w>
nan o
som atic</w>
volum es</w>
ur g
intra operative</w>
H a
ap ical</w>
Ac cording</w>
emerg ed</w>
Jap an</w>
recru itment</w>
invol ve</w>
uc tu
In tr
bi ofil
ro tation</w>
H ep
qu antum</w>
ay er</w>
b ol
hydroph obic</w>
i ae</w>
Wom en</w>
0.0 4</w>
con flic
pro spectively</w>
ot es</w>
satis factory</w>
Dros ophila</w>
differenti ally</w>
NA D
main taining</w>
GAB A</w>
leth al</w>
quanti fied</w>
fer til
of luorescence</w>
B A
gl auc
ens ure</w>
phen otypic</w>
idi opathic</w>
T ak
ester ase</w>
as one</w>
paras ite</w>
Afr ica</w>
mil lion</w>
ta il</w>
for ces</w>
atyp ical</w>
immunohisto chemistry</w>
e in</w>
ma kes</w>
post natal</w>
c ro
angi ogenesis</w>
iv es</w>
gl ands</w>
CR P</w>
Sub jec
TN F</w>
competi tive</w>
part um</w>
fil ms</w>
odi alysis</w>
g all
sol ub
pro per</w>
3. 1</w>
princi ples</w>
quanti fication</w>
plat form</w>
great est</w>
suff ering</w>
hep arin</w>
ag e
sus pen
morph ine</w>
ses sions</w>
transf ected</w>
al in</w>
U p
m itral</w>
r a</w>
F our
represent ative</w>
secre ted</w>
organis m</w>
sc en
pancre as</w>
2 9
H is
hist ologic</w>
ann ed</w>
2. 9</w>
end s</w>
we ak
ong oing</w>
str ial</w>
D B
Prote in</w>
perform ing</w>
ref lex</w>
ar is</w>
con sequence</w>
follow s</w>
cl onal</w>
M 1</w>
In dex</w>
effici ents</w>
y ed</w>
at rophy</w>
adi pose</w>
par adig
sp ar
construc t</w>
P H
Jun e</w>
clin ic
pum p</w>
lin king</w>
mis sions</w>
U -
mamm ary</w>
pyr id
assess ments</w>
lun gs</w>
ul y</w>
ti g
H ere
infil tr
t um</w>
MA IN</w>
ter tiary</w>
e ating</w>
elucid ate</w>
immunohisto chemical</w>
tr ic</w>
T 2</w>
h old</w>
sup pressor</w>
accur ately</w>
ol ed</w>
interfer on</w>
z er
sens or</w>
mon ol
5- HT</w>
aca demic</w>
pre ferred</w>
sub group</w>
sequ ential</w>
y r</w>
Long -
echocardi ography</w>
de press
stimul ate</w>
endometr ial</w>
con g
ta kes</w>
Staphyloc occus</w>
ha pl
B re
ar t</w>
cardi a</w>
In dia</w>
effici ently</w>
acc id
questionn aires</w>
sha red</w>
res h</w>
integr ity</w>
new born</w>
I GF-
contamin ation</w>
am eth
S ci
malign ancies</w>
re modeling</w>
P ot
ograph s</w>
bl ack</w>
p g</w>
serot onin</w>
em bed
as h</w>
incorpor ated</w>
abol ic</w>
cat ech
ac ous
regul ator</w>
Inte restingly</w>
St atis
surge ons</w>
6. 7</w>
enhanc ing</w>
ac tual</w>
sur vi
sho ul
ma p</w>
produc es</w>
ventr al</w>
s we
u g
CR C</w>
deter i
abund ant</w>
on line</w>
gu an
inter ference</w>
fl uctu
termin ation</w>
carri er</w>
drain age</w>
lin kage</w>
ho use
V I</w>
ox idi
expl an
co efficients</w>
adi p
ac id-
S equ
cum ulative</w>
og rams</w>
R B
out side</w>
MEASU RE
ure th
an ch
Gen etic</w>
y me-
8 0
larg est</w>
compar isons</w>
pe di
le g</w>
y ces</w>
st o
I mp
l ist</w>
hem is
Sal mon
b ands</w>
f atal</w>
e as
ulc er</w>
withdraw al</w>
U .
ro ute</w>
I s
sum mary</w>
der m
H PLC</w>
path ologic</w>
3. 6</w>
cy steine</w>
di hydro
f aster</w>
ther mo
gener alized</w>
substitu tion</w>
3. 8</w>
B acter
im etr
os ens
r ice</w>
n ext</w>
del e
T a
toler ated</w>
acc ep
open ia</w>
4. 7</w>
hypertroph y</w>
repres enting</w>
ul tim
3 5
hy pot
O ver</w>
unc ture</w>
lo x
vi able</w>
G r
S c
ner ves</w>
abol ished</w>
promin ent</w>
thre at
demonstr ating</w>
phosphor ylated</w>
respon ded</w>
induc ible</w>
pan el</w>
v ital</w>
og rap
transpor ter</w>
stom ach</w>
id ae</w>
solv ent</w>
over view</w>
biomar ker</w>
C X
super oxide</w>
prec ision</w>
en cour
las tic</w>
ic illin</w>
compl ementary</w>
v an
random ised</w>
omer ic</w>
der ing</w>
consider ation</w>
v a</w>
ide -
double- blind</w>
Di ab
promot ed</w>
glomer ular</w>
oc ca
T s</w>
re adily</w>
scre en</w>
om otor</w>
g ing
ne igh
enh ances</w>
dis sem
pre mature</w>
bre ak</w>
ev ent
W H
li th
deriv ative</w>
grad u
paren tly</w>
R ole</w>
AR T</w>
el et
ch im
distrib utions</w>
h e</w>
par athyro
Ch em
autom ated</w>
k ap
glycer ol</w>
fr on
oste opo
blu e</w>
or a</w>
Z n</w>
mi RNAs</w>
I tal
ob acter</w>
con formation</w>
Un der
hem odynamic</w>
impl anted</w>
sti ff
selec tivity</w>
dimin ished</w>
predomin ant</w>
bri ef</w>
descrip tion</w>
de pressed</w>
strom al</w>
st ain
a udi
stud ying</w>
of l
calcul ations</w>
ur on
mod alities</w>
N R
resour ce</w>
neo plastic</w>
TNF- alpha</w>
micro som
vascular ization</w>
wor se</w>
wid th</w>
shap ed</w>
t ative</w>
dis ruption</w>
C at
suic ide</w>
quanti fy</w>
u fact
th eless</w>
rup ture</w>
ec tions</w>
ever theless</w>
and -
ul atory</w>
B ra
gener ating</w>
High -
ic ardi
As soci
min er
F D
S ym
in her
ol ym
no ver</w>
V al
mandi bular</w>
t ext</w>
si al</w>
ker at
dend ritic</w>
bi di
exac erb
tin -
rou gh
stand ards</w>
B L</w>
n mol</w>
otox icity</w>
f ts</w>
ach e</w>
defic it</w>
of ib
Ig M</w>
addres sed</w>
t ab
A G
ish ment</w>
yiel ds</w>
sc ap
s ent</w>
mon ocytes</w>
di al</w>
contr al
tum or-
P M</w>
os ing</w>
pregn ancies</w>
c ats</w>
op sis</w>
eff ort</w>
vi sible</w>
particip ate</w>
se ed</w>
fil am
protec ted</w>
con sci
met allo
- negative</w>
vas o
co vered</w>
N ot
ac ch
disco vered</w>
U K</w>
kap pa
ca us
ter al</w>
comput ational</w>
Org an
hist amine</w>
j ust</w>
Elec tr
ca ud
ec tom
percep tions</w>
pas sive</w>
cat tle</w>
p e</w>
TI ONS</w>
polyp eptide</w>
H b
4. 2</w>
immun ization</w>
app a</w>
IL- 2</w>
expl o
igh t-
NS CLC</w>
neutroph il</w>
pre ference</w>
iso forms</w>
Salmon ella</w>
tis m</w>
en ia</w>
ke ys</w>
Hy dro
cyto plasm</w>
wal king</w>
0. 6
N s</w>
L C</w>
j o
1 4-
s n
fol ding</w>
bo ys</w>
ech n
process ed</w>
compr ised</w>
ne gl
In flu
pot ency</w>
f el
cy st</w>
inf u
consider ably</w>
l d</w>
infra red</w>
sub type</w>
star ted</w>
d ly</w>
ab sc
veh icle</w>
A k
D 2</w>
perman ent</w>
f ur
wa vel
Elec tro
carbohyd rate</w>
m om
repe ti
no vi
chem ic
dis c</w>
physi ology</w>
b er
instrum ent</w>
accoun ted</w>
hist one</w>
E T</w>
al c
oste o
an ical</w>
countr y</w>
t us</w>
if er
200 9</w>
dis sociation</w>
ar ticular</w>
trac tion</w>
gen ce</w>
gluc ocortico
2 2
peri od
post operatively</w>
e gg
pos sess
str and</w>
bloc king</w>
larg e-
reduc tions</w>
sc al
0. 5
for ward</w>
plac ental</w>
pathophysi ology</w>
form ulation</w>
1 A</w>
Qu ality</w>
radi ographic</w>
w ash
8. 5</w>
carr ying</w>
contro ver
N T</w>
myel oid</w>
T 4</w>
kin ases</w>
pre d
id ation</w>
por cine</w>
micro tub
mod ality</w>
S 1</w>
r ace</w>
to ph
3. 4</w>
cri tically</w>
princ ipal</w>
off spring</w>
ch ro
to oth</w>
intr aper
foc using</w>
over come</w>
hemat opoietic</w>
hemis ph
1 1-
immun ological</w>
L P
f resh</w>
neuro pathy</w>
v acu
tur nover</w>
consider ing</w>
immuno assay</w>
mo bile</w>
ver tical</w>
f if
substitu ted</w>
acu ity</w>
u ous</w>
Pseud omonas</w>
transl ational</w>
scen ari
P u
el ong
der mat
S ol
c ran
my co
ic king</w>
pap ill
om e-
sub groups</w>
s arcoma</w>
pressu res</w>
condi tioning</w>
se e</w>
M ac
dep end</w>
el igible</w>
wh ole-
promis e</w>
mar k</w>
adap ted</w>
C E</w>
us c
o ocytes</w>
oz o
t ex
sul ph
gene tically</w>
R an
CA D</w>
L ow
fin ed</w>
in ally</w>
Ig E</w>
ec on
bloc ks</w>
pren atal</w>
R etro
M arch</w>
p .
immunore activity</w>
4. 4</w>
Di rec
virul ence</w>
n ever</w>
S ou
Inhib ition</w>
defin ition</w>
protec t</w>
po x
4. 3</w>
Objec tive</w>
experim entally</w>
4 5
ap parently</w>
tra ff
2 A</w>
prop ag
mod es</w>
M ed</w>
E lev
un affected</w>
de form
on ed</w>
orb ent</w>
v ae</w>
propor tional</w>
Com pl
to ok</w>
ass embl
re tained</w>
in suffici
amylo id</w>
Immun o
pro mp
H 2</w>
radi ological</w>
guine a</w>
I sol
situ ations</w>
E 1</w>
ic k</w>
osi tive</w>
os us</w>
osi tion</w>
I D</w>
mod ulated</w>
C d
az ine</w>
re combination</w>
co d
tend on</w>
R 1</w>
continu e</w>
encoun tered</w>
min ute</w>
visi t</w>
alter ation</w>
M s</w>
contral ateral</w>
E P</w>
In iti
acous tic</w>
man ufact
ventr icle</w>
ac idic</w>
view ed</w>
pan ic</w>
mon th
w ast
embol ism</w>
anes the
preven tive</w>
recor ding</w>
AU C</w>
hyper plasia</w>
A M</w>
B o
av ing</w>
ch olec
bon ds</w>
ster oid
imp acts</w>
equ ation</w>
il lin
moder n</w>
Ig A</w>
c as
n ight</w>
lat ency</w>
com b
3. 7</w>
syndrom es</w>
k b</w>
fill ed</w>
ul ating</w>
acr yl
H ear
20 18</w>
-1 ,
chamb er</w>
C y
ad a</w>
regi stered</w>
eu tical</w>
e- induced</w>
de pos
tre e</w>
Nor th</w>
amin o-
shor ten
irradi ated</w>
ar ched</w>
D 3</w>
ul cer
power ful</w>
mon onuclear</w>
4. 0</w>
optim ized</w>
ch i
fracti on
famil ial</w>
dec ade</w>
c ation</w>
lab el</w>
- positive</w>
psych osocial</w>
top ical</w>
0. 0</w>
can al</w>
retur n</w>
Dep ar
ag ic</w>
in n
be an</w>
practition ers</w>
eu kary
ro ots</w>
d al
or ally</w>
gly col
1 25</w>
d ur
In tra
M or
sign alling</w>
cy sts</w>
Surve y</w>
E GFR</w>
P -1</w>
ere ly</w>
contrib uting</w>
P erc
inj ured</w>
pl ant
ff e
pro ton</w>
ol amine</w>
aut ologous</w>
autophag y</w>
pre disp
S V</w>
conform ational</w>
SE M</w>
5- year</w>
4. 1</w>
sem i-
conn ected</w>
wee kly</w>
I P</w>
enz yme-
aff eren
W T</w>
programm e</w>
4. 6</w>
Fac tors</w>
Tak en</w>
nat ur
isol ate</w>
se arched</w>
az ep
lif est
S M</w>
prescrib ed</w>
prostagland in</w>
squ are</w>
gen cy</w>
int ell
stre t
M HC</w>
si um</w>
highligh ts</w>
1 3-
Co x</w>
an thro
sc atter
brea ks</w>
institu tion</w>
O L</w>
retin a</w>
exhib its</w>
facil ities</w>
row th</w>
hist or
epti des</w>
plas ticity</w>
- 5</w>
a virus</w>
phosph o
hormon al</w>
C- terminal</w>
b ound
iti n</w>
sen sing</w>
D ue</w>
S O</w>
ath l
ker atin
M ed
cros s</w>
C u
op ulmonary</w>
Qu estionn
can ine</w>
9 0
hor iz
anat omy</w>
discus sion</w>
Soci ety</w>
bidi ties</w>
C enter</w>
glauc oma</w>
em ul
bal lo
bronch ial</w>
candi dates</w>
V er
5. 6</w>
ac ks</w>
ac etic</w>
compar tment</w>
H e</w>
Im pro
b -
u gin
0.00 5</w>
P G</w>
ex act</w>
reas on</w>
cat ar
en larg
le ad
lab elled</w>
for ced</w>
c ows</w>
accep ted</w>
form er</w>
12 5
rel ations</w>
Q -
nutri ent</w>
per m
su d
arrang ement</w>
ocom pati
eg g</w>
saliv ary</w>
per oxidase</w>
ex pressions</w>
contrib uted</w>
κ B</w>
el astic</w>
P- 2</w>
diarr he
dig estion</w>
ex ec
le ge</w>
differenti ate</w>
om eter</w>
m ers</w>
smal l-
po ol</w>
Character ization</w>
m olar</w>
electro des</w>
F A
ex on</w>
T en</w>
architec ture</w>
hom ology</w>
E s</w>
sev erely</w>
shoul der</w>
mo ther</w>
arom atic</w>
cis platin</w>
aer ugin
L A</w>
cre ate</w>
us ting</w>
difficul ty</w>
phyl ogenetic</w>
deta il</w>
Ph ot
un related</w>
guid ance</w>
con duction</w>
os arcoma</w>
buff er</w>
erythro cytes</w>
ucle ar</w>
L V
com for
P ub
or dered</w>
strong er</w>
omat ous</w>
breath ing</w>
as ked</w>
disturb ances</w>
Can di
pur ification</w>
m RNAs</w>
lar vae</w>
per tur
fist ula</w>
isi on-
fre e
n em
duc ts</w>
combin ing</w>
i asis</w>
am bul
gen s</w>
rele asing</w>
M g
Here in</w>
D IN
exc essive</w>
aster n</w>
recor d</w>
ap o
g els</w>
L D</w>
G lu
radi al</w>
R H</w>
tub ular</w>
T i
stiff ness</w>
do g</w>
scatter ing</w>
cord ance</w>
ta il
hospit alized</w>
ST AT
pers on</w>
retur ned</w>
tur ally</w>
cop y</w>
E P
I .</w>
5. 7</w>
amin ation</w>
require ment</w>
opportun ities</w>
4. 8</w>
whe at</w>
pal li
ple ural</w>
en ables</w>
cont ex
di vision</w>
i a-
reticul um</w>
f ies</w>
cul tural</w>
Man agement</w>
aerugin osa</w>
J uly</w>
pancre atitis</w>
c asc
neon ates</w>
inos itol</w>
f f</w>
Be havi
war ran
l ands</w>
Meas ure
indu stry</w>
g ate</w>
trache al</w>
dem and</w>
el -
G ene</w>
med ull
i x</w>
ri l</w>
M C</w>
s ess</w>
vi br
connec tivity</w>
curren ts</w>
N one</w>
con current</w>
graph y</w>
ej un
amin ergic</w>
fe ed</w>
otyp ing</w>
person ality</w>
m ent-
7. 4</w>
pro l
un common</w>
pl an</w>
o es</w>
i. v.</w>
commun ity-
Sel f-
el ve</w>
F l
For ty-
w s</w>
seiz ure</w>
sph er
cap ture</w>
ge red</w>
met als</w>
L in
wor ds</w>
am bi
volt age</w>
st aging</w>
O UT
9. 5</w>
dis placement</w>
em a</w>
coord ination</w>
e bo
two- dimensional</w>
P RO
arb ox
ca dian</w>
k appa</w>
open -
L if
In c
indic ation</w>
A 1
pl ates</w>
bio tic</w>
Differen t</w>
log ical</w>
bre eding</w>
suppl emented</w>
in ic</w>
fo ods</w>
sur fact
clim ate</w>
Z n
OUT CO
nod ules</w>
gl ass</w>
optim ization</w>
super ficial</w>
ses sion</w>
M -1</w>
spont aneously</w>
S w
IFN- gamma</w>
With in</w>
sur ance</w>
Depar tment</w>
chic ken</w>
IL -1</w>
system atically</w>
on ia</w>
EC T</w>
Dru g</w>
Im port
M ay</w>
0. 3
tryp sin</w>
exclu sively</w>
mus cular</w>
EC G</w>
tes ticular</w>
fr ame</w>
C 1</w>
i m</w>
bor ne</w>
SL E</w>
weigh ts</w>
moti f</w>
lymph oid</w>
nur se</w>
rest ored</w>
ace ae</w>
cholin ergic</w>
200 8</w>
as part
in hal
cereb ellar</w>
E igh
analog ues</w>
incid ent</w>
b rom
ophil ic</w>
P an
pneumon iae</w>
alk al
concep ts</w>
insuffici ency</w>
ox in</w>
dec lined</w>
clar ify</w>
tra it</w>
W il
obl astoma</w>
lig ament</w>
ol es</w>
empir ical</w>
sat uration</w>
in stead</w>
w k</w>
est ed</w>
eas y</w>
r ag
mid -
dys plasia</w>
vec tors</w>
En gl
ob lastic</w>
Ad mini
anti depress
ran k</w>
plas ms</w>
er ia</w>
5. 2</w>
de man
INT ER
hel p
vas odi
G iven</w>
E l
cr yp
R 2</w>
0.00 2</w>
am ycin</w>
5. 3</w>
to o</w>
anti tumor</w>
4 0-
equ ally</w>
c ef
beli eved</w>
t esti
h n</w>
L ow</w>
K n
tain ty</w>
Ad v
ili ary</w>
over weight</w>
F S</w>
Simil ar</w>
hist ology</w>
H ER
enc e-based</w>
chemic als</w>
phospholip id</w>
Sec ond
N ur
aspir ation</w>
conf oun
3. 9</w>
algorith ms</w>
embed ded</w>
n c
di methyl
S we
flex ible</w>
foll icular</w>
1 6-
refer ral</w>
pro v
s light</w>
case- control</w>
cy st
li pop
com orb
enc ap
grad ually</w>
ther mia</w>
aneurys ms</w>
j ejun
Subjec ts</w>
l et
eng er</w>
-1 5</w>
stabil ization</w>
rhyth m</w>
ps ori
ter -
libr ary</w>
S even</w>
A pri
acceler ated</w>
idi um</w>
appro ved</w>
P T</w>
S ept
util izing</w>
analog ue</w>
ob i
surge on</w>
ju ven
sy novi
rou ght</w>
F O
d ness</w>
tend ency</w>
M V
en in</w>
st one</w>
con ven
quin ol
cataly zed</w>
Apri l</w>
anomal ies</w>
surve ys</w>
2 8.
F am
use fulness</w>
N K
underg one</w>
V is
r ic
coc aine</w>
cul tiv
bi polar</w>
in side</w>
re flux</w>
de m</w>
Com mun
categ ory</w>
condi tioned</w>
kidne ys</w>
us ti
MA P</w>
ul tr
p es</w>
b ab
g ated</w>
ameth asone</w>
C yt
Euro pe</w>
pol i
ery them
G n
oc in</w>
emph asis</w>
am ni
popul ation-based</w>
expos ures</w>
mus cul
effec tor</w>
retro viral</w>
orb ital</w>
hear ts</w>
C V</w>
help ful</w>
z en</w>
head ache</w>
dy e</w>
C d</w>
op posite</w>
arthro plasty</w>
conserv ative</w>
fru it</w>
controver sial</w>
tub ation</w>
ost atic</w>
wavel eng
L eu
En h
olog ist</w>
distingu ish</w>
osyn thetic</w>
B B
Experim ental</w>
r RNA</w>
mat ch</w>
DI SC
perf used</w>
C oun
fit ness</w>
at oms</w>
D em
T M
ab in
N E</w>
d ent
Syn thesis</w>
acetyl choline</w>
C ro
an al</w>
Diag nos
contin ence</w>
period ontal</w>
sh are</w>
i er</w>
Hear t</w>
ept or</w>
bir ds</w>
at o</w>
G ol
mar ine</w>
M SCs</w>
compati ble</w>
Out comes</w>
immun ofluorescence</w>
statis tics</w>
col onic</w>
ocy an
sel ves</w>
refl ected</w>
spec tives</w>
upreg ulated</w>
P 3</w>
peri operative</w>
Q o
phen ol</w>
dri ving</w>
l uc
N evertheless</w>
Centr al</w>
Mo del</w>
fer tility</w>
L T</w>
we a
fin anc
att ached</w>
in active</w>
cellul ose</w>
E ight</w>
d in
B cl
col itis</w>
ga it</w>
ethn ic</w>
Tran sc
D T
er arch
sw elling</w>
it em</w>
om ing</w>
ide al</w>
R T
plac ent
conjug ated</w>
repor ter</w>
cess ation</w>
antic ancer</w>
ch le
T o
f ine</w>
BM D</w>
Quanti tative</w>
anti viral</w>
sug ar</w>
SI ON</w>
gover n
pr is
s cler
pos sess</w>
compar t
opath ological</w>
1 -</w>
trans membrane</w>
dom es
o ther
tum orig
trig gered</w>
Surg ery</w>
cran i
omy el
T est</w>
loc ally</w>
chec k
U r
c at</w>
et a</w>
opportun ity</w>
Simil arly</w>
recor dings</w>
t ure-
inten se</w>
yt e</w>
align ment</w>
H P</w>
C och
res embl
w aves</w>
o ural</w>
press es</w>
P SA</w>
In divid
den se</w>
I S</w>
exc itation</w>
leuk ocyte</w>
off ered</w>
N C</w>
ep igen
at omic</w>
6. 2</w>
preser vation</w>
SN Ps</w>
ure tic</w>
Austral ia</w>
b und
es are
transfer red</w>
analge sia</w>
A I</w>
ir ation</w>
ligh t-
all y-
per oxide</w>
esc ent</w>
vis c
leuk in</w>
op ia</w>
od y</w>
os ensi
pl atin
examin ing</w>
cl one</w>
6. 3</w>
W ist
ex ual</w>
us age</w>
Au g
C er
pharmaco kinetic</w>
th in
par tly</w>
- 4</w>
F uture</w>
lu pus</w>
5. 8</w>
sat ell
gen omes</w>
An aly
Det ection</w>
HL A</w>
nico tine</w>
bil ities</w>
un g</w>
attemp ts</w>
5. 4</w>
influ encing</w>
str ic</w>
omeg al
dos ing</w>
rib onucle
H L</w>
labor at
Mech anis
C ros
preser ved</w>
qu it
lep tin</w>
exam ples</w>
investig ating</w>
olig onucle
s p</w>
mit tent</w>
dec ision-
in sufficient</w>
at onin</w>
neo plasms</w>
en vel
l en
C ap
age- related</w>
os en</w>
commun ic
v ast
6. 4</w>
v ill
E r
- to-
R .</w>
CO VI
prescrip tion</w>
cohor ts</w>
lifest yle</w>
casp ase-
de b
omer ase</w>
paradig m</w>
lif e
S hor
medi ators</w>
exten sively</w>
precurs ors</w>
in et
ost omy</w>
duod enal</w>
hem odialysis</w>
ag ain</w>
remark able</w>
ob ut
cytos olic</w>
second -
neu rom
res tim
po oled</w>
R am
alcoh olic</w>
socio economic</w>
esare an</w>
centr e</w>
epidemi ology</w>
tra jec
trans -
mo od</w>
an k</w>
N ov
b ic</w>
glob ulin</w>
fil ter</w>
C r</w>
HD L</w>
le ak
Bac illus</w>
op ening</w>
6. 6</w>
fibrobl ast</w>
7. 8</w>
V T</w>
ag o</w>
up stream</w>
mig r
T 2
Differen ces</w>
them selves</w>
em ed</w>
6. 8</w>
re mia</w>
G P</w>
elet on</w>
PK C</w>
M i
self- reported</w>
func tionally</w>
D D
suc rose</w>
es -
ampl ified</w>
homogene ous</w>
U. S.</w>
od g
m osph
immun otherapy</w>
sh ear</w>
DISC US
s or</w>
membran e-
threat ening</w>
dist ant</w>
go als</w>
dram atically</w>
do x</w>
B- cell</w>
sel en
ax ons</w>
mon keys</w>
mix tures</w>
Co A</w>
low ering</w>
st a
C 57
pharmaco kinetics</w>
ol factory</w>
7. 1</w>
val id</w>
instrum ents</w>
adren aline</w>
ogen es</w>
bec omes</w>
N 1</w>
assi st</w>
T F
pred n
ch osen</w>
TB I</w>
0. 2
an aerobic</w>
os mo
glomer ul
physi ologic</w>
pr ag
Pub Med</w>
DISCUS SION</w>
ub icin</w>
qu ite</w>
d l</w>
V i
3 3
0. 4
lipop ol
aspec t</w>
y outh</w>
En ter
Wor ld</w>
MA PK</w>
emergen ce</w>
pros thesis</w>
gangli on</w>
F IN
ish es</w>
line age</w>
Sept ember</w>
a emic</w>
appl ying</w>
Imp act</w>
obl asts</w>
L S</w>
o x</w>
T arg
ograph ical</w>
adj usting</w>
contamin ated</w>
n as
Oc tob
gli oma</w>
ati cal</w>
COVI D
exp on
ogene ic</w>
simil arly</w>
acc ess
shif ts</w>
caregi vers</w>
ultrason ography</w>
te trac
ent ations</w>
f ash
egg s</w>
inn ate</w>
reli ef</w>
osteopo rosis</w>
immunore active</w>
objec t</w>
ser ial</w>
no re
id opsis</w>
A sian</w>
st ored</w>
g yn
5 0-
H odg
cir cadian</w>
transcrip t</w>
l a</w>
B 2</w>
aro se</w>
R F</w>
exp anded</w>
sol ved</w>
t one</w>
diff r
def ective</w>
a w</w>
through put</w>
AC h
histopath ological</w>
os p
proper ty</w>
si bility</w>
pp m</w>
spec imen</w>
T E</w>
E GF</w>
some times</w>
ec osy
6 00</w>
config uration</w>
compl etion</w>
electro l
hydrox y-
2. 0
id ase</w>
vi r</w>
Qo L</w>
publ ic
en ess</w>
Arab idopsis</w>
nucle otides</w>
ptoc occus</w>
an tic</w>
bl in
n t</w>
clin ics</w>
Octob er</w>
clu sive</w>
No vel</w>
MA R
man ual</w>
2 9.
termin us</w>
tan dem</w>
ar sen
hydr ation</w>
the size</w>
Me dian</w>
compr ising</w>
am eli
mod elling</w>
CV D</w>
fung i</w>
IL- 10</w>
per ox
occ i</w>
nov o</w>
fal se</w>
in complete</w>
anat omic</w>
1 80</w>
ing u
me al</w>
def ense</w>
biom ass</w>
anal og</w>
a dic
progenit or</w>
schem e</w>
G S
aqu es</w>
avi an</w>
cardiomy opathy</w>
AT A</w>
Admini stration</w>
m um
gen -
contrib utions</w>
predic tions</w>
cigaret te</w>
ov ary</w>
dex amethasone</w>
over l
graf ting</w>
O C</w>
In stitute</w>
neur on</w>
cere visi
Medic ine</w>
200 1</w>
see king</w>
CA 1</w>
G I</w>
St and
meth ion
T ur
b a
well- being</w>
clu ster
un iform</w>
200 7</w>
anc h</w>
CI PA
op res
ep s</w>
acryl amide</w>
s me
sc oring</w>
conduc tance</w>
v esti
anthro p
mi as</w>
scho ols</w>
COVID -19</w>
Th en</w>
diarrhe a</w>
in verse</w>
neurolog ic</w>
er o
fabr ic
un able</w>
const ants</w>
cerevisi ae</w>
200 5</w>
A E</w>
seas on</w>
ere bral</w>
AD HD</w>
gran ules</w>
wat er-
leuk ocytes</w>
ti tis</w>
descrip tive</w>
B G</w>
ammon ium</w>
B one</w>
otox ic</w>
bl ing</w>
ra ine</w>
qu ar
Ak t</w>
CM V</w>
E F</w>
a red</w>
ma them
C ul
I U</w>
7. 2</w>
ax el</w>
6. 0</w>
s ac
part ners</w>
construc tion</w>
s ound</w>
e jection</w>
micro scope</w>
B AL
an kle</w>
vir us-
me an
inter view</w>
f ri
Spec ific</w>
sud den</w>
H ence</w>
to p</w>
5. 1</w>
four th</w>
par i
ballo on</w>
las ting</w>
T ox
athl etes</w>
as sumed</w>
strati fied</w>
L a</w>
viol ence</w>
pre -</w>
ger m</w>
re dox</w>
pl oid</w>
respon ders</w>
Nor thern</w>
aw are</w>
pu ts</w>
Braz il</w>
de t
myocardi um</w>
discus ses</w>
ation ally</w>
Tum or</w>
am p</w>
fash ion</w>
microbi ota</w>
at om</w>
4. 9</w>
equ ip
micro -
blo od-
tr unc
concentr ation-
ac yl
cu es</w>
natur ally</w>
g p
MATERI AL</w>
trig g
co chle
mat ching</w>
op sy</w>
FIN DIN
mamm als</w>
ynam ic</w>
n al
EC s</w>
T P
T er
st ac
7. 3</w>
trans mitted</w>
C 3</w>
Questionn aire</w>
Therap y</w>
numer ical</w>
bur n</w>
B ur
coun sel
p to
kin in</w>
Hodg kin</w>
ver ified</w>
U V
t ap
luo ro
1 7-
ol er
ifor m
ar ising</w>
Con tr
rest oration</w>
PT SD</w>
g yr
N MDA</w>
FINDIN GS</w>
ur ic</w>
thresh olds</w>
colon y</w>
dem ia</w>
enco des</w>
competi tion</w>
G P
F SH</w>
electro chemical</w>
depri vation</w>
in formed</w>
R ap
bo x</w>
pl e-
lev i
200 6</w>
erythro cyte</w>
in adequate</w>
OUTCO ME</w>
cler otic</w>
contracti le</w>
op s</w>
gal act
fib res</w>
Candi da</w>
si fication</w>
sp or
P RE
flex ion</w>
trac king</w>
psych otic</w>
medi ating</w>
polic ies</w>
im mature</w>
L ym
immun op
as -
H 1</w>
Compar ative</w>
3 8
est ers</w>
gli a</w>
SO D</w>
ph asic</w>
consist ency</w>
wast e</w>
T G</w>
de ep
op in
cal ib
interpre ted</w>
Sur viv
adren oc
- resistant</w>
Anti -
lam p
6. 1</w>
efflu x</w>
Myco bacterium</w>
b if
O ral</w>
addi tive</w>
quantit atively</w>
enrich ment</w>
optim um</w>
continu ously</w>
umb il
ch el
1 10</w>
design ated</w>
h eld</w>
troph ic</w>
G SH</w>
paras ites</w>
en anti
pri vate</w>
f os
Ph osph
aspart ate</w>
prost atic</w>
bl otting</w>
bl ast
minim ally</w>
at mosph
arom yces</w>
d L</w>
c ranial</w>
m aps</w>
u tri
e an</w>
anti bacterial</w>
S am
pl anned</w>
-1 0
fal ls</w>
IGF- I</w>
ti bial</w>
sc in
cop ing</w>
m enti
separ ately</w>
T R</w>
x y
se c</w>
Ex pos
aut onomic</w>
ell es</w>
h in
an g</w>
g es</w>
bod y-
de ed</w>
Long- term</w>
7. 0</w>
ger min
j our
j usti
a ur
spl en
cir cular</w>
H b</w>
applic able</w>
f s</w>
w ards</w>
epigen etic</w>
conserv ation</w>
polym ers</w>
stres s-
Fin dings</w>
pol lution</w>
si de-
promis ed</w>
os yl
indu strial</w>
TNF- α</w>
Na Cl</w>
p uber
In formation</w>
m ast</w>
e es</w>
ain t</w>
m ill
inte resting</w>
I L</w>
St ate</w>
py ru
persist ence</w>
cerebro spinal</w>
andro gen</w>
max illary</w>
stit utes</w>
per oxidation</w>
. 01</w>
e- related</w>
sp in</w>
gene sis</w>
en ough</w>
achiev ing</w>
g ives</w>
sc ar
ef s</w>
ho sts</w>
7. 6</w>
en demic</w>
te e</w>
Can ada</w>
al ised</w>
sh e</w>
A B</w>
t ot
transpl anted</w>
ut able</w>
5. 9</w>
G O</w>
pur poses</w>
ex clusion</w>
acch aromyces</w>
haem at
F i
fill ing</w>
t ary</w>
x yl
elucid ated</w>
ec lamp
per spectives</w>
iz umab</w>
7 ,
if ug
por e</w>
P U
super nat
magne sium</w>
g -1</w>
su m</w>
inter mittent</w>
S H
leak age</w>
D u
recomm end</w>
fet uses</w>
bi a</w>
epi demic</w>
rou tin
tin c
pin ephrine</w>
bon ding</w>
abnormal ity</w>
transcrip tom
re vision</w>
post partum</w>
uni versity</w>
Retro spective</w>
manip ulation</w>
F F
ip si
Engl ish</w>
lig ation</w>
la p</w>
Ac tivity</w>
th o
di c</w>
accum ulated</w>
ver bal</w>
ad y
non invasive</w>
iv al</w>
pro motion</w>
a pl
in patient</w>
C ir
mas sive</w>
4 -</w>
moder ately</w>
Statis tical</w>
m ium</w>
micro organisms</w>
exp ensive</w>
correc tly</w>
cryst als</w>
edi c</w>
bul k</w>
graph ene</w>
on ectin</w>
cour ses</w>
ot -
G rowth</w>
R o
behavi oural</w>
des c
ad dic
200 2</w>
carb on
con vul
ti ally</w>
Spec ific
ti p</w>
lab or</w>
it ro
ca usal</w>
Bra in</w>
ambul atory</w>
repres entation</w>
He pati
Con si
Pro spective</w>
Coch rane</w>
Wist ar</w>
0.00 0
anaes thesia</w>
adop ted</w>
WH O</w>
inoc ulated</w>
br anch</w>
ass ayed</w>
ori ented</w>
decision- making</w>
an o
i k
ebo -
or bidities</w>
al levi
foc uses</w>
Pre valence</w>
rang es</w>
ne ar-
ph yto
M ex
cycl ase</w>
umin escence</w>
ar y-
G T</w>
pharmac eutical</w>
ar rays</w>
respon ding</w>
M 2</w>
contr actions</w>
de struction</w>
G al
T SH</w>
3 2
y- state</w>
7. 7</w>
R P</w>
ant en
inter leukin</w>
inser ted</w>
constric tion</w>
S ocial</w>
c row
A SD</w>
M ater
G ram
gi ant</w>
adv anc
episod e</w>
CT s</w>
tachy cardia</w>
horiz ontal</w>
st at
0. 25</w>
extrem ity</w>
ist er</w>
cathe ter
defin itive</w>
sh ell</w>
splic ing</w>
wh y</w>
a u</w>
men str
L arg
r ings</w>
CK D</w>
shor t
less er</w>
ren tly</w>
c ure</w>
ol ing</w>
IF N</w>
join ts</w>
on ally</w>
AC S</w>
life time</w>
transf ection</w>
dar k</w>
aspir in</w>
ro tic</w>
kin e
astro cytes</w>
y el
pea ks</w>
in nov
lat ent</w>
ocyt o
g ing</w>
analy zing</w>
6. 9</w>
199 8</w>
conver ted</w>
lys ine</w>
profil ing</w>
8. 3</w>
disturb ance</w>
flu ids</w>
h u
sup press</w>
ish man
me et</w>
f resh
perin atal</w>
multic enter</w>
eng agement</w>
S 2</w>
form ulations</w>
anis h</w>
De pression</w>
t t
activ ates</w>
sequ enced</w>
examin es</w>
an ion</w>
in nerv
ocompati bility</w>
connec tion</w>
dex tr
U SA</w>
empor al</w>
inter acting</w>
recogn ize</w>
m asses</w>
buil ding</w>
ens ity</w>
tryp toph
pene tr
Inv estig
w t</w>
cap ability</w>
suff ered</w>
lox acin</w>
objec tives</w>
g ri
SI S</w>
deta ils</w>
199 9</w>
AM L</w>
cr ude</w>
sep tic</w>
Pro g
hi erarch
non linear</w>
end it
suspen sion</w>
ome dical</w>
at ri
ve ter
T K
diffr action</w>
19 90</w>
deteri oration</w>
prev ents</w>
PI 3
fing er</w>
l id
lat ation</w>
aph rag
fr uc
re aching</w>
S cre
fro zen</w>
NF- κB</w>
ag ricul
if ying</w>
reas on
p yro
financ ial</w>
endoth elium</w>
phenomen a</w>
m on</w>
M orph
dis h</w>
Physi cal</w>
biofil m</w>
str anded</w>
Stre ptococcus</w>
palli ative</w>
gro s
A no
evalu ations</w>
s- -
an ium</w>
res in</w>
w ing</w>
PAR TI
Influ ence</w>
Q OL</w>
P at
synerg istic</w>
M O</w>
fe ar</w>
app reci
consider ations</w>
recipi ent</w>
surg ically</w>
- mediated</w>
O ste
co ver</w>
valid ate</w>
oph yl
L im
regul ators</w>
part ner</w>
establ ishment</w>
- of-
post menopausal</w>
H ow</w>
n ig
pul ses</w>
cholec yst
iton e
Cardi ac</w>
B D</w>
un stable</w>
seg reg
mach ine</w>
aut osomal</w>
testi s</w>
enti ty</w>
mit otic</w>
ph age</w>
illustr ate</w>
capsul e</w>
cat al
anastom osis</w>
PARTI CIPA
re placed</w>
μ m</w>
ent an
stri atum</w>
id ed</w>
selec t</w>
embol ization</w>
po rous</w>
t uring</w>
di lution</w>
P ain</w>
an ticip
Aug ust</w>
discrim in
B M</w>
modul ating</w>
enabl ed</w>
M it
ob vious</w>
2 1-
ell um</w>
sim pl
s a</w>
comfor t</w>
umbil ical</w>
mac ular</w>
antigen ic</w>
trans duc
PARTICIPA NTS</w>
con stitute</w>
- 10</w>
per g
R enal</w>
Ph ase</w>
discre p
Im aging</w>
Under standing</w>
oxygen ation</w>
expl oration</w>
6 ,
kappa B</w>
Diab etes</w>
air y</w>
E M</w>
ch ir
pap illary</w>
ast ed</w>
aggreg ates</w>
mer cur
histo chemical</w>
bl astoma</w>
i ar</w>
in surance</w>
determin ant</w>
F em
extrem e</w>
ogra fts</w>
endoscop y</w>
aden oma</w>
thyro idism</w>
t RNA</w>
imp ed
Rep ort</w>
oscop ic</w>
arrhyth mias</w>
G R</w>
ing estion</w>
un k</w>
Ad ditional</w>
ow ing</w>
ost atin</w>
trans forming</w>
neuro degenerative</w>
odynam ics</w>
esophag us</w>
vi ously</w>
Ran dom
E th
radi ographs</w>
direc tions</w>
intra ocular</w>
stem s</w>
ro bo
attrib utable</w>
my osin</w>
19 -
ob ste
M V</w>
com orbidities</w>
pene tration</w>
R i
venti l
te m</w>
cont acts</w>
radic als</w>
pic ture</w>
plac ebo-
nore pinephrine</w>
Heal th
menti oned</w>
cal ci
V it
th ood</w>
al umin
h aled</w>
rib osomal</w>
CO X
S uc
ho use</w>
pros thetic</w>
at trac
M g</w>
- derived</w>
ear s</w>
ta u</w>
princi ple</w>
ge ometry</w>
199 7</w>
ox y-
m V</w>
ulc ers</w>
sl ices</w>
amph et
A ge</w>
ar ise</w>
carcin ogenesis</w>
fac e-
S F</w>
vide o</w>
h ind</w>
modi fy</w>
Diag nosis</w>
sist ance</w>
P op
200 4</w>
equ ations</w>
Ser v
sil ver</w>
satell ite</w>
pari etal</w>
ther m
ac compl
M M</w>
lo g</w>
hel ix</w>
tid ine</w>
ang les</w>
stri atal</w>
pes tic
oxidi zed</w>
eth ical</w>
asym metric</w>
C 2</w>
in tim
epilep tic</w>
En do
ol ab
3 4
ap tic</w>
R a
19 95</w>
trig ger</w>
hom ogen
equip ment</w>
bec oming</w>
attenu ation</w>
r atings</w>
P or
pat ch</w>
myel oma</w>
ser op
upreg ulation</w>
glyc ine</w>
C57 BL</w>
psych o
app ly</w>
L s</w>
om al</w>
pertur b
sc av
hypox ic</w>
li p</w>
mel atonin</w>
exer t</w>
d itary</w>
sep tal</w>
cod on</w>
AC TH</w>
B ri
anesthe tized</w>
ob last</w>
tin ib</w>
en op
other wise</w>
analge sic</w>
e -</w>
lum en</w>
calc ulation</w>
stimul ates</w>
prol actin</w>
immunos orbent</w>
G e
gangli a</w>
summar ize</w>
ameli or
evid ence-based</w>
lam b
repe at
ch e
P os
PC s</w>
discre te</w>
i pati
dop aminergic</w>
phot on</w>
filam ents</w>
v om
f ig
-1 1</w>
pre clinical</w>
attr active</w>
nit rate</w>
L Y
gi ving</w>
or ubicin</w>
ca ro
ap par
os acchar
ultim ately</w>
Op tim
o k
N et
N D
exp endit
vas opres
st e</w>
Tw enty</w>
catar act</w>
su stain
end ocardi
t od
un g
si x
epit opes</w>
ox al
con junc
i e</w>
in- induced</w>
draw n</w>
electro cardi
h ence</w>
i ii</w>
B as
knock down</w>
on ine</w>
sh unt</w>
R E</w>
Syn drom
direc tional</w>
Ep idemi
p ip
ac tin
di mer</w>
Li ver</w>
k al
PT H</w>
ore r</w>
in form</w>
cat enin</w>
eosin oph
cardi opulmonary</w>
Pr acti
aff ective</w>
Gen er
t an</w>
N either</w>
avoid ance</w>
ti zation</w>
E ven</w>
attemp ted</w>
Z e
ox if
ot rophic</w>
Expos ure</w>
oph en
Ap plication</w>
visu alization</w>
o rous</w>
dy sp
int ended</w>
g ained</w>
speci alized</w>
ome tri
at ro
sub sets</w>
Sh e</w>
F C</w>
immunosup pressive</w>
beli eve</w>
n a</w>
yt es</w>
institu tions</w>
continu ation</w>
00 -
ot actic</w>
distr ic
usc itation</w>
TN F
pr one</w>
evol ved</w>
pro ve</w>
mo tiv
out break</w>
ac tor</w>
stres s
ve ins</w>
at tending</w>
Fif ty-
A ff
dri ve</w>
on eph
hypothalam ic</w>
M us
ed ge</w>
bl ic</w>
p ep
in -1</w>
199 6</w>
epid ural</w>
ca ffe
chromat ographic</w>
run ning</w>
st ones</w>
D at
Th rough</w>
ch ori
thromb ocyt
L ac
G ra
N ine</w>
se a</w>
G MP</w>
bo w</w>
plas min
Cros s-
ang ina</w>
visc eral</w>
al do
w ounds</w>
warran ted</w>
bloc kers</w>
fl am
con dens
trim ester</w>
end ometri
clon ing</w>
all ogeneic</w>
verte br
G D</w>
br ady
B A</w>
Ul tras
ipsi lateral</w>
cardi o
midd le-
us er</w>
exten d</w>
juven ile</w>
osteo arthritis</w>
sil ica</w>
in versely</w>
m ir
sar co
Diagnos tic</w>
large- scale</w>
pyru vate</w>
stead y-state</w>
An im
los ses</w>
8. 6</w>
ograph ically</w>
var ies</w>
do or</w>
alcoh ol
C K</w>
fibrin ogen</w>
am ic</w>
ham ster</w>
A A
sp ind
6 0-
l ic
lat er
sam pled</w>
nephro pathy</w>
amin e-
re mot
inter f
facilit ated</w>
us h</w>
ipati ng</w>
T 1
casc ade</w>
att ack</w>
hist ologically</w>
histor ical</w>
rh iz
propor tions</w>
d ent</w>
Wh at</w>
IL- 4</w>
l ity</w>
stead y</w>
ay ers</w>
mis sing</w>
In dian</w>
dec ay</w>
M el
calcul ate</w>
atheros clerotic</w>
Inte gr
am id
or ic</w>
s ular</w>
b rate</w>
S accharomyces</w>
ret ard
200 3</w>
I T</w>
form ula</w>
heter o
L ip
preferen ces</w>
con junction</w>
hypothalam us</w>
or y-
anti coagul
G lob
in continence</w>
prophyl actic</w>
O VA</w>
Direc t</w>
fore ign</w>
Vari ous</w>
ep ing</w>
st ain</w>
oc occal</w>
Ap pro
F U</w>
normal ized</w>
p et
P b</w>
con clusions</w>
develop ments</w>
lam y
ec es</w>
0.00 3</w>
quanti ty</w>
charg es</w>
F V
stud ent</w>
7. 9</w>
f ecal</w>
all ograft</w>
endo plasmic</w>
ph thal
acces sible</w>
M agnetic</w>
ma st
trac e</w>
f en
me at</w>
hom olog
Pro gram</w>
uncer tainty</w>
mig raine</w>
enzyme- linked</w>
inoc ulation</w>
objec ts</w>
doc tors</w>
Gen eral</w>
Second ary</w>
counsel ing</w>
lim bs</w>
bro w
excit atory</w>
S ensi
du al-
u e-
all ergy</w>
engine ered</w>
obser ve</w>
8. 2</w>
resid ent</w>
polymer ization</w>
S r
del ine
wa ve
ol l
-1 4</w>
T ime</w>
em atic</w>
m iti
rib ed</w>
inc ision</w>
igh t
Rec om
P V</w>
simil arities</w>
colon ization</w>
C N</w>
adhe sive</w>
frag mentation</w>
par asi
1 30</w>
or p
ophthal m
Austral ian</w>
oxy genase</w>
od ec
susp ici
c ity</w>
elim inated</w>
epith eli
ome- wide</w>
fol ate</w>
ar ms</w>
reproduc ibility</w>
four -
al isation</w>
appar atus</w>
organ ized</w>
requ ency</w>
System atic</w>
odon tic</w>
er adic
it ated</w>
SN P</w>
laborat ories</w>
In trac
resp iration</w>
ent ory</w>
routin ely</w>
refl ects</w>
S tro
belong ing</w>
mal formations</w>
cogni tion</w>
struc turally</w>
in ous</w>
exc eption</w>
igh ts</w>
thym idine</w>
e us</w>
ol ateral</w>
R I</w>
ER K</w>
Multi variate</w>
slow ly</w>
em enting</w>
her nia</w>
An gi
p ation</w>
high- performance</w>
di oxide</w>
F eb
medi as
ad junc
po is
trans verse</w>
ren in</w>
ess entially</w>
lipos omes</w>
H I</w>
D aw
knock out</w>
sha m</w>
hor ses</w>
di az
at ch</w>
Ger many</w>
tr is
M ic
m outh</w>
om od
relati ves</w>
describ ing</w>
viol et</w>
3 7
construc ts</w>
absc ess</w>
I Q
t onic</w>
Struc tural</w>
multi disciplinary</w>
reproduc ible</w>
pos ites</w>
si s-
emplo ying</w>
bio availability</w>
m t
tic a</w>
car ies</w>
- treated</w>
bal anced</w>
R D</w>
ob arb
n ull</w>
hy dra
el ast
cis -
CH D</w>
r ule</w>
er t</w>
R ats</w>
preferen tially</w>
cluster ing</w>
obser ver</w>
over lap</w>
ur ance</w>
br ac
survi ved</w>
dist or
predic ts</w>
as cor
cor tic
vast atin</w>
P W
retri ev
ter med</w>
seas onal</w>
iso form</w>
In tro
cohe rence</w>
Gl uc
benz ene</w>
1 40</w>
l nc
e pa
c a</w>
swit ch</w>
criter ion</w>
ide a</w>
F ib
var ic
mathem atical</w>
8. 8</w>
g ed</w>
od es</w>
Feb ru
ul ed</w>
am yg
Associ ated</w>
mi RNA</w>
regar ded</w>
aug mented</w>
ti ters</w>
transmit ter</w>
A1 c</w>
mos quit
ur ane</w>
glyc ogen</w>
T rial</w>
non- invasive</w>
P ac
vom iting</w>
in sp
bor ns</w>
P ulmonary</w>
ici an</w>
-1 8</w>
dam aged</w>
den sities</w>
so y
d airy</w>
iod ine</w>
pol e</w>
Ac tivation</w>
it e-
PA P</w>
desi r
di aphrag
in organic</w>
hydrox ylase</w>
ax onal</w>
har b
r ing
se arch
hem e</w>
H u
S il
lim itation</w>
Syndrom e</w>
ph al
oc aine</w>
f ate</w>
- 2
dro pl
half- life</w>
sl ope</w>
ro und</w>
influ x</w>
Com pu
aden omas</w>
T O
Ram an</w>
eukary otic</w>
c .
ec topic</w>
disper sion</w>
lipopol ysaccharide</w>
high- dose</w>
adul thood</w>
canc er-
hom ozygous</w>
N 2</w>
Rel ati
ab str
anal ogs</w>
v ap
aver aged</w>
micro vascular</w>
fi er</w>
immobil ized</w>
stabil ized</w>
10 1</w>
xim ab</w>
envel ope</w>
re versal</w>
eclamp sia</w>
distingu ished</w>
in he
ad missions</w>
wa ste
De sign</w>
z er</w>
mes enteric</w>
placent a</w>
h all
immun ized</w>
fet us</w>
Nov ember</w>
compl aints</w>
integr in</w>
Amer ica</w>
hel ical</w>
icardi al</w>
cad her
introduc e</w>
al izations</w>
scin ti
aut on
over -
nan ot
cho ro
C s
4 8
sens ors</w>
Respon se</w>
Febru ary</w>
co ating</w>
arach id
glyc emic</w>
CYP 2
methion ine</w>
transi tions</w>
proc e
fre e-
surfact ant</w>
explan ation</w>
ation- induced</w>
col lo
5- HT
S af
protein ase</w>
in tubation</w>
s lower</w>
beli efs</w>
parathyro id</w>
S m
x ia</w>
foll icles</w>
Reg i
zer o</w>
S prag
leg al</w>
transl ated</w>
amyg dal
inher ited</w>
t ability</w>
immunop recip
dimen sion</w>
po orer</w>
r y</w>
highligh ted</w>
8. 9</w>
fertil ization</w>
fr am
m entally</w>
nan oc
gradu ate</w>
3 6
L ung</w>
B W</w>
P lat
o ides</w>
ep sil
Daw ley</w>
dis ulf
Relati onsh
IC 50</w>
gal ac
employ ment</w>
epa m</w>
intraper itoneal</w>
ph ant
EM G</w>
den at
S e</w>
st op
mut ase</w>
MEASURE S</w>
hydro ly
c ut</w>
all ic</w>
method ological</w>
exper t</w>
domes tic</w>
P L</w>
F 2</w>
manifest ation</w>
ph on
ad ding</w>
an k
ris t</w>
regi stration</w>
B s</w>
fluor ide</w>
se eds</w>
oz yme</w>
fer mentation</w>
desi red</w>
uni versal</w>
sensiti zation</w>
G A
res ected</w>
tr ab
F ood</w>
HIV- infected</w>
mut ated</w>
datas et</w>
P 2
ag ar</w>
them es</w>
um inal</w>
micro environment</w>
compet ence</w>
res uscitation</w>
Bre ast</w>
ogen -
qu i
os an</w>
199 4</w>
In j
b atter
re production</w>
Pot ential</w>
z ones</w>
spl enic</w>
epit ope</w>
ti um</w>
C- MS</w>
fl ight</w>
8. 0</w>
D I</w>
ha ir
n ex
dro p</w>
i. p.</w>
peri odic</w>
wor sen
derm atitis</w>
m us</w>
ac il</w>
con fined</w>
all erg
vol u
cl amp</w>
P BM
osmo tic</w>
her pes</w>
in struc
si zed</w>
an sw
ab ine</w>
ame ters</w>
com ing</w>
M n</w>
e diatric</w>
conver ting</w>
ear ly-
wor d</w>
plan ar</w>
C ycl
app en
DN F</w>
TGF- beta</w>
phospholip ase</w>
mutag enesis</w>
psori asis</w>
junc tions</w>
bil ir
sub mitted</w>
al i
ul ty</w>
prop yl
B in
all ergen
establ ishing</w>
plasmin ogen</w>
tryptoph an</w>
lat or</w>
ech anical</w>
Post operative</w>
lin ks</w>
P 450</w>
sequ ent</w>
pl ans</w>
ocy te-
conduc t</w>
synth et
phosphor us</w>
f asc
care ful</w>
cortico steroids</w>
ver ies</w>
high- resolution</w>
repeti tive</w>
hol ds</w>
gluc ose-
ver ing</w>
R N
pre treated</w>
O l
gluc ag
carr y</w>
gonad otrop
f used</w>
minim ize</w>
Experim ent</w>
micro gram</w>
Ad ult</w>
nucle ic</w>
calib ration</w>
circu it</w>
cycl in</w>
mo ving</w>
bi omedical</w>
pro found</w>
Cro hn</w>
assembl ed</w>
fu r</w>
cost- effective</w>
rati on
nam ed</w>
depl eted</w>
S tim
- 8</w>
8. 4</w>
precip itation</w>
g o</w>
enti onal</w>
T ogether</w>
re al
Ph en
inhal ation</w>
mening itis</w>
k y</w>
duod en
spermat ozo
ograp hy
acti vely</w>
li e</w>
dram atic</w>
vulner able</w>
ograph ics</w>
e y</w>
w w
sco red</w>
elong ation</w>
gen etics</w>
la w</w>
flex ibility</w>
P N
Con tin
U V-
u si
l aryngeal</w>
aberr ant</w>
cycl ing</w>
co de</w>
saliv a</w>
placebo- controlled</w>
ogni tive</w>
ari um</w>
trans form</w>
thrombo tic</w>
recur ren
kin ds</w>
5 p</w>
it ting</w>
el as
ter a</w>
re constitu
cord ingly</w>
ar ri
vesti bular</w>
Ca uc
ectom ized</w>
hemorrh agic</w>
High er</w>
g i</w>
ambi ent</w>
er ies</w>
insec t</w>
b red</w>
S K
K in
b uc
aer os
trab ec
hyper sensitivity</w>
10 5</w>
B ay
hypo theses</w>
Per form
Con sequently</w>
coll abor
en ously</w>
CA M</w>
Tw elve</w>
fluctu ations</w>
angi oplasty</w>
Transc rip
T P</w>
posi tioning</w>
entr icular</w>
U C</w>
ili ac</w>
ch -
P N</w>
i ents</w>
partic ipating</w>
verte brate</w>
G M</w>
mark et</w>
cycl ospor
em ental</w>
optim ize</w>
promo ters</w>
TL R
ex plic
ion ization</w>
mechanis tic</w>
po int
Differen tial</w>
jo b</w>
Eff icacy</w>
Specific ally</w>
overl apping</w>
R I
tr unk</w>
m o</w>
repe ats</w>
V s</w>
estim ating</w>
low ered</w>
- 7</w>
datas ets</w>
admini str
ge ographic</w>
as sum
ho t</w>
marg inal</w>
im ide</w>
use a</w>
9. 2</w>
h aps</w>
molec ul
caro ten
prob able</w>
po protein</w>
scaff olds</w>
sph eres</w>
menstr ual</w>
continu es</w>
cur ative</w>
commerc ially</w>
kill ing</w>
arrang ements</w>
dom eth
ophil ia</w>
un saturated</w>
i ety</w>
8. 1</w>
fac ility</w>
Y -
L ys
marg in</w>
consci ous</w>
us p
fo rest</w>
Lif e</w>
VE N
am o
autom atic</w>
Fac tor</w>
vis cos
C op
waveleng th</w>
dele tions</w>
integr al</w>
connec tions</w>
M odi
erythem at
fer ri
sol id-
l ib
cut -
Sou thern</w>
H s</w>
ang ular</w>
l t</w>
y o
IB D</w>
x anth
sil encing</w>
pro to
an us</w>
new borns</w>
mercur y</w>
detec tor</w>
fibr onectin</w>
SC T</w>
crystall ine</w>
re fr
ong ue</w>
C arb
arti le</w>
infer tility</w>
colon ies</w>
intrav enously</w>
Ch rom
bol us</w>
rec all</w>
non specific</w>
star ch</w>
ab oration</w>
N i</w>
8. 7</w>
low- dose</w>
pal sy</w>
N inet
persist ed</w>
cereb ellum</w>
pre frontal</w>
vic tim
C 3
play ing</w>
cho ol</w>
M ice</w>
ig u
M ale</w>
dis charged</w>
mo iety</w>
AL L</w>
bre ast
micro array</w>
pl aques</w>
cent ury</w>
se emed</w>
lith ium</w>
man age</w>
progres sively</w>
person nel</w>
heter ozygous</w>
chic k
Res p
poly acrylamide</w>
retin opathy</w>
hy gi
in dex
F ren
In flam
pro pi
D A
ud ge</w>
pro vision</w>
qu artile</w>
Cl assi
os keletal</w>
circum st
M Y
str a
os ity</w>
fac ts</w>
refl ecting</w>
haz ards</w>
on ds</w>
In sul
20 19</w>
del ta
k el</w>
soci o-
ru n</w>
1 60</w>
synovi al</w>
su ture</w>
con sumed</w>
1 a</w>
mo id</w>
F o
rel im
pac ing</w>
bloc ker</w>
si ded</w>
ap ine</w>
scaff old</w>
B S</w>
Can adi
er ous</w>
ch it
di s</w>
PI3 K</w>
P ri
B ut</w>
n om
RA S</w>
i on-
house hold</w>
smo ke</w>
evid enced</w>
cent res</w>
N .</w>
conjug ates</w>
pig ment</w>
9. 4</w>
bra fish</w>
9. 6</w>
angi ogenic</w>
kill ed</w>
Bcl -2</w>
b ones</w>
bio active</w>
opath ology</w>
moti fs</w>
benz o
desc ending</w>
or atory</w>
Ma j
categor ized</w>
te ach
hypot ension</w>
sist ent</w>
deman ds</w>
ob taining</w>
dist ances</w>
Surviv al</w>
constr aints</w>
gros s</w>
connec tive</w>
E A</w>
neurom uscular</w>
desir able</w>
IN E</w>
9. 3</w>
b y-
dis mutase</w>
qu ic
propag ation</w>
poll ut
IL- 8</w>
re acted</w>
eth an
INTER VEN
accept ance</w>
oxid ants</w>
retard ation</w>
c e
foc i</w>
RO C</w>
u sive</w>
Lym ph
G G</w>
swit ching</w>
1 -1
do w</w>
en or
interfer on-
bri ef
pris ingly</w>
il lo
bi ologically</w>
hep ar
d odec
azep ine</w>
here ditary</w>
199 2</w>
ar ial</w>
199 3</w>
presum ably</w>
infarc t</w>
L oc
retro grade</w>
C o</w>
pap ers</w>
Sec ond</w>
reser vo
fabric ated</w>
ph orb
Cauc asi
lip i
triglycer ide</w>
ak er</w>
glyc emia</w>
prin ting</w>
fu sions</w>
L a
r ating</w>
pro po
prote olytic</w>
cur ricul
b ud
sem i
16 S</w>
O P</w>
rein forc
P D-
K .</w>
fin ally</w>
cyt ology</w>
met al-
p up
flav on
tic -
lin ing</w>
mon ic</w>
Perform ance</w>
tem plate</w>
mor tem</w>
fib rom
im ag
V e
ran olol</w>
C p
BAL B</w>
or imetr
oth i
Scre ening</w>
ogen e</w>
mar ks</w>
Th ose</w>
remot e</w>
facilit ates</w>
perfor ation</w>
sc at
G V
aryn x</w>
V ol
S a
demonstr ation</w>
sp in
CA SE</w>
d ine</w>
wal ls</w>
ot roph
L- C</w>
p iv
challeng ed</w>
seg mental</w>
hyp oglyc
e pox
plasm ids</w>
cop e</w>
N at
mo un
posi tivity</w>
so ils</w>
feren ces</w>
au gh
abor tion</w>
Con versely</w>
Y oun
c itr
cop ies</w>
he dr
ul in
Al l
nat ri
L abor
Kore an</w>
tin s</w>
post- operative</w>
res orption</w>
at osis</w>
ultra structural</w>
b ases</w>
hy al
9. 1</w>
compart ments</w>
thic k
N CT
f ell</w>
B u
h ard</w>
Ex amination</w>
adequ ately</w>
waste water</w>
pri or
MI C</w>
M id
pat h</w>
f t-
anti retroviral</w>
Gn RH</w>
AD P</w>
centr ifug
G .</w>
inter acts</w>
Sing le</w>
GF P</w>
PR L</w>
T U
re vascularization</w>
amphet amine</w>
A N</w>
vir tual</w>
brid ge</w>
g aps</w>
diff ers</w>
Intro duction</w>
s acr
Pre vention</w>
i res</w>
ost er</w>
anes thetic</w>
M ental</w>
ic idal</w>
prim ers</w>
meth anol</w>
w rit
in ates</w>
D er
transpor ters</w>
constitu ents</w>
quin one</w>
N- acetyl
8 00</w>
Mat erials</w>
is c
ul ates</w>
cle ft</w>
classi c</w>
sph inc
mim ic</w>
di latation</w>
cor ro
time- dependent</w>
ous ness</w>
he ating</w>
B a
glut amine</w>
Gol gi</w>
ophosph ate</w>
inf used</w>
conjug ate</w>
public ations</w>
kin d</w>
na usea</w>
an ter
spermatozo a</w>
Cur rently</w>
C ys
T issue</w>
haem orrh
win dow</w>
suc cin
ru b
re a</w>
p 38</w>
up uncture</w>
u ed</w>
PG E2</w>
i otic</w>
ag it
shorten ing</w>
s ure</w>
H er
up- regulated</w>
onc ology</w>
ati onic</w>
ophosph amide</w>
id a</w>
n es
d ated</w>
4 6
F GF
E N</w>
E v
p mol</w>
Incre asing</w>
fruc t
nico tin
IO P</w>
produc tivity</w>
life- threatening</w>
Glob al</w>
y a</w>
cal ves</w>
ph yt
leng ths</w>
ste in</w>
phospholip ids</w>
trop ical</w>
stres ses</w>
T ai
ul t
con sent</w>
N -</w>
un de
volt age-
neuro endocrine</w>
enc e-
exper ts</w>
ten d</w>
R V</w>
viscos ity</w>
V .</w>
m apped</w>
T n
am el</w>
mess enger</w>
event ually</w>
dis soci
encap sul
ic ac
b order</w>
ic illin
s arcom
k now</w>
T T</w>
dometh acin</w>
tempor ary</w>
T2 DM</w>
lymph omas</w>
hab its</w>
EB V</w>
D Cs</w>
rec essive</w>
lymph atic</w>
alb icans</w>
ten si
eg ative</w>
er ship</w>
mobil ization</w>
Be sides</w>
ti gh
E LL
u n</w>
et c</w>
n on</w>
D ay</w>
uni variate</w>
me eting</w>
Post -
projec tion</w>
mean ing
modul ates</w>
H or
ty ph
0.0 6</w>
H ol
vacc inated</w>
ot opic</w>
glyco l</w>
a ren
ycl ine</w>
en tered</w>
Dat ab
ke ts</w>
CA T</w>
d ust</w>
mum ol</w>
electro physiological</w>
He ter
dis appeared</w>
therapeu tics</w>
organ izations</w>
design s</w>
sched ule</w>
cle a
f MRI</w>
Combin ed</w>
AT P-
1- year</w>
Q T
phen olic</w>
re l</w>
a un
calc ification</w>
Organ ization</w>
amp ut
cover ing</w>
Ha em
mic rom
uncer tain</w>
re str
aug mentation</w>
solub ility</w>
L o
ST -
fav our
f ra
B or
N i
olig osacchar
En d
ads orb
-1 6</w>
accoun ting</w>
man aging</w>
av ig
grad ed</w>
E stim
E mer
ra w</w>
health -related</w>
diag nose</w>
R CTs</w>
si RNA</w>
o king</w>
impair ments</w>
typ ing</w>
au tism</w>
sp ent</w>
gro w</w>
B ody</w>
O CT</w>
2 a</w>
Reg ulation</w>
aut opsy</w>
O T</w>
ul us</w>
multi variable</w>
M G</w>
gluc uron
Ger man</w>
V AS</w>
polar ized</w>
play ers</w>
Out come</w>
ain -
W est</w>
S mall</w>
fi able</w>
sugg estive</w>
c ot
sp ite</w>
hand ling</w>
In duced</w>
comm it
ur ium</w>
e sian</w>
H2 O</w>
R CC</w>
C ognitive</w>
caus ative</w>
continu ing</w>
triglycer ides</w>
P al
Six ty-
K O</w>
ir reversible</w>
dis sec
Sci ence</w>
H elic
bran ches</w>
D ATA</w>
volun tary</w>
termin als</w>
land scap
ant -
oc at
pro line</w>
accoun ts</w>
beg an</w>
St age</w>
II I
gradi ents</w>
J o
ot rex
μ M</w>
H al
b asi
scenari os</w>
H SP
defin ing</w>
st al
ub es</w>
k ept</w>
S HR</w>
it ance</w>
si al
sec onds</w>
F P</w>
encephal opathy</w>
li ves</w>
ur acil</w>
immun ocom
sub cellular</w>
am orph
P CI</w>
en es</w>
Wh ite</w>
pharmac y</w>
ol in</w>
path ic</w>
adv ance</w>
sti g
an tr
thym us</w>
Ital y</w>
T im
g rap
fib rous</w>
retriev al</w>
Therap eu
care fully</w>
lys osomal</w>
n aph
Pe diatric</w>
in activated</w>
blin ded</w>
inter mediates</w>
electrol yte</w>
H2 O2</w>
her ni
Z -
amin ase</w>
ography -
L P</w>
di mer
S AR
bra in
S eph
glucocortico id</w>
m Ab</w>
fo ot
no tic
pass age</w>
ap oli
expec tations</w>
y ment</w>
sou thern</w>
synthet ase</w>
ic on
ell ul
rel ating</w>
nar row</w>
Sprag ue-
t us
nor thern</w>
il ian</w>
we ar</w>
E duc
mod est</w>
P ositive</w>
cadher in</w>
prescrib ing</w>
analy se</w>
MM P-
mat urity</w>
Compl ete</w>
er n
0.00 4</w>
M n
tend s</w>
M ei
dem ographics</w>
ser ves</w>
9. 7</w>
199 1</w>
kill er</w>
pow der</w>
at ology</w>
bound ary</w>
concentr ated</w>
N H</w>
har v
ann ot
tr ain
M emb
form in</w>
char acter</w>
spectro scopic</w>
s un
coord inated</w>
f ly</w>
prote as
att acks</w>
ogly can</w>
Canadi an</w>
nor adrenaline</w>
l ign
ging ival</w>
nutri ents</w>
E X
z ol
SP ECT</w>
ot e</w>
am idal</w>
remo ve</w>
Sprague- Dawley</w>
P en
- 2-
lo t</w>
dox orubicin</w>
T echn
docum ent</w>
ch lo
uter us</w>
N ig
exhib iting</w>
y tic</w>
ocy cl
poll en</w>
alg ia</w>
reg urg
sed ation</w>
Pur pose</w>
d B</w>
9. 8</w>
vasopres sin</w>
diff ering</w>
om et
e ties</w>
m ang
individu ally</w>
W here
is let</w>
abol ism</w>
end ovascular</w>
ne -
os se
En viron
pac k
medi ator</w>
it -
bir ths</w>
nar row
Rap id</w>
glycos ylation</w>
c ations</w>
L ab
con e</w>
sex es</w>
per haps</w>
U NL
3 p</w>
His panic</w>
seg mentation</w>
TA TION</w>
Import antly</w>
S core</w>
scre w</w>
inter viewed</w>
l actic</w>
c ess</w>
acet yl-
AB ELL
endoth el
ABELL ED</w>
UNL ABELLED</w>
incorpor ating</w>
K 2</w>
cad mium</w>
programm es</w>
first- line</w>
Re si
bur st</w>
Fren ch</w>
nan os
gyr us</w>
omyel itis</w>
eff icac
s ati
sp oradi
innov ative</w>
sporadi c</w>
c ement</w>
cochle ar</w>
mod al</w>
1 st</w>
M c
mac rom
cathe ters</w>
Kn ow
stimul atory</w>
AM P-
form al</w>
ax illary</w>
Me di
COX -2</w>
sp ot</w>
chir al</w>
b is</w>
ep in
afferen t</w>
deform ity</w>
sp as
B L
PE G</w>
it ability</w>
ter ing</w>
dyst rophy</w>
at ectomy</w>
k g-1</w>
SM A</w>
Where as</w>
c e-
ati onary</w>
F re
re sted</w>
pop ular</w>
CB F</w>
100 ,000</w>
conduc ting</w>
cor on
Hb A1c</w>
ze brafish</w>
fir ing</w>
ethn icity</w>
Amer icans</w>
ag ers</w>
in puts</w>
calci um-
reason able</w>
computer ized</w>
b est
Sev ere</w>
age- matched</w>
end otoxin</w>
t ongue</w>
S le
Tai w
ic o</w>
conduc tivity</w>
ro x
bra ins</w>
lymph o
pro inflammatory</w>
circumst ances</w>
Pro tec
imped ance</w>
solub il
S em
2, 3-
addres sing</w>
T F</w>
hum oral</w>
circum ference</w>
lum inal</w>
Meth od</w>
O V
polymorph ic</w>
C CR
transc ribed</w>
program ming</w>
prec ed
CD 34</w>
at opic</w>
od op
IQ R</w>
medi ation</w>
ub in</w>
treat ment-
fibr in</w>
benz odi
M W
modi fying</w>
lymph ocytic</w>
st ock</w>
end point</w>
E ast</w>
conflic t</w>
com mod
caffe ine</w>
hydro l
leuc ine</w>
tre es</w>
C lo
enabl ing</w>
T CR</w>
pro pan
pa ediatric</w>
shif ted</w>
pi per
vascul ature</w>
M- CSF</w>
auto antibodies</w>
ir respective</w>
Random ized</w>
ur gent</w>
depos its</w>
ucle otide</w>
Pa ren
el ae</w>
consul tation</w>
we t</w>
projec tions</w>
l avage</w>
in ver
sp ray</w>
ol ine</w>
defin ite</w>
mic rom</w>
regi stry</w>
rel ate</w>
off -
C B</w>
arach no
occ ip
tr ich
fl an
parame tric</w>
ul as</w>
tit anium</w>
ock et</w>
mon key</w>
id ing</w>
h tt
st atin</w>
pre operatively</w>
f ol</w>
ush ing</w>
retri eved</w>
5 -</w>
ubiqu it
oscill ations</w>
aff or
pois oning</w>
quanti ties</w>
K m</w>
F GF</w>
anti body-
yl in
cen tered</w>
th elial</w>
polyp eptides</w>
re m
modi um</w>
tic us</w>
nit ros
bi ologic</w>
L it
cycl ophosphamide</w>
i or</w>
agit tal</w>
F c</w>
institu tional</w>
sal v
af ter
fic i
soy bean</w>
id in</w>
thre at</w>
per si
En dos
pseud o
otrex ate</w>
win ter</w>
suppor tive</w>
f entan
CE A</w>
cost- effectiveness</w>
we b
line ages</w>
ap nea</w>
asym metry</w>
me tic</w>
adv oc
b all</w>
se ed
ra ise</w>
D D</w>
gall bladder</w>
as ci
EC M</w>
gluc os
eff usion</w>
S ep
all- cause</w>
re d
min ority</w>
Lev el</w>
aly tic</w>
est s</w>
endoth eli
be hind</w>
Ir an</w>
sex ually</w>
har ve
v ig
B al
Inf ection</w>
disp ens
aldo sterone</w>
provid er</w>
os s</w>
M es
absorb ed</w>
circul atory</w>
en amel</w>
cross over</w>
St ress</w>
Lev els</w>
sensiti zed</w>
bin ary</w>
isot ope</w>
cholester ol
writ ten</w>
ac idosis</w>
soci ety</w>
disulf ide</w>
S CI</w>
u als</w>
nod al</w>
Cal ifor
co valent</w>
ec ology</w>
inhe rent</w>
brief ly</w>
tri ple</w>
organ iz
en e-
prop ranolol</w>
tumorig enesis</w>
sign al-
microsom al</w>
radio activity</w>
fem ur</w>
vertebr ates</w>
Tran si
reci proc
S Y
ME DL
fron t</w>
sub til
ifer ase</w>
iv ac
counter parts</w>
MAR Y</w>
o protein</w>
met er</w>
obacter ia</w>
10 2</w>
fal ci
sup ra
S s</w>
Bin ding</w>
sion ally</w>
plex us</w>
x- ray</w>
anti hypertensive</w>
CD 3</w>
P 4</w>
tox ins</w>
ubiqu i
ti ce</w>
chick ens</w>
F .</w>
encephal itis</w>
P PAR
Cal c
He La</w>
wea kness</w>
car inic</w>
fact orial</w>
- ATPase</w>
lamb da</w>
Know ledge</w>
constitu tive</w>
ad ec
T M</w>
A l</w>
per -
sp ots</w>
cit rate</w>
pa re
o ocyte</w>
he at-
Mg 2</w>
intell ig
et te</w>
trac er</w>
opo ie
-1 7</w>
E s
in effective</w>
particip ant</w>
Fam ily</w>
infu l</w>
r -
oc yst
surve yed</w>
ac illus</w>
am il</w>
isol one</w>
vesi cle</w>
chic k</w>
catal ase</w>
ac ycl
L og
thrombocyt openia</w>
fracti onal</w>
2 8-
z e-
falci par
anti fungal</w>
lip ase</w>
pa inful</w>
the -
MEDL INE</w>
c .</w>
Kore a</w>
al og
prec eding</w>
F T</w>
stric t</w>
neo plasia</w>
mat r
L R</w>
f ail</w>
al and</w>
-1 3</w>
cytos ol</w>
mT OR</w>
an os
ill ing</w>
ox yt
pac lit
m is</w>
B I</w>
down regulated</w>
sim plex</w>
1, 000</w>
l ings</w>
F lu
publ ication</w>
lipo proteins</w>
consum ing</w>
mon otherapy</w>
un likely</w>
Al tern
cataly st</w>
am -
ureth ral</w>
olec ules</w>
sh ed</w>
es cap
tel eph
ine- induced</w>
0 2</w>
p in</w>
te dly</w>
GI ST
H 3
Datab ase</w>
ot om
TR I
immun ocyto
Plas modium</w>
prote ases</w>
DNA s</w>
vol atile</w>
Tra um
brain stem</w>
erythemat osus</w>
ab ro
Medic are</w>
au x
sedi ment</w>
spher ical</w>
thic k</w>
struc tive</w>
lar val</w>
prim ing</w>
c ra
y- based</w>
AM I</w>
H 3</w>
myel in</w>
lo ok</w>
od end
F R</w>
p al</w>
identi fies</w>
synap ses</w>
R V
path ologies</w>
1 11</w>
sk ull</w>
well- known</w>
Ex peri
ound ation</w>
oph aryngeal</w>
lo ads</w>
shar ing</w>
i as</w>
adip ocytes</w>
fibr e</w>
Ap proxim
Therapeu tic</w>
in ium</w>
SU M
k eleton</w>
Bi om
un expected</w>
p ass</w>
le an</w>
sacr ific
alloc ated</w>
cholin esterase</w>
li um</w>
w el
mo tivation</w>
ang er</w>
peri odon
dic ated</w>
c m
st ationary</w>
Le w
G o
plac ing</w>
sp ong
3 H-
summar izes</w>
t i</w>
tub ules</w>
Th rom
cal modul
remark ably</w>
c ogn
C yto
behavi ours</w>
co sis</w>
phen y
enti n</w>
sym metry</w>
Califor nia</w>
hy ste
coun ting</w>
s o-
si dase</w>
B DNF</w>
am ylase</w>
3 9
nor mot
S elec
lear ned</w>
gra in</w>
is lets</w>
co des</w>
eng ue</w>
immun ost
nor mo
glyco proteins</w>
X enop
ther mod
z ym
oc occus</w>
Cor relation</w>
par ac
li ved</w>
radi us</w>
ultra violet</w>
Thir ty</w>
ti ter</w>
lymph aden
1 2.5</w>
Ar ter
exp iratory</w>
on cho
P F</w>
proced ural</w>
illustr ated</w>
rest or
li vers</w>
ech o</w>
Par t</w>
N umer
govern ment</w>
it ating</w>
G D
S B</w>
chron ically</w>
Mei er</w>
Experim ents</w>
o der
B O
in haled</w>
here in</w>
o venous</w>
i tions</w>
agricul tural</w>
coll aboration</w>
down regulation</w>
degrad ed</w>
ac upuncture</w>
Contro lled</w>
M B</w>
sp ond
Vis ual</w>
a way</w>
re pression</w>
cut- off</w>
Ad olesc
c esarean</w>
H is</w>
natri uretic</w>
mar ri
cou gh</w>
the ories</w>
Xenop us</w>
W nt</w>
microsom es</w>
NF- kappaB</w>
Mor tality</w>
se al</w>
Ze aland</w>
W he
mon ocyte</w>
ma ize</w>
vir tually</w>
C- reactive</w>
initi ate</w>
lac tation</w>
ICA L</w>
o is
ed ull
gen ome-wide</w>
all ed</w>
a stric</w>
monol ayer</w>
10 4</w>
O H-
Ex trac
indic ative</w>
k it</w>
yr in</w>
grad ing</w>
amygdal a</w>
c ru
glucag on</w>
po real</w>
Saf ety</w>
suffici ently</w>
asc ites</w>
thromb us</w>
H ar
meaning ful</w>
a i</w>
str ies</w>
AK I</w>
hemisph ere</w>
gran ule</w>
emb le</w>
4 4
oler ance</w>
Hy po
O s
diagnos ing</w>
Im plications</w>
on ym
in domethacin</w>
- di
in- hospital</w>
mix ing</w>
Ad en
f um
in appropriate</w>
extr ap
falcipar um</w>
tub es</w>
Ne w
trans l</w>
alk yl
buil t</w>
Col lege</w>
pac em
al ters</w>
ir rig
M IC
catheter ization</w>
wee k
emis sions</w>
dil ated</w>
bro mo
fl aps</w>
mach in
adolesc ence</w>
oc t
o -</w>
interf ere</w>
neutr alizing</w>
depart ments</w>
9. 0</w>
ol a</w>
itr on</w>
Ab out</w>
et ting</w>
elic it</w>
TH E</w>
car ni
expendit ure</w>
program med</w>
ac id
L ocal</w>
MR SA</w>
L ap
pos ing</w>
pal mit
aden ine</w>
my ocytes</w>
ut ely</w>
re agents</w>
co oling</w>
regul arly</w>
har m
he avi
ro dent</w>
9. 9</w>
deli ver</w>
R BC</w>
quic kly</w>
As perg
hel per</w>
Cl ass</w>
fol ded</w>
raz ole</w>
war f
Ma xim
strong est</w>
attit ude</w>
predn isolone</w>
pyr idine</w>
C o-
tw in</w>
Helic obacter</w>
nem at
brow n</w>
cor pus</w>
fl ora</w>
agglutin in</w>
opath ies</w>
coll ap
K apl
beta 1</w>
muscul oskeletal</w>
T D</w>
inten sities</w>
10 3</w>
dose- response</w>
Ig G
sum mer</w>
V- 2</w>
arachid onic</w>
el e</w>
n ar</w>
Kapl an-
agre ed</w>
ex ha
high- throughput</w>
scav eng
immunosup pression</w>
discrim inate</w>
c ationic</w>
concer ned</w>
od al</w>
lipi demia</w>
possi bilities</w>
ne y</w>
exce eded</w>
0. 75</w>
k il
arachno id</w>
di lu
fil ament</w>
grad es</w>
characteris ed</w>
emo tion</w>
E c
sw ine</w>
dissem inated</w>
cerebro vascular</w>
caud al</w>
p all
st ents</w>
S ER
Y or
r ational</w>
un iform
H E</w>
- associated</w>
e tine</w>
ap ati
1- 2</w>
hydro chloride</w>
dis plays</w>
cyclo hex
sw im
7 5
PF S</w>
cur v
l o</w>
ar ate</w>
co il</w>
Labor atory</w>
onc ogene</w>
tra in</w>
il st</w>
oid al</w>
cal f</w>
st ate-
0 5</w>
favour able</w>
ver ify</w>
strati fication</w>
sp ut
sup presses</w>
dig estive</w>
bilir ubin</w>
ammon ia</w>
insul in
summar ized</w>
impl ement</w>
ti de</w>
e tin</w>
expl oratory</w>
sp an</w>
log ic</w>
AN OVA</w>
ophysi cal</w>
applic ability</w>
ren ew
access ory</w>
accompl ished</w>
in- like</w>
Initi al</w>
sul fur</w>
po ie
neo plasm</w>
ing ual</w>
lin ear
elim inate</w>
decom pression</w>
oc rine</w>
sp p.</w>
NS AI
0. 15</w>
Net work</w>
there after</w>
pres entations</w>
colon y-
GT P</w>
0.0 8</w>
ac commod
Cor onary</w>
is tics</w>
g ar
c s</w>
protec ts</w>
bi ased</w>
sc ar</w>
S G</w>
sol ar</w>
pat ency</w>
intra uterine</w>
expon ential</w>
r as</w>
break down</w>
initi s</w>
full- length</w>
en comp
D ys
Fr ance</w>
keratin ocytes</w>
ser ological</w>
poly clonal</w>
dri vers</w>
paren teral</w>
allel ic</w>
De termination</w>
T em
co chemical</w>
neut rop
percep tual</w>
ail s</w>
rig id</w>
medic inal</w>
cortico sterone</w>
A O
r ules</w>
exer ted</w>
t ories</w>
14 C</w>
hom ocy
gro und
dis location</w>
unde restim
perox is
if t</w>
prop ensity</w>
reconstruc ted</w>
rh in
con focal</w>
ax on</w>
thym ic</w>
hemat oma</w>
electrophore tic</w>
tr ip
n esses</w>
Be fore</w>
int ox
2, 4-
h ole</w>
de plo
Kaplan- Meier</w>
stre ptoc
C he
low- density</w>
spec ified</w>
non- small</w>
LP S-
meth ane</w>
immun omod
pro- inflammatory</w>
comorb idity</w>
- free</w>
Inv entory</w>
duc tal</w>
198 9</w>
s orption</w>
ar ding</w>
tetra hydro
h CG</w>
B C
Addi tion</w>
cre ating</w>
eri atric</w>
es thetic</w>
epin ephrine</w>
grou ped</w>
fact or
resc ue</w>
Sim ult
y ph
198 8</w>
aden ylate</w>
Inj ury</w>
A V</w>
um p</w>
well ing</w>
m ating</w>
Pre gn
radio active</w>
e able</w>
pathophysi ological</w>
regurg itation</w>
dis continuation</w>
phant om</w>
A sia</w>
n if
ro c
saf ely</w>
S .
Elev en</w>
fif th</w>
ti a</w>
ocardi al</w>
one ur
FL D</w>
iton in</w>
antidepress ant</w>
confir ming</w>
PA H</w>
anti sense</w>
0.0 7</w>
f ill</w>
experi encing</w>
amni otic</w>
oc clud
Met a-
R em
month ly</w>
off ic
percent ages</w>
cont empor
rest ore</w>
platel et-
alter ing</w>
ofl urane</w>
ole ic</w>
fi ve-
g lu
sph ing
Pre operative</w>
spind le</w>
G i
ge ographical</w>
M ont
fore arm</w>
emb olic</w>
overex pressed</w>
sequ elae</w>
e o
in equ
Approxim ately</w>
ulcer ative</w>
ap on
Reg istry</w>
fin ite</w>
marg ins</w>
C 4</w>
anti serum</w>
epti dase</w>
or poreal</w>
sp orts</w>
Sequ ence</w>
vulner ability</w>
breast feeding</w>
tran s</w>
leuk emic</w>
sp p</w>
un ion</w>
ven om</w>
SUM MARY</w>
partic ulate</w>
r ight-
stri king</w>
Rec ur
- 1.
piv otal</w>
as sumption</w>
sec tor</w>
a ic</w>
pl ur
Vit amin</w>
ferri tin</w>
gra y</w>
1- 3</w>
T D
2 2-
e rec
I g</w>
inter ventional</w>
abdom en</w>
meth otrexate</w>
sti ll
L R
Al coh
out breaks</w>
FD G</w>
inf eren
tub ulin</w>
sl udge</w>
Mater nal</w>
concentration- dependent</w>
o dic
sem en</w>
Sub sequently</w>
n avig
traff icking</w>
loc omotor</w>
omegal ovirus</w>
exer ts</w>
fabr ication</w>
Sev enty-
electr on-
endometri osis</w>
neuro blastoma</w>
S i</w>
osens ory</w>
con sequently</w>
disrup ted</w>
confir ms</w>
recei ver</w>
S BP</w>
ic eptive</w>
matr ices</w>
differenti ating</w>
con sol
wor m</w>
dis solved</w>
SE S</w>
bo y</w>
Un like</w>
e au</w>
e k</w>
Larg e</w>
ex tinc
sens or
Ab s</w>
post synaptic</w>
char t</w>
habit at</w>
Asperg illus</w>
inter cellular</w>
3, 4-
thalam ic</w>
de formation</w>
vit re
exec utive</w>
pl ast</w>
ib ution</w>
aff in
neuro psychological</w>
inv ari
R ob
hierarch ical</w>
suff er</w>
Emer gency</w>
Str at
V R</w>
LD H</w>
aqu atic</w>
Con centr
scinti graphy</w>
Ul tra
hom es</w>
b up
Mut ations</w>
transp os
S pain</w>
differen tly</w>
chim eric</w>
psych osis</w>
dec arbox
ta ste</w>
mil l</w>
n ude</w>
osi des</w>
gener a</w>
s agittal</w>
V O
co bal
luc iferase</w>
ac cordance</w>
c ylin
th ening</w>
isch aemic</w>
tr if
suppl ement</w>
th ous
expec t
w rist</w>
NA D</w>
gran ular</w>
A 4</w>
ran ts</w>
pol ysaccharide</w>
methyl ated</w>
lat e-
cro p</w>
ocor tical</w>
in sensitive</w>
cor n</w>
salv age</w>
4 9
le ft-
emphasi ze</w>
IC C</w>
H om
oth or
ultras onic</w>
125 I-
pe er</w>
id y</w>
der line</w>
ph one</w>
tra di
brom ide</w>
gen ous</w>
spi ke</w>
ai ve</w>
de polarization</w>
ex tending</w>
t ants</w>
disease- free</w>
noc tur
qu asi
Bay esian</w>
t rou
P B</w>
flo or</w>
investig ators</w>
Youn g</w>
sp ort</w>
ge ometric</w>
weak ly</w>
traff ic</w>
suic idal</w>
special ist</w>
fac ulty</w>
b it
end- stage</w>
om ically</w>
cop ic</w>
fing er
IL-1 β</w>
P relim
PC A</w>
hygi ene</w>
ster ic</w>
di i</w>
y ran
Pro f
E L
oc ul
Ital ian</w>
re arrangement</w>
os per
aberr ations</w>
mus carinic</w>
fung us</w>
S elective</w>
appen dic
to sis</w>
heter ozyg
reli ably</w>
micro glia</w>
contr ary</w>
ro dents</w>
F -1</w>
oste oc
fraction ated</w>
g ol
D E</w>
At l
cl aims</w>
the red</w>
Maj or</w>
ro utes</w>
phenyl alanine</w>
sen escence</w>
protein uria</w>
PC R-
recurren ces</w>
har d
i us</w>
ivac aine</w>
enh ancer</w>
ip ot
pri ority</w>
judg ed</w>
Analy ses</w>
t s
cer ti
intr on</w>
at ax
tel om
leuk o
gam ma
sal ts</w>
w an
initi ating</w>
Di etary</w>
conjunc tiv
satis fied</w>
res ec
lap se</w>
y rate</w>
neigh b
Prelim inary</w>
Intr av
Tr yp
du plication</w>
cap abilities</w>
A u</w>
re ward</w>
in ase</w>
qu en
we aning</w>
ys in</w>
infu sions</w>
energ ies</w>
O SA</w>
avoid ed</w>
it oring</w>
H sp
dri ed</w>
teleph one</w>
carb oxy
br oncho
CT L</w>
mor ning</w>
attrib utes</w>
guid eline</w>
Clin ic
clin ician</w>
dis abilities</w>
P ap
cop olym
pre p
A ca
us sion</w>
propo fol</w>
ch ance</w>
par allel
tus sis</w>
C arcin
confoun ding</w>
f er</w>
in directly</w>
o in</w>
inter rup
Four ier</w>
down- regulation</w>
D esc
adhe rent</w>
m u</w>
arrhyth mia</w>
prin ted</w>
adrenoc eptor</w>
amino transferase</w>
Tw o-
oxif en</w>
some what</w>
re di
phorb ol</w>
am il
facilit ating</w>
substitu tions</w>
N GF</w>
te ar</w>
medic ines</w>
Relationsh ip</w>
G ly
w ire</w>
Chem ical</w>
b ar</w>
encapsul ated</w>
V ascular</w>
Strat eg
ET -1</w>
neur ones</w>
opin ion</w>
3 A</w>
ter at
somat ostatin</w>
r on
bund le</w>
b ub
cap ill
concep tual</w>
aden ovirus</w>
Measure ment</w>
ai ting</w>
Enh anced</w>
Dis e
enlarg ement</w>
Measure ments</w>
Ne ur
apoli poprotein</w>
Met abolic</w>
asc ending</w>
i v</w>
anth rac
Fif teen</w>
plo idy</w>
AL T</w>
it u
medull ary</w>
be ads</w>
dis solution</w>
id ol</w>
Ano ther</w>
paclit axel</w>
phag ia</w>
HB s
Ob serv
air ways</w>
orig ins</w>
en ol
collag en
chemo therapeutic</w>
B NP</w>
os elective</w>
hyste rectomy</w>
par a
poly ethylene</w>
br ids</w>
deb ate</w>
sym metric</w>
laparo tomy</w>
Th re
carb ons</w>
on ical</w>
AC h</w>
sc aling</w>
i ana</w>
dissem ination</w>
oneph ritis</w>
morph ologic</w>
PF C</w>
fraction ation</w>
12 3</w>
echocardi ographic</w>
confir mation</w>
at tend
sol e</w>
tax a</w>
drug- resistant</w>
jec t</w>
bl asts</w>
Gl c
det achment</w>
so- called</w>
lamin a</w>
in consistent</w>
Dec re
creatin e</w>
as par
4, 5-
de trim
u ve
ach ial</w>
radi olab
high- grade</w>
ept ors</w>
U s</w>
Cardi ovascular</w>
- re
om avirus</w>
Electr on</w>
ti ght</w>
e z
contrac eptive</w>
out flow</w>
ad ducts</w>
transfer rin</w>
om o
I S
harve sted</w>
IGF B
S mo
NA FLD</w>
orig inating</w>
visu alized</w>
cu ff</w>
Consi dering</w>
AP C</w>
gen otyp
Col lec
h ind
Sensi tivity</w>
EM T</w>
spre ading</w>
di ameters</w>
Up on</w>
r id
stres sed</w>
function ality</w>
SU B
il ing</w>
sle ep
spe a
di hydroxy
cytos keleton</w>
up- regulation</w>
ch aper
biom echanical</w>
curricul um</w>
yn aptic</w>
radio immunoassay</w>
ene di
hypertroph ic</w>
domin ated</w>
com promised</w>
h r
te a</w>
i NOS</w>
Com po
lec tin</w>
tim ely</w>
cri sis</w>
odend ro
enco de</w>
ser ving</w>
pos tin
Ac cur
hydro philic</w>
diver gence</w>
Lit tle</w>
Pre -
Del ta
cou ples</w>
di aly
catech ol
H TL
ex ons</w>
assist ance</w>
os um</w>
den er
Or th
normot ensive</w>
pharmac ologic</w>
D ist
A min
prim er</w>
C ri
in us</w>
tail ored</w>
M il
n ation
bra in-
min -1</w>
H N
hydrox yl</w>
cr im
Follow -up</w>
chit osan</w>
F ail
iz er</w>
acceler ation</w>
accept or</w>
chemo kine</w>
it ors</w>
trunc ated</w>
ac tually</w>
id ectomy</w>
ap amil</w>
D ou
re act</w>
Lap aro
cu stom
D ig
idi d
vi ri
pul sed</w>
my ri
ur idine</w>
silic on</w>
vi x</w>
grad ual</w>
tis h</w>
k o
gir l</w>
denti n</w>
tot ally</w>
circu its</w>
We b</w>
R SV</w>
eg ia</w>
she et</w>
E G
Sing le-
hydro gel</w>
decom position</w>
sal ic
wat ers</w>
polyp s</w>
spi ro
ti tle</w>
dat ory</w>
ir on-
am ong
solv ents</w>
am en</w>
am ate</w>
el eg
orig inally</w>
198 7</w>
trajec tories</w>
up date</w>
steroid al</w>
Physi ci
SM C</w>
ME NTS</w>
mt DNA</w>
Nor mal</w>
d res
potenti ation</w>
4 7
transpl ants</w>
O ut</w>
mal formation</w>
b rought</w>
yel low</w>
pros theses</w>
anti oxidants</w>
p ran
periodon titis</w>
end points</w>
sulf on
fit ted</w>
l ide</w>
ICA M-1</w>
15 7</w>
tod ay</w>
syn thesi
10 6</w>
6- month</w>
accum ulate</w>
2 3-
w ri
insulin- like</w>
fl ag
hapl otype</w>
n aive</w>
teri ous</w>
30- day</w>
100 -
1 B</w>
fel t</w>
bl ast</w>
- 9</w>
at rop
System ic</w>
immobil ization</w>
clea ved</w>
ak es</w>
pen icillin</w>
O 3</w>
oun d-
um ination</w>
CR F</w>
NA C</w>
l ex
6 7
lact am
ot emporal</w>
homogene ity</w>
in ing</w>
an es</w>
ysacchar ides</w>
pur su
deri ve</w>
Insul in</w>
ur able</w>
promp t</w>
En gland</w>
Braz ilian</w>
M F</w>
β 1</w>
N r
D SM
contrib ut
inst ances</w>
NAD PH</w>
alloc ation</w>
pa id</w>
succ essive</w>
sched uled</w>
w est</w>
Ac cordingly</w>
5- FU</w>
spac es</w>
pul p</w>
ir regular</w>
cholecyst ectomy</w>
di lation</w>
f is
an te
manifest ed</w>
ac tors</w>
al s.
ger m
go es</w>
S n
onc ogenic</w>
conven ient</w>
T op
Ex c
il -
occip ital</w>
par aff
im mer
ro d</w>
cut off</w>
re agent</w>
mom ent</w>
interfer ing</w>
post ulated</w>
antigen -
impl ementing</w>
ren sic</w>
throm ycin</w>
p 21</w>
v ocal</w>
c all</w>
m ass
enti rely</w>
G M-CSF</w>
phag ocytosis</w>
col lege</w>
hedr al</w>
neuro protective</w>
syn thesize</w>
at ase</w>
predic table</w>
is ely</w>
ser otype</w>
sol ely</w>
fail ures</w>
N B
Pos sible</w>
On c
c umin</w>
Whe ther</w>
rec ycl
ing redi
retin oic</w>
lat tice</w>
com ycin</w>
M K
perc enti
Taiw an</w>
SUB JEC
har m</w>
at tended</w>
PM N</w>
M F
exc ised</w>
insec tic
reve aling</w>
omat osis</w>
G E
selen ium</w>
mes h</w>
G B</w>
del ays</w>
Y et</w>
harm ful</w>
suppl ements</w>
SIG N
sign ature</w>
platin um</w>
lab elling</w>
atr y</w>
oph er
ophyl line</w>
for tun
rel ig
o esophageal</w>
ox one</w>
len ses</w>
resi li
st aphyloc
anti coagulation</w>
2- year</w>
in tran
bre ath</w>
br ile</w>
fit ting</w>
Sur face</w>
MC F-
le b
m e</w>
Re sistance</w>
acr ylate</w>
distric t</w>
I K
le af
an ia</w>
Stro ke</w>
ap art</w>
as k</w>
arsen ic</w>
V L
tab lets</w>
chromat ography-
ration ale</w>
angi ographic</w>
osi tis</w>
R ab
dis ordered</w>
efficac ious</w>
C re
hel ps</w>
refl ection</w>
oligonucle otide</w>
B l
t et
addic tion</w>
mol ars</w>
g em
ograp h</w>
RE GIST
Peri ph
CR T</w>
ogen y</w>
vol ution</w>
I F</w>
d ural</w>
epider mis</w>
ofl av
rough ly</w>
v is</w>
is s</w>
strom a</w>
compens ation</w>
so on</w>
pyr amidal</w>
v or
M u
eradic ation</w>
C am
contex ts</w>
dele terious</w>
cl ients</w>
posi tional</w>
in ability</w>
extrem ities</w>
his tidine</w>
erythro poie
un like</w>
1, 2-
foll icle</w>
anticoagul ant</w>
cre ation</w>
suspici on</w>
Gen ome</w>
sol itary</w>
design ing</w>
Ar g
Low -
bil ayer</w>
down- regulated</w>
bas ement</w>
month -old</w>
ill a</w>
e ste
g ast
AK T</w>
depos ited</w>
el bow</w>
scenari o</w>
Suc cess
distinc tive</w>
c m2</w>
cad aver
F E
An xi
re generative</w>
O per
ec tual</w>
F low</w>
meth an
typ e-
hyper glycemia</w>
asth matic</w>
on itr
lear n</w>
N eu
produc tive</w>
go v</w>
bor derline</w>
F er
acet ylation</w>
3 5-
al ive</w>
S ens
PM A</w>
contempor ary</w>
cortico steroid</w>
AP P</w>
apati te</w>
W a
streng ths</w>
met formin</w>
virul ent</w>
g et</w>
medull a</w>
metr ics</w>
bi osens
physi cochemical</w>
community- based</w>
RA TION</w>
ox y</w>
Bas eline</w>
negl igible</w>
i ence</w>
pollut ants</w>
E ch
ven a</w>
Commun ity</w>
val ves</w>
subtil is</w>
co vari
D en
roph yl
ic os
dop ed</w>
er ation</w>
us sian</w>
micro mol</w>
r if
inter active</w>
Clo str
ker atin</w>
edull ary</w>
extra -
5 3-
landscap e</w>
ov ine</w>
TE M</w>
Pol ym
F EV
alk yl</w>
T S
hor t</w>
defici encies</w>
idid ym
γ -
reser ve</w>
i odi
among st</w>
mis sed</w>
develop s</w>
stre pto
qu ine</w>
gen e-
pan demic</w>
hepat ocyte</w>
sump tions</w>
hy brids</w>
Ur inary</w>
heter ologous</w>
electro static</w>
PA GE</w>
post ural</w>
h ands</w>
micr o</w>
10 8</w>
sub populations</w>
bi phasic</w>
bl ings</w>
scop ically</w>
function alized</w>
c GMP</w>
an di
alb umin
inv asi
ta m</w>
oste otomy</w>
L ear
des ensi
h app
Yor k</w>
N utri
AD P-
wid er</w>
caspase- 3</w>
SUBJEC TS</w>
refl ex
gener ic</w>
prof en</w>
an z
diagnos tics</w>
- -</w>
I M</w>
ot ed</w>
hem odynamics</w>
allerg en</w>
fru its</w>
8 ,
pal ate</w>
supernat ant</w>
dis comfort</w>
adv ice</w>
pat ches</w>
Rel ated</w>
Tri als</w>
0 3</w>
opath ologic</w>
NCT 0
r yst
mal nutrition</w>
ED TA</w>
dis abl
ul ins</w>
arg ue</w>
p ocket</w>
l umin
00 1</w>
az one</w>
accid ent</w>
can onical</w>
Ch lamy
13 3</w>
C as
pol ys
n ess
po res</w>
qu estion
gen tam
ov ulation</w>
trigg ers</w>
L 2</w>
I sl
ecosy stem</w>
atmosph eric</w>
transcriptom e</w>
possess es</w>
ch a
vi ro
SD S-
cross- linking</w>
ill nesses</w>
sta ke
Rep e
wo od</w>
c ured</w>
Isol ation</w>
escap e</w>
struc ture-
meth oxy
health -
necess arily</w>
en oic</w>
itud es</w>
prolifer ating</w>
organiz ational</w>
day -old</w>
lin early</w>
Sp anish</w>
no tion</w>
non- specific</w>
intrav ascular</w>
util ize</w>
endocardi tis</w>
ater ally</w>
ic us</w>
ber g</w>
A v
ar ranged</w>
g ating</w>
oph ore</w>
thick ening</w>
mon omer</w>
CL IN
st op</w>
log y</w>
galac to
in di
B SA</w>
detrim ental</w>
microtub ules</w>
olig odendro
MEASURE MENTS</w>
rac ial</w>
2 B</w>
surg eries</w>
L- arginine</w>
M r</w>
In duction</w>
proxim ity</w>
me aning</w>
Sam ples</w>
sep tum</w>
q PCR</w>
hypo thermia</w>
fav or</w>
adop tion</w>
cer vix</w>
ra is
Sle ep</w>
high- density</w>
parasi tic</w>
perm its</w>
hor n</w>
198 5</w>
correspon ded</w>
e igh
sp in-
S DS</w>
phosphatidyl choline</w>
metr ical</w>
an tin
serot on
agg ed</w>
expl oring</w>
acces sibility</w>
Ex pl
immunoprecip itation</w>
por ph
On t
temper at
hyper cholesterol
appropri ately</w>
dend r
H o
sem antic</w>
w it
MT T</w>
tr ib
bo ard</w>
polymer ic</w>
M en
Func tion</w>
yr ic</w>
leuk aemia</w>
10 7</w>
t ar
mening i
STAT 3</w>
G astro
Periph eral</w>
disp arities</w>
Im pl
2- 3</w>
arteri ovenous</w>
REGIST RATION</w>
1 15</w>
oxyt ocin</w>
chondro cytes</w>
devi ations</w>
us tion</w>
auth or
GB M</w>
im urium</w>
Gl yc
MCF- 7</w>
tit ude</w>
st y
ati vity</w>
P ear
progenit ors</w>
re per
in version</w>
ish able</w>
vi sions</w>
hormon e-
st yle</w>
P arti
J NK</w>
tic k</w>
bab ies</w>
hypo thyroidism</w>
Bacter ial</w>
lid ocaine</w>
per tussis</w>
segreg ation</w>
medias tinal</w>
com posites</w>
Caucasi an</w>
an il
P he
k cal</w>
mes oth
CX CR
altern atives</w>
inf requ
ste in-
agglutin ation</w>
sup pressing</w>
sed entary</w>
de duced</w>
epidemi ologic</w>
tain ment</w>
dis appearance</w>
C EN
famil iar</w>
exist ed</w>
contracti lity</w>
mil itary</w>
incre mental</w>
5- fold</w>
F -1
T el
stand ar
perm it</w>
docum entation</w>
Ne ther
re arrangements</w>
val ently</w>
v oc
batter y</w>
are s</w>
L oss</w>
innerv ation</w>
noctur nal</w>
p uncture</w>
In deed</w>
Ex erc
her bal</w>
special ty</w>
paren chym
Com mit
m y</w>
diab etics</w>
check point</w>
tun nel</w>
A β</w>
out patients</w>
M et</w>
spectro phot
agg ression</w>
198 6</w>
ati zation</w>
cigaret tes</w>
el lo
ep ididym
d engue</w>
pol arity</w>
sp o
mod eled</w>
N ic
In -
ec e</w>
ac ro
analy tic</w>
mod ule</w>
lo ops</w>
yiel ding</w>
expan ding</w>
oste osarcoma</w>
19 80</w>
Gu id
computer -
im balance</w>
ho st-
micr ons</w>
0.00 6</w>
ris ing</w>
ul ae</w>
osse ous</w>
hydrol ase</w>
sub clinical</w>
M G
7 0-
met allic</w>
Cl 2</w>
lute al</w>
z ine</w>
nitr ite</w>
spar ing</w>
g ains</w>
employ ees</w>
Tran spl
p ed
AC L</w>
MT X</w>
on a</w>
reservo ir</w>
rheum atic</w>
warf arin</w>
aggreg ate</w>
gli oblastoma</w>
Swe den</w>
toler ability</w>
surviv ing</w>
ampl itudes</w>
Grou ps</w>
gu anine</w>
ab is</w>
special ists</w>
T yr
C T-
P t</w>
h an
Di str
s and
L ang
Hist ological</w>
F il
trac k</w>
2 40</w>
my c</w>
24- h</w>
step wise</w>
bi osynthetic</w>
anc e-
pro pri
enti ties</w>
cat alysis</w>
Rep or
cl e-
em inal</w>
gener ates</w>
avoid ing</w>
presum ed</w>
b and
es cal
plur ipot
imp ly</w>
chol angi
Sp ont
os mol
B lack</w>
prep are</w>
P AC
Classi fication</w>
te ams</w>
si mp
K E
O ve
A ver
HER 2</w>
Ch ild</w>
en ters</w>
as sumptions</w>
Immuno histochemical</w>
2 1
vir us
exc ited</w>
Mit ochond
em ent
sphinc ter</w>
gu n</w>
defin itions</w>
MD D</w>
Le ft</w>
2 R</w>
hyper activity</w>
or n
ad ox
eri an</w>
Nether lands</w>
d s
toler ant</w>
n ich
acet ab
ca emia</w>
0.9 9</w>
L iter
PA F</w>
met a
Pan cre
Success ful</w>
mo ve</w>
hy pe
con stitutes</w>
O X
si blings</w>
spl it</w>
fl at</w>
ly tic</w>
sulph ate</w>
pos itron</w>
Pre viously</w>
Inc idence</w>
AT 1</w>
C RE
pati al</w>
ph i</w>
do si
radi ography</w>
estro gens</w>
AV P</w>
mot oneur
ran ean</w>
distingu ishable</w>
oxid es</w>
inc i
Rev er
U L
hypoglyc emia</w>
Long itudinal</w>
12 6</w>
exp and</w>
obarb ital</w>
sput um</w>
CA P</w>
W ater</w>
tigh tly</w>
al ge
es us</w>
N ec
over load</w>
ro bu
phot osynthetic</w>
his ti
puber tal</w>
thal ass
cry op
insec ts</w>
cho ices</w>
plo ts</w>
free zing</w>
A SA</w>
cong ru
micro spheres</w>
ile um</w>
enlarg ed</w>
ac yl</w>
lit er</w>
Mex ico</w>
lac ks</w>
10 9</w>
neuro transmitter</w>
amput ation</w>
mit ogen-
on uc
d ol
T GF
Four teen</w>
de al</w>
physi cally</w>
Qu al
µ g</w>
S L</w>
un necessary</w>
CLIN ICAL</w>
som nia</w>
Struc ture</w>
simp ly</w>
0.0 9</w>
pestic ides</w>
is op
inter play</w>
m .</w>
man n</w>
w ater
pran dial</w>
ingu inal</w>
f 2</w>
N ot</w>
L y
compet ent</w>
onucle ase</w>
atin s</w>
tw ins</w>
H yp
broad er</w>
Plat el
PC a</w>
necess ity</w>
de ad</w>
ut ch</w>
evol ving</w>
Vir us</w>
β- catenin</w>
refr active</w>
anti sera</w>
R ou
emphasi zed</w>
self- efficacy</w>
hemat ological</w>
accid ents</w>
real istic</w>
ul um</w>
mal on
dodec yl</w>
ent rop
eosinoph ils</w>
B ro
cyt omegalovirus</w>
en su
tri phosphate</w>
sex -
co ded</w>
Ox y
la g</w>
In di
clinic opathological</w>
vesi cular</w>
FI SH</w>
rel ies</w>
ac idi
par alysis</w>
covari ates</w>
reg ime</w>
fil ters</w>
B el
prec isely</w>
s en</w>
orth op
Cor rec
depend ency</w>
Isol ated</w>
beta- D-
du plex</w>
Fem ale</w>
D oes</w>
R C</w>
v ular</w>
1 12</w>
I U
plac es</w>
ph ase-
Ol der</w>
fu el</w>
ther mic</w>
machin ery</w>
top ics</w>
icon duc
phosph odi
I X</w>
0 4</w>
condi tional</w>
fac ing</w>
cap tured</w>
fluoresc ein</w>
Ove rex
ol og</w>
Compu ted</w>
Low er</w>
pro pos
n ev
amin op
P O</w>
in takes</w>
D N</w>
sy ring
allergen s</w>
mir ro
Le ishman
integr ating</w>
u sions</w>
Stand ard</w>
Gr ade</w>
cell- mediated</w>
tw enty-
victim s</w>
age ing</w>
ri t</w>
An g
fin ement</w>
tid al</w>
immun ologic</w>
impl ies</w>
cataly sts</w>
electro my
requ is
ha m</w>
gr ass</w>
potenti ated</w>
prote ren
obacter ium</w>
histopath ology</w>
chol est
comorb id</w>
Sym ptom
sig ma</w>
normal ization</w>
Anxi ety</w>
Mo der
ur a</w>
eng aged</w>
Stim ulation</w>
selec ting</w>
config ur
b im
t ag
ar yl</w>
Con sistent</w>
N B</w>
Serv ice</w>
inc is
per iton
b atch</w>
extr a</w>
extinc tion</w>
reser ved</w>
Com plex</w>
intell ectual</w>
le i
il ty</w>
9 ,
hem angi
ific ations</w>
P i
4 5-
Ac et
d rought</w>
C ity</w>
PC OS</w>
toc opher
rel in</w>
Ac id</w>
A 3</w>
cardiomy ocytes</w>
miner alization</w>
Gram -negative</w>
anticip ated</w>
1 b</w>
Com plications</w>
cong estive</w>
exerc ises</w>
gener ations</w>
2 b</w>
GV HD</w>
s mar
Inter net</w>
v ast</w>
ev ery
re d-
sustain able</w>
ep sin</w>
projec ts</w>
M H
Educ ation</w>
F M</w>
determin es</w>
adsorb ed</w>
bec tomy</w>
tetr am
pyr ro
prec eded</w>
flow s</w>
rot ational</w>
pat ent</w>
L E</w>
spati ally</w>
mechan ics</w>
sedi ments</w>
represent ations</w>
atin ib</w>
depend ed</w>
- 3
Ch ol
occa sionally</w>
E SR
W I</w>
neph rectomy</w>
di chloro
k e-
e i</w>
D im
orth odontic</w>
sto ol</w>
flan king</w>
con cordance</w>
toxic ities</w>
reg res
ogly co
st ores</w>
anomal y</w>
obste tric</w>
nanop article</w>
ocyst s</w>
als. gov</w>
anaes the
FEV 1</w>
P s
bic arb
nec rotic</w>
sc ann
but yrate</w>
Fail ure</w>
vo ice</w>
nan o-
oin t</w>
Fe w</w>
Pre treatment</w>
tho rough</w>
C G
eleg ans</w>
Thre e-
tetrac ycline</w>
exclud ing</w>
ma kers</w>
fortun ately</w>
pres ynaptic</w>
PP V</w>
pro ton
ke eping</w>
til es</w>
Individ uals</w>
doc king</w>
N- methyl-
ter ic</w>
CR I
plat eau</w>
rup tured</w>
ad mill</w>
IV F</w>
As s
Nur sing</w>
ex tern
yl- CoA</w>
R ho
bronch i
VI P</w>
k a</w>
5 5
Inter action</w>
penetr ating</w>
de tox
opi oids</w>
ac in
hemat ologic</w>
o edema</w>
Clostr idium</w>
CH F</w>
monol ayers</w>
Hepati tis</w>
p unc
Pri or</w>
compens atory</w>
alg ae</w>
Met ast
Collec tively</w>
cyt ogenetic</w>
Nat ural</w>
inf ancy</w>
o con
immunost aining</w>
ver apamil</w>
AN P</w>
bon y</w>
aud i</w>
disper sed</w>
ar ded</w>
II -
neo adjuvant</w>
otrop y</w>
parenchym a</w>
Co hort</w>
edi pine</w>
survi ve</w>
nucle oside</w>
vul g
oper ate</w>
rh initis</w>
proteas ome</w>
Cr yst
AC C</w>
di mers</w>
err y</w>
An d</w>
rec tum</w>
prin t</w>
Desc rip
diarr ho
ing e</w>
4 50
up dated</w>
inform atics</w>
hapl otypes</w>
epsil on</w>
appro val</w>
lymph oblastic</w>
oci ties</w>
CA BG</w>
PA R</w>
Ab str
off ice</w>
Th yro
G Ps</w>
fal se-
correspon d</w>
Elev ated</w>
lo oked</w>
bi o-
resid ence</w>
5 49</w>
flu idic</w>
NA c</w>
worsen ing</w>
radi ologic</w>
anten atal</w>
coll ateral</w>
Gl ut
am ol</w>
.00 01</w>
Eigh ty-
ir r
W S</w>
For mul
electr on
under lie</w>
bu ild</w>
sh i
P a</w>
os clerosis</w>
am ides</w>
B CG</w>
V III</w>
prost atectomy</w>
sur face-
5- hydroxy
10- year</w>
0. 10</w>
pepti d
secre ting</w>
microbi ome</w>
Ad ults</w>
f lies</w>
integr ate</w>
sion- free</w>
mix ed-
si d</w>
Endos copic</w>
she ath</w>
aut oradi
st och
Character istics</w>
prop yl</w>
re vised</w>
en ke
S P-
p y</w>
A Z
u z
anc ing</w>
Pop ulation</w>
V alu
pelv is</w>
L VE
E ar
pacem aker</w>
Cl -</w>
lip id-
ich i
incorpor ate</w>
ubiqu itin</w>
E 3</w>
intram uscular</w>
excit ability</w>
TRI AL</w>
consci ousness</w>
emul sion</w>
Ar e</w>
g .
haem oglobin</w>
thi o
teach ers</w>
24- hour</w>
electro encephal
compe ting</w>
son ography</w>
import antly</w>
Ad ju
IL-1 2</w>
i um-
vel ocities</w>
i- square</w>
obl ast
min d</w>
s ac</w>
Resp iratory</w>
de myel
ed om</w>
fri end
bound aries</w>
trajec tory</w>
F as</w>
gra vity</w>
histopath ologic</w>
Re duc
pl asts</w>
ere bro
centrifug ation</w>
it ch</w>
reciproc al</w>
not ably</w>
view ing</w>
stabil izing</w>
per ic
L F</w>
ex in</w>
constitu tively</w>
self- report</w>
we en-
conf er</w>
A Q
ubiqui tin
hem olytic</w>
C- H</w>
PL ICA
bl es</w>
opa edic</w>
as tig
l ag
stress ors</w>
Rel ative</w>
dis pers
ac tu
vascul itis</w>
sec urity</w>
carni tine</w>
ec to
compr ises</w>
ED s</w>
int enti
progres sed</w>
Spont aneous</w>
uber cul
C erebral</w>
consum ers</w>
guine a-
n als</w>
Six teen</w>
d le</w>
ent ous</w>
middle- aged</w>
ju ice</w>
Cr yp
Hep at
Min im
R PE</w>
HBs Ag</w>
D F</w>
t ying</w>
M H</w>
K D</w>
ad d</w>
gen otyping</w>
proper ly</w>
O ne-
age -</w>
5- fluoro
it ate</w>
hyp og
ath eter</w>
ex ud
kin ase-
remo ving</w>
no -
Med iter
D ynamic</w>
propor tion
mon ophosphate</w>
2- fold</w>
pul s
collabor ative</w>
colum ns</w>
S kin</w>
ing dom</w>
rhe a</w>
fe brile</w>
13 5</w>
Individ ual</w>
ipp ed</w>
G H
mis match</w>
II I-
an ions</w>
wh ilst</w>
o ils</w>
resul tant</w>
M CI</w>
at or-
pers on-
k m</w>
ish er</w>
9 0-
E d
cul tivation</w>
ser um-
psych ometric</w>
Pu blic</w>
20 1</w>
metallo protein
nal oxone</w>
where by</w>
B F</w>
sup pressive</w>
transi t</w>
ro ta
selec tin</w>
highligh ting</w>
nod ule</w>
simul ate</w>
eth ics</w>
por tions</w>
ob stac
oglyc ans</w>
dis k</w>
ster ile</w>
v ent
is omers</w>
pre eclampsia</w>
In c</w>
intr ad
quad r
tissu e-
id el
fruct ose</w>
abs orp
ham sters</w>
l aryng
der al</w>
G W
on ium</w>
Ad he
T PA</w>
pro x
thalam us</w>
S TI
N PC</w>
nan ow
Com put
F E</w>
col our</w>
Car lo</w>
em ent-
GR P</w>
Mus cle</w>
Me an
12 8</w>
fro g</w>
usp id</w>
13 1</w>
0 6</w>
sem inal</w>
th en
graph ic</w>
oc rit</w>
peri -
preferen tial</w>
arch a
t acti
MA -
silic one</w>
br achial</w>
stret ch</w>
read mission</w>
G- CSF</w>
co operation</w>
oc ks</w>
high- quality</w>
n ic</w>
Shor t</w>
P t
HC l</w>
disturb ed</w>
ill i</w>
po ols</w>
eng age</w>
am y
all op
0 9</w>
L N</w>
aeros ol</w>
tun ing</w>
MMP- 9</w>
ec ta
shap es</w>
ecosy stems</w>
oc ele</w>
accept ability</w>
B loc
mag n
sarco idosis</w>
of requency</w>
tam oxifen</w>
enro ll
test es</w>
ï ve</w>
V A
fibr ils</w>
v on</w>
Dise ases</w>
index es</w>
ur onic</w>
Thir teen</w>
ox ane</w>
transpor ted</w>
B P
m l
transi ently</w>
impl ant
cam pa
casp ase</w>
multic entr
Re duction</w>
18 7</w>
0.00 7</w>
xi a-
microtub ule</w>
simpl ified</w>
omorph ic</w>
consi st</w>
V acc
SP R</w>
os ed</w>
W M</w>
scar ce</w>
th an
b us
ari an</w>
or um</w>
d .</w>
Mon itoring</w>
fol i
M is
D X
ch ip</w>
pon ectin</w>
sub arachnoid</w>
ch i</w>
M N</w>
ac utely</w>
fo rensic</w>
hol ders</w>
cas ein</w>
prote olysis</w>
sup ine</w>
Overex pression</w>
- binding</w>
f are</w>
N uclear</w>
re place</w>
f ec
quanti tation</w>
Commit tee</w>
ana emia</w>
Log istic</w>
Eff ici
bel ong</w>
prof loxacin</w>
az ide</w>
A x
ynam ics</w>
phen ols</w>
V max</w>
is ometric</w>
imid azol
Lac tob
se d-
MD A-
b aro
ca va</w>
form at</w>
Ri ver</w>
dys regulation</w>
paras it
infiltr ating</w>
neuro pathic</w>
n ame</w>
Pear son</w>
coll ecting</w>
il eal</w>
shar p</w>
coll ect</w>
rhyth ms</w>
M em
Dis orders</w>
achiev ement</w>
continu ity</w>
inher itance</w>
M ass</w>
sol ving</w>
si x-
mig rants</w>
er ated</w>
mim icking</w>
Objec tives</w>
sk ill</w>
gre w</w>
correspon ds</w>
FO X
it or</w>
sub tle</w>
A sp
Symptom s</w>
co res</w>
M SC</w>
ket amine</w>
tre admill</w>
thir ds</w>
gastro enter
end urance</w>
p H-
ocy st</w>
S -1</w>
paren chymal</w>
inter medi
Th 1</w>
0. 12</w>
mod ules</w>
CH O</w>
z ot
F ree</w>
C lu
isch aemia</w>
ster il
organ elles</w>
back bone</w>
Mediter ranean</w>
si veness</w>
micro satellite</w>
RE M</w>
smal l
pur ity</w>
phosphatidyl inositol</w>
Ac tiv
0 7</w>
gli omas</w>
Ob esity</w>
hist ocompatibility</w>
morph ologically</w>
Mont e</w>
colon oscopy</w>
re ad</w>
PD- L1</w>
htt p</w>
2 7-
tr on</w>
contr ast-
neutrop enia</w>
14 5</w>
P rom
n d</w>
ti tr
trig eminal</w>
mandi ble</w>
F F</w>
pa rox
accompan ying</w>
DNA- binding</w>
ro lim
ti se</w>
haemorrh age</w>
S- Co
t os
socio demographic</w>
3- year</w>
or in</w>
vibr ation</w>
auton om
Dis order</w>
7 00</w>
0.9 8</w>
K i-
ell -
R as</w>
Environ mental</w>
Ar ti
co operative</w>
Aver age</w>
low- grade</w>
X 2</w>
Respon ses</w>
bl ed</w>
perform ances</w>
o plas
cam era</w>
S o</w>
overex pressing</w>
corne a</w>
ascor bic</w>
surro gate</w>
weigh t-
end er</w>
cap sular</w>
man datory</w>
T C
BB B</w>
C x
ophil us</w>
ti vities</w>
Ne on
periton itis</w>
ventr icul
oper ator</w>
ubiquit ous</w>
choro idal</w>
bac te
Bar r</w>
L i</w>
99 mT
V TE</w>
gro unds</w>
fil es</w>
E 2
in ve
resec table</w>
C aro
clu stered</w>
neuro imaging</w>
trabec ular</w>
y mo
mo ist
Pe ople</w>
Hep G2</w>
immun e-
s ulation</w>
Swe dish</w>
ge ometr
h at
aro usal</w>
reper to
a etiology</w>
ad ver
Clin ic</w>
intox ication</w>
Simult aneous</w>
explic it</w>
og aster</w>
diver gent</w>
bicarb onate</w>
MA C</w>
t ent
ultra -
R b</w>
oligonucle otides</w>
quad ru
op yran
relap sed</w>
Rec or
is tically</w>
Zn O</w>
mitogen- activated</w>
Impro vement</w>
ap o</w>
plac ements</w>
it atively</w>
obl otting</w>
cann abin
form ulated</w>
endometr ium</w>
prote omic</w>
tub ule</w>
x ine</w>
hyper thermia</w>
Regi onal</w>
Bri tish</w>
inter faces</w>
sem in
prev ent
opoie sis</w>
C ellular</w>
ure teral</w>
arrhyth mic</w>
libr aries</w>
h id
discrep ancy</w>
Q T</w>
g eriatric</w>
D H
0.00 8</w>
ox etine</w>
ca ver
s av
bacteri oph
van comycin</w>
co valently</w>
Ar g</w>
glycos ylated</w>
know led
r ate-
B B</w>
o ter
5 6
ultr af
resol ve</w>
therap ists</w>
D H</w>
capill aries</w>
f uc
prot otype</w>
sem iconduc
oc ar
molecul ar-
with in-
pre y</w>
For ty</w>
omeg a-
hist ories</w>
U N
manufact uring</w>
gentam icin</w>
veget ables</w>
ocyt oma</w>
E t
Ac tive</w>
cos metic</w>
ti d</w>
st enting</w>
meas urable</w>
L N
her pes
CL L</w>
ub ic</w>
A OR</w>
investig ates</w>
fentan yl</w>
cal ls</w>
dise ased</w>
Phy l
op ac
2 6-
neuro trophic</w>
R ed</w>
Recom bin
B T</w>
radi onuc
b ending</w>
FL P</w>
a ult</w>
prim ed</w>
te ars</w>
CM L</w>
m ol-
align ed</w>
vit amin
illustr ates</w>
1 70</w>
air -
T radi
tom ographic</w>
ipp ing</w>
bi ore
histo chemistry</w>
L M</w>
sh un
Nig eria</w>
L F
en osis</w>
lei omy
tra vel
robo tic</w>
Liter ature</w>
T or
ati s</w>
Ad verse</w>
ri o</w>
1 16</w>
b ing</w>
P ul
Cs A</w>
i ate</w>
tom ato</w>
An g</w>
onitr ile</w>
L as
fun ding</w>
macro scopic</w>
oper ational</w>
C ases</w>
capsul es</w>
pre fer
co at</w>
L I</w>
co w</w>
estr us</w>
t 1</w>
papill omavirus</w>
B ax</w>
ang e</w>
bro il
curv ature</w>
c ame</w>
chlo rophyl
Pro per
h op
dis placed</w>
Anim als</w>
om ide</w>
thrombo embolism</w>
A po
bon ded</w>
in- releasing</w>
work place</w>
oper oxidase</w>
hospit alizations</w>
M CP
hypo thesize</w>
onym ous</w>
Ve ter
amph i
en teen</w>
1 17</w>
Medic aid</w>
extrac orporeal</w>
L u
am yl
y- related</w>
attenu ates</w>
expl ores</w>
see k</w>
inten tion</w>
sedi mentation</w>
E W</w>
D own</w>
antidepress ants</w>
le aving</w>
comb ine</w>
ati d</w>
fibro tic</w>
el ia</w>
answ er</w>
di e</w>
un detectable</w>
l in</w>
thre onine</w>
ch er</w>
cell- free</w>
Mechanis ms</w>
app rais
lab our</w>
stig ma</w>
pro gen
laparo scopy</w>
1. 3
Lear ning</w>
coord inate</w>
C amp
co x
li thi
Lew is</w>
protec ting</w>
al ism</w>
adi pos
w aiting</w>
H Y
ton si
IF ICA
y sis</w>
pa in
manif est</w>
0. 95</w>
analog ous</w>
xen ograft</w>
b one-
att entional</w>
M L</w>
ad min
ep ig
M er
em e
dropl ets</w>
1 14</w>
ar tan</w>
at ur
carbon yl</w>
fac ed</w>
germin ation</w>
om yc
Investig ation</w>
12 2</w>
gri p</w>
ocarcin omas</w>
responsi bility</w>
lys ozyme</w>
K idne
o val
pharmac ists</w>
swim ming</w>
de dicated</w>
mun ic
dextr an</w>
op posed</w>
mon ocyt
S chool</w>
PLICA TIONS</w>
K A</w>
intern alization</w>
hyp oc
fin e-
Pro gnostic</w>
morph ogenesis</w>
B ir
Laparo scopic</w>
suspen sions</w>
RN ase</w>
k ling</w>
transcrip tase</w>
ser otypes</w>
si bly</w>
scal p</w>
tensi le</w>
vitre ous</w>
Im proved</w>
0 8</w>
condens ation</w>
P y
sil ent</w>
W s</w>
Bi ological</w>
trigg ering</w>
Tra ining</w>
cy ste
Spec tr
iso proteren
jour nals</w>
Spec tro
po t</w>
na ïve</w>
preser ving</w>
BA SE</w>
conflic ting</w>
seed lings</w>
Sur prisingly</w>
in patients</w>
imp acted</w>
enter oc
dro pp
c ities</w>
SIGN IFICA
st ments</w>
L eg
cephal us</w>
tol u
S o
E VI
x es</w>
P GF
con tra
homocy steine</w>
posi tioned</w>
compati bility</w>
emp tying</w>
T ech
D utch</w>
G ST
in spec
um e</w>
val vular</w>
AB C</w>
PD T</w>
domin ance</w>
oste ogenic</w>
sor ting</w>
Pro ject</w>
an ore
In dic
nation wide</w>
IC A</w>
le ak</w>
well- defined</w>
C CL
encour age</w>
tin g-
administr ative</w>
ma ze</w>
ot echn
physi ologically</w>
0.8 5</w>
im idine</w>
ol ate</w>
i osis</w>
P neum
reinforc ement</w>
Th 2</w>
Ep stein-
r d</w>
gonadotrop in</w>
ser o
D om
D ental</w>
I -1</w>
not e</w>
com promise</w>
sug ars</w>
R et
ab s</w>
Exerc ise</w>
E g
ph aryngeal</w>
e e</w>
V ib
adjunc t</w>
ultim ate</w>
wor th
SIGNIFICA NCE</w>
M uc
y e</w>
L OS</w>
ar yl
S G
2 10</w>
3 50</w>
mol- ec
atrop ine</w>
ar te
regul ations</w>
L ibr
meas les</w>
ili ated</w>
Rec on
instrum ental</w>
or rho
don ation</w>
Com mon</w>
s acc
O s</w>
at tained</w>
tradi tionally</w>
ol itis</w>
expect ancy</w>
factor- alpha</w>
p H
periph ery</w>
scienti sts</w>
h ap
distingu ishing</w>
practi c
1 13</w>
Leishman ia</w>
conc eption</w>
contr ain
Pro v
sign atures</w>
M align
oligosacchar ides</w>
as cer
e ur
Pro duction</w>
bran ching</w>
cl ock</w>
in- depth</w>
f a</w>
el usive</w>
al op
obser vers</w>
anthrop ometric</w>
gast rectomy</w>
CD K
di ploid</w>
V D</w>
r at
Not ably</w>
125 I</w>
anti psychotic</w>
an i</w>
micro biological</w>
Al ter
heter odi
synchron ous</w>
non- Hodgkin</w>
modul us</w>
decarbox ylase</w>
oste ocl
del eted</w>
infec tive</w>
Contin uous</w>
S k
encour aging</w>
Sp inal</w>
F O</w>
id one</w>
neigh bor
emo tions</w>
deteri or
re sts</w>
galact ose</w>
conform ations</w>
ER K1</w>
melan ogaster</w>
tro pon
alumin um</w>
Su per
exacerb ation</w>
Ninet y-
in deed</w>
Inflam matory</w>
omo tion</w>
cytos keletal</w>
ic ol</w>
Mean while</w>
dysp nea</w>
z -
serop ositive</w>
configur ations</w>
b es</w>
inter personal</w>
My ocardial</w>
activ ators</w>
por ted</w>
ay ing</w>
3- fold</w>
p i</w>
ti bia</w>
contamin ants</w>
edi ting</w>
sul fat
re ality</w>
habit ats</w>
inter quartile</w>
Ox id
CT A</w>
T i</w>
transduc er</w>
calc itonin</w>
shorten ed</w>
glob ally</w>
Ste m</w>
IGF -1</w>
impa ir</w>
R ating</w>
trac ts</w>
s oph
super family</w>
calmodul in</w>
es in</w>
Hepati c</w>
nif edipine</w>
lat est</w>
eti ological</w>
D Q
Alcoh ol</w>
percenti le</w>
Lactob acillus</w>
S F-
0.9 6</w>
al- based</w>
T ol
qual itatively</w>
S N</w>
dy es</w>
the ast</w>
at rium</w>
man agers</w>
muc us</w>
inform ative</w>
F I</w>
tryp t
nic kel</w>
dis continued</w>
intr ap
log -
gl and
con clusive</w>
spec ially</w>
c il
sti tis</w>
ventil atory</w>
discus sions</w>
prim ates</w>
puber ty</w>
6 -</w>
method ologies</w>
end ocytosis</w>
cann abis</w>
col li
ag en
P i</w>
e astern</w>
lead ership</w>
Epstein- Barr</w>
heavi ly</w>
MM A</w>
trans m
ir ium</w>
dr ying</w>
Sub sequent</w>
A er
li sts</w>
micro RNAs</w>
arr ative</w>
comm itment</w>
NP Y</w>
introduc ing</w>
irrig ation</w>
CX CL
Pac ific</w>
thi ol</w>
graf ted</w>
t z</w>
ast al</w>
an e-
hor se</w>
o facial</w>
character izing</w>
T X
mid line</w>
ob enz
diaphrag m</w>
abs tin
ex chang
cut aneously</w>
C ost
iz able</w>
ra ising</w>
op re
ro ad</w>
SM Cs</w>
as certain</w>
0.9 7</w>
Re duced</w>
pro spec
exper tise</w>
dys phagia</w>
persi st</w>
ari th
conjug ation</w>
cyclospor ine</w>
cul t</w>
phosphor yl
Tr ic
h ope</w>
Reg arding</w>
HI V
M N
under -
GAB A
th ecal</w>
somat osensory</w>
re pl
sc oli
arti facts</w>
T MS</w>
hydro carbons</w>
el le</w>
poli tical</w>
collap se</w>
EM BASE</w>
W F</w>
Th ough</w>
non- coding</w>
B RA
E E</w>
c iliary</w>
glob in</w>
ot axis</w>
id azole</w>
L ig
A pop
H U
addres ses</w>
cle an
ke wise</w>
ner ship</w>
probl ematic</w>
pedi cle</w>
reconstitu ted</w>
duoden um</w>
Ga stric</w>
bur ns</w>
gyn ec
1 18</w>
A Es</w>
weak er</w>
stoch astic</w>
we d
pre dat
L ong</w>
G am
f air
mit osis</w>
Con genital</w>
E st
ch ond
2 31</w>
path ogenicity</w>
comp ul
r DNA</w>
thermod ynamic</w>
0 s</w>
IM PLICATIONS</w>
sens ation</w>
nan ocom
quasi -
z i</w>
E u
atax ia</w>
thin king</w>
Inter vention</w>
En g
a sive</w>
practition er</w>
12 9</w>
Li ke</w>
erythro id</w>
Cp G</w>
Behavi or</w>
1 21</w>
plat forms</w>
dep ic
sch ist
b er</w>
m ari
INTERVEN TIONS</w>
un complicated</w>
neuro toxicity</w>
ti te</w>
Eigh teen</w>
eu tic
7 9
f oundation</w>
dis ed</w>
splic e</w>
dis charges</w>
er ve</w>
pneum ococcal</w>
care er</w>
h ept
exclu sive</w>
ri ver</w>
Ad ap
prote omics</w>
ci profloxacin</w>
1. 5
radi ology</w>
Bio chemical</w>
exc ep
1. 25</w>
di ure
war ming</w>
MM P</w>
du plic
vag al</w>
U S-
rh esus</w>
ocom ial</w>
1 p</w>
B D
RE VI
PBM C</w>
bl ind
L C
sti s</w>
intellig ence</w>
omer ization</w>
an ionic</w>
cer amic</w>
adap t</w>
w anted</w>
ra ises</w>
f arm</w>
ey el
A H</w>
men op
ris k-
l ingual</w>
moder ate-
transfer ases</w>
sub cutaneously</w>
associ ate</w>
sic kle</w>
ul ing</w>
house holds</w>
scre ws</w>
em pl
bio tics</w>
4 8-
glucocortico ids</w>
capac ities</w>
R he
sph ere</w>
N egative</w>
vaso constriction</w>
chem oradi
MD R</w>
v ox
affin ities</w>
micro wave</w>
trans gene</w>
Pharmac o
TR H</w>
S audi</w>
NAD H</w>
n- 3</w>
- containing</w>
198 4</w>
itone ally</w>
guan osine</w>
my ofib
attenu ate</w>
N u
prescrip tions</w>
ene m</w>
ail ed</w>
instrum entation</w>
multi ple-
2 20</w>
z yme</w>
le ishman
com positions</w>
8 6
CP R</w>
azol am</w>
C 1
comp act</w>
c ue</w>
Q U
cur cumin</w>
P- 450</w>
un favorable</w>
c d
ov aries</w>
carcin ogenic</w>
individu alized</w>
pass ed</w>
sit e-
AD C</w>
far ms</w>
Practi ce</w>
P lac
thir d-
post ure</w>
cro ps</w>
enti nel</w>
Formul a</w>
de polar
the ophylline</w>
mic elles</w>
DE NCE</w>
blo od
compr ise</w>
pa rotid</w>
mit ting</w>
Mi x
tic ated</w>
perf ect</w>
nod ular</w>
re alized</w>
in soluble</w>
perturb ation</w>
rem n
homogen ates</w>
12 7</w>
le pro
resili ence</w>
X T</w>
fresh water</w>
G M
bet ween-
tax onomic</w>
DSM -
hem i
Immun e</w>
nas opharyngeal</w>
fig ures</w>
techn ological</w>
met ac
pac kage</w>
be ats</w>
2- year-old</w>
sacrific ed</w>
F TI
pair ing</w>
volu metric</w>
10- fold</w>
O .</w>
Stud ents</w>
en sur
Sup pl
spar se</w>
v ic</w>
pr amine</w>
bacter icidal</w>
O 1</w>
pu ps</w>
plex es</w>
H H
re activation</w>
fre edom</w>
og rou
degrad able</w>
Numer ous</w>
brac hy
D ic
vis ited</w>
si ella</w>
p an</w>
mar ital</w>
nicotin ic</w>
Rec eptor</w>
cohe rent</w>
exclud e</w>
lig and-
addi tionally</w>
un controlled</w>
K en
3- 4</w>
in somnia</w>
cultiv ars</w>
br ing</w>
SA H</w>
pa rous</w>
fos sa</w>
T 1-
Eff ec
er nal</w>
B H
F u
sci atic</w>
omegal y</w>
progres sion-free</w>
sme ars</w>
plan k
Ultras ound</w>
requis ite</w>
V S</w>
ot ted</w>
Adv anced</w>
D HA</w>
aden o
ing er</w>
pro tr
stop ped</w>
red und
determin ations</w>
classi fy</w>
Associ ations</w>
un ded</w>
prior iti
L ist
orig inated</w>
pen ile</w>
carbohyd rates</w>
str al</w>
notic ed</w>
E S
cirrho tic</w>
possess ed</w>
iodi de</w>
convul s
me g
des orption</w>
A gg
go ats</w>
ul nar</w>
F H</w>
Calc ium</w>
su ited</w>
sp ores</w>
k D</w>
p ter
leg is
M ann
ver -
ob lig
acqu ire</w>
1, 3-
phen yl-
mos aic</w>
AM D</w>
p m</w>
ic um</w>
ben ch
she ets</w>
EVI DENCE</w>
S NA
es sion</w>
b ever
u ation</w>
an ic</w>
sub stitute</w>
s. c.</w>
pac king</w>
r on</w>
equ ine</w>
doc tor</w>
O ff
acceler ate</w>
Eff ective</w>
6 5
T 2-
ste el</w>
sme ar</w>
H el
u ximab</w>
chro mo
0.9 4</w>
eutic als</w>
high- affinity</w>
we b</w>
hydro gels</w>
ou tw
li ve
person alized</w>
sol ve</w>
Th at</w>
sto ichi
linear ity</w>
V C</w>
germ line</w>
mater n
ph er
acet yl</w>
Nutri tion</w>
lam bs</w>
al titude</w>
broad ly</w>
prolong ation</w>
un infected</w>
scaveng ing</w>
br and</w>
prim ate</w>
K ingdom</w>
in er
Behavi oral</w>
augh ter</w>
sp anning</w>
an aphy
supernat ants</w>
ill ed</w>
m id</w>
adi ponectin</w>
clos er</w>
ari o</w>
fore brain</w>
lnc RNAs</w>
Libr ary</w>
A 549</w>
0.9 2</w>
mas k</w>
refl ec
junc tional</w>
prov ince</w>
PP I</w>
bl unt</w>
AL P</w>
bif ur
Radi ation</w>
lig am
0.9 3</w>
acyl glycerol</w>
Tem per
In vol
a ided</w>
one- third</w>
be ef</w>
clon idine</w>
E astern</w>
super vised</w>
3 a</w>
L ight</w>
Kidne y</w>
F DA</w>
assign ment</w>
ti tration</w>
silic o</w>
z z
inst ance</w>
rolim us</w>
A AA</w>
pac ked</w>
transcrip tion-
sl ice</w>
distinc tion</w>
EP O</w>
cath epsin</w>
s ent
en o
GL UT
catech olamine</w>
o ventricular</w>
I 2</w>
lamin in</w>
j e</w>
pri v
sh el
progen y</w>
pro lapse</w>
t or-
O K
is land</w>
M en</w>
B R</w>
intr al
diarrho ea</w>
radi ologists</w>
T V</w>
pa res</w>
fi ers</w>
Proper ties</w>
trem or</w>
conjunctiv al</w>
Health y</w>
tel e
Fif ty</w>
is one</w>
immun ogenicity</w>
Un it</w>
v -
an um</w>
Qual itative</w>
ill umination</w>
schizophren ic</w>
de structive</w>
ane u
c AMP-
im entin</w>
day time</w>
stabil ize</w>
ep tic</w>
ca ution</w>
t ym
HR H</w>
tocopher ol</w>
grow th-
avi r</w>
sub optimal</w>
re pressor</w>
interpre t</w>
un differentiated</w>
afferen ts</w>
dig esti
luoresc ent</w>
ver atro
replic ated</w>
at orial</w>
In stead</w>
altern ate</w>
ou pling</w>
SC -
si vity</w>
resid ential</w>
receptor- mediated</w>
D r
V P</w>
buc cal</w>
A ST</w>
T ow
er up
hyd rate</w>
wa ist</w>
13 2</w>
vers atile</w>
F K
nanot ubes</w>
L U
t- test</w>
Un fortunately</w>
dri ver</w>
fr ont
ne sted</w>
ubercul osis</w>
amorph ous</w>
mutag enic</w>
di aldehyde</w>
E- cadherin</w>
re p
AM PK</w>
collo idal</w>
othor ax</w>
For mation</w>
cl ass
Appro ach</w>
endotheli um-
ic an-
amin idase</w>
g -induced</w>
di -
co factor</w>
dendr ites</w>
ou ab
y ol
recommend ation</w>
SE N
er ate</w>
st ance</w>
caregi ver</w>
op ol
out line</w>
tor que</w>
deep er</w>
oste oblasts</w>
tra vel</w>
per icardial</w>
blood- brain</w>
de stro
min ing</w>
trans fusions</w>
insp iratory</w>
in ations</w>
schem es</w>
over t</w>
SA R</w>
Experi ence</w>
intraper itoneally</w>
manufact ure
acetab ular</w>
re tain</w>
neuro peptide</w>
consum er</w>
U p</w>
aden ocarcinomas</w>
G ran
my ot
new er</w>
fe et</w>
ic ide</w>
R u
0.8 9</w>
lute in
F V</w>
allo y</w>
0.8 8</w>
recycl ing</w>
Psych i
menop ause</w>
ord inary</w>
mamm ography</w>
disp osition</w>
H un
vers y</w>
vulg aris</w>
1 24</w>
diaz epam</w>
I CD
4 3
ang l
T G
N F</w>
N T-
adap tations</w>
Met S</w>
Parti al</w>
lin ker</w>
f loc
K d</w>
R G
l acti
par ity</w>
SC D</w>
p ir
enter ing</w>
Multi -
IC D</w>
F isher</w>
wal k</w>
tex ture</w>
monocyt ogenes</w>
ER T</w>
catechol amines</w>
F ox
post prandial</w>
hel ped</w>
Carcin oma</w>
inver ted</w>
High ly</w>
ag gra
hepat ectomy</w>
loc omotion</w>
no v</w>
N ucle
st ated</w>
vin yl</w>
kne es</w>
Twenty- four</w>
A z
swe red</w>
l enti
o chemical</w>
ro ll
PL A</w>
sin us
7 7
arg um
U til
wor ms</w>
repeat edly</w>
in o</w>
mic s</w>
pot ato</w>
A NCE</w>
0.8 3</w>
w .
ur nal</w>
R at</w>
alpha -</w>
mal e
de ox
rel la</w>
DF T</w>
os exual</w>
v ated</w>
tel omerase</w>
hol ding</w>
confoun ders</w>
mim ic
re th
mosquit o</w>
psychi atry</w>
os pec
av en
0.9 1</w>
stake holders</w>
cent ro
multi drug</w>
sk eleton</w>
chemo kines</w>
b ite</w>
D BP</w>
sti pation</w>
pl ain</w>
F L</w>
T I</w>
S er</w>
extr av
out lined</w>
Pl ant</w>
concentr ate</w>
preser ve</w>
depri ved</w>
lo bin
symptom atology</w>
Lin ear</w>
PA -
it an</w>
AF P</w>
n ail</w>
Dem ographic</w>
w et
h il
K ey</w>
phil is</w>
el ution</w>
6 6
tr apping</w>
ho using</w>
in expensive</w>
9- year-old</w>
replic ate</w>
le gs</w>
cer amide</w>
transi tional</w>
sh am-
medi um-
LO G
Is ra
an swered</w>
di thi
1. 00</w>
beta- adrenergic</w>
R D
Rep u
dig it
dec id
PT EN</w>
SP SS</w>
interleukin -6</w>
phosph on
co astal</w>
occup ied</w>
j aun
le ph
Combin ation</w>
app end
vi tis</w>
approxim ate</w>
methyl ene</w>
tiv e-
jug ular</w>
se q</w>
tic ks</w>
uniform ly</w>
bacte remia</w>
oz one</w>
fa ec
rel ates</w>
syn cy
AB A</w>
00 0-
c ass
high- fat</w>
rest enosis</w>
post traumatic</w>
quen ching</w>
autom atically</w>
D U
0.8 6</w>
ra in
Em base</w>
insulin- dependent</w>
A- I</w>
earli est</w>
OR s</w>
pitu it
um en</w>
carri age</w>
Shor t-
ADP- rib
S cal
0. 11</w>
carb onate</w>
anis otropy</w>
O D</w>
hy pop
th eta</w>
Cross- sectional</w>
p ens
3 44</w>
pharmac ology</w>
per mitted</w>
de aling</w>
lin e-
plant ar</w>
Prov ince</w>
hydro cephalus</w>
0.8 7</w>
mis sense</w>
Distr ibution</w>
hum eral</w>
AC s</w>
An tim
deli vering</w>
1 19</w>
susp ended</w>
dic ine</w>
car ing</w>
VE GF
s orb
TLR 4</w>
S ex</w>
cap top
specific ities</w>
dent ate</w>
op y</w>
mon omers</w>
epti n</w>
ag encies</w>
constr ained</w>
co al</w>
tem po
biofil ms</w>
star vation</w>
intram olecular</w>
int olerance</w>
usi tis</w>
0. 13</w>
wash ing</w>
re actor</w>
disc ord
consol idation</w>
mang anese</w>
5 8
0. 14</w>
g p</w>
equ iv
K leb
PC P</w>
om eth
scat tered</w>
appear ing</w>
I ll
S exual</w>
b umin</w>
tab let</w>
y- induced</w>
enroll ment</w>
anomal ous</w>
dis advantages</w>
Rec o
V 1</w>
angiotens in-
Compar ing</w>
g au
hom olog</w>
V F</w>
cultiv ated</w>
x in</w>
hepat oma</w>
os urg
emph ys
SI -
hypo xia-
gro o
reco ver</w>
search ing</w>
y go
c ing
methyl transferase</w>
A or
galacto sidase</w>
Del ta</w>
orthop edic</w>
robu st
5 9
met aph
di ce</w>
ischem ia-
elev ations</w>
oper idol</w>
N ext</w>
Sr c</w>
onch ial</w>
gn ess</w>
plic ity</w>
carbox ylic</w>
in dependence</w>
yl es</w>
s elling</w>
4- year-old</w>
modul ators</w>
M U
pec ul
intra hepatic</w>
ad duct</w>
under goes</w>
expl aining</w>
- C</w>
M DS</w>
post- treatment</w>
ys mal</w>
cap sa
beg in</w>
F c
rif amp
bir th
stal k</w>
reperto ire</w>
HR V</w>
cel i
re operation</w>
i ans</w>
multi plex</w>
Pre par
A NA
explo ited</w>
st ably</w>
id us</w>
ev ity</w>
lif es
bro th</w>
pig lets</w>
do ts</w>
sh rin
scoli osis</w>
Pat tern
H L-
th y
con v
cruc iate</w>
strat um</w>
ari atric</w>
retro peritoneal</w>
a str
til t</w>
mast ectomy</w>
5 3
conven ience</w>
immun oblotting</w>
HP V
- a</w>
in door</w>
me ga
arb itr
coll ective</w>
aggreg ated</w>
itone um</w>
ex tends</w>
ev ent-
pur ch
lo l</w>
ri m</w>
ophthal mic</w>
R ac
ar ises</w>
oper on</w>
V II</w>
liter acy</w>
Aut om
com pares</w>
A PO
o ks</w>
ob sc
D V</w>
el abor
obste tr
occa sions</w>
psych opathology</w>
10 ,
De termin
li tis</w>
2 93</w>
Gl u</w>
f low-
isoproteren ol</w>
Oxid ative</w>
cul ating</w>
char ts</w>
continu um</w>
ati ve-
un explained</w>
moist ure</w>
I Q</w>
attrac ted</w>
vent ro
li st
b FGF</w>
MR T</w>
Ac c
T c
glomerul onephritis</w>
Hyper tension</w>
c rest</w>
telom ere</w>
mut ational</w>
h n
e tra
initi atives</w>
search es</w>
veratro l</w>
0.7 8</w>
3- kinase</w>
ero sion</w>
medic ally</w>
imid azole</w>
L C-MS</w>
gland ular</w>
l ay</w>
System s</w>
PK A</w>
n ous</w>
dur ations</w>
electr ons</w>
amylo idosis</w>
r ights</w>
f air</w>
top ois
dissec ted</w>
xanth ine</w>
chem otactic</w>
radi ofrequency</w>
per mis
bund les</w>
H G
sty rene</w>
gonad al</w>
out -of-
fram es</w>
sugg estions</w>
approxim ation</w>
0. 16</w>
thal iana</w>
X 1</w>
otox ins</w>
opportun istic</w>
desensi tization</w>
impair s</w>
out growth</w>
granul osa</w>
Perc utaneous</w>
r ic</w>
om a-
ultr y</w>
ie ties</w>
Dis c
di ethyl
amp ing</w>
Wh it
el ings</w>
dispens able</w>
RE L
Gen es</w>
B E
ox yl
expl ains</w>
re fined</w>
dis closed</w>
am phen
ribonucle ic</w>
Kleb siella</w>
Mo use</w>
ent um</w>
membrane- bound</w>
audi t</w>
l ich
marri ed</w>
O M</w>
oc cult</w>
c im
d a
mon omeric</w>
ti fication</w>
cyt osine</w>
bab y</w>
IC P</w>
ous -
ar ization</w>
rever sibly</w>
D PP
yn chron
198 3</w>
0. 90</w>
im es</w>
Physici ans</w>
entrop y</w>
0.8 4</w>
C an</w>
em ma</w>
typh imurium</w>
F R
for d</w>
benz o</w>
guinea- pig</w>
sho ot</w>
Sev erity</w>
aim ing</w>
m erg
facil itation</w>
ure ly</w>
Intrav enous</w>
di ol</w>
per s</w>
lay ered</w>
gon dii</w>
combin es</w>
prote ome</w>
cal orimetr
On ce</w>
M e</w>
0.00 9</w>
Signific antly</w>
con ve
li poly
apprais al</w>
side- effects</w>
e icos
Ph il
S ho
Mech anical</w>
C 2
A- induced</w>
PA C</w>
Meas ures</w>
1 R</w>
F ri
198 2</w>
1 0.5</w>
til l</w>
F us
beta- lactam
Ar thro
este em</w>
14 4</w>
tw o
uve itis</w>
De f
pseud o-
T OF</w>
neutr alization</w>
ac clim
Gluc ose</w>
dec lines</w>
Nan op
par kin
0. 5-
E thi
mul tin
Repu blic</w>
A im</w>
resid ency</w>
mel ting</w>
Pur kin
thym ocytes</w>
Ki- 67</w>
gastr itis</w>
f lower</w>
T 3-
transmit ters</w>
ventil ated</w>
sho p</w>
it on</w>
12- month</w>
ging i
pressu re-
mo ieties</w>
tes tinal</w>
long- lasting</w>
lac ked</w>
nit us</w>
SDS- PAGE</w>
predn isone</w>
fra ilty</w>
po pl
HS V</w>
at om
V P
re paired</w>
&apos; t</w>
DF S</w>
effici encies</w>
pro poses</w>
micro fluidic</w>
GABA ergic</w>
pol ysaccharides</w>
it er</w>
ec ond</w>
ver sions</w>
ev ac
co incid
be red</w>
modul ator</w>
anore xia</w>
friend ly</w>
es --
SAR S-Co
flavon oids</w>
B ilateral</w>
hel ic
iso electric</w>
0. 35</w>
Con t
chori onic</w>
mu sic</w>
M CA</w>
cal ibr
BM T</w>
post mortem</w>
stric tly</w>
Reg ister</w>
veter inary</w>
co st
excre ted</w>
granul ocyte</w>
Mitochond rial</w>
ad versely</w>
pa uc
polymorph onuclear</w>
u be</w>
Recombin ant</w>
fre ely</w>
0.8 2</w>
Onc ology</w>
fir e</w>
osensi tivity</w>
chem il
om ial</w>
roti zing</w>
oti tis</w>
docum ents</w>
ACh E</w>
ca vities</w>
emerg ent</w>
NSAI Ds</w>
expec tedly</w>
Clinic al
En ergy</w>
M Hz</w>
5 62</w>
Anim al</w>
scho ol
ESR D</w>
protein- protein</w>
par am
antagon ism</w>
ch ap
tropon in</w>
Epidemi ology</w>
sho t</w>
G li
HIV- positive</w>
under graduate</w>
tri pl
od ing</w>
str ips</w>
sic s</w>
albumin uria</w>
Con di
Surve illance</w>
Reco very</w>
gen der
iz ers</w>
Nur ses</w>
C U
m ur
dra w</w>
5-fluoro uracil</w>
IC H</w>
atri oventricular</w>
fund us</w>
cor onal</w>
99 m</w>
in qu
low- risk</w>
Re al-
Purkin je</w>
not able</w>
ail ing</w>
fo s</w>
lo os
PA I-1</w>
umb er</w>
or ch
13 7</w>
I schem
arthro scopic</w>
e ae</w>
glycol ysis</w>
C 6</w>
1, 0
pig mented</w>
Con ventional</w>
r ad
br ush</w>
qu erc
at resi
perme able</w>
Nr f2</w>
c ast</w>
T ext</w>
for -
ww w.
all ografts</w>
di electric</w>
Recom m
Pro state</w>
F D</w>
tra p</w>
d ang
D on
mechan ically</w>
C ry
lys ates</w>
theore tically</w>
b le-
sion ed</w>
brady kinin</w>
di ch
TH E
sp ra
character s</w>
Com preh
im otor</w>
tw elve</w>
Stud ent</w>
ove restim
con dyl
poly po
n arrative</w>
k Hz</w>
1- 4</w>
chic ks</w>
ar abin
sarcom as</w>
two fold</w>
R eli
bran ched</w>
Neon atal</w>
Leu k
de oxy-
pi x
prim itive</w>
im pul
multi factorial</w>
suppl ied</w>
dis playing</w>
ag ree</w>
etr y</w>
tubercul ous</w>
distor tion</w>
MP a</w>
CA R</w>
ag arose</w>
B 6</w>
rom ycin</w>
abdom y
FTI R</w>
cl av
Au th
ac ic</w>
ol us</w>
N V</w>
contra dic
cyt ometric</w>
hal oth
0. 80</w>
resembl ing</w>
0. 45</w>
Med line</w>
M UC
Inter actions</w>
wel fare</w>
free ze-
bup ivacaine</w>
at or
veget ation</w>
Centr e</w>
phag ocytic</w>
j aw</w>
vap or</w>
pl ot</w>
D anish</w>
Not ch</w>
oz ym
reser vation</w>
idel ity</w>
immunoglob ulins</w>
inter facial</w>
electro magnetic</w>
PA Hs</w>
Po is
P ak
re dox
pl au
IL-1 beta</w>
n out</w>
10 ,000</w>
diff u
off ering</w>
col le
induc er</w>
RE T</w>
6 5-
micr on
G ST</w>
de hydration</w>
every day</w>
hum idity</w>
paren ting</w>
Diab etic</w>
clar ified</w>
th ec
ou ts</w>
0.8 1</w>
Spec ial</w>
T ren
solid- phase</w>
B lu
diff ic
d welling</w>
13 8</w>
oc ap
Throm b
atis m</w>
anastom otic</w>
analy tes</w>
supr am
cortis one</w>
3 D-
colony- stimulating</w>
Lip id</w>
re min
f oun
K S</w>
or ylation</w>
parathyro idism</w>
wor ked</w>
H GF</w>
infer red</w>
intra -</w>
ap ex</w>
en ses</w>
og lobin
t agged</w>
Serv ices</w>
rec eptive</w>
d re
RO M</w>
synap t
inten si
nos ocomial</w>
energ etic</w>
nitro -
anti- tumor</w>
MIC s</w>
intrac erebral</w>
me als</w>
discrep ancies</w>
neuro degeneration</w>
K i</w>
contex tual</w>
L L</w>
ac he
0.7 6</w>
strepto zot
h on
mit ogenic</w>
4 A</w>
wri ting</w>
In t
carri es</w>
V E</w>
cho ose</w>
Stre ptom
orn ith
ac ia</w>
dropp ed</w>
exten sor</w>
. .</w>
st atins</w>
K Cl</w>
high er-
phosphodi esterase</w>
harv esting</w>
K Y</w>
acti on-
del irium</w>
BR CA1</w>
bi ogenesis</w>
AB P</w>
br uc
mor al</w>
2 nd</w>
cogn iti
micro bes</w>
adren al
veter ans</w>
high- frequency</w>
energ y-
6- year-old</w>
CF U</w>
secre tions</w>
week -old</w>
belong s</w>
Sm ad
nich e</w>
impl ying</w>
Ne ural</w>
influenz ae</w>
p raz
B E</w>
E GF
CI s</w>
chloro plast</w>
Al ph
lit ter</w>
AR DS</w>
py raz
leuko tri
carb am
maxim ize</w>
pluripot ent</w>
oc clusive</w>
SA S</w>
e NOS</w>
Anti bodies</w>
poin ted</w>
orth og
15 5</w>
HR QoL</w>
trou t</w>
trim eth
di chro
sub cortical</w>
in otropic</w>
lob es</w>
me iotic</w>
HM G
l asted</w>
R ot
nig ra</w>
one y</w>
ann ually</w>
Differen ti
vasodi lation</w>
dres sing</w>
ap ha
LD L-C</w>
T g</w>
e g</w>
nor ms</w>
HI F-1
phot ocat
0.0 25</w>
5 th</w>
regar ds</w>
4- fold</w>
Pro vid
navig ation</w>
parkin son
sy philis</w>
D P
car c
trypt amine</w>
olig o
k it
REVI EW</w>
F e-
F rac
long evity</w>
CP B</w>
eosin ophilic</w>
Vib rio</w>
IFN- γ</w>
enc y-
extr insic</w>
0 ,
QT L</w>
1 H</w>
neuro genic</w>
degrad ing</w>
g ases</w>
0.7 7</w>
C GRP</w>
Fam il
inferen ce</w>
G AT
Th i
er mal</w>
CD 44</w>
atresi a</w>
psych otherapy</w>
F N</w>
Val idation</w>
c age</w>
on ec
Aut o
for sk
atmosph ere</w>
amphen icol</w>
col oc
C .
s m
ke ep</w>
di uretic</w>
po ultry</w>
Sc ot
altern ating</w>
mi x</w>
VE L</w>
ter re
Tech niqu
sof t-
A P-
open- label</w>
centr ic</w>
obut yric</w>
J un</w>
descrip tions</w>
cut ting</w>
B AL</w>
NH S</w>
gra ins</w>
epith elia</w>
NH L</w>
thyro xine</w>
recogn ised</w>
16 5</w>
Che m</w>
age- specific</w>
spac er</w>
fil tering</w>
ph atic</w>
ist an</w>
Nor way</w>
I HC</w>
prob ing</w>
gastr in</w>
emphasi zes</w>
hydrox y</w>
3 rd</w>
an hydr
calcul ating</w>
deter gent</w>
in bred</w>
Cri tical</w>
v imentin</w>
con stipation</w>
8 0-
incre ment</w>
R elev
ret arded</w>
f eces</w>
adop t</w>
0. 18</w>
W eb
sequ e
cal cin
thromb oxane</w>
stress- induced</w>
AP -1</w>
robust ness</w>
Guid elines</w>
os yl</w>
morph ometric</w>
fa ecal</w>
single- stranded</w>
gram -negative</w>
ob ia</w>
umb ens</w>
corro bor
O CD</w>
con ti
ho c</w>
Sup port</w>
res ections</w>
B 12</w>
Targ eting</w>
su itability</w>
trache a</w>
lat ex</w>
M ag
C SA</w>
predisp osing</w>
E L</w>
sav ings</w>
B er
ud ine</w>
s s
expl ants</w>
es h
efflu ent</w>
ev ap
fair ly</w>
immunomod ulatory</w>
predisp osition</w>
t- generation</w>
embry ogenesis</w>
erythropoie tin</w>
sit ting</w>
es h</w>
sw allowing</w>
B PD</w>
R emo
ph alin</w>
harb oring</w>
feren tial</w>
D aily</w>
perc ei
Sch iz
Ont ario</w>
t ure
E ry
scann er</w>
hydrox ylation</w>
Strateg ies</w>
war m</w>
B r</w>
TK A</w>
0.7 4</w>
ser ous</w>
Modi fied</w>
sub population</w>
AT P
anti le</w>
it a</w>
bil aterally</w>
perturb ations</w>
flex or</w>
4 2
F etal</w>
s aving</w>
Carb on</w>
thromb olysis</w>
th igh</w>
em it
j apon
vari eties</w>
00 0
gam e</w>
bas olateral</w>
fe elings</w>
14 7</w>
l ar</w>
sh ips</w>
atin e</w>
correspon d
g us</w>
my x
B CL
Sev enteen</w>
ile y</w>
mes ang
cot ton</w>
0.7 9</w>
X- linked</w>
g ation</w>
V O2</w>
F X
L ate</w>
hum an
EC TION</w>
appendic itis</w>
hemat ocrit</w>
anos oma</w>
dispers al</w>
3- methyl
S ar
Concentr ations</w>
an cre
evac izumab</w>
coll ec
My el
V ic
ati zed</w>
eosinoph il</w>
ob r
conf ers</w>
MM P-2</w>
of- the-
dissoci ated</w>
Phot o
ascor b
D 4</w>
per icardi
11. 2</w>
af en
fail s</w>
Gen omic</w>
sal inity</w>
c is</w>
II a</w>
top ography</w>
O d
pig mentation</w>
tric uspid</w>
dos ages</w>
hal operidol</w>
in ed</w>
os elec
li sted</w>
cit abine</w>
contrast- enhanced</w>
HD L-C</w>
li que</w>
r ater</w>
nan ofib
exce eding</w>
idi a</w>
prostagland ins</w>
E B</w>
tissu e-specific</w>
ore duc
diver ticul
tor sion</w>
ec k
0. 17</w>
c- myc</w>
M ain</w>
gel atin</w>
brachy therapy</w>
A g-
jaun dice</w>
P d</w>
st and</w>
xen ografts</w>
Six ty</w>
rec re
Mod els</w>
a vid
qu ick</w>
S AM
cataly zes</w>
migr ant</w>
effec tors</w>
eti ologies</w>
b cl
gen omics</w>
it ates</w>
chem otaxis</w>
H i
P il
ass ing</w>
easi er</w>
Pancre atic</w>
ti me
advanc ement</w>
multi modal</w>
o pro
d ying</w>
EM I</w>
desi re</w>
N itr
benzodi azepine</w>
19 0</w>
dilu ted</w>
Effec tiveness</w>
nucle oti
T ex
orth opaedic</w>
el emental</w>
spir al</w>
Tryp anosoma</w>
andi bular</w>
chlorophyl l</w>
chlor inated</w>
my c
T 2D</w>
sensiti vities</w>
neighb oring</w>
en icity</w>
mim ics</w>
G raph
C 5
G DM</w>
phosph ate-
ass urance</w>
leuk em
as best
13 4</w>
bri de
0.7 1</w>
est rous</w>
vis ually</w>
th in-
ga thered</w>
Cer vical</w>
O H
TGF- β</w>
T esting</w>
od ont
S ea</w>
REL EV
Memb rane</w>
Health care</w>
low -</w>
T om
kary otype</w>
V L</w>
ith elial</w>
ta z
double- stranded</w>
hyper parathyroidism</w>
rota virus</w>
O 4</w>
h -
Dep end
ell ate</w>
B en
F ibr
predomin ance</w>
Cd c
ut roph
Pregn ancy</w>
ca emic</w>
sensor imotor</w>
radiolab eled</w>
phosph ates</w>
fo am</w>
profes sion</w>
F 3</w>
D o</w>
ul ic</w>
UT R</w>
disc s</w>
glutam ic</w>
CI S</w>
rap amycin</w>
substanti a</w>
real- world</w>
evalu ates</w>
transc ranial</w>
0.7 3</w>
ulin um</w>
water- soluble</w>
co enzyme</w>
Adv ances</w>
Malign ant</w>
restor ations</w>
and a</w>
s low-
epis odic</w>
mini -
py rene</w>
flu xes</w>
B K</w>
en te
MCP -1</w>
loc alize</w>
AR CH</w>
integr ative</w>
spea king</w>
P DE
genotyp ed</w>
quanti fying</w>
N R</w>
in distinguishable</w>
RELEV ANCE</w>
contro versy</w>
kine sia</w>
ob viously</w>
el lip
Hem at
sh ed
CD D</w>
stret ching</w>
po d
hemisph eric</w>
Impro ving</w>
0. 65</w>
immun ogenic</w>
a rent</w>
Mod ulation</w>
Op tical</w>
tri ed</w>
antagon ized</w>
mid w
U A</w>
yol k</w>
E qu
3 T3</w>
conver gence</w>
D VT</w>
- 4
abstin ence</w>
Streptom yces</w>
chec k</w>
cl usal</w>
vaso active</w>
immunocom promised</w>
ic le-
C ys</w>
if e</w>
13 6</w>
U ro
trans form
an der</w>
Ph e</w>
e GFR</w>
NA ME</w>
psych ology</w>
pestic ide</w>
7- year-old</w>
rein forced</w>
propi onate</w>
lact ose</w>
vitamin s</w>
tic ation</w>
ra f
Sw it
Thyro id</w>
Pattern s</w>
a OR</w>
MS M</w>
im bur
di urnal</w>
comp any</w>
pro of</w>
CA -
In ternal</w>
0. 50</w>
intr ag
encap sulation</w>
cl o
ocy stis</w>
proto zo
chol ic</w>
MA LD
s ounds</w>
y ros
uni qu
cy tic</w>
I ran
palmit o
u ght</w>
ew es</w>
pattern ing</w>
m sec</w>
Intrac ellular</w>
trif luoro
attend ance</w>
M otor</w>
Th ail
PR P</w>
cr is
liqu id-
cross- linked</w>
diffic ile</w>
R B</w>
sub acute</w>
nano structures</w>
astro cyt
veget able</w>
par adox
ex port</w>
pre- treatment</w>
poly cystic</w>
K er
discrimin ant</w>
y lob
Phyl ogenetic</w>
Chlamy dia</w>
sig moid</w>
stress ful</w>
chrom ium</w>
adi um</w>
bi ocompatibility</w>
T- cells</w>
P HA</w>
Inter ventions</w>
mul tim
ke ting</w>
Em erg
k ill</w>
Optim al</w>
man eu
multi focal</w>
R CT</w>
A .
dener vation</w>
ingredi ents</w>
poly unsaturated</w>
do ing</w>
lys osomes</w>
antin oc
tr ust</w>
allevi ate</w>
exerc is
0. 20</w>
adequ acy</w>
V as
bot t
j et</w>
explan ations</w>
M am
CB T</w>
PT C</w>
pedi atr
yl transferase</w>
peri odic
Coun ty</w>
SE ARCH</w>
enke phalin</w>
anti platelet</w>
D oc
re fu
R FLP</w>
ic e-
ap point
re ferences</w>
s entinel</w>
an ase</w>
par v
omat erials</w>
ash es</w>
flo x
198 1</w>
F requency</w>
po ver
pa st
PL C-
Atl antic</w>
h un
u ate</w>
anaes thetic</w>
gen tly</w>
LE VEL</w>
muc in</w>
hydroxy apatite</w>
autonom ous</w>
soph is
emerg e</w>
well- established</w>
meth acrylate</w>
oph armac
R S
inter cal
Pr o</w>
A di
Th or
mag net
pea ked</w>
13 9</w>
mess ages</w>
osi dase</w>
con sequent</w>
im etic</w>
perme ation</w>
whole- body</w>
Arter ial</w>
ensur ing</w>
me ters</w>
har monic</w>
mo sis</w>
bi ases</w>
olig omers</w>
elas ticity</w>
occlud ed</w>
h ips</w>
interrup ted</w>
or us</w>
Transi ent</w>
transp osition</w>
Ac t</w>
ch ew
c ari
k et</w>
chol era</w>
reconstruc tions</w>
recogn izing</w>
prob abilities</w>
Thail and</w>
o plasma</w>
absc esses</w>
cobal t</w>
St atus</w>
ju ana</w>
a f</w>
end onuclease</w>
opo rous</w>
s -1</w>
graf t-
of- life</w>
te g
ulcer ation</w>
L G
ycl ic</w>
parti tion</w>
o roph
s i</w>
A ch
secre te</w>
year -
insp ired</w>
promp ted</w>
pa y</w>
neutr on</w>
pe ers</w>
N GS</w>
parti tioning</w>
al im
pro thrombin</w>
mo ther
lat encies</w>
men isc
14 2</w>
granul ocytes</w>
PD -1</w>
cre te</w>
sy l
G ene
tur ned</w>
G h
ac on
ou red</w>
Sp ear
6 9
F luorescence</w>
D G</w>
DB S</w>
10. 0</w>
dev oid</w>
Gl y-
diaphrag matic</w>
multi functional</w>
atro genic</w>
le tic</w>
be ams</w>
implic ation</w>
cros sing</w>
cap sid</w>
O P
pre clud
noc iceptive</w>
fresh ly</w>
be at</w>
fol ds</w>
ylob acter</w>
Correc tion</w>
bride ment</w>
Ch i
Bi ol</w>
ch ymo
it rate</w>
Sch wan
seroton ergic</w>
ultra structure</w>
bacterioph age</w>
poin ting</w>
g ad
2- 4</w>
compreh ension</w>
filam entous</w>
R ates</w>
ide as</w>
ing ested</w>
incid ences</w>
gener al
hydro carbon</w>
alkal oids</w>
S odium</w>
un successful</w>
plan es</w>
occup ation</w>
br y
ad ine</w>
Ab normal</w>
CD 11
H CO
lam ellar</w>
delta -
si ve-
minim izing</w>
electrocardi ogram</w>
is -
oc o
n ary</w>
acc umbens</w>
lig ase</w>
bi g</w>
6- phosphate</w>
am ox
phot osynthesis</w>
str ands</w>
R R
vacu um</w>
eukary otes</w>
pur ine</w>
infec tivity</w>
broncho alveolar</w>
Seph arose</w>
1 75</w>
kn esses</w>
J oint</w>
Q RS</w>
H SCT</w>
a ids</w>
bio informatics</w>
adhe sions</w>
dropl et</w>
em atics</w>
constitu ent</w>
fist ulas</w>
c DNAs</w>
im per
pl eth
re distribution</w>
emphys ema</w>
con du
cell- cell</w>
anc ient</w>
Compreh ensive</w>
sci ences</w>
L 3</w>
lea ve</w>
icillin -resistant</w>
Maxim um</w>
H 1
on idazole</w>
ig uous</w>
CR -
ozym es</w>
D HE
chloro quine</w>
ser i
Per s
3, 5-
s ement</w>
uter o</w>
tr y</w>
adipos ity</w>
mon oc
un less</w>
agg res
Uni variate</w>
neph ritis</w>
os pas
mas ked</w>
CF TR</w>
auto immunity</w>
cat abolism</w>
a vir
mesoth eli
m ates</w>
oscop e</w>
ov sk
ro pol
par tur
implant able</w>
ME T</w>
frame works</w>
reconstruc tive</w>
h en</w>
p ra
an ox
In dependent</w>
if ies</w>
glu con
pituit ary-
adju stments</w>
ion izing</w>
Electr onic</w>
adrenoc eptors</w>
fil tered</w>
lutein izing</w>
F as
b om
sulf ide</w>
neuro lep
quar ter</w>
IFN- alpha</w>
temperat ure-
14 6</w>
l av
HLA- DR</w>
self- esteem</w>
shif ting</w>
muc ous</w>
jejun al</w>
dichro ism</w>
ine ural</w>
f idelity</w>
tw enty</w>
ol ive</w>
PE G-
ab iotic</w>
glycos amin
bar ley</w>
el es</w>
Child hood</w>
Al most</w>
V 2</w>
auton omy</w>
dis si
con flu
DE S</w>
ro -
re pressed</w>
lab ile</w>
ar ing</w>
Recur rent</w>
cru zi</w>
IB S</w>
-re test</w>
B PA</w>
1. 5-
1 1.5</w>
Sw iss</w>
deli veries</w>
1- year-old</w>
beli ef</w>
q RT-PCR</w>
parallel ed</w>
trim ethyl
reflex es</w>
rib osomes</w>
W eight</w>
0. 67</w>
dextr in</w>
TR AI
inter disciplinary</w>
Abstr act
cing ulate</w>
Schwan n</w>
F oc
er ine</w>
ej ac
restric tions</w>
orb idity</w>
seas ons</w>
I a</w>
tacti le</w>
w illin
Al a</w>
reg imes</w>
M S-
metabol ized</w>
pro kary
neuro developmental</w>
V O</w>
rig orous</w>
16 8</w>
k 1</w>
eth eless</w>
brid ging</w>
intra epithelial</w>
at ar
swit ched</w>
Reg ion</w>
vill i</w>
emplo y</w>
heal ed</w>
0. 22</w>
oin osi
el ig
sched ules</w>
sym path
photo receptor</w>
lact ating</w>
man nose</w>
PD GF</w>
sist er</w>
malon dialdehyde</w>
0. 33</w>
6 8
eff eren
pen dic
S 100
ag eous</w>
pol lin
15 4</w>
ov ulatory</w>
pyr imidine</w>
immun ob
pec tor
micro RNA</w>
nanoc ryst
encoun ter</w>
coun selling</w>
acet one</w>
An t
the tical</w>
Hy bri
vibr ational</w>
elast ase</w>
de acetyl
normal -
neo vascularization</w>
de sis</w>
IF N
fo ve
pin eal</w>
tin nitus</w>
nemat ode</w>
P TH
u ps</w>
Ac cum
M K-
topois omerase</w>
Spear man</w>
1. 4
P ow
iter pen
nan om
ind ole</w>
lifes pan</w>
blind ness</w>
g lo
osurg ery</w>
ol ith
ex empl
top ological</w>
0. 72</w>
hyper insulin
ta urine</w>
HS V-1</w>
solubil ized</w>
vesi cal</w>
n ish</w>
morb id</w>
multicentr e</w>
Ac tin
F As</w>
1 A1</w>
deform ities</w>
Descrip tive</w>
G ood</w>
su tures</w>
H B</w>
re imbur
shed ding</w>
us crip
awa ke</w>
bl un
B 3</w>
E PR</w>
St at
coron avirus</w>
fici ency</w>
dic ation</w>
vol ution
Abstract Text</w>
Predic tion</w>
ob lique</w>
shor tly</w>
ad one</w>
et opo
EC MO</w>
S um
metast asi
ster ol</w>
l- like</w>
mess age</w>
hex a
VE GF-
detox ification</w>
par s</w>
work load</w>
Ch alleng
II b</w>
mosquit oes</w>
B T
sit e-specific</w>
Gram -positive</w>
neuro genesis</w>
ma ster</w>
g ian</w>
B row
of-the- art</w>
nanos cale</w>
P le
0. 21</w>
relig ious</w>
List eria</w>
M ig
ir rit
optim izing</w>
L ack</w>
osom iasis</w>
15 2</w>
ch air</w>
stere otactic</w>
allo steric</w>
L p</w>
micro glial</w>
self- assembly</w>
mo ved</w>
im posed</w>
ar tic
M ob
be sides</w>
no vation</w>
bas e-
amb iguous</w>
train ees</w>
sub scales</w>
w ann
LD L-
Mal ay
Ag ing</w>
-1 4
miti gate</w>
here sis</w>
ste atosis</w>
1 53</w>
sen ior</w>
oxygen ase-
re jec
oc clusal</w>
non coding</w>
HR s</w>
ovari ectomized</w>
G O
Apop tosis</w>
gene ic</w>
qual ity-
granul omatous</w>
homolog ue</w>
socio- economic</w>
etopo side</w>
in clusions</w>
c- fos</w>
b an
el uted</w>
op eptide</w>
Compar isons</w>
in still
mesang ial</w>
sym metrical</w>
spi kes</w>
or h
dru g-induced</w>
oter icin</w>
un event
manip ulated</w>
chlor amphenicol</w>
ari ans</w>
meta- analyses</w>
0. 70</w>
1 P</w>
di phenyl
el vic</w>
Kin etic</w>
d an
celi ac</w>
Ti O2</w>
Rh od
c ed
dam aging</w>
f uro
lepro sy</w>
al bin
ro stral</w>
as simil
in su
advant ageous</w>
chap ter</w>
Pur ification</w>
LT P</w>
stra ight</w>
Inc ub
S pl
W -
THE SIS</w>
Prote ins</w>
ornith ine</w>
ob liter
T GF</w>
hu ge</w>
perform s</w>
Clinical Tri
thalass emia</w>
ket o
indi genous</w>
N itro
pepti de-
trac hom
s angu
collagen ase</w>
veget ative</w>
Reg ression</w>
self- management</w>
exce ed</w>
repeti tion</w>
amin oph
oste omyelitis</w>
con currently</w>
at able</w>
ch al
ch ie
inter neurons</w>
b ath</w>
pl u
icul us</w>
an in</w>
bi os
coll ections</w>
i P
Y AG</w>
constitu ted</w>
0. 24</w>
AT -
i tic</w>
et axel</w>
in yl</w>
Decre ased</w>
cre d
cl ade</w>
Morph ological</w>
ap heresis</w>
inte rested</w>
d ac
f ast-
S SR
termin ated</w>
ery thromycin</w>
ap p</w>
CC K-
PC NA</w>
anti convuls
C 5</w>
hypo phy
amb igu
lo oking</w>
Endo thelial</w>
Consi der
A ir
squ ares</w>
crystall ization</w>
cy clin
bio diversity</w>
bul b</w>
ev ing</w>
ac ros
low er-
dis til
3- D</w>
co ffe
radi ation-induced</w>
buff ered</w>
set t
5 A</w>
extrap ol
u -
pre requisite</w>
ex osomes</w>
man uscrip
o vir</w>
v ar</w>
se a
cephal ospor
co stly</w>
Camp ylobacter</w>
leth an
2 C</w>
at erials</w>
ent h</w>
anti- cancer</w>
st ation</w>
fol ic</w>
hypercholesterol emia</w>
projec ted</w>
streptoc occi</w>
P b
Pres sure</w>
top ology</w>
idi tis</w>
0.00 0</w>
.0 2</w>
14 3</w>
di z
amp icillin</w>
fr ic
exacerb ations</w>
possess ing</w>
c ited</w>
glut ar
im mor
fiel d-
succin ate</w>
epitheli al-
se w
0. 19</w>
In tensive</w>
less ons</w>
M B-
TI ON
super vision</w>
Develop mental</w>
smo oth
consul tations</w>
K i
Veter ans</w>
but yr
ox azole</w>
migr atory</w>
a esthetic</w>
standar dised</w>
res emble</w>
anth ocyan
phen otyp
HC V-
tryp an
terre strial</w>
t ude</w>
ospas m</w>
ar um</w>
it eal</w>
Recomm end
cle aning</w>
lnc RNA</w>
intr at
wed ge</w>
0. 23</w>
l ingu
C ho
1 D</w>
lact one</w>
pat ernal</w>
sial ic</w>
c ep
intrac table</w>
ab rup
ure ter
pare sis</w>
pack aging</w>
coun ted</w>
gradu ates</w>
ST EMI</w>
restric tive</w>
ANA LY
16 3</w>
Effici ent</w>
f asci
small est</w>
9 00</w>
in ward</w>
L ys</w>
an ne
assum e</w>
sal t-
Repe ated</w>
TH A</w>
alg inate</w>
Chang e</w>
p 16</w>
dev ast
it um</w>
D ip
HTL V-
th aw
yo u</w>
antagon istic</w>
D T</w>
adjunc tive</w>
ground water</w>
low- income</w>
b ariatric</w>
GL P-1</w>
in significant</w>
h a</w>
crib ed</w>
harv est</w>
thrombo embolic</w>
ol im
si d
- down</w>
d yn
er i</w>
tic um</w>
id ate</w>
p 53-
caroten e</w>
Per son
rib osome</w>
C 18</w>
acetyl cholinesterase</w>
un translated</w>
po l</w>
cap ital</w>
is oflurane</w>
0. 32</w>
bir d</w>
1. 73</w>
is oc
the astern</w>
D S
Iran ian</w>
ter ol</w>
pheny leph
Tradi tional</w>
canc erous</w>
puls atile</w>
L BP</w>
M S.</w>
review ers</w>
nec rotizing</w>
Aor tic</w>
b .
antigen -specific</w>
reth ral</w>
S he
transpor tation</w>
t ate</w>
s an
gen otoxic</w>
Re action</w>
lipo xy
t ou
rh abdomy
disrup t</w>
Sh ig
Mod eling</w>
G 3</w>
- sensitive</w>
analge sics</w>
Tur key</w>
chamb ers</w>
cyt ological</w>
her bic
clos ing</w>
hydroph ob
oc utaneous</w>
infrequ ent</w>
com pressive</w>
LVE F</w>
liqu ids</w>
naph th
calorimetr y</w>
fer ro
ACh R</w>
alge sia</w>
it real</w>
dig ested</w>
Ser tol
INTERVEN TION</w>
low- cost</w>
reconstitu tion</w>
ke y
CC K</w>
A my
synchron ization</w>
W iley</w>
E A
c f
tr u
w ine</w>
Tre g</w>
restr aint</w>
leth ality</w>
Las er</w>
S of
ur in
port able</w>
deox yn
guid ing</w>
b y
erec tile</w>
C on</w>
wor ker</w>
semi- structured</w>
F T
E PA</w>
R IA</w>
tun n
sequ entially</w>
Ninet een</w>
trac ing</w>
di methyl</w>
bi ophysical</w>
r umin
Antim icrobial</w>
M ain
distr action</w>
erythem a</w>
Mechanis m</w>
protein- coupled</w>
f en</w>
con ferred</w>
oc ation</w>
pat ellar</w>
mega kary
ME NT</w>
my opia</w>
consi ders</w>
ul e-
lead ers</w>
J -
ind ol
advanc ing</w>
P sy
In testinal</w>
Remo val</w>
n .</w>
Ir on</w>
z yg
Rhe um
l ers</w>
M as
anti proliferative</w>
form aldehyde</w>
at l
imetr y</w>
me gal
i aceae</w>
remain der</w>
negl ected</w>
IO L</w>
bi otechn
Alter ations</w>
gin sen
ren in-
po uch</w>
pre- existing</w>
conduc tive</w>
AR S</w>
immunocyto chemistry</w>
chec ked</w>
norm ative</w>
micro structure</w>
intra thecal</w>
O vari
in one</w>
s kin
v oid
2, 6-
C le
carb ach
hel ping</w>
bio tin</w>
alcoh ols</w>
cou ple</w>
haloth ane</w>
de uter
denti sts</w>
is omer</w>
ra ft</w>
H O</w>
off set</w>
hom ozyg
end or
ple as
15 6</w>
har dness</w>
E SR</w>
surroun ded</w>
s aph
III a</w>
Traum a</w>
14 8</w>
od ys
0. 55</w>
derm is</w>
3 60</w>
air s</w>
PT P</w>
immunocom pet
contrac eption</w>
state- of-the-art</w>
PC C</w>
tris omy</w>
ac ral</w>
W KY</w>
C ha
im possible</w>
an ni
opin ions</w>
tr ap
arri val</w>
CA L</w>
BRA F</w>
P Y
av alin</w>
aminoph en</w>
As p</w>
il is</w>
um b</w>
Ab dom
mid azolam</w>
if ers</w>
son ographic</w>
phot osensi
Vi et
PC 12</w>
eo chrom
ascer tained</w>
parox ysmal</w>
hem olysis</w>
infer tile</w>
R os
ol -induced</w>
nephro tic</w>
osph ere</w>
querc etin</w>
ar one</w>
ca v
3- year-old</w>
iz ation-
Cir culating</w>
W BC</w>
standardi zation</w>
RE S</w>
is lands</w>
crani ofacial</w>
bre ast-
bot tom</w>
20 20</w>
AI S</w>
val pro
e uc
pe ti
at uration</w>
w i
off s</w>
comb at</w>
g al</w>
enz a</w>
lys ate</w>
In si
macrom olecules</w>
of ur
to oth
ed ges</w>
al an
orig inate</w>
ca ve
py el
B 4</w>
tran ce</w>
az o
hall mark</w>
UT I</w>
Paren ts</w>
ep sy</w>
CI N</w>
z eta</w>
su stain</w>
Meth yl
mo tions</w>
tom e</w>
belong ed</w>
D CS</w>
ME S</w>
b ach</w>
Smo king</w>
SF- 36</w>
N U
acr ylic</w>
pep tic</w>
radionuc lide</w>
tal k</w>
ER G</w>
ER D</w>
man nit
syn geneic</w>
0. 28</w>
se where</w>
co vers</w>
sist ant</w>
Ig G1</w>
A si
pe a</w>
GB S</w>
acin ar</w>
op yr
bar ic</w>
transp arent</w>
sic kness</w>
S en
param agnetic</w>
sophis ticated</w>
Adolesc ents</w>
A trial</w>
i ens</w>
M W</w>
ogen ously</w>
hydr ated</w>
m Abs</w>
in ia</w>
elig ibility</w>
absorb ance</w>
Poly morph
0. 68</w>
F os</w>
B N</w>
S patial</w>
afen ib</w>
LPS- induced</w>
Identi fying</w>
Predic tors</w>
no ur
TE XT</w>
ascorb ate</w>
B ene
pl egia</w>
im ine</w>
hydrox yl
D ynamics</w>
visu alize</w>
20 5</w>
N G
equ ipped</w>
de bridement</w>
ro ds</w>
PA D</w>
Ga ussian</w>
iter ative</w>
RESUL T</w>
ch or
DO X</w>
en oid</w>
splen ectomy</w>
0. 66</w>
amin oglyco
SI R
I E</w>
thor ax</w>
pauc ity</w>
coun ter</w>
E I</w>
HD AC
trachom atis</w>
flox acin</w>
it ly</w>
sha ft</w>
granul oma</w>
Pro cess
over night</w>
sub mucosal</w>
pro lac
cl oz
bur g</w>
benz yl
nex t-generation</w>
KE Y</w>
entr ic</w>
carbox yl</w>
Assess ing</w>
f alling</w>
0. 26</w>
encour aged</w>
INTER PRE
Mac roph
V ery</w>
tin a</w>
bio assay</w>
Al together</w>
t ons</w>
phosph oinosi
hypo plasia</w>
re organization</w>
s r
thorac otomy</w>
on asal</w>
infiltr ate</w>
ap tam
yto in</w>
sym bi
pre- operative</w>
Sa har
E .
fe el</w>
th ing</w>
sand w
mono amine</w>
my ometr
opi ate</w>
ventr icles</w>
5 5-
b evacizumab</w>
99mT c-
af lat
electro spray</w>
w are</w>
C PAP</w>
ouab ain</w>
oxal ate</w>
fac ile</w>
er as</w>
ag inal</w>
HR P</w>
Dis ability</w>
Rh iz
gre en
comm is
bi og
inf antile</w>
Afr ican-
0. 56</w>
enter al</w>
rab ies</w>
S us
cont our</w>
ca p</w>
sing let
F S
op tera</w>
0. 63</w>
he ads</w>
S j
melan omas</w>
ER P</w>
fibr illary</w>
jejun um</w>
tolu ene</w>
en em
prevent able</w>
pol y-
14 1</w>
P- 3</w>
W .</w>
Pe ak</w>
SO 4</w>
pe red</w>
Pu bl
D C
ad vis
no ea</w>
e IF
lab els</w>
thir ty-
F abr
E V</w>
dent ure</w>
eyel id</w>
molecular- weight</w>
neigh bo
ob ium</w>
N 2
leishman iasis</w>
HO -1</w>
Platel et</w>
dose- dependently</w>
immer sion</w>
sh ut
instruc tions</w>
coffe e</w>
compan ies</w>
B ank</w>
compens ated</w>
B is
der m</w>
read ers</w>
oder ma</w>
we an
Pro -
C ong
en a</w>
An terior</w>
Ethi opia</w>
neuro psychiatric</w>
PE C</w>
An es
Le u</w>
implic it</w>
fa thers</w>
IN G</w>
S eg
PRE SEN
ti bi
ear -
tw itch</w>
ClinicalTri als.gov</w>
D eli
od or</w>
auth en
Mex ican</w>
hel ices</w>
dys lipidemia</w>
wash ed</w>
willin gness</w>
ad ri
inv ited</w>
str ated</w>
el sewhere</w>
As th
B V</w>
wash out</w>
hypo thetical</w>
19 7
un identified</w>
INTERPRE TATION</w>
0. 1-
caver nous</w>
vic inity</w>
vi an</w>
mar keting</w>
pr ice</w>
correc ts</w>
cal oric</w>
bac ks</w>
u tively</w>
o b</w>
ro oms</w>
interleukin -1</w>
ch lamy
icro bi
Li kewise</w>
dynam ical</w>
Pro long
di g</w>
3- month</w>
saf er</w>
Mid dle</w>
Oxy gen</w>
mid brain</w>
l arynx</w>
C enters</w>
elim inating</w>
mat ches</w>
Abdom inal</w>
B U
L at
0. 69</w>
lik re
coc ul
Intra operative</w>
mari juana</w>
Y .</w>
az epam</w>
ver ification</w>
appro ached</w>
negl ect</w>
0. 64</w>
Clin ically</w>
Targ eted</w>
motoneur ons</w>
adj ust</w>
grap h</w>
captop ril</w>
ar rested</w>
carb on-
ultras ound-
glucos amine</w>
rough ness</w>
F 4</w>
fav ored</w>
mat ri
ol uminescence</w>
lin k
osom e-
hall uc
flow ering</w>
2 4.
A rea</w>
rom andibular</w>
z ers</w>
in struction</w>
D S-
devast ating</w>
tic ism</w>
v ent</w>
igh ten
do t</w>
Cr iter
be ds</w>
aspar ag
V LDL</w>
6 4
micr on</w>
hydrox ide</w>
neur ite</w>
but yl</w>
ap ril</w>
um s</w>
Thir d</w>
thous and</w>
hy ph
dig oxin</w>
he ated</w>
olip id</w>
ten sor</w>
Col labor
Li qu
K ne
inter molecular</w>
veh icles</w>
cl of
hy brid
L- NAME</w>
Eg yp
Prepar ation</w>
eg ic</w>
ul o
alcohol ism</w>
con es</w>
tin ent</w>
Op en</w>
chrom atic</w>
AP 1</w>
propos al</w>
Extrac ellular</w>
vaso constric
eng raf
R 3</w>
Sch ist
in ogen</w>
ard ous</w>
Haem ophilus</w>
A c</w>
SS c</w>
AN G</w>
Incub ation</w>
car pal</w>
st ains</w>
be gun</w>
go at</w>
open ed</w>
bre ed</w>
basi lar</w>
B PH</w>
small- cell</w>
caud ate</w>
oc ta
ropol itan</w>
in- embedded</w>
amo eb
CON TEXT</w>
co atings</w>
15 1</w>
Inter leukin
0. 36</w>
six th</w>
inf est
odi um-
mut ual</w>
ic o
CF U-
spermat ogenesis</w>
TGF- β1</w>
cadaver ic</w>
herpes virus</w>
odop sin</w>
b at
D ow
al be
PRESEN TATION</w>
medias tin
her bi
preced ented</w>
at ed
r onate</w>
two- step</w>
ti ps</w>
prior ities</w>
ven tive</w>
underestim ated</w>
Sur ge
uro thelial</w>
infra structure</w>
l an
Den mark</w>
di valent</w>
graph s</w>
spl itting</w>
sal mon</w>
ep icardial</w>
fe eling</w>
sol eus</w>
trans formations</w>
hum an-
plau sible</w>
evol ve</w>
Cat eg
gau ge</w>
bre eds</w>
fe at
narrow ing</w>
SARS-Co V-2</w>
divid ing</w>
g as
fer tile</w>
M Ps</w>
jour nal</w>
W C</w>
elev en</w>
re ticular</w>
ANALY SIS</w>
at ally</w>
pe er-
aug ment</w>
0. 62</w>
b ig
c amp
m ist
d ating</w>
reas oning</w>
Un til</w>
live stock</w>
k Pa</w>
or rhea</w>
sp ic
orthog onal</w>
Gra ves</w>
p 1</w>
cho osing</w>
CA S</w>
Protec tion</w>
compar atively</w>
Sci ences</w>
evalu able</w>
ca st
em itting</w>
SA P</w>
pal p
Gre ater</w>
L ey
util izes</w>
De ep</w>
Whit ney</w>
Sertol i</w>
g as-
ex it</w>
kin ematics</w>
connec ting</w>
0. 27</w>
gem citabine</w>
pi ece</w>
gu ar
at ed-
5 4
omy cosis</w>
yl yl</w>
capsa icin</w>
eti ologic</w>
haem odynamic</w>
beg ins</w>
ren dered</w>
Mut ation</w>
wh ites</w>
os oph
CP P</w>
m Glu
particip ates</w>
set up</w>
clinic opathologic</w>
prote oglycan</w>
- deoxy
oscill atory</w>
it ely</w>
MP O</w>
renew al</w>
Sim ple</w>
suppl emental</w>
Hor mon
sic k</w>
sl ides</w>
nucle ation</w>
bul l
ectom ies</w>
Psych ological</w>
HR T</w>
onc ogenes</w>
consec utively</w>
J our
G al</w>
abro gated</w>
th west</w>
For m</w>
HL- 60</w>
equi val
scat ter</w>
stric ture</w>
T2- weighted</w>
T c-
distric ts</w>
b erry</w>
a h
obarb it
P rec
L ond
can als</w>
dyst roph
zo on
hem ostasis</w>
chic ine</w>
cl op
DM SO</w>
ful filled</w>
mon oxide</w>
Ser ial</w>
0. 30</w>
speci es
tri ple-
sur prisingly</w>
w r
LOG Y</w>
C 3H</w>
ello sis</w>
im i
resembl es</w>
Emerg ing</w>
de tom
orth otopic</w>
orb it
far mers</w>
MM C</w>
P 450
inflam ed</w>
fing ers</w>
con azole</w>
o- 2</w>
PB S</w>
interferon- gamma</w>
fail ing</w>
broad -
Mem ory</w>
justi fied</w>
rot ator</w>
inve stment</w>
deplo yment</w>
denat uration</w>
N-methyl- D-
0. 38</w>
ocyan ate</w>
assum ing</w>
20 6</w>
Twenty- one</w>
Ep id
sulfat e-
ac ne</w>
orimetr ic</w>
Br d
inter ven
PC -
ket one</w>
IC S</w>
pre conditioning</w>
as tically</w>
on co
pneum othorax</w>
Res on
PD A</w>
NL R</w>
fibrin olytic</w>
gel atin
H 4</w>
la ws</w>
inspec tion</w>
res veratrol</w>
on i
S l
ib u
Vir al</w>
ros ity</w>
fa ther</w>
hid den</w>
cle an</w>
gen i
um oral</w>
e sia</w>
r als</w>
hem agglutinin</w>
F GF-
di a
AD AM
A qu
op ent
anti psycho
MA b</w>
dis proportion
end- diastolic</w>
Combin ing</w>
nec rop
l umb
CYP 3
not es</w>
son i</w>
pa in-
st omy</w>
pa w</w>
andro gens</w>
12 ,
AM PA</w>
meth adone</w>
n yst
tun able</w>
wor th</w>
isot opic</w>
k ain
0. 48</w>
ac k
prim e</w>
disp arity</w>
to- noise</w>
synerg istically</w>
u a</w>
s er</w>
my o
colle ag
oth yr
vasodi lator</w>
EC 50</w>
di pine</w>
Epidemi ological</w>
osyl transferase</w>
0. 42</w>
Ex tensive</w>
self- administered</w>
De ath</w>
l ati
1. 7
as on</w>
copolym er</w>
. The</w>
ri b</w>
Recommend ations</w>
y clin
st aged</w>
Por tu
ti m</w>
gh relin</w>
intim al</w>
ist ering</w>
anc estr
2, 3,
. ..</w>
metallo proteinase</w>
br is</w>
disabl ed</w>
mannit ol</w>
8- year-old</w>
fic ially</w>
end otox
conver t</w>
0. 34</w>
spati otemporal</w>
ocycl ic</w>
cl ient</w>
inser t</w>
paradig ms</w>
ot ec
T yr</w>
brid ges</w>
end orph
Transpl antation</w>
health- care</w>
F NA</w>
W ar
per t</w>
trans duced</w>
E F
ag enesis</w>
ine- rich</w>
hyal uron
dro ps</w>
pic tures</w>
11. 1</w>
S an</w>
ti tre
17 4</w>
antr al</w>
ad -
1- 5</w>
interleukin -2</w>
prot ons</w>
tet anus</w>
spectro meter</w>
HC s</w>
S qu
relap ses</w>
Psy c
NL R
S MA
Pro gram
injec ting</w>
Twenty- five</w>
cyclo oxygenase</w>
near- infrared</w>
m ar</w>
cl ot</w>
h exam
d in</w>
micro circulation</w>
arom atase</w>
permis sive</w>
appe tite</w>
h ot
Sahar an</w>
techn ically</w>
rich ness</w>
am el
perme abil
random ization</w>
er- based</w>
Rh o</w>
Myco plasma</w>
simul ating</w>
m ite</w>
compens ate</w>
pur pur
chemil uminescence</w>
W al
acidi fication</w>
S 3</w>
Gener ation</w>
5 -1
ti an</w>
Sym p
I VI
ad esh</w>
Inf ants</w>
ap eptide</w>
H3 K
ir is</w>
xim e</w>
c ies</w>
bur nout</w>
anti- CD
RNA i</w>
DR G</w>
A 2
im pression</w>
deline ate</w>
s ap
or ide</w>
arbitr ary</w>
2 2.
S ul
mer cap
17 7</w>
person- years</w>
syn cope</w>
hand -
in sem
an ide</w>
post- translational</w>
3 3.3</w>
rel ess</w>
hel min
pit ch</w>
am a</w>
fo od
od ine</w>
ophag y</w>
endothel in</w>
G C-
de vised</w>
cyt ologic</w>
B I
PBM Cs</w>
0. 58</w>
He ad</w>
compul sive</w>
Ap pl
3 6-
mesotheli oma</w>
h ir
neon ate</w>
Symp tom</w>
A ra
ag onal</w>
main tains</w>
MM P
disco ver</w>
un altered</w>
E MS</w>
amin obutyric</w>
O lig
Con cer
glomerul i</w>
cl eral</w>
et tes</w>
bra e</w>
un precedented</w>
m A</w>
saph enous</w>
lin oleic</w>
brady cardia</w>
on y</w>
pr ur
L ess</w>
congru ent</w>
b anding</w>
fri ends</w>
amph otericin</w>
c ock
kal likre
2 -1
H H</w>
TU NE
herni ation</w>
c c</w>
ax es</w>
assemb lies</w>
nerv osa</w>
can cell
synap se</w>
RB Cs</w>
Fin land</w>
eti dine</w>
ET s</w>
forsk olin</w>
i atrogenic</w>
ure mic</w>
H ong</w>
tr apped</w>
G 6
pover ty</w>
acetyl transferase</w>
H PA</w>
parac rine</w>
vag in
ab le-
A sc
is in</w>
in ergic</w>
phenyleph rine</w>
di morph
ir con
ex -
3- 5</w>
Sign aling</w>
Q AL
sur pr
thyro idectomy</w>
incid ental</w>
choro id</w>
muc inous</w>
Coun c
Mann -
- 2.
post- traumatic</w>
electrol ytes</w>
C ac
Fi eld</w>
k ingly</w>
chaper one</w>
sha res</w>
IM T</w>
T emporal</w>
cl otting</w>
y ch
il es</w>
dis ul
Tim e-
syn ucle
myel inated</w>
un ic
li ons</w>
ga ze</w>
isop ren
ore sistance</w>
re acting</w>
cylin dr
ol i</w>
0. 31</w>
doc etaxel</w>
im aged</w>
dis aster</w>
CD C</w>
s ely</w>
G ender</w>
Ley dig</w>
AD L</w>
pharmac odynamic</w>
K 3
cat ast
ec ia</w>
crow n</w>
C are
mirro r</w>
La ke</w>
13. 3</w>
13. 5</w>
dimer ic</w>
N Y
substitu ents</w>
Invol vement</w>
rec tus</w>
St ar
sarco plasmic</w>
nan omaterials</w>
M an</w>
Kne e</w>
Q I</w>
HF D</w>
e ast</w>
19 79</w>
PC L</w>
azep ines</w>
Pois son</w>
autoradi ography</w>
Lond on</w>
bio degradable</w>
N- acetyl-
0. 52</w>
8 7
resc ued</w>
transf ers</w>
phot odynamic</w>
ar by</w>
t ness</w>
cyclospor in</w>
0. 61</w>
v an</w>
al li
re placing</w>
rim al</w>
14 9</w>
aver aging</w>
ol one</w>
P ren
Wil le
over dose</w>
H SA</w>
peroxis ome</w>
vers us-
IN FO</w>
adip ocyte</w>
f im
dou bling</w>
3 20</w>
0. 54</w>
AT CC</w>
n ationally</w>
neighbor hood</w>
shrin kage</w>
Cr on
X R</w>
CN Ts</w>
rhyth mic</w>
is othi
legis lation</w>
mut ans</w>
specific ation</w>
un folding</w>
S train</w>
ure ter</w>
discipl ines</w>
G ly</w>
ran ked</w>
re modelling</w>
l ut
kin d
trans loc
CEN T</w>
s ors</w>
strateg ic</w>
join ing</w>
0. 43</w>
L IN
ev acu
haz ardous</w>
Impl ementation</w>
lac to
associ ates</w>
F at
di am
0. 60</w>
AR F</w>
amph ib
r ash</w>
gover ning</w>
tempor ally</w>
princ ip
Col orectal</w>
op ter
pa d</w>
post er
fo od-
Est abl
0. 46</w>
anti arrhythmic</w>
detom idine</w>
iod othyr
at- risk</w>
contrac ep
µ m</w>
P 3
re aches</w>
pl ei
per pendic
dec lining</w>
cros sed</w>
The ore
benz yl</w>
stra ight
eth yl-
t oral</w>
random -
interpre ting</w>
elucid ation</w>
cre ates</w>
CXCR 4</w>
Pol and</w>
groo ve</w>
in clin
ip olar</w>
lign in</w>
gre y</w>
uniqu ely</w>
biosens or</w>
PL A2</w>
moun ted</w>
a dex</w>
Ar g-
0. 37</w>
15 8</w>
asth enia</w>
Fib ro
0. 40</w>
enanti omers</w>
2 1.
K ong</w>
self- care</w>
I so
f ishes</w>
har mon
anch ored</w>
adv ent</w>
P it
transpl ant
speci ation</w>
T ask</w>
neuro cognitive</w>
coord inates</w>
Wille brand</w>
W ol
di ox
L atin</w>
popl iteal</w>
0. 29</w>
AF M</w>
Det ailed</w>
for amen</w>
og u
or ange</w>
ing ton</w>
0. 44</w>
acet onitrile</w>
ma z
naph thal
qui escent</w>
A O</w>
RE CENT</w>
Disc ussion</w>
or bit</w>
in i</w>
aut o-
aer ob
0. 53</w>
instill ation</w>
w arr
er h
Traum atic</w>
moti le</w>
Counc il</w>
Ti O</w>
as in</w>
hol es</w>
pro gnos
tem plates</w>
so y</w>
equi valence</w>
2 30</w>
arteri oles</w>
s h</w>
M b</w>
50 6</w>
sol ids</w>
Pro lifer
3 2-
SV 40</w>
drin kers</w>
lo bectomy</w>
f eline</w>
16. 7</w>
PO RT</w>
gynec ologic</w>
situ ated</w>
amelior ated</w>
br ight</w>
ab domin
chol ate</w>
16 6</w>
35 S</w>
Ne is
ti fied</w>
pharmac otherapy</w>
concep tu
de af
TN M</w>
imper ative</w>
thin k</w>
16 4</w>
electrocardi ographic</w>
Q Ds</w>
be e</w>
waveleng ths</w>
K ar
membran ous</w>
ko v</w>
8 -</w>
su perim
0.0 15</w>
ser ov
def ence</w>
ti i</w>
os sification</w>
statis tic</w>
emul sions</w>
vide o-
Spec ies</w>
ac i
sinus oidal</w>
bur sts</w>
y er</w>
tun ed</w>
vis co
albe it</w>
di et
my opathy</w>
de er</w>
multi dimensional</w>
2 80</w>
comp uting</w>
2 3.
per idone</w>
S ter
morph ogenetic</w>
H T-
famil i
resembl ed</w>
H amil
micr onucle
Wh ole</w>
P- induced</w>
hydro gen-
electr ically</w>
a ver</w>
X RD</w>
si bling</w>
superi ority</w>
emp ty</w>
16 2</w>
M BP</w>
psori atic</w>
loc king</w>
in cur
di um</w>
2, 5-
h sp
nucle ase</w>
resi ding</w>
or dering</w>
myco bacterial</w>
digesti bility</w>
ome ters</w>
bcl -2</w>
Anti body</w>
mimic ked</w>
t- PA</w>
check list</w>
lip id
bifur cation</w>
G G
carbo platin</w>
in novation</w>
heterozyg osity</w>
pres ently</w>
annot ation</w>
Oc cu
early- stage</w>
per tinent</w>
my of
U g
18 5</w>
ide ation</w>
Biom ar
paraff in-embedded</w>
chol er
int ent</w>
f lex</w>
myofib ro
neuro transmitters</w>
si mi
ac a</w>
acet aminophen</w>
Wor king</w>
S to
Mic ha
20 4</w>
ion ophore</w>
de emed</w>
li sten
Tum ors</w>
vacu oles</w>
B asal</w>
a dish</w>
0. 57</w>
e- 1</w>
C e
par an
plank ton</w>
1, 4-
Accur ate</w>
F lor
SI I</w>
17 2</w>
warr ant</w>
Twenty- two</w>
un met</w>
elong ated</w>
extr usion</w>
pow ered</w>
to ur
staphyloc occal</w>
dri ves</w>
- independent</w>
analy zer</w>
Tr ich
od or
2, 000</w>
carb ap
ischemia- reperfusion</w>
19 5</w>
con fusion</w>
hyper thyroidism</w>
neuro fibrom
With out</w>
20 2</w>
K 562</w>
mo x
cer tainty</w>
re programming</w>
Gre en</w>
S ud
s and</w>
ã o</w>
Lim ited</w>
immunocompet ent</w>
J AK
min us</w>
bot ulinum</w>
cyan ide</w>
tend ons</w>
Sc anning</w>
E volution</w>
mas king</w>
o .</w>
K r
path ogenetic</w>
rit uximab</w>
ygo tic</w>
corro sion</w>
0. 59</w>
lu x
pul sion</w>
ep razole</w>
ab normally</w>
objec tively</w>
de bris</w>
cancer- related</w>
po rosity</w>
g ates</w>
phil osoph
R M</w>
PT A</w>
fix ed-
troph oblast</w>
scar ring</w>
nanow ires</w>
2 9-
contracep tives</w>
tern ary</w>
we ed</w>
R ib
cl ou
alc in</w>
broil er</w>
affor ded</w>
CRE B</w>
her oin</w>
NI R</w>
l em
phyl ogeny</w>
sp oro
soft- tissue</w>
shap ing</w>
om i
whole- cell</w>
M ass
neuro transmission</w>
s phen
stat ements</w>
r umen</w>
ar a</w>
0. 39</w>
ori entations</w>
integr ins</w>
ens emble</w>
0. 47</w>
mod ular</w>
titre s</w>
CRI SPR</w>
m entary</w>
Ne o
oly b
c c
Pro toc
occup ancy</w>
sch wann
hydro gen
Selec tion</w>
tur b
immunocyto chemical</w>
Compo unds</w>
F T-
iti dis</w>
M o</w>
g aining</w>
sub traction</w>
occa sional</w>
f mol</w>
prov oked</w>
equiv ocal</w>
Pro ced
meta plasia</w>
bil ayers</w>
verte brae</w>
cod ons</w>
Ac ross</w>
age- dependent</w>
Psychi atric</w>
sin uses</w>
worth y</w>
AC R</w>
sor tium</w>
I l
lipoxy genase</w>
test -retest</w>
ot ax
mem bered</w>
Mann- Whitney</w>
aut ocrine</w>
0. 41</w>
false- positive</w>
pl ating</w>
qu ater
ser ia</w>
comput ation</w>
spong e</w>
suppl ementary</w>
intran asal</w>
METHO DO
ep ist
Intra -
co re-
amelior ate</w>
anticoagul ants</w>
commit ted</w>
synchron ized</w>
Tur k
first- order</w>
concomit antly</w>
5- 10</w>
H 7</w>
of loxacin</w>
O G</w>
infec ting</w>
PC T</w>
p 65</w>
N L</w>
abil istic</w>
ric eps</w>
but yl
p A</w>
phot ographs</w>
Arab ia</w>
ud ed</w>
biom aterials</w>
d i</w>
ser adish</w>
compl aint</w>
gastro esophageal</w>
int entional</w>
rec ap
efferen t</w>
open ic</w>
expec t</w>
precip itated</w>
z oster</w>
qu it</w>
conver gent</w>
phen ytoin</w>
0. 51</w>
oste oblast</w>
inser tions</w>
row ing</w>
w ind</w>
initi ative</w>
end ym
conc an
contr asting</w>
Immuno histochemistry</w>
refer rals</w>
K s</w>
tum oral</w>
common est</w>
a a</w>
o estrogen</w>
Ste re
at rophic</w>
compl eting</w>
cloz apine</w>
en ucle
Clin icians</w>
short -</w>
co existence</w>
dex tro
neuro surgical</w>
osteopo rotic</w>
20 3</w>
R u</w>
Rec ognition</w>
For ce</w>
clim atic</w>
10. 3</w>
l ass</w>
t ospor
tho roughly</w>
Vari ation</w>
0 -1
rub ber</w>
G C-MS</w>
LI F</w>
streng thening</w>
pro biotic</w>
sal mon
chromatography- mass</w>
a .
6 3
endo tracheal</w>
S ph
ti az
M AC
on egative</w>
trans ection</w>
G le
stat ement</w>
m ole</w>
protein -1</w>
cre am</w>
pres chool</w>
te en
CD 14</w>
W D</w>
anesthe tics</w>
migr ating</w>
colleag ues</w>
s tive</w>
Asth ma</w>
bronch itis</w>
eu than
GT Pase</w>
s aid</w>
F ul
hydroly zed</w>
Fus arium</w>
IP V</w>
Neis seria</w>
Re tin
c- Jun</w>
infiltr ates</w>
pri on</w>
u ality</w>
- in</w>
recogn izes</w>
i o</w>
0. 49</w>
2 D3</w>
h im
cardi over
b ib
F OR</w>
unevent ful</w>
S CLC</w>
al izes</w>
inter vertebral</w>
u k
accum ulating</w>
AD A</w>
birth weight</w>
ch i-square</w>
beta- galactosidase</w>
tac rolimus</w>
re ti
streptoc occal</w>
1.0 5</w>
b ox
invari ant</w>
two- stage</w>
ancestr al</w>
erh ans</w>
Integr ated</w>
Sam ple</w>
as e
hy ster
acchar ide</w>
pre menopausal</w>
olip ids</w>
PK C
abstr act</w>
P f
fav our</w>
ic tal</w>
sac ral</w>
HA ART</w>
par asym
dic s</w>
Sequ encing</w>
mit ogen</w>
work shop</w>
ana plastic</w>
albin o</w>
L A-
19 2</w>
germin al</w>
thous ands</w>
de d-
b arium</w>
ter r
lic ens
bi -
GF AP</w>
distor ted</w>
S A-
tripl et</w>
S TS</w>
hypot ensive</w>
dec ided</w>
UD P-
K et
compl ementation</w>
illo facial</w>
de fibrill
B angl
rig idity</w>
low- frequency</w>
NE T</w>
il ance</w>
perf ec
alg al</w>
anti epileptic</w>
lymphaden opathy</w>
brea king</w>
peri oste
sub family</w>
ham pered</w>
E SCC</w>
don or-
inter ruption</w>
b ath
op ancre
Del ayed</w>
antipsycho tics</w>
di one</w>
trac ted</w>
PA T</w>
Pres ence</w>
invasi veness</w>
y cle</w>
ay -
My c</w>
re absorption</w>
therap ist</w>
cou mar
bio chemistry</w>
streng then</w>
Po or</w>
log arith
asbest os</w>
bov is</w>
out lines</w>
Al k
dimer ization</w>
sc anned</w>
NI H</w>
carcin ogens</w>
Altern ative</w>
ir s</w>
Temper ature</w>
14 C-
- 3-
Go og
L atin
od om
transc atheter</w>
Ta king</w>
Ken ya</w>
9 8
in- vitro</w>
bed side</w>
Isl and</w>
as cribed</w>
dou bled</w>
din itro
hepat otoxicity</w>
supram olecular</w>
ad el
suspici ous</w>
d b</w>
D ose</w>
uc e</w>
modul atory</w>
Techn ology</w>
lithi asis</w>
di visions</w>
mill im
im pulse</w>
el ite</w>
CA 2</w>
n ings</w>
calc ified</w>
ant i</w>
0.0 12</w>
3 1-
st ature</w>
obr onchial</w>
grou p-
discrim inating</w>
encephal ic</w>
addi tives</w>
plasm on</w>
viol ent</w>
lec tins</w>
ente sis</w>
commit tee</w>
prospec ts</w>
ex ocytosis</w>
V H</w>
retin ol</w>
MDA- MB-
H U</w>
O -</w>
dis closure</w>
me detomidine</w>
PC B</w>
c ist
hyp ogly
am ing</w>
P H-
vin yl
sub cl
y litis</w>
nephro toxicity</w>
op ens</w>
salic ylic</w>
E ye</w>
bo ost</w>
xen obi
se al
osy stem</w>
semiconduc tor</w>
co ar
de grade</w>
osmol ality</w>
ic ate</w>
Ovari an</w>
L 4</w>
work force</w>
ph eochrom
S- transferase</w>
G yn
dr astically</w>
one uro
h s
Adolesc ent</w>
L -1</w>
Prolong ed</w>
Tren ds</w>
glycol ytic</w>
A K</w>
pr e</w>
phot o-
E U</w>
toxic ological</w>
seque stration</w>
PD H</w>
Lang erhans</w>
METHODO LOGY</w>
2 70</w>
her ds</w>
min d
Occu pational</w>
al a</w>
inf lation</w>
pher om
con ference</w>
ag ency</w>
CYP2 C
decom pens
Inter view</w>
S etting</w>
1 1,
Compo und</w>
intra- abdominal</w>
gl ot
emph ig
L ith
CB CT</w>
compreh en
ureth ra</w>
S on
p ene</w>
N erve</w>
K ir
2 60</w>
7 5-
h ens</w>
R ati
CR S</w>
af il</w>
Organ ic</w>
F B
ag ulation</w>
Leu -
weigh ing</w>
PC Bs</w>
oc ephal
inc enti
epi phy
rest oring</w>
Hun ting
R us
ph ages</w>
pr us
mil dly</w>
intrav itreal</w>
tetrac h
yl ine</w>
HN SCC</w>
man ually</w>
19 75</w>
porph yrin</w>
2, 2</w>
tumorig enic</w>
my ogenic</w>
phosphor ylase</w>
p assi
8 01</w>
Inflam mation</w>
sem ide</w>
ac knowled
7 50</w>
la b</w>
convul sive</w>
el -based</w>
im port</w>
fun ded</w>
al .</w>
mol-ec ules</w>
ac ea</w>
id og
le aching</w>
TGF- beta1</w>
ye asts</w>
judg ment</w>
re form</w>
tax on
asc ent</w>
mar row
angiotensin- converting</w>
Path way</w>
14. 3</w>
judg ments</w>
S K</w>
The ory</w>
in dispensable</w>
tri age</w>
esophag itis</w>
Pol y</w>
phthal ate</w>
AL E</w>
15 9</w>
an teri
intr ons</w>
irr itation</w>
prepar ing</w>
sub sp.</w>
paren t-
gad ol
osteocl asts</w>
R ight</w>
dop ing</w>
4 th</w>
e zing</w>
econ omically</w>
viri ons</w>
answ ers</w>
T u
to uch</w>
re ds</w>
dyst onia</w>
on as</w>
NP V</w>
mig rate</w>
flu oxetine</w>
author ities</w>
crystall ographic</w>
intram edullary</w>
vin cris
MR S</w>
Seph adex</w>
intrav entricular</w>
iodothyr onine</w>
Recon struction</w>
at o
J u
ibu profen</w>
z inc
fluctu ation</w>
out let</w>
O 157</w>
6 J</w>
id er</w>
quinol ine</w>
S pe
har bo
ta g</w>
high- level</w>
re traction</w>
bio activity</w>
sew age</w>
er vical</w>
C HI
10. 2</w>
contrac ted</w>
vit rectomy</w>
Three- dimensional</w>
der ma</w>
inequ alities</w>
fo etal</w>
var ices</w>
ater ial</w>
galact os
gri d</w>
19 78</w>
h us
re feren
ur ies</w>
read ings</w>
our ce</w>
l ot
Chem otherapy</w>
motiv ated</w>
- 5
oscill ation</w>
obstac les</w>
orph ine</w>
di ap
Tr iton</w>
mem ories</w>
Enter ococcus</w>
site- directed</w>
s pro
regi stries</w>
fore sts</w>
ic eption</w>
in- dependent</w>
perin eal</w>
macrom olecular</w>
restor ative</w>
single- cell</w>
PU FA</w>
si l</w>
metr onidazole</w>
Se q</w>
epox ide</w>
os oma</w>
si aly
neutroph il
re ared</w>
over looked</w>
- stimulated</w>
non- diabetic</w>
HP V-
Ter m</w>
D G
- out</w>
lit ers</w>
II A</w>
smo ked</w>
Goog le</w>
thromb olytic</w>
hol low</w>
herbi v
PR I
inflam mas
read er</w>
anc ement</w>
Ech ocardi
imag ery</w>
be et
Pharmac ological</w>
spas m</w>
t etro
ser ogrou
surfact ants</w>
straight forward</w>
In jection</w>
PA S</w>
E AE</w>
pa yment</w>
antim icrobi
ü ll
16 1</w>
if era</w>
PT X</w>
sw abs</w>
am enable</w>
ac o
ket t
ang itis</w>
manip ulations</w>
eng aging</w>
mom ents</w>
R NP</w>
ak i</w>
13 C</w>
trans activation</w>
peri vascular</w>
m 3</w>
D ri
k yph
y og
flow ers</w>
reimbur sement</w>
counter part</w>
re finement</w>
Blu e</w>
obacter iaceae</w>
c 2</w>
metalloprotein ases</w>
disp osal</w>
uni ver
tr in
ocy anine</w>
sub strat
T ax
cataly ze</w>
benzo ate</w>
A cin
ur gently</w>
deoxy glucose</w>
lac tam</w>
N early</w>
intes tin
hydrophob icity</w>
f asted</w>
cord ant</w>
Ex p
uz umab</w>
nour ished</w>
lipo philic</w>
yros ine</w>
ph os
repeat ability</w>
infec t</w>
in correct</w>
AL A</w>
educ ators</w>
Inf ec
C 4
structure- activity</w>
Isra el</w>
K u
d t</w>
single- center</w>
am ne
oste ogenesis</w>
cyto kin
GT P
vascular ized</w>
B enz
per taining</w>
D DM</w>
1.0 2</w>
dat a-
lim bic</w>
appreci ated</w>
detec tors</w>
Tox oplasma</w>
de fl
di pole</w>
reg ister</w>
R est
m ate</w>
at ergic</w>
Con nec
DR B1</w>
le sioned</w>
1.0 3</w>
hyper lipidemia</w>
phosph onate</w>
Ch ic
vig orous</w>
myocardi tis</w>
hair pin</w>
c nem
in completely</w>
propyl ene</w>
nor adrenergic</w>
arter itis</w>
aly zed</w>
poly cyclic</w>
Dis tinc
ig enic</w>
T ob
Pak istan</w>
no is
prolac tin
back grounds</w>
lingu istic</w>
el uting</w>
D 6</w>
k el
x ic</w>
review ing</w>
DB A</w>
n s
PD GF-
it ual</w>
1. 6
Trans fer</w>
campa ign</w>
Li ving</w>
tis tic</w>
R AD
sc ars</w>
con crete</w>
ter t-
lead er</w>
A 23
tub al</w>
mon oph
R ate</w>
ab ut
aldehy des</w>
ost at</w>
Mac ro
intrac or
adren ocortical</w>
or ship</w>
compl i
ear th
qual ified</w>
re uptake</w>
oligosacchar ide</w>
b ank</w>
pre existing</w>
ur tic
id ent</w>
FV C</w>
inform al</w>
16 7</w>
Em bry
confir matory</w>
lith o
I B</w>
sub scale</w>
W at
vi d</w>
classi fications</w>
plas min</w>
leaf let</w>
rec tom
ubiquitin ation</w>
dialy s
Wor k
Gn R
Criter ia</w>
di version</w>
meningi oma</w>
TN BC</w>
ep endym
smar t
O SCC</w>
fig ure</w>
A h
x 2</w>
An at
p etro
Inter fer
Accur acy</w>
Non etheless</w>
ru g
neuro -
CN V</w>
bran ch
Ap plications</w>
pe an
dose- related</w>
F FA</w>
patient- reported</w>
sub divided</w>
arg ued</w>
C a-
anis otropic</w>
faec alis</w>
on- line</w>
10. 6</w>
get ting</w>
C S-
E SB
my cel
Der mat
k its</w>
re generating</w>
ME K</w>
osteoc last</w>
ac yl-
to- face</w>
Pro bl
col o
nitro prus
fer ment
out door</w>
head aches</w>
Al tered</w>
serop re
exec ution</w>
AR C</w>
vin ces</w>
ic ally-
ing -related</w>
S per
om n
DO I</w>
defin es</w>
10. 4</w>
hab di
ol act
carbach ol</w>
S ha
M ild</w>
fe deral</w>
eosin ophilia</w>
ardi ac</w>
Cl oning</w>
S cop
perpendic ular</w>
d osis</w>
ell ae</w>
op on
inte rests</w>
diab et
L AD</w>
1.0 4</w>
tonsi ll
ech an
Cas 9</w>
introduc es</w>
re war
l axis</w>
ost om
ureth ane</w>
them atic</w>
T L</w>
C ES</w>
G ro
tain ties</w>
sed- phase</w>
A PS</w>
press ors</w>
Contr ary</w>
F- actin</w>
ti vitis</w>
Reson ance</w>
encoun ters</w>
pol yn
mu -
quinol ones</w>
Gastro intestinal</w>
ER CP</w>
sym b
H G</w>
Psyc INFO</w>
inter acted</w>
percei ve</w>
Ne ph
In duc
10. 8</w>
trans aminase</w>
Re tinal</w>
IL- 5</w>
remn ant</w>
14. 5</w>
im migrants</w>
hor seradish</w>
ref ers</w>
el ementary</w>
agricul ture</w>
acycl in</w>
m .
ref er</w>
T est
palp able</w>
N-methyl-D- aspartate</w>
dang erous</w>
endothel in-1</w>
Up per</w>
leng thening</w>
gen otypic</w>
concan avalin</w>
H er</w>
R ad
Ther mal</w>
De fin
un covered</w>
lat ors</w>
B asic</w>
ex am</w>
cop enia</w>
fasc ia</w>
4 00
al istic</w>
ultraf il
if f</w>
cul turally</w>
Dig ital</w>
AD H</w>
arbox ylic</w>
T W
gluc osidase</w>
st ore</w>
ar k
cell -based</w>
L- type</w>
in conclusive</w>
bu d</w>
N I</w>
r ing-
anch or</w>
Ar gen
I GF</w>
stro kes</w>
oglob ulin</w>
Micro bial</w>
encomp assing</w>
M PA</w>
ish -
maxim ally</w>
pum ps</w>
bub ble</w>
W n
al in-
tempo romandibular</w>
spac ing</w>
outw ard</w>
- 4-
EV s</w>
andro st
persist s</w>
anc e
ab an</w>
on- like</w>
Multi variable</w>
W ales</w>
soci eties</w>
us cul
equival ents</w>
la ev
miner als</w>
F ung
s odium-
ogene tically</w>
casc ades</w>
bio tin
sc ru
ow ad
tiaz em</w>
Eng ine
Repor ting</w>
OR F</w>
er us</w>
Re ference</w>
T uberculosis</w>
An n
extrav as
T N</w>
immunohisto chemically</w>
w earing</w>
cl aim</w>
Rou tine</w>
g um</w>
vi al</w>
8 9
ocompati ble</w>
c us</w>
T RE
sh ad
str ing</w>
Sec re
stitu tion</w>
Met abol
c o</w>
i .</w>
Uni on</w>
Mater ial</w>
marg inally</w>
MM Ps</w>
R are</w>
1, 25</w>
Amin o</w>
us ate</w>
Deli very</w>
F IT
anastom oses</w>
rh od
ecta sia</w>
accid ental</w>
Develop ing</w>
Del etion</w>
gly can</w>
1 C</w>
scav enger</w>
fu sion-
Jour nal</w>
Meth od
owad ays</w>
non- linear</w>
Differenti ation</w>
leukotri ene</w>
Ca P</w>
l ides</w>
slow ing</w>
j ing</w>
dam s</w>
A beta</w>
idog rel</w>
onc ological</w>
M uch</w>
L act
ep ide
one- dimensional</w>
gly cin
st un
h an</w>
A 5</w>
ly ase</w>
d ut
μ mol</w>
b ad</w>
anti- HB
18 6</w>
pul l
cyclohex imide</w>
en tion</w>
oc clusions</w>
ox azol
sugg estion</w>
om atic</w>
16 9</w>
immor t
Trans mission</w>
I MRT</w>
retin oblastoma</w>
P- glycoprotein</w>
NC A</w>
lymphaden ectomy</w>
W all
Bri ef</w>
wave form</w>
thre e
h oney</w>
alcohol ics</w>
con dom</w>
contin ent</w>
Cron bach</w>
de als</w>
res um
ra inf
chem opre
lay ing</w>
endocardi al</w>
col chicine</w>
lethan olamine</w>
Hy pox
fer mented</w>
Cor relations</w>
calc ifications</w>
Nanop articles</w>
dr ift</w>
polypo sis</w>
7 A</w>
at eness</w>
Spec i
solid- state</w>
CL -
disrup ting</w>
C CA</w>
ren ic</w>
syn ergy</w>
contribut or</w>
col d-
d am</w>
Pren atal</w>
2 25</w>
out -
SE L
fluo roph
Ac qu
Di et</w>
eff usions</w>
home ostatic</w>
pass ing</w>
ID DM</w>
sustain ability</w>
em in
tro chan
quad riceps</w>
ometr ically</w>
prost acyclin</w>
arth ritic</w>
prin ts</w>
insul t</w>
Tex as</w>
centr ally</w>
tig o</w>
U R</w>
ex agg
on ide</w>
oselec tivity</w>
m atism</w>
mor bidities</w>
cylindr ical</w>
En zym
dosi metry</w>
Es ophag
Physi ological</w>
frag ile</w>
T O</w>
Im age</w>
anes thesi
long est</w>
18 8</w>
educ ated</w>
PB L</w>
E stro
complex ed</w>
un resectable</w>
TI s</w>
s na
sp ore</w>
w ires</w>
n inet
deman ding</w>
ER -
hand le</w>
rom a</w>
com a</w>
el in</w>
void ing</w>
S in
ell ularly</w>
classi fier</w>
Gle ason</w>
chemoradi otherapy</w>
gangli onic</w>
Tran sl
op eptides</w>
la ke</w>
op r
ran king</w>
T ib
NH 2</w>
p r</w>
unc tional</w>
hyper algesia</w>
Hunting ton</w>
Th 17</w>
p a</w>
assemb le</w>
3 T3-
TP 53</w>
re as</w>
A ir</w>
bac illi</w>
follow up</w>
compl ained</w>
phosph o-
ill es</w>
acet amol</w>
incorpor ates</w>
H an</w>
o estradiol</w>
bl y
cis platin
CD s</w>
work flow</w>
war ning</w>
let ter</w>
explic itly</w>
O 2-
at ous</w>
immuno assays</w>
X- rays</w>
serum- free</w>
phosphat ases</w>
cry o
se eded</w>
cin nam
shi el
gon orrho
V CA
rid ge</w>
AC P</w>
di phosphate</w>
ab er
ith romycin</w>
El derly</w>
SC N</w>
in habit
drin k</w>
SS R</w>
al th</w>
modi fiable</w>
Es s
simi an</w>
hydro dynamic</w>
Ac tion</w>
ev en
las er-
meningi omas</w>
R M
10. 7</w>
3 -1
end arte
ospec ific</w>
ev o
glyc ans</w>
DE Gs</w>
4- 6</w>
sev oflurane</w>
met ropolitan</w>
haemat ological</w>
gastroenter itis</w>
path ologically</w>
onec rosis</w>
In corpor
IL-1 7</w>
habdi tis</w>
n ip
D- glucose</w>
os up
warran ts</w>
g t</w>
im age-
sc ene</w>
Cryst al</w>
intenti ons</w>
imetr ic</w>
conjunc tivitis</w>
parasym pathetic</w>
gluc an</w>
ne bul
calibr ated</w>
po d</w>
mig rated</w>
ation- related</w>
anaesthe tized</w>
ten s</w>
blast ocyst</w>
F requ
Glc NAc</w>
men ting</w>
sham- operated</w>
ear able</w>
gastro cnem
loos ening</w>
z ircon
er ul
Import ance</w>
regres sions</w>
abstr acts</w>
6 2
C -1</w>
Qu e
equ ilib
Fl ex
reproduc e</w>
paraff in</w>
1.0 6</w>
three fold</w>
l es
SD s</w>
Angi otens
ill ar</w>
SC ID</w>
inter course</w>
om ic
ser ologic</w>
Sim ulation</w>
re ment</w>
par ap
N a-
met atar
0.0 0</w>
gluc opyran
throm bin
P ig
cross- reactivity</w>
Or ig
e osin</w>
ser onegative</w>
appreci able</w>
W ash
Adhe rence</w>
B ay</w>
beta- catenin</w>
l ose</w>
CA 3</w>
spe eds</w>
Prof ile</w>
15 00</w>
organis ation</w>
yn e</w>
ap ple</w>
manuscrip t</w>
re produced</w>
Im paired</w>
Wil cox
gre n</w>
endoc rin
ather ogenic</w>
l uminescence</w>
vincris tine</w>
S S-
k J</w>
public ly</w>
di ode</w>
Inf ections</w>
E con
for ty-
Swit zer
S pi
amin e-induced</w>
Tox icity</w>
MALD I-
f all
rh o</w>
ti ometry</w>
surg e</w>
ine- treated</w>
fis sion</w>
lipos omal</w>
non diabetic</w>
oper able</w>
MR A</w>
motiv ational</w>
hydra ulic</w>
17 6</w>
Stand ardi
blun ted</w>
ol aryng
blo ts</w>
trans late</w>
CD 25</w>
Aca demic</w>
ff er</w>
sec ure</w>
loc k</w>
esc ens</w>
li ximab</w>
tetra zol
chew ing</w>
carcin ogen</w>
long- range</w>
20 9</w>
best -
seropre valence</w>
batter ies</w>
tig mine</w>
T h</w>
ox o-
diver sification</w>
B on
extra hepatic</w>
insu red</w>
A im
PR A</w>
SA M</w>
Dru gs</w>
characteris ation</w>
species -specific</w>
pecul iar</w>
ob es
w ar</w>
flavon oid</w>
mu g</w>
j i</w>
v able</w>
4 -1
dys functions</w>
clos ed-
admin istering</w>
PD AC</w>
scre ens</w>
Quanti fication</w>
Cac o-2</w>
itr y</w>
ac king</w>
spec ulate</w>
CR H</w>
b ine</w>
sequ enc
7, 8-
trich loro
subcl avian</w>
0.0 13</w>
identi fiable</w>
hyper cap
17 1</w>
exacerb ated</w>
Switzer land</w>
Anti biotic</w>
Auth ors</w>
PG E</w>
as perg
bronch oscopy</w>
Surge ons</w>
tra de-
cyclo dextrin</w>
t .</w>
pol lu
7 8
CF A</w>
E PS</w>
c iti
B ul
hab it</w>
denti stry</w>
D an
Initi ally</w>
thyro trop
Mel an
st ellate</w>
2 5.
nitroprus side</w>
sk illed</w>
FD G-
atri sts</w>
neuro toxic</w>
multi level</w>
de tr
question ed</w>
Inhib itors</w>
hyal uronic</w>
AD R</w>
discord ant</w>
K v
be ha
Nitr ic</w>
su rethral</w>
Protec tive</w>
v ac
dys functional</w>
comprehen sively</w>
val is</w>
meth icillin-resistant</w>
ogen in</w>
te re
sit y-
l ax
at ography</w>
oper ators</w>
cost al</w>
cl amping</w>
Met abolism</w>
TUNE L</w>
Im pair
en al
Al a-
cont acted</w>
ec z
nit rous</w>
a es
thro at</w>
ab ov
phen obarbital</w>
C ob
H1 N1</w>
cim etidine</w>
hist ones</w>
P- gp</w>
synucle in</w>
exc iting</w>
.0 3</w>
TR PV
uc tal</w>
NI DDM</w>
ker atitis</w>
N ative</w>
haem odialysis</w>
elas tin</w>
sep tic
chemo attrac
c up</w>
er ization</w>
ul line</w>
activ ity-
worsen ed</w>
alpha- tocopherol</w>
Valu e</w>
long- acting</w>
terr itory</w>
endorph in</w>
col orimetric</w>
SP E</w>
dehydro gen
s outh</w>
ch in</w>
frequ ency-
DN ase</w>
proce eds</w>
pro vo
0.0 16</w>
pig e
b an</w>
dur able</w>
per ovsk
two- thirds</w>
pol es</w>
Hist opathological</w>
ligam ents</w>
hy pos
EC D</w>
exp ense</w>
L and
reco veries</w>
annot ated</w>
at tainment</w>
H ip</w>
x 1</w>
ml -1</w>
ad ds</w>
EB V-
AC A</w>
B CL</w>
Per sistent</w>
i ensis</w>
soci etal</w>
al ert</w>
D end
han dic
bil lion</w>
6- fold</w>
IL-1 8</w>
cross linking</w>
Tric ho
her d</w>
benzodi azepines</w>
y algia</w>
adver tis
indu stries</w>
conflic ts</w>
pyrid ox
princip ally</w>
amino- terminal</w>
hyper -
enor m
ere b
ca esarean</w>
9 37</w>
Tr p</w>
a g</w>
EM A</w>
Con comit
Arter y</w>
const antly</w>
l ated</w>
k a
ori ent
glutam atergic</w>
prote oglycans</w>
dise qu
ste adily</w>
Syn thetic</w>
Re pair</w>
hund reds</w>
in tu
fer rom
CO L
air borne</w>
ate- specific</w>
volt am
metaph ase</w>
in -</w>
TA C</w>
pro long</w>
immun o-
CD I</w>
Mul tic
af luoro
bur g
Ac cess</w>
aneurys mal</w>
ble omycin</w>
diffu sion-
ang eal</w>
sten oses</w>
ighten ed</w>
is cal</w>
Transcrip tion</w>
avir in</w>
ing ent</w>
e ip
tryp tic</w>
ag ue</w>
sec tors</w>
om eprazole</w>
wa ke</w>
con gen
li er</w>
zin ess</w>
mi R</w>
C ON</w>
L HRH</w>
neuro physiological</w>
v itr
rate- limiting</w>
ho g</w>
allo ys</w>
D eri
coun ty</w>
physi otherapy</w>
un a</w>
nicotin amide</w>
interpre tations</w>
Sup pression</w>
blood stream</w>
s- of-
g ut
ob ses
K RAS</w>
0.0 14</w>
epididym al</w>
reflec tance</w>
te es</w>
LI MI
aw s</w>
deaf ness</w>
D WI</w>
dam ages</w>
CL A</w>
11. 4</w>
carc ass</w>
ar ized</w>
il le</w>
insul a</w>
mm 2</w>
p est</w>
CN T</w>
mon o-
π -
S GA</w>
otec an</w>
m E
form ulas</w>
in in</w>
At tention</w>
C yp
v ice</w>
ro t</w>
ag mus</w>
compet e</w>
ine a</w>
spir ation</w>
me iosis</w>
SR S</w>
excep tional</w>
id omide</w>
dis infection</w>
r al
fum ig
Str ong</w>
meth amphetamine</w>
graft- versus-
u pr
Real- time</w>
cortic es</w>
St ability</w>
radi ograph</w>
in ae</w>
un ra
seri ously</w>
be ar</w>
To ol</w>
bus iness</w>
ev ening</w>
Dep ending</w>
anticonvuls ant</w>
incid ents</w>
uni vers
man soni</w>
ed es</w>
19 9</w>
fibrin olysis</w>
tit udes</w>
expendit ures</w>
Meta- analysis</w>
En zyme</w>
in tub
m ou
p un
lev odop
hyp no
uncer tainties</w>
Electr ical</w>
Pr P</w>
cent rom
deoxyn ucle
hard ware</w>
clof en
Par tic
ur ate</w>
enorm ous</w>
C ushing</w>
HIF-1 α</w>
for aging</w>
M .
fer ric</w>
ter rit
time- consuming</w>
tr id
aden os
ot on
micro arrays</w>
oc ene</w>
por ts</w>
Mon oclonal</w>
pro vinces</w>
2 56</w>
200 -
A S-
econ omy</w>
end os
f ection</w>
par a-
hyper calc
R h</w>
mitochond ri
st ations</w>
co variance</w>
laev is</w>
long- chain</w>
c ulation</w>
on- specific</w>
ultrason ographic</w>
I G
condu it</w>
Fat ty</w>
circu itry</w>
En dom
Is su
Acin et
re taining</w>
correspond ence</w>
Ca enor
steril ization</w>
3 7.5</w>
exha ustion</w>
rel and</w>
choler ae</w>
Com pon
combin atorial</w>
18 4</w>
sp ines</w>
d oll
M apping</w>
19 77</w>
20 7</w>
myco bacteria</w>
D am
PT CA</w>
engraf tment</w>
st aff
D ual</w>
sh allow</w>
prob abilistic</w>
triglyc eri
osp ir
y cin
M 3</w>
w illing</w>
hyper ox
cle ared</w>
11. 8</w>
second- order</w>
oxid ase-
inf er</w>
a eg
et ching</w>
clu es</w>
1. 1-
ion- exchange</w>
trem end
draw ing</w>
Pati ent-
wor st</w>
phot ore
cholecyst o
L 5</w>
stac king</w>
recre ational</w>
Techn ical</w>
resol ving</w>
anthrop ogenic</w>
bronch odi
grou p
is ozymes</w>
18 2</w>
bo ok</w>
withdraw n</w>
r uled</w>
absorp tiometry</w>
In don
CA s</w>
CB 1</w>
Inv asive</w>
splic ed</w>
wh el
Incre ases</w>
L yme</w>
Av ail
TI MP
gl ass
exchang er</w>
redund ant</w>
diure tics</w>
Heter ogene
Caenor habditis</w>
plas monic</w>
Path ological</w>
im pregn
succ e
mac aques</w>
Nor we
h anded</w>
gonad otroph
allevi ated</w>
c ar</w>
anil ine</w>
SO UR
MA O</w>
par av
T en
ic it</w>
disease- specific</w>
Turk ish</w>
VE C</w>
arthro scopy</w>
beta-lactam ase</w>
t rough</w>
b abo
en ever</w>
Re habilitation</w>
Bar ri
sc rip
Hydro xy
rever sed-phase</w>
st yles</w>
ab is
stric tures</w>
s chol
purpur a</w>
de bil
escal ation</w>
CD DP</w>
PD E</w>
face- to-face</w>
DE X</w>
Enter obacteriaceae</w>
gr as
intim ate</w>
streng th
Acinet obacter</w>
R y
en ol</w>
em -
respon der</w>
work up</w>
man n
Le sions</w>
bever ages</w>
second- line</w>
A ther
G ERD</w>
refu ge
in ev
Path ology</w>
furo semide</w>
os si
V al</w>
carcin oid</w>
coun ties</w>
F luoro
Modi fication</w>
am iod
I .
sulf oxide</w>
HR QOL</w>
Gener ally</w>
av a</w>
Inf ra
p emphig
is omerase</w>
gener ator</w>
in ant</w>
special ties</w>
er in</w>
ST I</w>
cer vic
Sep ar
p. o.</w>
fric tion</w>
if er</w>
myri state</w>
gastrocnem ius</w>
TT P</w>
en de
mus h
bi directional</w>
D y
anti thrombin</w>
al t</w>
fo rec
ag er</w>
e tings</w>
17 8</w>
quater nary</w>
eli ac</w>
tur bul
c Tn
Ultra structural</w>
E IA</w>
hat ching</w>
schist osomiasis</w>
Be ing</w>
sub dural</w>
PA s</w>
pal atal</w>
F ab</w>
17 3</w>
multi drug-resistant</w>
omet abolic</w>
su staining</w>
minim ized</w>
Ep il
ep ic
gly caemic</w>
c et
5-hydroxy tryptamine</w>
prolifer ate</w>
es el</w>
environ mentally</w>
P I-
11. 3</w>
osi s-
T od
8 5
or ific
t PA</w>
m ant
prim or
S po
of luorescent</w>
tum our
bub bles</w>
a e
K I</w>
analy te</w>
metabol omics</w>
ch in
sup posed</w>
las ers</w>
cyst ectomy</w>
rh am
d ens</w>
k an
ex presses</w>
contrac ture</w>
j ump</w>
sh rim
path s</w>
cryop reservation</w>
- 20</w>
V enous</w>
sea water</w>
cass ette</w>
um n</w>
T1- weighted</w>
p I</w>
Y ear</w>
V ar
Hybri d</w>
AL K</w>
G las
practic ing</w>
p ell
low- level</w>
conti gu
ex ocrine</w>
Hist ologic</w>
analy sing</w>
MR -
sleep -
0.0 11</w>
signal- to-noise</w>
conserv atively</w>
expec tation</w>
proton ated</w>
ing ing</w>
rot ating</w>
Ob ste
Perc eived</w>
ifer ous</w>
air flow</w>
I reland</w>
carbam azepine</w>
ta iled</w>
fel low
th western</w>
psych omotor</w>
PM Ns</w>
w ide-
ol ysin</w>
di clofen
00 00
sin usitis</w>
Wilcox on</w>
ent gen
myel odys
synthesi zing</w>
X a</w>
Loc alization</w>
g est</w>
us e-
St reng
synchron y</w>
Ne utroph
di asis</w>
Ac tivities</w>
cul turing</w>
singlet on</w>
reconstruc t</w>
V D
N O-
at e
MA PK
f oster</w>
h rs</w>
he ifers</w>
cholester ol-
ogene tics</w>
1. 01</w>
St .</w>
myel operoxidase</w>
N MD
hyper plastic</w>
persist ently</w>
Nu tritional</w>
collo id</w>
ri es</w>
p 27</w>
19 76</w>
shar ply</w>
Ch loro
induc tive</w>
Exc ept</w>
sk y</w>
Col om
immunob lot</w>
eip t</w>
path ies</w>
Ch lor
id ine-
18 3</w>
Col lag
l ic</w>
p tive</w>
dynam ically</w>
deep -
H en
19 6</w>
18 1</w>
antimicrobi als</w>
bud ding</w>
Mat rix</w>
cre di
car in
E mp
He at</w>
St able</w>
h i</w>
ac ul
tetrazol ium</w>
f us
r 2</w>
RE PORT</w>
ad o</w>
osp inal</w>
L C-
aspar tic</w>
path ologists</w>
a ke</w>
oder m</w>
P eptide</w>
plas mac
Br uc
C- peptide</w>
m i</w>
Twenty- three</w>
mar king</w>
W B
evid ences</w>
function alization</w>
erup tion</w>
S ig
oroph aryngeal</w>
de aminase</w>
hemat uria</w>
emphasi zing</w>
Theore tical</w>
vers a</w>
practi cally</w>
macroph age-
treatment- related</w>
us ability</w>
CI NA
ast ly</w>
thou ghts</w>
inhabit ants</w>
estro genic</w>
C utaneous</w>
1 0.1</w>
edi atr
Gre at</w>
im printed</w>
spectro metric</w>
glucuron ide</w>
Schist osoma</w>
Leg ion
out puts</w>
Rec ei
fer ring</w>
mis use</w>
H R-
co inc
event- related</w>
VO 2
Chol ester
V entricular</w>
eme dicine</w>
n am</w>
10. 9</w>
sulf hydr
R o</w>
poly p</w>
I di
occu pati
p om
r o</w>
loc ked</w>
32 P</w>
ox ib</w>
non steroidal</w>
an ser
SE P</w>
volunte er</w>
Deri ved</w>
Medi ated</w>
tym pan
PE P</w>
Tol l-like</w>
Ch est</w>
mit es</w>
ST s</w>
glyco sides</w>
in- binding</w>
DT PA</w>
compli ant</w>
glycer in</w>
2 alpha</w>
CD 40</w>
uni or</w>
- O-
AC TI
p 2</w>
TA TIONS</w>
por ation</w>
log- rank</w>
under pin
1.0 8</w>
K e
ne arby</w>
communic ating</w>
S H-
N d</w>
need les</w>
exac tly</w>
br ush
distinc tly</w>
fac eted</w>
e ased</w>
og ran
dep ths</w>
poly phenols</w>
to- treat</w>
C um
18. 5</w>
S atis
lympho proliferative</w>
ret t</w>
R om
arthro sis</w>
T es
lig ated</w>
methyl prednisolone</w>
Phe -
o kinase</w>
al er
A part</w>
favor ably</w>
cholest asis</w>
A gency</w>
at en
Mar kov</w>
tic es</w>
thi one
F ast</w>
enti on-
ris ky</w>
N- H</w>
short age</w>
anth in</w>
cat abolic</w>
T CM</w>
co m</w>
TRAI L</w>
O B</w>
in c</w>
un recognized</w>
CY P</w>
T K</w>
cell- specific</w>
cad aver</w>
anne aling</w>
O ri
rever se-
M ad
sul fam
max illa</w>
T yph
chol angitis</w>
A -</w>
og luc
empir ically</w>
lo ts</w>
f urthermore</w>
IL- 3</w>
Neuro logical</w>
benz oic</w>
ate- induced</w>
R N</w>
disequ ilibrium</w>
pi eces</w>
nyst agmus</w>
anaphy laxis</w>
ol ia</w>
rec ti
jejun i</w>
2 6.
hy pon
qual ities</w>
DM D</w>
pel lets</w>
Predic ting</w>
ac illin</w>
19 8</w>
sa w</w>
acch ari
din ucleotide</w>
SC F</w>
predisp ose</w>
o vid
dys plastic</w>
ch ose</w>
fl our</w>
miR- 2
ju x
discus sing</w>
intern alized</w>
n u</w>
c uc
nemat odes</w>
obut amine</w>
H- 2
voltage- dependent</w>
electron ics</w>
1.0 7</w>
Pol ic
in- treated</w>
be es</w>
physi cs</w>
ann ular</w>
AA V</w>
dor m
omy ces</w>
H UV
id ene</w>
dist ension</w>
let ters</w>
a ural</w>
CB D</w>
rel ia</w>
glycol ip
Lab el</w>
con vers
otom ies</w>
4- 5</w>
CINA HL</w>
obsc ure</w>
C ou
glyc ation</w>
cor rhiz
f in</w>
immun ophen
lib itum</w>
matri x-
t ann
requ ested</w>
land marks</w>
institu tion
Ra ther</w>
kil ob
P PD</w>
o u</w>
un satisfactory</w>
UV B</w>
Metast atic</w>
paradox ical</w>
k 2</w>
mas titis</w>
ie u</w>
implic ate</w>
vas ospasm</w>
cogn ate</w>
hydro cortisone</w>
BM P</w>
reg s</w>
descrip tors</w>
kine sis</w>
G el</w>
ap illary</w>
pector is</w>
sub mandibular</w>
alop ecia</w>
Fr ag
mu si
Estim ation</w>
m ography</w>
dec or
RA NK
al ia</w>
Al a
miner alized</w>
ro unds</w>
og astric</w>
as phy
CP T</w>
h older</w>
M etal</w>
cyto keratin</w>
ac ies</w>
Appro pri
7 6
w alled</w>
11. 6</w>
Norwe gian</w>
Re active</w>
17 9</w>
MA T</w>
he d
retur ning</w>
pip eline</w>
7 3
Pl us</w>
fib ros
inoc ulum</w>
Fr ame
PL GA</w>
satur able</w>
early- onset</w>
dil tiazem</w>
esti n</w>
or g</w>
sp astic</w>
coincid ed</w>
Sci enti
PT T</w>
bl acks</w>
proce ed</w>
web -based</w>
di ph
1. 8
time- of-
alcoh ol-
amino- acid</w>
trac ers</w>
1 20
HD L-
E F-
th umb</w>
ong side</w>
head -
Sequ ential</w>
id ated</w>
er sin
per itoneum</w>
en yl</w>
osteoc alcin</w>
cell- derived</w>
endarte rectomy</w>
spond ylo
P yr
C 6
Th r</w>
j um
Di strict</w>
Evalu ating</w>
M t
op posing</w>
F a
kallikre in</w>
gen ders</w>
P -1
M ay
val ine</w>
correl ating</w>
fir m</w>
is s
Optim ization</w>
Rel ease</w>
ser ology</w>
SM D</w>
apopto sis-
Targ et</w>
Prof es
t ables</w>
y stitis</w>
g in</w>
typ e-specific</w>
HC A</w>
hol istic</w>
ster nal</w>
AS 1</w>
4 a</w>
OV X</w>
o ate</w>
ap omorph
me etings</w>
F B</w>
a pro
Influ enza</w>
hyper tonic</w>
controll able</w>
co existing</w>
anc est
prefer able</w>
concentr ates</w>
incenti ves</w>
invasi vely</w>
Te aching</w>
dia stere
aff ord
co ils</w>
RA TION
go w</w>
e- like</w>
community- dwelling</w>
V ide
meth oxy-
Cer tain</w>
Ug anda</w>
kin ematic</w>
thyro iditis</w>
15. 5</w>
elucid ating</w>
b erg
es sively</w>
HY PO
oc arb
pan ze
hin dered</w>
Categ ory</w>
11. 7</w>
calcul i</w>
elic its</w>
che ese</w>
d d
Maxim al</w>
ho used</w>
Am pl
E GF-
C asp
M PS</w>
soci ally</w>
denat ured</w>
m ati
stimul ator</w>
cil ia</w>
ion ized</w>
no xi
circum ferential</w>
Bangl adesh</w>
c enti
cross- over</w>
Post erior</w>
encephal omyelitis</w>
stre p
Te tra
qu er
0.0 17</w>
p ts</w>
dens it
diclofen ac</w>
N ep
Ge org
In clusion</w>
bac ter</w>
B ot
Wh ole-
incre ments</w>
suc tion</w>
astig matism</w>
ne al</w>
fac et</w>
explo it</w>
sti l
an y
er ase</w>
separ ating</w>
Liqu id</w>
A23 187</w>
produc ers</w>
sus pec
oxidi zing</w>
deg ran
HMG B1</w>
Depend ent</w>
ut ter</w>
myel o
numer ically</w>
In s</w>
um -based</w>
di d
NA SH</w>
PT B</w>
6 00
Radi o
CO D</w>
n evertheless</w>
S ulf
cent red</w>
swe at</w>
Mix ed</w>
melan in</w>
cannabin oid</w>
Re stric
venti lator</w>
pup il</w>
morph ologies</w>
IP F</w>
Glas gow</w>
Dou ble</w>
I AP</w>
BM P-2</w>
pa ste</w>
gingi valis</w>
b inge</w>
form alin</w>
transcrip tionally</w>
cul ture-
Sing ap
B ab
K a
ic al-
munic ipal</w>
gener alization</w>
osi tivity</w>
V PA</w>
n ul
X R
orph an</w>
U rine</w>
incis ors</w>
fer rin</w>
Ter min
ul ator</w>
con tain
mit omycin</w>
LIMI TATIONS</w>
pre maturity</w>
TH C</w>
hyper polarization</w>
associ ative</w>
clop idogrel</w>
sandw ich</w>
event ual</w>
Ischem ic</w>
O pi
refl ective</w>
termin i</w>
trans dermal</w>
stre ptom
E US</w>
dut y</w>
AR s</w>
ff in</w>
condyl ar</w>
ro l
thromb i</w>
photo receptors</w>
com pressed</w>
HC MV</w>
HE V</w>
19 7</w>
fet oprotein</w>
R L</w>
cat ch
P ER
phot onic</w>
mes h
constr aint</w>
Flor ida</w>
1 7.5</w>
poly styrene</w>
Th r
metabol ically</w>
3 C</w>
ther to</w>
plei otropic</w>
refer ring</w>
Bacter ia</w>
si ze-
relap sing</w>
demyel inating</w>
cann ula</w>
RATION ALE</w>
ag en</w>
Fin nish</w>
dor fer
Jo hn</w>
S SI</w>
RNA- seq</w>
transpos on</w>
re acts</w>
requ est</w>
Bacter i
RA P</w>
sc rap
Con serv
toc occus</w>
arcom as</w>
HH V-
Wor k</w>
abov e-
de phosphorylation</w>
un cover</w>
a sion</w>
met amorph
un predictable</w>
W B</w>
micro particles</w>
Bar rett</w>
p p</w>
re act
ME N
ph o
MA S</w>
at oid</w>
24 h</w>
my ocl
granul omas</w>
B AC</w>
E co
V 3</w>
str ip</w>
radi o-
mm 3</w>
str ip
Infec tious</w>
simul ator</w>
18 9</w>
an o</w>
h ur
fluoro scopy</w>
categor ical</w>
ill -
osper mia</w>
pr o</w>
ST R</w>
long- standing</w>
Nan o
MA bs</w>
sati va</w>
instrum ented</w>
achiev es</w>
GW AS</w>
L -</w>
comfor table</w>
coagul ant</w>
TM J</w>
dimin ish</w>
bench mark</w>
B ei
scho ol-
LP L</w>
Short- term</w>
syncy tial</w>
en thal
ab ra
determin ate</w>
long itud
homolog ues</w>
con cordant</w>
R NF
bin ocular</w>
ho ur
recru it</w>
GT T</w>
hypog on
rel ational</w>
D O</w>
9 5
oph ores</w>
NAD PH-
phen ol
den itr
call osum</w>
U re
D CM</w>
exercis e-induced</w>
burg dorfer
amy otrophic</w>
BM SCs</w>
ound ly</w>
harb or</w>
Bo ard</w>
sex- matched</w>
v ol</w>
cu st
epide mics</w>
H g
dow s</w>
Y 1</w>
inter ro
Hal f</w>
NLR P3</w>
slow ed</w>
VCA M-1</w>
con spic
H ome</w>
M ach
platelet- derived</w>
ated ness</w>
osp ice</w>
anti thrombotic</w>
hypox emia</w>
chie f</w>
cy tidine</w>
C MR</w>
Twenty- six</w>
compet ency</w>
H CT</w>
19 70</w>
induc ers</w>
cochle a</w>
Viet nam</w>
sphing omyel
evap oration</w>
t amp
trache ostomy</w>
Ery thro
insem ination</w>
ore dox
arti fact</w>
Observ ational</w>
cl aimed</w>
ac cordingly</w>
us or</w>
inter ior</w>
-1 7
oxid oreduc
dra in</w>
Er b
y al</w>
m ec
R as
reason ably</w>
ist -
H an
deline ated</w>
syn onymous</w>
colon ized</w>
sle eping</w>
PR ACTI
collec tively</w>
K C</w>
w ells</w>
hem ostatic</w>
ST- segment</w>
extravas ation</w>
D SA</w>
B P1</w>
zoon otic</w>
weigh ed</w>
ex ome</w>
cor al</w>
Enh ancement</w>
gyn a
c ubic</w>
swe et</w>
5 000</w>
homolog s</w>
ic ol
d aughter</w>
I SO</w>
6 6.7</w>
hepar an</w>
n ial</w>
im ported</w>
P SC</w>
Ch eck
staphyloc occi</w>
micro dialysis</w>
geni stein</w>
phosphati dy
land -
disper sive</w>
signal- regulated</w>
ess ness</w>
dys regulated</w>
altern atively</w>
us ly</w>
popul arity</w>
sal ient</w>
fat ality</w>
PO 2</w>
al lin
o hex
evolution arily</w>
plas ma-
amiod arone</w>
communic ate</w>
aux in</w>
run s</w>
transcriptom ic</w>
tr aps</w>
D AT</w>
1. 15</w>
inv entory</w>
An dro
hist omorph
s ows</w>
T anz
X Y</w>
neuro science</w>
En doc
E G</w>
aflat oxin</w>
cortic otrop
candi diasis</w>
M os
ur ic
hypothalam ic-
vit ell
Statis tically</w>
TA L</w>
African- American</w>
D AP
M üll
ac tin-
A m</w>
then ium</w>
ar c</w>
rec t
activ e-
inflammas ome</w>
syndrom ic</w>
ba g</w>
12. 8</w>
At t
hydra z
one- year</w>
ther ing</w>
lamin ar</w>
13 1
tetr adec
Thor acic</w>
g m</w>
Rem ark
apos i</w>
yr in
deterior ated</w>
stoichi ometry</w>
des cent</w>
chondro itin</w>
litho trip
em pathy</w>
resp ir
conv inc
bro ken</w>
cycl ization</w>
R FA</w>
sub- Saharan</w>
tric ho
m olyb
12. 3</w>
menisc us</w>
care rs</w>
advoc ated</w>
cholec ystitis</w>
pig ments</w>
Expl oring</w>
Sj ö
diz ziness</w>
pepti dase</w>
pyro phosphate</w>
Tom ography</w>
1.0 9</w>
dem y</w>
illo sis</w>
trans locations</w>
en chym
disabl ing</w>
Malay sia</w>
A edes</w>
tel omeric</w>
post treatment</w>
over whel
rib avirin</w>
un folded</w>
1. 9
sel dom</w>
hypon at
lac rimal</w>
therm ally</w>
I P-
li d</w>
pati ent
bio degradation</w>
facilit ators</w>
hom odi
wea ther</w>
duc tus</w>
Sus cepti
dop a</w>
emul sification</w>
K aposi</w>
thermo philic</w>
1. 2-
Throm bo
occ idi
Ultras on
antim al
ex changes</w>
12. 2</w>
noxi ous</w>
p urely</w>
represent atives</w>
T Y
H A-
upr ight</w>
M oun
under took</w>
demyel ination</w>
13. 6</w>
trimeth op
develop mentally</w>
guid es</w>
ar i</w>
or b</w>
e V</w>
Predic tive</w>
appropri ateness</w>
H N</w>
c ement
4 80</w>
N- nitros
abl ative</w>
An y</w>
al azine</w>
tr ast
reservo irs</w>
deacetyl ase</w>
a em
pro to-
nec ro
TL R</w>
prof oundly</w>
20 8</w>
Relationsh ips</w>
flu conazole</w>
lipos ome</w>
ec centric</w>
D L</w>
oligodendro cytes</w>
nam es</w>
un responsive</w>
agg ing</w>
Comput ational</w>
SN R</w>
non- Hispanic</w>
immun ologically</w>
y ou
we alth</w>
ribonucle ase</w>
el iness</w>
T CDD</w>
am al
ou rea</w>
1. 0-
sc ro
estro gen-
thin ning</w>
chymo trypsin</w>
U T</w>
par acetamol</w>
Dou ble-
dig it</w>
N N</w>
bor on</w>
hospit al-based</w>
13 ,
grou ping</w>
Autom ated</w>
archa e
Pil ot</w>
PAR P</w>
ori e</w>
frag mented</w>
discrimin ative</w>
R Y
seg mented</w>
poly amine</w>
bene fici
d yl</w>
z ole</w>
su n</w>
H am
Q L</w>
t DCS</w>
i x
MM SE</w>
pleth ys
nanocryst als</w>
F oundation</w>
W L</w>
Dis co
V- infected</w>
br a</w>
vill ages</w>
di hedral</w>
he ightened</w>
reli eve</w>
19 74</w>
d m
- A</w>
ex foli
G AD
2 12</w>
cycl ine</w>
socio- demographic</w>
super -
in- mediated</w>
Em plo
dor sol
ak a</w>
hemat opoiesis</w>
drin ks</w>
ache al</w>
In s
3 8-
FDG- PET</w>
Insi ghts</w>
radi osurgery</w>
SC P</w>
Comput er</w>
si ed</w>
Challeng es</w>
un il
concentr ic</w>
put amen</w>
Scop us</w>
IV C</w>
1, 3
Condi tions</w>
marrow -derived</w>
melan ocytes</w>
link ages</w>
complic ating</w>
rub ella</w>
w asting</w>
infarc ts</w>
0.0 18</w>
13. 2</w>
y z
T d
der ang
ampl ify</w>
Person ality</w>
Be h
thre ats</w>
prost ate-specific</w>
inc eption</w>
hind limb</w>
av e-
ver tigo</w>
ore -
colony- forming</w>
2 .</w>
z ona</w>
0.000 5</w>
Probl ems</w>
J ur
H cy</w>
pot ently</w>
aldehy de-
DO PA</w>
des m
lipoly sis</w>
n ut</w>
hex idine</w>
onc ologic</w>
Fi x
burgdorfer i</w>
yr s</w>
Famil ial</w>
intr igu
re generated</w>
correc ting</w>
ner -
M CA
viro logical</w>
psych otropic</w>
pharmac euticals</w>
inequ ality</w>
C SCs</w>
W is
V DR</w>
T1 D</w>
j i
Ach illes</w>
granul ocyte-
c eption</w>
assess es</w>
19 4</w>
prob ands</w>
compet encies</w>
TE C</w>
le is
mid ine</w>
carbox ylate</w>
D ensity</w>
Ar th
w ant</w>
SC E</w>
an oic</w>
oph ytes</w>
chim panze
str um</w>
ici ting</w>
en umer
contr asts</w>
potenti ate</w>
26 4.7</w>
re alize</w>
dialys ate</w>
R ed
O L
cos tim
apha sia</w>
Sol u
2 7.
form alin-
gr ating</w>
oin tim
re mediation</w>
30 8</w>
carbox yl-
temper ate</w>
E pig
1 -1</w>
su b</w>
Activ ated</w>
T 3
rec eipt</w>
chloro plasts</w>
A reas</w>
un tary</w>
co oking</w>
mal ate</w>
po ds</w>
stre ams</w>
1- -</w>
gam bling</w>
t z
ac rom
Pro p
am ide-
O cular</w>
E 7</w>
tran surethral</w>
condens ed</w>
sulf ated</w>
19 3</w>
B F
beta- cell</w>
aff iliated</w>
omeg a</w>
I A
B CR</w>
sub total</w>
optim ally</w>
enc h</w>
fl ur
Up take</w>
respon ds</w>
neuro peptides</w>
H PLC-
pit falls</w>
relax ed</w>
spi ked</w>
Cul ture</w>
rel atedness</w>
bi an</w>
PA R-
12. 1</w>
2 51</w>
ati co
Thirty- two</w>
h os
met agen
Kn ock
attrib ute</w>
G AD</w>
spl in
anti- apoptotic</w>
lo op
12. 6</w>
exce eds</w>
tumor- bearing</w>
antinoc iceptive</w>
myel ination</w>
TE E</w>
-1 -</w>
U I</w>
toxic ology</w>
Neur onal</w>
P .
embol i</w>
B le
M TH
ereb ellar</w>
F MD</w>
virus- infected</w>
insectic ide</w>
gamma- aminobutyric</w>
ad here</w>
injec table</w>
mil ieu</w>
C i</w>
Repor ted</w>
dev oted</w>
I H</w>
pyr imid
Z inc</w>
ci sion</w>
alk ylation</w>
3 000</w>
un diagnosed</w>
N M
ex y</w>
end op
obser ving</w>
CD 45
iso enzymes</w>
insectic ides</w>
con to
pl asi
contigu ous</w>
des tin
manufacture rs</w>
di esel</w>
sl ide</w>
homogen ate</w>
D SS</w>
tre otide</w>
eur in</w>
Caucasi ans</w>
S er-
reduc tive</w>
cong estion</w>
rifamp icin</w>
star ts</w>
p K
trans thoracic</w>
3 4-
re aring</w>
TL C</w>
abrup t</w>
cholangi ocarcinoma</w>
Bet ter</w>
Al g
insi cally</w>
ser s</w>
am plic
left- sided</w>
sleep iness</w>
del ib
f 1</w>
Ar c
un labeled</w>
sim plicity</w>
CT C</w>
pollu ted</w>
S W</w>
c uring</w>
PE G
ecz ema</w>
1. 12</w>
util isation</w>
et us</w>
pen is</w>
pe t</w>
lac Z</w>
echan ics</w>
S tri
Mes enchymal</w>
G PR
recur red</w>
hemisph eres</w>
ig no
Twenty- eight</w>
cardio respiratory</w>
In strum
econ omical</w>
micron utri
un usually</w>
us er-
Reli ability</w>
b ru
tur ning</w>
H M</w>
f as
encephal on</w>
my oglobin</w>
hy n
sp on
ren der</w>
oxy cycline</w>
hierarch y</w>
oplas mosis</w>
s acchar
SL N</w>
L ateral</w>
ra in</w>
arti ficially</w>
1. 11</w>
zer o-
C PA</w>
car p</w>
prolifer ator-
ase- 1</w>
Mic ros
beta- hydroxy
R F
metabol izing</w>
3- hydroxy
S ir
k B</w>
op rine</w>
sl opes</w>
hum erus</w>
R O</w>
h it</w>
Ear th</w>
year- olds</w>
1. 14</w>
perf usate</w>
ec um</w>
AT 2</w>
ochond ral</w>
C ost</w>
l iz
ST Z</w>
14 ,
Commun ication</w>
copolym ers</w>
mus cle-
har dly</w>
cave ol
4 2-
rele ases</w>
T A-
ym ic</w>
ten sin</w>
embed ding</w>
photocat alytic</w>
n ascent</w>
es .</w>
Hist ologically</w>
is otropic</w>
.0 4</w>
P ic
nor th</w>
g ang
dra ft</w>
4, 5</w>
pen icillin
iform is</w>
titr e</w>
C los
oun ded</w>
on yl</w>
max illofacial</w>
micro scop
justi fy</w>
palmit ate</w>
geometr ies</w>
acetyl ated</w>
ell er</w>
Vari ations</w>
Pro cess</w>
list ening</w>
oflav in</w>
raph e</w>
promis es</w>
mut ually</w>
obacter ial</w>
or age</w>
distil led</w>
oval bumin</w>
ma zine</w>
argum ents</w>
az ol-
Dim en
corne as</w>
renin- angiotensin</w>
levodop a</w>
shrim p</w>
y our</w>
pass ages</w>
sim vastatin</w>
acceler ates</w>
vill ous</w>
2. 5-
organ izing</w>
iso enzyme</w>
ful min
wh ite-
ill icit</w>
dent ures</w>
pharmac ist</w>
lys ed</w>
Dem entia</w>
late- onset</w>
H 5
calc ane
alkal oid</w>
N in
phosphoinosi tide</w>
o regional</w>
asth m
FA K</w>
og r
op ost
C ox
PK C-
intral uminal</w>
n- 6</w>
K ine
ST AT</w>
pair wise</w>
middle- income</w>
DSM- IV</w>
ris es</w>
CS C</w>
al ongside</w>
8 8
Impair ment</w>
cros ses</w>
partur ition</w>
re ads</w>
s cleral</w>
A β
vacc inia</w>
prox y</w>
offic ial</w>
peer- reviewed</w>
read missions</w>
pheochrom ocytoma</w>
recap it
Cor tical</w>
Sp 1</w>
gover ned</w>
Sub st
xyl ose</w>
ign s</w>
visi ting</w>
hybridi zed</w>
diph ther
substitu ent</w>
az o</w>
squ ared</w>
dom ain-
H SCs</w>
D Y
2 22</w>
ic ated</w>
A II</w>
pean ut</w>
her itability</w>
sl iding</w>
Meas uring</w>
streptozot ocin</w>
p ing
orph yrin</w>
HUV ECs</w>
RE SEARCH</w>
ery th
g ar</w>
per it
HIV -1-
fif ty-
2- 5</w>
L OH</w>
3 B</w>
def ec
back ward</w>
di pl
quadr ant</w>
AL I</w>
bi ocompatible</w>
CA G</w>
longitud inally</w>
4- hydroxy
hi therto</w>
keratin ocyte</w>
posi tives</w>
stop ping</w>
os tigmine</w>
accum ulates</w>
assimil ation</w>
l on
yr ight</w>
reson ances</w>
Par ameters</w>
G over
vag ina</w>
r arity</w>
di x</w>
Sjö gren</w>
R ic
transf used</w>
inos it
c t
st ag
SEL ECTION</w>
detec ts</w>
merg ed</w>
drain ing</w>
PG I2</w>
DT I</w>
PC S</w>
restr ained</w>
gra zing</w>
radi ologist</w>
1- 7</w>
umin escent</w>
deplo yed</w>
colli sion</w>
az id</w>
reli eved</w>
Bir th</w>
2 13</w>
aden ylyl</w>
system ically</w>
moderate- to-
initi ates</w>
Protoc ol</w>
well being</w>
Ch i-square</w>
esophag ectomy</w>
new -
TNF alpha</w>
tre hal
Au tism</w>
E bol
1. 13</w>
des er
surpr ising</w>
au tistic</w>
I on</w>
S cat
T regs</w>
ester ified</w>
aren cy</w>
H SC</w>
L H-
G DP</w>
pro biotics</w>
19 1</w>
Incre ase</w>
iso ther
P ON
ren dering</w>
HB e
termin ally</w>
ren orphine</w>
mo tional</w>
GAB AA</w>
c ab
y ne
un resolved</w>
read iness</w>
cardiomy ocyte</w>
2- yl</w>
hypo thesi
Idi opathic</w>
ro entgen
K T</w>
inhib in</w>
chel ating</w>
1. 10</w>
C ad
enter o
Oper ative</w>
ex tubation</w>
robo t</w>
beta -</w>
2- hydroxy
SO C</w>
Pl ants</w>
Am ph
IC SI</w>
L uc
lob ular</w>
MA R</w>
gastro -
bic eps</w>
g out</w>
V M</w>
on t</w>
ap e</w>
tom ic</w>
caroten oids</w>
obstac le</w>
un selected</w>
6 -1
mol l
deb ated</w>
Y outh</w>
PA M</w>
therap y-
discipl ine</w>
Moder ate</w>
IT P</w>
HYPO THESIS</w>
anser in</w>
athi oprine</w>
proliferator- activated</w>
hum or</w>
Top ical</w>
exagg erated</w>
X 3</w>
scler osing</w>
amox icillin</w>
E 6</w>
persi sting</w>
N et</w>
li a</w>
MDA-MB- 231</w>
L astly</w>
MI S</w>
3 75</w>
Gl n</w>
In clud
l ac</w>
an abolic</w>
initi o</w>
spir itual</w>
time-of- flight</w>
Ex ternal</w>
gp 120</w>
chlor ine</w>
ul ous</w>
graft-versus- host</w>
kal emia</w>
myel opathy</w>
am er</w>
iv a</w>
2 16</w>
abor tions</w>
Signific ance</w>
end odontic</w>
ali phatic</w>
C K-
D or
tre x
10 th</w>
CA A</w>
SOUR CES</w>
9 7
splen ocytes</w>
phosphon ates</w>
E 4</w>
K yo
bib li
hypercalc emia</w>
iti dine</w>
CF S</w>
ten -
In surance</w>
ultrasound- guided</w>
SC A</w>
alkal i</w>
C- terminus</w>
carbox ylase</w>
D ar
me rely</w>
auto antibody</w>
step -
d est</w>
chloro form</w>
rec an
Peri odic
B AT</w>
smar t</w>
D ays</w>
gyn ecological</w>
alog ue</w>
Tr ig
Reduc ing</w>
ant ec
Col um
comp ute</w>
M T-
j unior</w>
oc ean</w>
Ca M</w>
C ore</w>
victim ization</w>
ic lo
tr ate</w>
fl atten
nan oro
top ically</w>
Ag ainst</w>
yl osing</w>
b ag
T CP</w>
end azole</w>
entr ap
C CN
cann ulation</w>
end ers</w>
mes enchym
mes oporous</w>
chrom es</w>
part nership</w>
imi pramine</w>
loc alisation</w>
propi onic</w>
a- like</w>
er ly</w>
mo re
sho ots</w>
co oper
11. 9</w>
high- intensity</w>
hypoglyc emic</w>
bac k-
Distinc t</w>
f ile</w>
- activated</w>
rejec ted</w>
D 2
Inhib itory</w>
AT M</w>
in activating</w>
ch en
green house</w>
4, 6-
a 1</w>
R un
certi fied</w>
A E-
sur al</w>
F- FDG</w>
ec k</w>
myof ibr
h s-
o ting</w>
gam es</w>
herni as</w>
trans mis
T c</w>
stem -
time- resolved</w>
Oste o
accommod ate</w>
m eri
D HT</w>
ure sis</w>
demonstr able</w>
H V
biom olecules</w>
pre incubation</w>
Bei jing</w>
endothelium- dependent</w>
reson ant</w>
EGF R-
T it
ben th
child birth</w>
establ ishes</w>
oc ellul
og lut
N M</w>
12. 7</w>
met ab
mT OR
l -1</w>
IL-1 3</w>
Tob acco</w>
dorsol ateral</w>
h -1</w>
if i
vasoconstric tor</w>
Inf arc
blast ocysts</w>
Shig ella</w>
T ACE</w>
AN F</w>
H V</w>
prur itus</w>
s on-
CM C</w>
sensor ineural</w>
Y ersin
ob ac
is oflav
Bacter oides</w>
sing let</w>
broad- spectrum</w>
on ade</w>
autophag ic</w>
expon entially</w>
acro megal
ch ar</w>
year ly</w>
prob ed</w>
T ERT</w>
de pres
bud s</w>
muc os
P h</w>
ocor tex</w>
sero conversion</w>
PW V</w>
Phosph orylation</w>
O ld</w>
AI R</w>
polys omn
S- phase</w>
mach ines</w>
cryp tic</w>
et etra
ith in</w>
dos ed</w>
aneu ploidy</w>
right- sided</w>
re action-
spond ylitis</w>
olact one</w>
ha i</w>
yl ene</w>
pre fer</w>
M ol
B ovine</w>
leuc ocytes</w>
ance stry</w>
ADP-rib ose</w>
par apl
Ex amin
where in</w>
lit ter
CT P</w>
Kyo to</w>
1. 16</w>
prokary otic</w>
AD M</w>
thermo phil
cryp t</w>
ex tran
ff s</w>
destro yed</w>
tremend ous</w>
modi fies</w>
DI C</w>
photo chemical</w>
ob iliary</w>
pH i</w>
d y</w>
crim inal</w>
IC Us</w>
neuro vascular</w>
s in-
gamma- glutam
adrenal ectomy</w>
polym y
ED 50</w>
microm olar</w>
anxi ous</w>
Cu -
quinol one</w>
ge hog</w>
3 3-
pneumon itis</w>
pregn anc
P SS</w>
res ur
L B</w>
m as</w>
appro aching</w>
GAB A-
br ings</w>
neuro troph
id in
charg e-
conc ussion</w>
construc ting</w>
beta- estradiol</w>
helic ase</w>
k i
olig omeric</w>
QT c</w>
opost erior</w>
deriv ation</w>
praz osin</w>
laborat ory-
hom o
CB A</w>
25- dihydroxy
O HD
carbox y-
Recor d</w>
S ox
opath ogenic</w>
16. 5</w>
ul aris</w>
d otoxin</w>
per fluoro
hem ic
lich en</w>
fl oral</w>
micro globulin</w>
Tre ated</w>
lev er
3 T</w>
d obutamine</w>
wh enever</w>
inf eri
12. 0</w>
t ful</w>
epider mi
co al
fibrill ar</w>
.00 2</w>
Singap ore</w>
7- fold</w>
detr usor</w>
os acral</w>
ab and
gly ox
ag itation</w>
pair -
occ er</w>
Od ds</w>
cur rence</w>
G CS</w>
Cholester ol</w>
med ul
ba um
ho ods</w>
ecto dermal</w>
sub species</w>
in ert</w>
enzym atically</w>
wave forms</w>
for amin
thorac oscopic</w>
anti oxidative</w>
neuro inflammation</w>
NO D</w>
re polarization</w>
lo ad
electromy ography</w>
ul ary</w>
uniform ity</w>
inter observer</w>
IC E</w>
post- transcriptional</w>
aven ues</w>
evacu ation</w>
campa igns</w>
com ments</w>
Reg ulatory</w>
impul sivity</w>
c 1</w>
bas oph
X .</w>
ac eous</w>
htt ps</w>
tr al</w>
Fr anc
mutag enicity</w>
pig ment
communic ations</w>
them e</w>
DM A</w>
N 3</w>
adop ting</w>
is sion</w>
lex ical</w>
-1, 3-
Eigh ty</w>
un wanted</w>
T ests</w>
O t
In ten
UT P</w>
k at</w>
non- smokers</w>
D SC</w>
interf eres</w>
entrap ment</w>
no vel
ch us</w>
Con sen
ation- dependent</w>
at ria</w>
W I
bur ning</w>
B ey
ir y</w>
asym metr
sp ending</w>
GT P-
fra il</w>
2 35</w>
IN R</w>
replic ative</w>
d ap
transcription- polymerase</w>
p t</w>
5 1
acc ept</w>
debil itating</w>
fertil ized</w>
sna ke</w>
Cryp tospor
R and
Pharmaco kinetics</w>
call us</w>
S ten
P MMA</w>
car cer
viri on</w>
leng th
py re
hel i
neur aminidase</w>
observ able</w>
dic ations</w>
immort alized</w>
urtic aria</w>
glucon e
os ylation</w>
sy l</w>
1. 17</w>
aden omatous</w>
An gel
Wash ington</w>
or is</w>
pro hib
deriv atization</w>
pharmac ologically</w>
Recur rence</w>
N Z
MY C</w>
oph ytic</w>
factor -1</w>
pursu it</w>
nanocom posite</w>
Ap p
is th
MEASU RE</w>
CO X</w>
f ish
epidermi dis</w>
P S-
25- hydroxy
transm ural</w>
D- dimer</w>
extr am
F AS</w>
mother -
bis phosphate</w>
Hydro gen</w>
12. 9</w>
out standing</w>
inst ant
ul opathy</w>
ta p</w>
progres sing</w>
Com mission</w>
IGF- II</w>
rip ening</w>
chond ral</w>
thi azol
omy cin
Asi ans</w>
conflu ent</w>
organ elle</w>
later ally</w>
Hepat ocellular</w>
X X</w>
loc ate</w>
Bi oin
Ev ans</w>
ar ine</w>
M ur
pollut ant</w>
un stimulated</w>
tri ax
hypo thermic</w>
µ M</w>
ad vised</w>
10- 20</w>
Schiz ophren
m U</w>
hem oglobin
resi de</w>
flu idity</w>
G L</w>
n ation</w>
w il
Dis crim
quantit ated</w>
yl- L-
G- protein</w>
as ynchron
Sch iff</w>
R a</w>
un expectedly</w>
ip 1</w>
tur ns</w>
Aca demy</w>
cen sus</w>
emplo ys</w>
ik a</w>
aggres siveness</w>
intrigu ing</w>
Endom e
un desirable</w>
3- dimensional</w>
nitro gen-
aeg yp
H 4
G PC
aro x
gram -positive</w>
4, 4</w>
emit ted</w>
chr ys
cyt olytic</w>
R K
c ure
acon azole</w>
anti inflammatory</w>
I MP
tr am
ens in</w>
2 15</w>
Pr inc
V an
interleukin -1
play er</w>
N K-
DL BCL</w>
metac ar
U GT
cardi ogenic</w>
psychi atrists</w>
superim posed</w>
ul trac
co ast</w>
30 4</w>
im atinib</w>
2 26</w>
In stitu
hyper tensi
as eptic</w>
si ves</w>
M SH</w>
13. 8</w>
ont ology</w>
EX P
di acylglycerol</w>
pre pubertal</w>
Disco very</w>
en jo
tri iodothyronine</w>
re volution
Wh ere</w>
I SS</w>
P ent
R ay
bal ances</w>
c v</w>
Z n-
Initi ative</w>
intra- articular</w>
dec eased</w>
hon ey
disco veries</w>
atten d</w>
ap r
ad ol</w>
nucle olar</w>
contradic tory</w>
c ages</w>
infrequ ently</w>
dec on
dener vated</w>
inf low</w>
sub maximal</w>
depolar izing</w>
y- to-
200 0-
Perc ep
nor ing</w>
un modified</w>
sil k</w>
- 3.
pat ch-
oste oblastic</w>
Pr EP</w>
hype re
Ass ay</w>
rain bow</w>
G old</w>
lev er</w>
BM C</w>
pro BNP</w>
ingredi ent</w>
SER S</w>
epithelial- mesenchymal</w>
t ase-
e ens</w>
it abine</w>
over coming</w>
N- terminus</w>
di ary</w>
Pro phyl
intermedi ate-
pix el</w>
integr ates</w>
g avage</w>
H ir
Rati o</w>
one- step</w>
Fl av
post eri
gr ass
H- 2</w>
compl emented</w>
analy zes</w>
et y-
z om
gran ulation</w>
oco agulation</w>
os a
cent ros
trans esophageal</w>
high -</w>
a h</w>
o vi
SV R</w>
enhanc ers</w>
end ings</w>
sig mo
contamin ant</w>
in emia</w>
el iciting</w>
RA GE</w>
acti on
transi ents</w>
dys kinesia</w>
hemangi oma</w>
Util ization</w>
K up
lu x</w>
heter osexual</w>
nucleoti de-
lo ose</w>
ket o-
Import ant</w>
E PI</w>
NSAI D</w>
my asthenia</w>
cl ades</w>
S J
Gh ana</w>
wa it</w>
fos sil</w>
N l
dur ability</w>
Cycl ic</w>
Inf ant</w>
o tics</w>
avi um</w>
licens ed</w>
affor d</w>
G 4</w>
lo fen</w>
1. 18</w>
I F-
G ul
con fron
voltage- gated</w>
Yersin ia</w>
G H-
transl uminal</w>
ocor tic
a plastic</w>
7 4
cl au
cros stalk</w>
R L
more over</w>
HI T</w>
prev ailing</w>
nar co
udg et</w>
F v</w>
con finement</w>
C -1
F al
-1, 4-
Bey ond</w>
struc turing</w>
con dy
cir cle</w>
at ech
sacc ades</w>
R U
le gi
oid -
Ebol a</w>
HO MA-
12. 4</w>
s- based</w>
up ward</w>
No .</w>
inter net</w>
shun ting</w>
leukem ias</w>
regul arity</w>
1, 4
A wa
ER S</w>
chol ed
pal m</w>
h es
e- dependent</w>
Techniqu e</w>
z a</w>
stere otyp
res ins</w>
se eding</w>
Tran sport</w>
val gus</w>
Anti oxidant</w>
stain less</w>
par all
self- assembled</w>
transp arency</w>
Ad ren
oster ol</w>
SIR T1</w>
n ight
pri ori</w>
shun ts</w>
lacti s</w>
Car ib
denat uring</w>
T CR
erc ept</w>
Fe atures</w>
adri amycin</w>
emergen cies</w>
Resp ond
cryop reserved</w>
Valu es</w>
di pyrid
incis or</w>
S r</w>
P- 4</w>
HC M</w>
vol ati
neuro protection</w>
yto plasmic</w>
innerv ated</w>
Th ai</w>
valu ed</w>
spin ning</w>
z in</w>
bi olog
RO P</w>
15. 4</w>
re fin
blu e-
str ingent</w>
dil emma</w>
nanocom posites</w>
lin a</w>
sar col
is omerization</w>
var .</w>
cou pl
fram esh
par ag
ple omorphic</w>
ca re-
Met -
propri oc
munic ip
ear th</w>
Ig E-
electro -
8- fold</w>
toler ate</w>
sac ro
m d
er ness</w>
matern ity</w>
oxygen -
myel ogenous</w>
F isch
ylo x
ang ulation</w>
Relev ance</w>
4- year</w>
acqu iring</w>
clos est</w>
fa eces</w>
poly aden
dis advantage</w>
unc oupling</w>
3 30</w>
End ogenous</w>
fl ash</w>
CO M
hemat oxyl
M K</w>
A maz
p ins</w>
1. 21</w>
contribut ors</w>
Periodic als</w>
low ers</w>
ac ylation</w>
presum ptive</w>
B ut
cer am
defin itely</w>
H 2-
13. 1</w>
super vis
is oni
posi t</w>
actin omyc
spas ticity</w>
intrac lass</w>
appro x</w>
less ness</w>
molecul e-1</w>
baro reflex</w>
ili ation</w>
Ro ot</w>
thir ty</w>
mediastin um</w>
3- hydroxy-
v WF</w>
spea kers</w>
is o-
factor- beta</w>
on ality</w>
st ocks</w>
M MR</w>
un explored</w>
chondro cyte</w>
spectrophot ometric</w>
E O
tap e</w>
aut op
doll ars</w>
S CA
E SI-
6 2.5</w>
leuc ocyte</w>
mar c
Twenty- seven</w>
Argen tina</w>
neuro chemical</w>
Indic ations</w>
K 3</w>
nanofib ers</w>
obstruc ted</w>
Pur ified</w>
gra vis</w>
frac tured</w>
protein ases</w>
Hist ory</w>
PV N</w>
fir stly</w>
obes ity-
propri a</w>
coord in
perfor ated</w>
M SI</w>
swe et
Com peti
Bet a-
Rever se</w>
actu arial</w>
S chol
C av
dec ide</w>
bar k</w>
C l-
trac ed</w>
pto sis</w>
C ath
anch oring</w>
micro surgical</w>
carb onic</w>
lys ophosph
di benz
cur ved</w>
cor p
hal ogen
mer its</w>
D il
1 c</w>
par amount</w>
my oblasts</w>
weigh ting</w>
acceler ating</w>
ac cred
pattern ed</w>
T f
anni i</w>
S -</w>
CL P</w>
T 7</w>
explan atory</w>
sp ous
p- nitro
co- culture</w>
photosensi ti
onc e-
Brd U</w>
r is</w>
Transcrip tional</w>
D Q</w>
ac hy
pe g
F ra
band width</w>
accommod ation</w>
phil icity</w>
d G</w>
an oid</w>
25 -</w>
A TION</w>
mon ocytic</w>
1 A2</w>
tor ial</w>
b 1</w>
2 S</w>
ma ffin</w>
marri age</w>
DX A</w>
uro logical</w>
cal orie</w>
chemoattrac tant</w>
1. 23</w>
acet aldehyde</w>
6 A</w>
E Q-
ot a
y .
Peri operative</w>
RANK L</w>
counter act</w>
inter phase</w>
Adju v
hypertensi ves</w>
re r</w>
15 ,
amylo id-
E BP</w>
Re placement</w>
re pairs</w>
hospit al-
vag otomy</w>
Min istry</w>
y i</w>
S 6</w>
F U
proton ation</w>
id o</w>
deline ation</w>
non- significant</w>
popul ation-
non- small-cell</w>
cryst allin
Spectr um</w>
retin itis</w>
4 D</w>
W A
ot onic</w>
ati de</w>
pseud ot
as tine</w>
conclud es</w>
4- week</w>
re placements</w>
ster ols</w>
spac ed</w>
0.0 19</w>
non smokers</w>
Prog ression</w>
ym ents</w>
stimul ant</w>
- B
Mn 2</w>
g il
PGF 2</w>
ep sia</w>
hypogly caemia</w>
HSP 70</w>
Ano ph
nes ota</w>
- B</w>
il lium</w>
aber ration</w>
e ight-
de his
L am
row s</w>
mo unt</w>
bio chemically</w>
2- week</w>
aper ture</w>
dyst rophic</w>
w ash</w>
gonorrho eae</w>
myelodys plastic</w>
oc kets</w>
pro mazine</w>
d anger</w>
CS S</w>
Subjec tive</w>
tag s</w>
oxygenase- 2</w>
infest ation</w>
L MW
res orb
There after</w>
sar copenia</w>
a -</w>
ir relevant</w>
iso propyl
pare dness</w>
N asal</w>
ann exin</w>
run ners</w>
hex agonal</w>
di methyl-
mis diagnosed</w>
web site</w>
thi oredox
pl ated</w>
IR I</w>
tamp onade</w>
influ ential</w>
A gro
m g.
stri kingly</w>
ME D</w>
un biased</w>
2 54</w>
replic ating</w>
S mal
N ICU</w>
7 -</w>
Bi och
umin a</w>
ant a</w>
fu si
a king</w>
c p
chrom ic</w>
intra operatively</w>
asthm atics</w>
hr l
y es</w>
ip enem</w>
Bor relia</w>
w earable</w>
Ex am
L M
e zo
Ep ithelial</w>
C our
suppl ies</w>
omega- 3</w>
ox amine</w>
Tanz ania</w>
Hospit als</w>
C 1-
indu stri
el- free</w>
ST D</w>
grad ation</w>
acid- base</w>
MH C-
199 0s</w>
metallo thione
om el
manufact ured</w>
microtub ule-
Scot land</w>
Rep orts</w>
- yl</w>
O phthal
Org an</w>
loc alised</w>
fil ari
ul ent</w>
be have</w>
oxal ipl
Econ omic</w>
men iscal</w>
dig iti
D -</w>
p- value</w>
sub class</w>
access ed</w>
sy -
s wa
l anth
asperg illosis</w>
cadaver s</w>
orific e</w>
H SD</w>
TNF α</w>
radi olig
13. 4</w>
h ospice</w>
S RE
Prog ressive</w>
rainf all</w>
ac idity</w>
o embryonic</w>
iod o
predat ors</w>
ker nel</w>
kerat oplasty</w>
dens ity-
heterozyg otes</w>
T CA</w>
N Cs</w>
L t
classi fying</w>
GT A</w>
Rho A</w>
triax one</w>
2 14</w>
authen tic</w>
inflam m
ho u</w>
loc oregional</w>
post- transplant</w>
rac es</w>
flu ency</w>
ultrafil tration</w>
computer- assisted</w>
appl ies</w>
absorb able</w>
listen ers</w>
Frame work</w>
2 0.0</w>
d h
ol ide</w>
Br assi
pro drug</w>
habit ual</w>
baum annii</w>
bio transformation</w>
opro lol</w>
beta- endorphin</w>
PA A</w>
ry an
pan els</w>
sor afenib</w>
N V
glob ular</w>
1- 10</w>
cardi ology</w>
an ode</w>
HTLV- I</w>
pum ping</w>
fove al</w>
te d-
dich otom
multi plex
arch e</w>
inf liximab</w>
denti tion</w>
vacu ol
f ast
oly tica</w>
wild life</w>
ard less</w>
cephal ic</w>
X -100</w>
manip ulate</w>
Ta q
complex ation</w>
ar abine</w>
Aim s</w>
S n</w>
smo k
morph ometry</w>
work -up</w>
prec au
architec tures</w>
disrup ts</w>
D B</w>
form atics</w>
ag inous</w>
Nec k</w>
fl at
carr age
C i
phosphatidyl serine</w>
in k</w>
trac es</w>
Altern atively</w>
Ess ential</w>
condy le</w>
t yline</w>
Ch ag
ocortico id</w>
- P
vag us</w>
F atigue</w>
sex -specific</w>
phosphatidy lethanolamine</w>
o y
ab duction</w>
gly caemia</w>
K re
wean ed</w>
3 90</w>
PPAR γ</w>
hospit alisation</w>
cardi ometabolic</w>
top ographic</w>
predat or</w>
s-of- function</w>
si der
S keletal</w>
iv ary</w>
pertur bed</w>
19 73</w>
los artan</w>
arthro desis</w>
well- characterized</w>
deoxy uridine</w>
2 H</w>
form erly</w>
w rap
cor ds</w>
Reg ardless</w>
tr ade</w>
caregi ving</w>
beta- blockers</w>
viv ax</w>
elast ography</w>
en th
tri ad</w>
o plastic</w>
in compatible</w>
bo oks</w>
in vertebrates</w>
ole ate</w>
ol ys
justi ce</w>
Ro yal</w>
adap ting</w>
Estro gen</w>
14. 6</w>
degran ulation</w>
chlor hexidine</w>
molec ularly</w>
C z
corrhiz al</w>
to e</w>
12 4
glyc ated</w>
double- strand</w>
bas in</w>
end ocytic</w>
notic eable</w>
are -
PL D</w>
resour ce-
nitro glycerin</w>
discrim inated</w>
pred ation</w>
sen ile</w>
SL C
H SP</w>
n id
ren ces</w>
PD s</w>
chromo ph
ph ones</w>
az athioprine</w>
yl- 2-
arteri ography</w>
se em
Cum ulative</w>
ec tin
od ed</w>
ari thromycin</w>
2 11</w>
antigen- presenting</w>
col ic</w>
L TB
1. 20</w>
C IN
biore actor</w>
I TS</w>
ograph ies</w>
u ti
kin et
dis ation</w>
energ etics</w>
DHE A</w>
crystall ography</w>
gluc oside</w>
phal angeal</w>
A TI
bi variate</w>
d oxycycline</w>
phenotyp ically</w>
Clu ster</w>
Mo thers</w>
-of- care</w>
S oil</w>
frag ility</w>
orth ostatic</w>
mono -</w>
olog y-
T e</w>
Medic ation</w>
p M</w>
1. 22</w>
CD11 b</w>
R FS</w>
Fe deral</w>
Respond ents</w>
A SC
isot onic</w>
iod inated</w>
memb ership</w>
Gran ul
Scienti fic</w>
ne ocortex</w>
crystall in</w>
c ept</w>
n adi
astrocyt oma</w>
cal pain</w>
Meta- Analysis</w>
Appropri ate</w>
tri -
a viruses</w>
pyrro lid
fif teen</w>
R inger</w>
PV R</w>
Thirty- six</w>
beta- carotene</w>
pre- eclampsia</w>
teach er</w>
ul i</w>
N umber</w>
Com posite</w>
adop tive</w>
beta 2</w>
Selec ted</w>
con venti
AB R</w>
gener ational</w>
geometr ical</w>
hil ar</w>
man nos
el ong</w>
stabil izes</w>
u al
om us</w>
Im mediate</w>
heter ocyclic</w>
ads orbent</w>
un ding</w>
expos ing</w>
stere o
CA C</w>
epil ept
30 2</w>
mant le</w>
iclo vir</w>
E specially</w>
SI L</w>
EC -
3 40</w>
connec t</w>
aldo ster
astro cyte</w>
IGFB P-3</w>
A PA</w>
1. 19</w>
14. 2</w>
sk i</w>
dissi pation</w>
bul bar</w>
Anoph eles</w>
str abis
C Cl
deep ly</w>
crow ns</w>
b yst
per oxides</w>
11. 0</w>
pathophysi ologic</w>
anz apine</w>
ar tem
cho w</w>
LT R</w>
2 23</w>
3 00
vide os</w>
HER 2-
midw ives</w>
z ens</w>
M CF
G N</w>
Sol id</w>
prag matic</w>
L ar
Ab s
s apon
ann abin
bene ath</w>
ide -induced</w>
oc e
gen otoxicity</w>
re tin</w>
ta ils</w>
in- 2</w>
Bruc ella</w>
c k</w>
ill umin
incid entally</w>
phon ological</w>
f ar-
coll ater
solubil ization</w>
olip in</w>
SI s</w>
Biomar kers</w>
c ing</w>
15. 6</w>
mini ature</w>
elim inates</w>
com promising</w>
198 0s</w>
gl it
G all
ting- state</w>
D SM</w>
rh odopsin</w>
enter ica</w>
Th rough
ow l</w>
HP T</w>
- 0.0
V Z
di sh
uro kinase</w>
k i</w>
taxon omy</w>
acclim ation</w>
ph arynx</w>
Micro RNAs</w>
M ACE</w>
t -</w>
2 58</w>
sulfhydr yl</w>
A ud
pre hospital</w>
ne ointim
IL D</w>
inc ap
sh ocks</w>
responsi bilities</w>
LV H</w>
a ks</w>
supr ac
odont ogenic</w>
fu els</w>
B K
ag le</w>
asp inal</w>
Not ch
capac itance</w>
adul t-
cl ath
C ell
epididym is</w>
Awa reness</w>
radi osensi
Int ell
1, 5
S ta
ur us</w>
visi bility</w>
pro fit</w>
ow ed</w>
70 s</w>
myel ocytic</w>
rest ores</w>
st oma</w>
TR s</w>
attemp ting</w>
intr insically</w>
deoxy cholic</w>
comb ustion</w>
st ump</w>
tumor- associated</w>
alkyl ating</w>
od a</w>
omen cl
dis locations</w>
is obut
a- induced</w>
o protective</w>
1. 24</w>
lip tin</w>
TL s</w>
anhydr ase</w>
am i</w>
poli ovirus</w>
hom in
Caro lina</w>
19- 9</w>
Radi otherapy</w>
im migrant</w>
impl ied</w>
trast uzumab</w>
At ten
tin y</w>
crani otomy</w>
G PI</w>
3- O-
part ner
f ene
tr uly</w>
innov ations</w>
Stand ards</w>
contr asted</w>
IL- 2R</w>
am enor
ta ught</w>
sec tioned</w>
break through</w>
patient- specific</w>
phot ons</w>
on ts</w>
hem ophilia</w>
alumin ium</w>
B V
de methylation</w>
mer ic</w>
Col on
G M1</w>
therapeu tically</w>
appen dix</w>
ble aching</w>
str ate</w>
5-HT 1A</w>
ir id
ol ite</w>
Z ika</w>
13. 7</w>
mon y</w>
A R-
PE S</w>
cholecysto kinin</w>
anti trypsin</w>
0. 2-
ore active</w>
sive- compulsive</w>
CA PD</w>
E ph
tel emedicine</w>
14. 8</w>
mar kets</w>
z on
Brow n</w>
Y s</w>
convul sions</w>
P SP</w>
op son
am bly
As sist
edi ble</w>
igno red</w>
five- year</w>
Arti ficial</w>
oxidoreduc tase</w>
quar ters</w>
Fe asibility</w>
L angu
inv ading</w>
dex medetomidine</w>
polymer ases</w>
unc h</w>
micro flora</w>
amp ed</w>
practi ced</w>
sev en-
instruc ted</w>
AI DS-
al o</w>
our ces</w>
cholester yl</w>
Bcl -
Min i-
H ost</w>
W W
aur icular</w>
TH P-1</w>
bre vi
H D-
4 B</w>
sul cus</w>
t ose</w>
Man ual</w>
benefici aries</w>
O PN</w>
ne u</w>
vacu olar</w>
direc ting</w>
L S
termin ology</w>
tel angi
com b</w>
AN S</w>
re alization</w>
promp tly</w>
Cryptospor idium</w>
coll iculus</w>
trap ez
ag r
His pan
nanot ube</w>
ethan ol-
P BC</w>
j ob
N O2</w>
comm entary</w>
16 ,
ator vastatin</w>
im printing</w>
pituitary- adrenal</w>
temperat ure
TI A</w>
frac tal</w>
day -
Nic o
an onymous</w>
es .
electromy ographic</w>
oc treotide</w>
def ensive</w>
A 6</w>
iti vely</w>
suc kling</w>
2 O3</w>
ann ulus</w>
3- 6</w>
dimen sion
pel let</w>
quadr atic</w>
apomorph ine</w>
c iv
myco sis</w>
av ul
Pro st
intrac erebro
id um</w>
my ocyte</w>
ak ia</w>
self- renewal</w>
epitheli oid</w>
one- way</w>
ap ps</w>
am ole</w>
tend erness</w>
ness ed</w>
col ectomy</w>
r atic</w>
icul ate</w>
down ward</w>
Investig ations</w>
oneph rosis</w>
tunn eling</w>
lithotrip sy</w>
ed -up</w>
b orders</w>
7 th</w>
ro l</w>
bal ancing</w>
anth ine</w>
at oma</w>
fl ame</w>
anat omically</w>
ad venti
Indi genous</w>
mom entum</w>
ph or
spher oids</w>
RNA- binding</w>
re fraction</w>
sk ew
qu oti
pepti de
C erebro
pot encies</w>
enal april</w>
fav oring</w>
epilep ticus</w>
temperature- sensitive</w>
Pa O2</w>
olec ule</w>
bronchi olitis</w>
parav entricular</w>
ep im
os ulf
1. 35</w>
spl anch
sent ence</w>
op olym
sim pler</w>
My o
intensi fied</w>
sc aled</w>
acu te-
time -</w>
olym ph</w>
bup renorphine</w>
aer ial</w>
no de-
G a</w>
P -</w>
Pan el</w>
Appl ying</w>
P VA</w>
u PA</w>
b li
y -</w>
R e-
2- chloro
an oids</w>
inci sions</w>
end- of-life</w>
Pharmaco kinetic</w>
od u
Suscepti bility</w>
l ou
O- H</w>
MK- 801</w>
C max</w>
sy ll
rhe ological</w>
community- acquired</w>
V SMC</w>
H and</w>
physici an-
T at</w>
ti sts</w>
in carcer
un ified</w>
hyper polar
E motional</w>
it ter</w>
correc tions</w>
un determined</w>
En d</w>
immune- mediated</w>
z able</w>
Amy lo
Kup ffer</w>
imp ing
is ozyme</w>
cr ic
Remark ably</w>
work -related</w>
alpha 1</w>
op tically</w>
draw backs</w>
t ones</w>
ca stration</w>
taz idi
spi king</w>
3 R</w>
B if
ph renic</w>
exist ent</w>
re bound</w>
famili arity</w>
tin ase</w>
thi azide</w>
school children</w>
periph er
bu ild
S SA</w>
ur gency</w>
AD -
ow -
rel ied</w>
PO R
aegyp ti</w>
arc tic</w>
DD T</w>
yst olic</w>
spiro metry</w>
2 21</w>
E H</w>
pent obarbital</w>
calcin eurin</w>
9 6
dec el
la un
hex ane</w>
c ecal</w>
1- mediated</w>
E lig
Process ing</w>
ce- free</w>
mening ococcal</w>
Jur kat</w>
plasm as</w>
us able</w>
at traction</w>
mos a
E HR</w>
high- energy</w>
andro sterone</w>
az ol</w>
A X</w>
progres ses</w>
Pregn ant</w>
Neur ons</w>
diverticul um</w>
e der</w>
Per in
sent ences</w>
in efficient</w>
hydro thermal</w>
2 2.5</w>
H ung
ML P</w>
ch itin</w>
sti n</w>
M ax
comp iled</w>
Hist or
appoint ment</w>
main stay</w>
dermat ology</w>
S 6
MI F</w>
tyros inase</w>
NF- kappa</w>
trex one</w>
LO D</w>
ent ate</w>
ri st
N ucleotide</w>
sev enth</w>
cyclin -dependent</w>
fulmin ant</w>
D L-
m c
dis satisfaction</w>
A d</w>
yn u
her bs</w>
phag ocytes</w>
micro liters</w>
mu st
n ap
x 10</w>
De fic
in ization</w>
hemorrh ages</w>
C 7</w>
Z IK
hyper glycemic</w>
in determinate</w>
b um
HB V-
meth ach
U .</w>
Ch emo
flu id-
hom eless</w>
attenu ating</w>
reinforc ing</w>
PATIEN T</w>
D uration</w>
R II</w>
post ulate</w>
B u</w>
enter otoxin</w>
dehis c
Pro b
s li
A CL
str adi
Col l
stom atitis</w>
re ally</w>
14. 7</w>
ensu res</w>
transm it</w>
Carib bean</w>
R AR
oc alization</w>
Ac celer
al ist</w>
tox in-
J D</w>
plas tics</w>
spl it-
ser ially</w>
speci alization</w>
2 90</w>
thyro globulin</w>
silic ate</w>
AC H</w>
exer tion</w>
ma il</w>
GS K-
av oids</w>
ram ycin</w>
citr ic</w>
cAMP- dependent</w>
os tim
e ing</w>
Ab original</w>
D ra
ulin emia</w>
tos econd</w>
k en
NT R</w>
te bral</w>
haemorrh agic</w>
CYP3 A4</w>
Prolifer ation</w>
t ar</w>
3 1
cephal y</w>
Tr p
ovid uc
plasmac yt
ey e-
His -
aux iliary</w>
L eng
U SP
mi RNA-
be ating</w>
man -
CCR 5</w>
50 ,000</w>
caroten oid</w>
F ar
W P</w>
Esophag eal</w>
O wing</w>
scler oderma</w>
bac eous</w>
Min nesota</w>
hydroly tic</w>
r TMS</w>
Legion ella</w>
ca sts</w>
Pow er</w>
b 2</w>
roll ing</w>
PE I</w>
Consen sus</w>
eli an</w>
fl urane</w>
P- selectin</w>
pol ice</w>
our inary</w>
str u
po x</w>
Vis u
Agg reg
5 50</w>
Integr ation</w>
def enses</w>
Hol stein</w>
Sev enty</w>
P 5</w>
iv e-
pul sive</w>
manufacture r</w>
1. 26</w>
high- speed</w>
cylin der</w>
O DC</w>
thym ocyte</w>
ac anth
go iter</w>
Q A</w>
1. 27</w>
bur gh</w>
sp rin
Res ear
IC G</w>
glutar aldehyde</w>
S 4</w>
v as</w>
K CN
MT s</w>
Vol ume</w>
t ad
D ose-
sulfate- polyacrylamide</w>
mercap to
opa que</w>
anter oposterior</w>
EG CG</w>
carin ii</w>
her itable</w>
st ays</w>
Numer ical</w>
Solu ble</w>
vi l</w>
PC D</w>
V SMCs</w>
oly ticus</w>
fumig atus</w>
Chag as</w>
F os
pr ick</w>
vir tu
tain ly</w>
hyper baric</w>
str aw</w>
an one</w>
Rev ised</w>
HLA- B
F asting</w>
im a</w>
qu ail</w>
ad ate</w>
epider moid</w>
one- induced</w>
under score</w>
col lim
Ex trem
actin omycin</w>
full- thickness</w>
S- induced</w>
PO D</w>
poly neuropathy</w>
thi amine</w>
aminop yr
serov ar</w>
ri an</w>
controll er</w>
2 18</w>
an thus</w>
Observ ations</w>
A de
si ght</w>
categor ization</w>
col ored</w>
glut aminase</w>
ket ones</w>
achiev able</w>
N em
ir al</w>
join ed</w>
SA A</w>
Frac ture</w>
dil ute</w>
formalin- fixed</w>
- the</w>
cy stitis</w>
log ists</w>
W in
or ization</w>
precip itate</w>
nom inal</w>
PTH r
D 4
F G</w>
P ap</w>
enro l
acti onal</w>
p ace</w>
A neur
ph in</w>
anti phospholipid</w>
Com m
wa ke
Se as
duc tor</w>
compl ement-
sulfam eth
0. 3-
Pa ul
C CT</w>
A th
mil lions</w>
a- 2</w>
G GT</w>
at tain</w>
per mitting</w>
br achi
5 a</w>
Accum ulation</w>
B -1</w>
sol utes</w>
e- to-
cri tic
o esophagus</w>
tox oplasmosis</w>
ont ogeny</w>
Gover n
l akes</w>
projec ting</w>
Ser a</w>
bott len
Bi opsy</w>
Statis tics</w>
lam p</w>
can al
Ob structive</w>
dis continuous</w>
5, 6-
Lys -
NY HA</w>
Ca regi
six ty-
defibrill ator</w>
anti diabetic</w>
TIMP -1</w>
T ub
oc rip
on us</w>
bul lying</w>
P ros
deoxy ribonucleic</w>
L et
op tics</w>
neuro biological</w>
Angiotens in</w>
lac un
I b
3- phosphate</w>
ocy te
3 &apos;
Sub stance</w>
TL R2</w>
aver sive</w>
maneu ver</w>
micro biology</w>
AM s</w>
Caro tid</w>
as m</w>
question able</w>
Tod ay</w>
an no
dam ycin</w>
i. d.</w>
5 00
peroxis omal</w>
1. 28</w>
en cl
exud ate</w>
H aving</w>
fentan il</w>
D o
if os
mon ocyte-
s occer</w>
Pol ish</w>
th ri
replic ates</w>
R MS</w>
fine- needle</w>
plant -
a .</w>
Co ord
Re sistant</w>
streptom ycin</w>
th yl
thro p
Al lo
recan alization</w>
yn itr
Pres ent</w>
B a</w>
Prog ress</w>
g lobe</w>
H earing</w>
the tics</w>
acknowled ged</w>
15. 2</w>
J ew
cyan obacteria</w>
IU GR</w>
Micro bi
oll en</w>
oc occi</w>
parkinson ism</w>
Ig G-
Qu antum</w>
contrain dications</w>
15. 3</w>
p anc
le -</w>
ed ent
direc t-
sim us</w>
adhe red</w>
sex uality</w>
relax ant</w>
y led
tri als.gov</w>
Engine ering</w>
ic in-
Adjuv ant</w>
y .</w>
os patial</w>
BC VA</w>
T am
Glu -
aeros ols</w>
3 b</w>
micro scopically</w>
con ferring</w>
char d</w>
AD s</w>
15. 8</w>
cell- surface</w>
ent a
12- week</w>
4 000</w>
papill oma</w>
Tow ard</w>
isoni azid</w>
antimal arial</w>
3 22</w>
co- expression</w>
Endo th
tran sist
Fem ales</w>
I AA</w>
ig o</w>
c ili
hypo thyroid</w>
3 3.
sh ops</w>
perovsk ite</w>
U 937</w>
de methyl
mac aque</w>
DE s</w>
mechan o
amelior ates</w>
phot osystem</w>
ocyan in</w>
v um</w>
second- generation</w>
glucuron idase</w>
whe el
Sign al</w>
b are</w>
a rest</w>
G AL
fat -
M Cs</w>
VA TS</w>
bruc ei</w>
identi ties</w>
c ic
UR E</w>
val ences</w>
oc tan
0.000 2</w>
O T
anti neoplastic</w>
13. 9</w>
le sional</w>
extern ally</w>
S- 2</w>
AB L</w>
pherom one</w>
antec ed
porph yr
poly amines</w>
aut ograft</w>
isc o</w>
bur dens</w>
multi plication</w>
shor test</w>
isol euc
EN T</w>
miti gation</w>
ti er</w>
vi remia</w>
ma res</w>
U ter
K- ATPase</w>
Separ ation</w>
II B</w>
aphy seal</w>
R ussian</w>
ter pen
gadol inium</w>
Contro ll
L PA</w>
view point</w>
the tically</w>
sn ail</w>
VO2 max</w>
y le
m g
moder ated</w>
NT- proBNP</w>
cogniti ve-
Ill umina</w>
seed ling</w>
oxid ases</w>
pancre atico
single- nucleotide</w>
dysp epsia</w>
d .
break age</w>
certi fic
a- associated</w>
adi c</w>
gro unded</w>
non human</w>
mobil ized</w>
am er
Sou theast</w>
diag ram</w>
ib ly</w>
over lying</w>
amil oride</w>
K B</w>
pre defined</w>
class room</w>
Fas L</w>
ch y</w>
multi faceted</w>
gangli oside</w>
ox o
Bec k</w>
Moder n</w>
B ond</w>
ac yl-CoA</w>
Ag NPs</w>
fim bri
F RET</w>
u bin
form e</w>
PG E1</w>
end osomes</w>
gl asses</w>
H aw
competi tively</w>
aor t
ac ial</w>
der -
8 7.5</w>
br um</w>
c emented</w>
micro injection</w>
pre optic</w>
iter pene</w>
ginsen g</w>
lu br
rein force</w>
F at</w>
T MD</w>
dend rim
CCK- 8</w>
dro p
CD 28</w>
4 C</w>
lux ation</w>
2 2.2</w>
penetr ate</w>
cephalospor ins</w>
visco elastic</w>
ol dest</w>
anti al</w>
Gul f</w>
Thirty- one</w>
complet eness</w>
sper mine</w>
Flu id</w>
angi opathy</w>
7- day</w>
arg on</w>
1. 3-
Cor neal</w>
histor ically</w>
advanc ements</w>
salic ylate</w>
T ru
under lies</w>
gen u
even ly</w>
ma iled</w>
PE EP</w>
1. 33</w>
TI C</w>
M ill
G as</w>
cancer- specific</w>
4 1-
at ell
ine- based</w>
bis -
amphi philic</w>
vill age</w>
self- rated</w>
sper midine</w>
consum e</w>
o prost
14. 1</w>
s c</w>
nom ogram</w>
25-dihydroxy vitamin</w>
SC H</w>
Indon esia</w>
my opic</w>
W ell-
non significant</w>
ol d-
argum ent</w>
multi cellular</w>
membrane- associated</w>
tran sep
b c
Dop amine</w>
mes oderm</w>
seem ingly</w>
N EC</w>
estr one</w>
BAL F</w>
E O</w>
igh ting</w>
Assist ed</w>
exerc ised</w>
hyp om
Second ly</w>
col pos
ris peridone</w>
HU VEC</w>
tric yclic</w>
sor ted</w>
duplic ated</w>
1 200</w>
nu triti
shel f</w>
3 01</w>
ho uses</w>
of- of-
D e</w>
wi reless</w>
can e</w>
restric t</w>
Adap tive</w>
F ull</w>
c ach
E DS</w>
Vari ability</w>
Der iv
2 32</w>
apo E</w>
au d</w>
At temp
immunosup pressed</w>
trabec ul
Gi ant</w>
oc entesis</w>
pan -
Sho ul
G AG</w>
to phore
plasi as</w>
mic ellar</w>
sk elet
17 ,
Hamil ton</w>
w -
extrac ting</w>
mass age</w>
c. v.</w>
Fac il
Micha el
perioste al</w>
C is
hom ing</w>
un it
ex tras
win dows</w>
A NCA</w>
Pers onal</w>
cultiv ar</w>
Un ilateral</w>
sed ative</w>
J A</w>
intra- arterial</w>
.00 5</w>
g ay</w>
Eff orts</w>
sym biotic</w>
Cal cul
pp b</w>
myot ubes</w>
1. 75</w>
high- pressure</w>
- K</w>
N F1</w>
form ans</w>
Dow n
Et OH</w>
1 .</w>
B -2</w>
retro virus</w>
Gre ece</w>
V itro</w>
j a</w>
sen escent</w>
admin ister</w>
fu zz
initi ator</w>
terat oma</w>
sev er
mod elled</w>
18. 2</w>
ad nex
medic ated</w>
explo iting</w>
EQ- 5
doub t</w>
RT- qPCR</w>
14- 3-
t ases</w>
nucle osome</w>
FV III</w>
heterodi mer</w>
100- fold</w>
F ran
ic am</w>
papill a</w>
Eth anol</w>
On line</w>
rot ations</w>
dis ks</w>
o- temporal</w>
Fe eding</w>
ophthalm itis</w>
forc ement</w>
f le
ap es</w>
R C
1.0 1-
PK D</w>
cl ay</w>
ore mentioned</w>
Con sec
Con tent</w>
PL E</w>
Rev e
APO E</w>
he el</w>
enedi one</w>
S GL
gam m
comput ationally</w>
p 3</w>
NO 3</w>
halluc inations</w>
dig ree</w>
be ans</w>
phant oms</w>
Ann ual</w>
potenti ates</w>
Sens ory</w>
norm als</w>
C b
L ei
4 86</w>
Twenty- nine</w>
man ure</w>
enucle ation</w>
Arth ritis</w>
ecta sis</w>
G o</w>
mon ey</w>
histi ocytosis</w>
dic t
bif unctional</w>
mid gut</w>
14. 4</w>
vasodi latation</w>
int us
fib ril</w>
pro top
ca strated</w>
Bl adder</w>
M ales</w>
inf in
cer ul
C ED
6 th</w>
stres sor</w>
gra vit
Aden osine</w>
langu ages</w>
access ing</w>
re t</w>
5 S</w>
mal treatment</w>
adjuv ants</w>
arteri olar</w>
synapt osomes</w>
M agne
O I</w>
acet amide</w>
Inter pre
activ in</w>
in um</w>
chro maffin</w>
pa y
af orementioned</w>
anth ra
guan idine</w>
st ory</w>
Colum bia</w>
buff ers</w>
d aun
ferrom agnetic</w>
CO S</w>
Satis faction</w>
iz ability</w>
Dip tera</w>
2 75</w>
fix ing</w>
ture -based</w>
pro vi
Ma king</w>
He ad
ac rine</w>
de feren
den afil</w>
ATP- dependent</w>
nor m</w>
adap tor</w>
one- half</w>
Y ears</w>
cl arithromycin</w>
2 24</w>
spond yl
thrombocyt openic</w>
tri tion</w>
- N</w>
communic able</w>
smart phone</w>
MP P</w>
spectrophot ometry</w>
P P-
A SC</w>
crow ding</w>
Rand om</w>
ste ep
F inal</w>
aff ir
P as
Pu er
si s
ith iasis</w>
CD -
whe y</w>
glycosamin oglycans</w>
E ating</w>
fac ets</w>
uc cin
syring e</w>
congen ers</w>
carrage en
rever sibility</w>
no st
ref ine</w>
sal but
e uro
bre ad</w>
Kin ase</w>
b udget</w>
univers ally</w>
Wh y</w>
pharmac ies</w>
oxygen ated</w>
c asting</w>
et ast
co incident</w>
Estim ates</w>
CS T</w>
Transi tion</w>
S Q
ro ot-
N 0</w>
10 -</w>
6- 8</w>
C la
cop per-
pseudo aneurysm</w>
ple uro
sem ic
steroid ogenesis</w>
vertebr a</w>
al ol</w>
Ex pert</w>
Latin o</w>
E H
irr itable</w>
met oprolol</w>
biosens ors</w>
ventro lateral</w>
ox ide-
separ ations</w>
o il-
Obste tr
9 -1
tim ed</w>
embry onal</w>
odi pine</w>
hear t-
Chrom osome</w>
nam ing</w>
modi fier</w>
immun ofluorescent</w>
S ite</w>
R .
Collag en</w>
re actors</w>
la id</w>
Langu age</w>
manip ulating</w>
Cont act</w>
nov .</w>
tetra -
5 &apos;
SC S</w>
mis e</w>
1- 6</w>
Ass emb
on eal</w>
un healthy</w>
diff usi
Kine tics</w>
E wing</w>
Str ains</w>
Net works</w>
lif elong</w>
hom ogenous</w>
F usion</w>
d- to-
CC 1</w>
ath letic</w>
RO I</w>
Treat ments</w>
T- 2</w>
Thirty- five</w>
periodic ally</w>
arg ues</w>
Acet yl
t yr
0.0 23</w>
2 39</w>
ow nership</w>
non- steroidal</w>
tempor arily</w>
M 0</w>
N P-
eng ers</w>
sub stitutes</w>
ol ding</w>
varic ella</w>
vig ilance</w>
st u
instant aneous</w>
aut umn</w>
1. 32</w>
com ings</w>
work -
2 28</w>
typ ed</w>
forc e-
intus sus
ensi tive</w>
Hispan ics</w>
p eren
dro w
neg ativity</w>
intrat umoral</w>
B CC</w>
ex tant</w>
onc ologists</w>
17. 6</w>
depic ted</w>
Schizophren ia</w>
μ L</w>
ag al
orch estr
2 p</w>
admini strat
in vertebrate</w>
yl amine</w>
Prog nosis</w>
re tains</w>
splanch nic</w>
Ac anth
ast atin</w>
il in</w>
id ov
De pressive</w>
throm bectomy</w>
micro vessels</w>
non- pregnant</w>
reli ance</w>
four fold</w>
PRACTI CE</w>
2 17</w>
le in</w>
aut ogenous</w>
yst rophy</w>
electro physiologic</w>
li ability</w>
fabric ate</w>
br ushing</w>
acyl glycer
oun ding</w>
G C
b at</w>
A mp
neo formans</w>
0.0 21</w>
Paren tal</w>
BO LD</w>
E SS</w>
E ST</w>
In du
brid ged</w>
photo electron</w>
2 66</w>
scap ular</w>
Zn 2</w>
stabil ities</w>
Res ection</w>
biotin ylated</w>
In stitutes</w>
multi pl
TA P</w>
be ad</w>
fib er-
poly chlorinated</w>
cellul arity</w>
Long- Term</w>
priv acy</w>
sw ollen</w>
necrop sy</w>
e po
prov ocation</w>
oph yte</w>
CRI SP
arteri osus</w>
olig omerization</w>
break fast</w>
hyd atid</w>
G Cs</w>
v illus</w>
thic knesses</w>
T rop
Ab err
bacteri ological</w>
ren ders</w>
S -100</w>
comp elling</w>
co oked</w>
Du chen
CT X</w>
join tly</w>
fibrom yalgia</w>
parkinson ian</w>
cancell ous</w>
2 38</w>
G 0</w>
sym metr
to id</w>
dehisc ence</w>
Nep al</w>
Pres entation</w>
retin oid</w>
ML C</w>
den tine</w>
I HD</w>
flo ating</w>
ch ances</w>
anti- HCV</w>
Standardi zed</w>
V iv
HD AC</w>
far ming</w>
Wil ms</w>
A HI</w>
G A-
proce eded</w>
ocrip tine</w>
co oled</w>
omencl ature</w>
ure ase</w>
1. 45</w>
b ats</w>
oct adec
Pat tern</w>
bilir ubin
mat ous</w>
L ept
0.0 24</w>
Concomit ant</w>
alcohol -related</w>
Util izing</w>
P IN
Intrac ranial</w>
astro cytic</w>
SY N
w a</w>
surviv in</w>
u ated</w>
SV M</w>
pharmac odynamics</w>
At titudes</w>
8 -1
mul tiv
TE A</w>
sh ock
Un expectedly</w>
li ver
HO X
scal able</w>
Exam ples</w>
salbut amol</w>
exten sions</w>
in stitute</w>
Experi ences</w>
W A</w>
over growth</w>
HOMA- IR</w>
cef triaxone</w>
cardi otoxicity</w>
Rus sia</w>
v oid</w>
magn ification</w>
schwann oma</w>
E 2-
ti um-
go ti
3 7-
hypercap nia</w>
un n
ib encl
diure sis</w>
fec und
bel t</w>
Contro ls</w>
neurolep tic</w>
4 3-
SE A</w>
Cx 43</w>
protein- coding</w>
CYP2 D6</w>
Q TLs</w>
tym panic</w>
un bound</w>
prepar ative</w>
trochan teric</w>
C anc
0.0 28</w>
are ly</w>
G on
bul ky</w>
ryan odine</w>
st ear
am ik
28. 6</w>
AD E</w>
Mil k</w>
QAL Y</w>
PR T</w>
mou th
om icro
bl astic</w>
grap e</w>
micro l</w>
hyponat remia</w>
S cores</w>
TP O</w>
wid ths</w>
nanos he
ge ographically</w>
S K-
ip ient</w>
c- Myc</w>
ubiqui tin-
ap er</w>
C ent
ne goti
thi ols</w>
Pt d
obses sive-compulsive</w>
aminop eptidase</w>
1 α</w>
ly ophil
IT Y</w>
S it
carcin oembryonic</w>
tion ality</w>
well- differentiated</w>
DE AE-
Hem odynamic</w>
M ich
Res olution</w>
S lo
W ound</w>
ru thenium</w>
avoid able</w>
ox -
self- administration</w>
alg a</w>
7 2-
ac y
ent orial</w>
SP 1</w>
but anol</w>
in activity</w>
15 0
Wis con
cell- cycle</w>
NH 2-
F ocal</w>
def ault</w>
broil ers</w>
NA DP</w>
6- OHD
transduc ers</w>
1. 34</w>
H K
omer ular</w>
graph ical</w>
prob and</w>
Radi ographic</w>
fir m
exha us
Vic tor
oc cosis</w>
neph ron</w>
inter- actions</w>
g ill</w>
emb ran
aper itoneal</w>
P ol</w>
Dys function</w>
agon ist
str is</w>
orth olog
p age</w>
half- lives</w>
Im ages</w>
omal acia</w>
trac ked</w>
l et-
h ip
entr ifug
ET E</w>
fac iens</w>
divid e</w>
w ish</w>
P J
DO C</w>
pre paredness</w>
Co operative</w>
A gre
vic tim</w>
Syn erg
1. 36</w>
it ably</w>
multi layer</w>
elabor ate</w>
5- H
PM L</w>
Soci o
stimul us-
S v</w>
IgG 4</w>
ure thro
chrom atid</w>
see ks</w>
athl ete</w>
T- lymphocyte</w>
20- 30</w>
3 .</w>
multi plicity</w>
certi fication</w>
cardio protective</w>
alk er</w>
Dis ruption</w>
bever age</w>
sr c</w>
non alcoholic</w>
Duchen ne</w>
od ular</w>
P in
Fac ial</w>
N ar
los s-of-function</w>
AL D</w>
anthrac ene</w>
interven ing</w>
cogniti vely</w>
valpro ate</w>
FT- IR</w>
Consec utive</w>
pleas ant</w>
tas k-
lif ting</w>
clinic al
O PG</w>
asym pto
o int
P ax
i. c.v.</w>
ger an
inter connected</w>
assign ments</w>
miR- 4
ra e</w>
lob ar</w>
P d
- 6
alpha- fetoprotein</w>
PG s</w>
Hem orrh
allo dyn
B CS</w>
- 9
1. 29</w>
abund ances</w>
R IP
threat ened</w>
ol or</w>
heter otopic</w>
F ore
Gen Bank</w>
re conc
ach loro
suspec t</w>
lea ks</w>
nadi r</w>
f ound
cryp toc
cyto chal
asym metrical</w>
2 68</w>
car go</w>
serogrou p</w>
patch- clamp</w>
A typical</w>
direc tors</w>
IC R</w>
chron ological</w>
Gener alized</w>
A -1</w>
lacto ferrin</w>
De gradation</w>
Ra dical</w>
ne arest</w>
B ol
n in
P ost</w>
3 6.
gro in</w>
modi fiers</w>
ti r
K o
fif ty</w>
16. 3</w>
Egyp t</w>
glit azone</w>
non pregnant</w>
Tow ards</w>
Ki 67</w>
C ell-
pur ities</w>
S R-
fur an</w>
eu thyroid</w>
asphy xia</w>
3 10</w>
full- term</w>
S D-
Cys tic</w>
p ush
evo ke</w>
CD 45</w>
off enders</w>
D CIS</w>
hem odi
Oc currence</w>
us k
cycl opent
methach oline</w>
2 42</w>
20 th</w>
cin ti
orig inates</w>
g ab
Co hen</w>
ardi a</w>
Spec imens</w>
swa b</w>
end- to-
Polym erase</w>
4 4-
8 3.3</w>
coc ain
brain- derived</w>
dar kness</w>
S ize</w>
tr a</w>
cust om</w>
3 5.
CH OP</w>
Transpl ant</w>
urb an
E Z
G d-
en trance</w>
form ate</w>
voltam metry</w>
herbic ide</w>
gam et
I MA
1. 30</w>
och lor
en ox
de af</w>
1 H-
ar tom
erb al</w>
ing -based</w>
magne tization</w>
predomin ated</w>
ver m
form ulate</w>
Partic ularly</w>
ot str
invari ably</w>
equ ity</w>
E GTA</w>
Aud itory</w>
aly st</w>
mes o
res ting-state</w>
isot opes</w>
accept ors</w>
propan e</w>
sten otic</w>
atin g-
nanow ire</w>
g n</w>
E- selectin</w>
Ev ents</w>
ZIK V</w>
ag end
Intr am
treat able</w>
ter ized</w>
- infected</w>
B P-
sup pur
lab yrin
12 3
Ther mo
rib oflavin</w>
cr ack</w>
monit ors</w>
exten ded-
An throp
wa x</w>
t led</w>
xim al</w>
acycl ovir</w>
el i</w>
fo res
rib ose</w>
adren ocortic
ty ly</w>
duplic ate</w>
de generate</w>
1, 6
ME P</w>
anth rene</w>
counter -
unc ou
an aerob
est -
Dic ty
zinc -
appear ances</w>
B max</w>
20 10-
his tid
mE q</w>
over- expression</w>
Q C</w>
C- C</w>
Revie ws</w>
TA M</w>
micro organism</w>
per pe
veh icle-
cef tazidi
ad ox</w>
bur ned</w>
hol o
0.0 26</w>
male imide</w>
hour ly</w>
disper se</w>
ol ence</w>
Ex pan
k ynu
pa di
m Category</w>
Con current</w>
Nl mCategory</w>
Ex traction</w>
Dr .</w>
o yl
PT FE</w>
acid -induced</w>
reg ist
h ang
cos me
Ter tiary</w>
B arr
az ithromycin</w>
estim ations</w>
ing -induced</w>
f an</w>
multi tude</w>
Re as
aw a</w>
Hi erarch
semi quantitative</w>
hall marks</w>
CM -
Vacc ination</w>
atic a</w>
glu e</w>
ach ments</w>
ati dyl
Fisch er</w>
genit ourinary</w>
manufact ure</w>
P SI</w>
ol umbar</w>
J ak
L ou
implic ating</w>
pac ed</w>
imping ement</w>
C CI</w>
lic ted</w>
Macroph ages</w>
F luorescent</w>
M SA</w>
advoc ate</w>
chromoph ore</w>
intrac ytoplasmic</w>
random- effects</w>
to ol
10 -15</w>
exc epti
conc eived</w>
N ile</w>
sub classes</w>
activ ations</w>
lig and
ox ime</w>
segreg ated</w>
I E
end osomal</w>
disp arate</w>
visc ous</w>
synth eses</w>
mo de
recurren ce-free</w>
tris phosphate</w>
-1 H-
index ed</w>
Wiscon sin</w>
T x</w>
ank ylosing</w>
du plications</w>
alog y</w>
con tract</w>
6- hydroxy
pi ezo
r uminal</w>
te zom
V en
2 M</w>
reco vering</w>
OUTCO MES</w>
co- chemical</w>
0.0 22</w>
biom echanics</w>
man ia</w>
resc ine</w>
Ade qu
C TS</w>
ut h</w>
ass er
S ide</w>
M PTP</w>
2- D</w>
vascul arity</w>
A gr
4 20</w>
pyel onephritis</w>
aco emulsification</w>
tr ying</w>
go t</w>
0- fold</w>
Graph ene</w>
comm ens
O m
sam e-
P ag
medul lo
O F
serop ositivity</w>
w etting</w>
Un usual</w>
Tyr -
em mal</w>
lymph edema</w>
D C-
anten na</w>
oblig ate</w>
NA A</w>
MT A</w>
PV P</w>
2 3.5</w>
ga m</w>
mon onucle
factor- α</w>
predic tability</w>
ta uro
1. 37</w>
dr astic</w>
rec ir
post s</w>
photo period</w>
2 52</w>
well- tolerated</w>
n im
il li
anox ic</w>
urin ol</w>
f ted</w>
telom eres</w>
nex in</w>
Strateg y</w>
2 45</w>
CT Cs</w>
kerat osis</w>
ig an</w>
Sub group</w>
pon tine</w>
2 D-
7 -1
over production</w>
JAK 2</w>
H op
bic ycle</w>
in accurate</w>
co us
caus ality</w>
ol anzapine</w>
um -induced</w>
cer tainly</w>
jejun ostomy</w>
Engl ish-
T an
VZ V</w>
ERI A</w>
fis sure</w>
false- negative</w>
nucle osides</w>
cl arity</w>
auto regulation</w>
ap sular</w>
2 19</w>
e thers</w>
pat ella</w>
ran itidine</w>
att ention-
Fe der
M atr
contrac ting</w>
pl egic</w>
HS V-2</w>
Epidemi ologic</w>
short comings</w>
granulocyte- macrophage</w>
Osteo arthritis</w>
se y</w>
ster ing</w>
P 300</w>
em power
Ex ogenous</w>
Wn t
Sh ang
16. 6</w>
C 12</w>
arc tation</w>
Ste p</w>
1. 31</w>
fluctu ating</w>
ac ity</w>
oph ene</w>
ex ia</w>
Pen ic
OR Fs</w>
neuro surgery</w>
3 65</w>
HLA- A</w>
muc ositis</w>
HL H</w>
1. 43</w>
Air way</w>
propag ated</w>
M CS</w>
2 48</w>
AV M</w>
Techniqu es</w>
transform ants</w>
co iled</w>
g ig
conver ts</w>
methyl- 4-
ME C</w>
Ver sus</w>
arthro pathy</w>
r CBF</w>
C P-
cr ime</w>
H SS</w>
Au NPs</w>
dipyrid amole</w>
nanom olar</w>
g un
gender -
leis ure</w>
sp un</w>
n is</w>
Publ ished</w>
2 34</w>
G el
bl end</w>
age- adjusted</w>
T- lymphocytes</w>
micro villi</w>
Sy rian</w>
protozo an</w>
To k
b us</w>
PI D</w>
V ie
denti st</w>
co eliac</w>
av ascular</w>
I- II</w>
chemoradi ation</w>
encomp asses</w>
Cost -
trans vaginal</w>
L ED</w>
ocon azole</w>
Portu gu
post- mortem</w>
A GE</w>
radi o</w>
hyper triglyceri
eth ane</w>
e at</w>
A E
gen e-related</w>
cap ping</w>
pul se-
glut en</w>
Foc us</w>
fuzz y</w>
sa ve</w>
t man</w>
Gen ome-wide</w>
magnit udes</w>
explo itation</w>
govern ance</w>
le um</w>
immer sed</w>
o yst
intrag astric</w>
I CI</w>
par ty</w>
point -of-care</w>
MR I-
MTH FR</w>
gover n</w>
D na
comp u
inferen ces</w>
scro tal</w>
N- methyl
pen ic
bot tom
Br it
Elec troph
in clusive</w>
HM G-
Ex isting</w>
Nin ety</w>
S earch</w>
ass ault</w>
Con fir
19 72</w>
D .
tech ne
3 4.
Bu il
ogu an
pro of-of-
non surgical</w>
Environ ment</w>
res or
Shoul der</w>
diet -induced</w>
0.0 27</w>
PR O</w>
Thirty- three</w>
vesti bul
mic ity</w>
mind fulness</w>
PD GF
Relev ant</w>
S AD</w>
palli ation</w>
synovi tis</w>
cr ash</w>
an orectal</w>
Di versity</w>
alop ram</w>
st en</w>
A SI
or yz
mis carriage</w>
Ben ign</w>
advant aged</w>
3 2.
PM C</w>
S ma
N ETs</w>
immunosup press
key words</w>
ecto derm</w>
15. 7</w>
1. 38</w>
Q 10</w>
Knock down</w>
fo relim
post translational</w>
resear ches</w>
tri acylglycerol</w>
trop ic</w>
19. 5</w>
G est
far nes
wake fulness</w>
varic eal</w>
M ong
neur algia</w>
Gu inea</w>
amik acin</w>
ip ients</w>
top -down</w>
Immun ization</w>
Indi ans</w>
F lo
BR CA2</w>
Heterogene ity</w>
as aki</w>
cra ving</w>
heavi er</w>
neurofibrom atosis</w>
L ater</w>
dis placements</w>
character izes</w>
hydr ate-
enanti omer</w>
Abs ence</w>
W ide</w>
perfor ations</w>
mi tic</w>
flav or</w>
PTHr P</w>
M CC</w>
elabor ated</w>
ste ers</w>
st on</w>
es ulf
Trans genic</w>
ass or
vul var</w>
L G</w>
J er
des atur
you ths</w>
pro ficiency</w>
ic ides</w>
Pop ul
s tic
emerg es</w>
E hrl
Care ful</w>
ser ver</w>
dys lex
2 27</w>
catech ol</w>
Hypox ia</w>
un planned</w>
empower ment</w>
BM -
fi ve
0.0 35</w>
ent olamine</w>
chim eras</w>
L O</w>
gall stones</w>
dur a</w>
maxim a</w>
non- alcoholic</w>
adeno viral</w>
atl as</w>
Endo vascular</w>
25-hydroxy vitamin</w>
pe digree</w>
recru iting</w>
bloc kage</w>
mo s</w>
P SCs</w>
curricul a</w>
ibencl amide</w>
ir in
trim eric</w>
fer rous</w>
custom ized</w>
F AD</w>
Inter -
ophosph orylation</w>
zircon ia</w>
G ram</w>
inter specific</w>
finger print</w>
invol untary</w>
ocul omotor</w>
C re</w>
immun operoxidase</w>
Re productive</w>
catast rophic</w>
Appro aches</w>
Phen otypic</w>
ul ose</w>
infarc ted</w>
30 5</w>
epsil on
M urine</w>
met e
b ites</w>
chaper ones</w>
T g
2 29</w>
electroencephal ogram</w>
intern ally</w>
clin damycin</w>
aten olol</w>
car d</w>
dec ont
tub ul
R ub
squ ir
plas tin</w>
appreci ation</w>
Leuk emia</w>
ur is
insec urity</w>
ap ne
mer it</w>
13. 0</w>
an tine</w>
spec ify</w>
k g-
oxalipl atin</w>
angi oma</w>
PRO CED
Del phi</w>
opac ity</w>
g ium</w>
M CT</w>
phen oxy
NI RS</w>
virus -specific</w>
ogr ade</w>
GS H-
sacc ade</w>
ic k
ph ys
Barri ers</w>
3 25</w>
el a</w>
antr um</w>
Colom bia</w>
targ et-
ancest or</w>
ST M</w>
1, 6-
Mal aria</w>
foll icle-
appoint ments</w>
mal to
non sense</w>
1 10
dens ely</w>
c ens
alle y</w>
-- a</w>
Main tenance</w>
kyph osis</w>
ob let</w>
extrac ranial</w>
vasodi l
arc uate</w>
mil der</w>
hydr ide</w>
H -</w>
in o
oth re
SS G</w>
gl enoid</w>
enol ase</w>
strength ened</w>
cath ode</w>
im ipenem</w>
chem oresistance</w>
Dam age</w>
or ities</w>
lumb osacral</w>
L K
dual- energy</w>
S ca
ligh ting</w>
less -
infiltr ated</w>
conventi onally</w>
u ing</w>
A HR</w>
andro gen
Determin ants</w>
Aut ophagy</w>
R P
HA V</w>
preced es</w>
uter i</w>
web sites</w>
correc tive</w>
at trition</w>
beta- lactam</w>
Mo vement</w>
bull ous</w>
Li ker
Multic enter</w>
MD M2</w>
ta x</w>
ass a</w>
flag ell
ch yl
perman ently</w>
PO 4</w>
cyst atin</w>
r in-
broad band</w>
I V-
AM S</w>
gel -
conc ei
oler ant</w>
Phy to
den um</w>
androst enedione</w>
strabis mus</w>
wea knesses</w>
R ural</w>
0.0 10</w>
inosit ol-
aly sts</w>
Larg er</w>
M end
C lim
hair y</w>
Memb ers</w>
virus -induced</w>
oblast omas</w>
con tu
peptid oglycan</w>
insul ts</w>
stom atal</w>
sh RNA</w>
spor ulation</w>
2 43</w>
osa hexa
E very</w>
del ay
PC O2</w>
pro collagen</w>
3 9-
W ar</w>
um es</w>
Adju sted</w>
av icular</w>
aminoglyco side</w>
al is
Memb ran
sign ed</w>
coagul opathy</w>
Cop yright</w>
N ature</w>
Par t
retin as</w>
Princ ipal</w>
transc utaneous</w>
Schol ar</w>
P- 43</w>
PE T-
tw o-</w>
allerg ies</w>
Immun ocyto
par at
emul si
intub ated</w>
hybrid oma</w>
os able</w>
re habil
under weight</w>
IC s</w>
Sum mary</w>
y o</w>
cru st
excepti onally</w>
bronch opulmonary</w>
Ch ile</w>
aspir ates</w>
S AP
te am
precau tions</w>
Epil epsy</w>
2 36</w>
Sof t</w>
am it
AB O</w>
al- like</w>
9 9.
CR 1</w>
E SW
ten ing</w>
2 55</w>
mot or
K I
cal ving</w>
phenomen ological</w>
S omat
iso thermal</w>
dem ented</w>
hetero chromatin</w>
0.00 001</w>
epi androsterone</w>
U VA</w>
conspic uous</w>
s ly</w>
H ex
sin ensis</w>
w as
mic ally</w>
hydroxy proline</w>
ut ation</w>
hydr onephrosis</w>
pep sin</w>
Ca MK
G in
PA G</w>
15. 1</w>
ter tile</w>
In direct</w>
rumin ants</w>
14. 9</w>
finger printing</w>
an tee</w>
yl us</w>
em etic</w>
bac lofen</w>
pac hy
clon ogenic</w>
hapl oid</w>
sle eve</w>
T GA</w>
Bi o-
thin- layer</w>
G J
met ach
excep tions</w>
Th ym
N- linked</w>
intrac ardiac</w>
Le ad</w>
Sym ptomatic</w>
fist ulae</w>
star ved</w>
Gra ft</w>
corrobor ated</w>
S can</w>
bi osis</w>
therap y-induced</w>
Post operatively</w>
allop ian</w>
un adjusted</w>
2 5.0</w>
E x</w>
pr ices</w>
immun ology</w>
Rel ation</w>
S ão</w>
catar acts</w>
L ag
oper itoneum</w>
pi one
flag ellar</w>
spec ulated</w>
absorp tive</w>
miner al
- 5-
l is
qu ant
thioredox in</w>
2 46</w>
Diff usion</w>
Incorpor ation</w>
acetyl- CoA</w>
E SD</w>
Atl as</w>
ex cur
SO X
ospor a</w>
clou d</w>
Impro vements</w>
16. 2</w>
P elvic</w>
IN K
bi phenyl</w>
e worthy</w>
. com</w>
ethyl enedi
Vir tual</w>
thaw ed</w>
sub lethal</w>
cross linked</w>
B Z
deferen s</w>
Assemb ly</w>
mim etic</w>
gol den</w>
append ectomy</w>
hib ern
S b</w>
am end
GF P-
pow ders</w>
Cop per</w>
thick ened</w>
char coal</w>
in- based</w>
alb um
glot tic</w>
L- N
diffusion- weighted</w>
gangli osides</w>
intrad ermal</w>
dys morph
graph ite</w>
partner ships</w>
oper ates</w>
CH 3</w>
ds DNA</w>
Hsp 70</w>
IVI G</w>
j e
te thered</w>
nal trexone</w>
Prost agland
lif t</w>
fib er
N2 O</w>
per v
In d
M ent
ME G</w>
S har
s lip
biotechn ology</w>
quar tiles</w>
I on
Fir stly</w>
iz ine</w>
micro L</w>
neuro toxin</w>
H SD
surviv orship</w>
rac emic</w>
foc us
T l</w>
TP N</w>
dom s</w>
refl ections</w>
yl line</w>
2 64</w>
ca ve</w>
he av
ti da</w>
e- derived</w>
pyl oric</w>
pe de
smo ker</w>
3 7.
or ative</w>
SI V</w>
streptozot oc
m it</w>
grow s</w>
de fibrillation</w>
omy osin</w>
Neph ro
oste onecrosis</w>
oblast oid</w>
2- amino-
tow n</w>
U CP
tr ains</w>
hyper sensitive</w>
thaw ing</w>
triti ated</w>
disproportion ately</w>
MALDI- TOF</w>
E pi
Portugu ese</w>
por in</w>
Forty- eight</w>
9 6-
cap turing</w>
F MR
Micro scopic</w>
accompl ish</w>
O GTT</w>
free- living</w>
in- 3</w>
estro gen
ag liptin</w>
cu ti
2. 5
Gre ek</w>
concentration- time</w>
necess itating</w>
lin ol
accur acies</w>
Diff icul
bronch us</w>
al -</w>
uro genital</w>
HER -2</w>
b ears</w>
nul li
hyperinsulin emia</w>
2 0.5</w>
Con jug
Avail able</w>
absorb ing</w>
uron ium</w>
Brassi ca</w>
c ements</w>
ch ips</w>
O DN</w>
P ho
inci sional</w>
fo uling</w>
R LS</w>
shiel ding</w>
trehal ose</w>
padi as</w>
un ipolar</w>
iz o
ome dicine</w>
guar antee</w>
ass ed</w>
be c</w>
intra oral</w>
I le
conf identi
Ag e-related</w>
glycos yl
exacerb ate</w>
MV D</w>
a- related</w>
drom ic</w>
t .
Cor yne
j as
fi re
co factors</w>
RNA -1
marg in
Rac 1</w>
I mag
TL E</w>
ham artom
tt age</w>
in sular</w>
o val</w>
O X</w>
T X</w>
R SA</w>
sh ells</w>
dextro se</w>
K it</w>
adi po
Pal li
t ut
in spiration</w>
AT G</w>
all ine</w>
3 70</w>
osi c</w>
5 ,000</w>
gran d
l or</w>
2 65</w>
Thirty- four</w>
run off</w>
los ing</w>
ion tophore
dystroph in</w>
6 4-
end ophthalmitis</w>
t elev
S SE
Sub -
c itations</w>
higher- order</w>
bul ls</w>
Pa ste
prot on-
sis- related</w>
endoscop e</w>
PI P</w>
dar k-
abil is</w>
V o
ine -</w>
S. D.</w>
non- responders</w>
Con struction</w>
ro d-
1. 42</w>
requ ests</w>
star tle</w>
I O</w>
ano ate</w>
intrac ellularly</w>
ic ism</w>
spl eens</w>
Immun ofluorescence</w>
Commun ity-
con sangu
amne sia</w>
mesenchym e</w>
Paul o</w>
PA I</w>
CT LA-
L umbar</w>
univer sities</w>
6 50</w>
op ty
rever sing</w>
g ib
U niqu
ed ings</w>
osom atic</w>
ar id</w>
sion ing</w>
MT 1</w>
character ise</w>
resi st</w>
MI P</w>
Br onch
reti rement</w>
Ar ch
habit uation</w>
Two- dimensional</w>
cl ip</w>
otrop in</w>
SN s</w>
DIN G</w>
ot olaryng
5- 6</w>
territ ories</w>
VE P</w>
pro- apoptotic</w>
bim odal</w>
cere us</w>
ile us</w>
t ul
otroph s</w>
whe ezing</w>
impregn ated</w>
E MR</w>
hyper responsiveness</w>
ex haled</w>
CM s</w>
land mark</w>
h GH</w>
shoul ders</w>
hyaluron an</w>
spro uting</w>
pec tin</w>
Oste opo
O 2-</w>
st asis</w>
lear ners</w>
ocon us</w>
CR IT
PS Ps</w>
collater als</w>
ra d</w>
S mar
be re
bul im
ethan olamine</w>
nev i</w>
ER Ps</w>
itr e</w>
b a</w>
d 1</w>
d on</w>
alpha- subunit</w>
en ium</w>
Physici an</w>
re oxygenation</w>
inter individual</w>
nar rati
lumin ance</w>
por k</w>
of lu
2 47</w>
LD 50</w>
if ier</w>
mul tis
NH 4</w>
il eg
per oneal</w>
atyp ia</w>
citr us</w>
T x
wast es</w>
mis matched</w>
concer t</w>
B ase</w>
S clerosis</w>
R GD</w>
Sim ulations</w>
al- to-
HC G</w>
G d</w>
B N
vagin alis</w>
s ings</w>
sp ur
sl augh
cle av
bo oster</w>
res us
trans located</w>
Wall is</w>
co erul
for age</w>
no on</w>
LTB 4</w>
of ovir</w>
osper m</w>
RNF L</w>
ep ir
CL s</w>
ox imetry</w>
rap e</w>
Gu ang
pain less</w>
PF GE</w>
Dev ice</w>
homozyg otes</w>
Polic y</w>
fecund ity</w>
M ath
Sil ic
c resc
V ec
conto urs</w>
des aturation</w>
hem ipl
harbo red</w>
T EM
si de
thic ker</w>
cr ashes</w>
EC S</w>
fal fa</w>
S cho
follow ed-up</w>
bio distribution</w>
ind welling</w>
isopren aline</w>
F ont
as y</w>
CRIT ERIA</w>
F AC
I b</w>
H 9
her b</w>
C MS</w>
iv udine</w>
stri ated</w>
R es</w>
dis ast
vi til
mis oprost
intu itive</w>
guan ylate</w>
Concentr ation</w>
ar bo
long er-
Uni ver
path ologist</w>
20- fold</w>
aptam er</w>
follow -
cap it
poster olateral</w>
3 80</w>
pu er
swit ches</w>
I RR</w>
x er
alpha 1-
framesh ift</w>
a dism</w>
Dec ision</w>
ou tre
Ab normal
A PD</w>
fem tosecond</w>
AV F</w>
nev us</w>
AB I</w>
pneum ophila</w>
13- acetate</w>
Collabor ative</w>
ra fts</w>
radiolig and</w>
od enal</w>
yclin es</w>
he ights</w>
Ta u</w>
Analy tical</w>
d ae</w>
hy stere
de activation</w>
LA B</w>
long us</w>
17. 2</w>
enanti oselective</w>
fl are</w>
break points</w>
mush room</w>
buff ering</w>
az id
clav ul
micro albuminuria</w>
vin bl
Lt d</w>
Fir st-
Mich igan</w>
C yst
gas eous</w>
ut amide</w>
MT C</w>
chi ro
F ive-
cataly tically</w>
min g
inferi ority</w>
Vari ables</w>
pre- clinical</w>
har ms</w>
sequenc e-specific</w>
whole- genome</w>
b un
opty sis</w>
15. 0</w>
myometr ial</w>
M OF</w>
N Q
I G</w>
uro spor
cell- to-
addi tions</w>
G6 PD</w>
tri azol
Hydro x
dy ads</w>
tetro dotoxin</w>
TI M
cyclo oxygenase-2</w>
isol ating</w>
Kr usk
Acqu ired</w>
ps i</w>
Con sortium</w>
v in</w>
New cast
metalloprotein ase-
3 8.
polymer ized</w>
L eb
diphther ia</w>
el essness</w>
Inter views</w>
adop ts</w>
acces sions</w>
produc er</w>
hyper methylation</w>
al- level</w>
ion ine</w>
rad on</w>
22 q
AP AC
intracor onary</w>
LV AD</w>
ev er-
re arranged</w>
os arcomas</w>
gen iculate</w>
del aying</w>
sp ider</w>
G AS</w>
ful le
opath ogenesis</w>
collag enous</w>
30 3</w>
4 R</w>
Am bul
remn ants</w>
poly cy
c us
2 1.4</w>
CD 19</w>
splen omegaly</w>
sud den
inter professional</w>
ys acchari
Mig ration</w>
dimorph ism</w>
lo d
AM H</w>
quadru pole</w>
1. 39</w>
nitro- L-arginine</w>
Psych osocial</w>
chlamy dial</w>
sev enty-
bar rel</w>
T ER
transcrip tase-
PE R</w>
ax anthin</w>
Spectro scopy</w>
free ze</w>
four teen</w>
C1 q</w>
un favourable</w>
1. 67</w>
vas omotor</w>
cm 3</w>
DPP H</w>
Al -
transpor ting</w>
S HB
ju dic
com pres
cl omi
B .
probl em-
20 11-
dy ne
il ia</w>
Forty- five</w>
ground -
olec tomy</w>
carcin ogenicity</w>
vul us</w>
myometr ium</w>
hydrox ylated</w>
phen otyping</w>
teg mental</w>
M C-
de posit</w>
contin gent</w>
18. 8</w>
pyrid yl</w>
n est</w>
two- fold</w>
ophyl l
hyperox ia</w>
S 1P</w>
beta- adrenoceptor</w>
De ficiency</w>
MM F</w>
determin istic</w>
concep tions</w>
F ine</w>
GTP ases</w>
compart ment
staff ing</w>
L .
R och
supra ventricular</w>
qui et</w>
ac company</w>
anticip ate</w>
o ocysts</w>
h olog
cyt ostatic</w>
hypoc alc
ac ellular</w>
ST N</w>
SO D1</w>
4 31</w>
sorb itol</w>
I SR
HBe Ag</w>
sy n</w>
16. 4</w>
cooper ativity</w>
F it
Ag e-
ti des</w>
hydra zine</w>
vol ta
cys tic
architec tural</w>
skin -
secre tin</w>
Cor d</w>
R G</w>
tic atory</w>
Asp -
Q 1</w>
Dimen sional</w>
w ave-
EC P</w>
te ach</w>
Frac tures</w>
G HRH</w>
ari us</w>
offic ers</w>
1 alpha</w>
HE K
Program me</w>
t uration</w>
1. 40</w>
synerg ism</w>
employ ee</w>
F 344</w>
wave guide</w>
a C</w>
PL P</w>
inser ts</w>
P NA</w>
re tic
17. 4</w>
auth ority</w>
oligodendro cyte</w>
ane oplastic</w>
dal tons</w>
Bel gium</w>
40 2</w>
moun tain</w>
mes enter
neuro pathies</w>
sulf onate</w>
Ather osclerosis</w>
Ear lier</w>
Ex p</w>
single- dose</w>
eme sis</w>
sun light</w>
E SCs</w>
coar se</w>
put rescine</w>
Fac ulty</w>
repe ating</w>
electroencephal ography</w>
L e</w>
Shang hai</w>
me an-
5 Y</w>
B 3
EB P
re par
tend er</w>
isoleuc ine</w>
idov udine</w>
bis -</w>
itr aconazole</w>
Q SAR</w>
in- vivo</w>
peri ventricular</w>
hem o
sing ly</w>
kappa -
2 α</w>
dou ble
Ul tim
Rheum atoid</w>
inter pol
Prote us</w>
recei ves</w>
misoprost ol</w>
acromegal y</w>
br inging</w>
16. 1</w>
sn ails</w>
anxi olytic</w>
J am
PM 2.5</w>
beta 2-
C BP</w>
Inhib itor</w>
envel op
in- house</w>
er v
glyco side</w>
hu b</w>
japon ica</w>
outre ach</w>
H ill</w>
ov a</w>
first- degree</w>
Pneum ocystis</w>
Bur kit
intussus ception</w>
form ats</w>
spermat og
im purities</w>
amoeb a</w>
P oint</w>
In patient</w>
epti d
quoti ent</w>
pre implantation</w>
shut tle</w>
c M</w>
1, 7
metatar sal</w>
T SA</w>
Vacc ine</w>
Fo rest</w>
artic ulation</w>
contex t-
Ur ban</w>
o oph
en tive</w>
cardi o-
kain ate</w>
n es</w>
C 8</w>
m W</w>
leiomy oma</w>
Seas onal</w>
i. m.</w>
Jo hn
H eli
colum nar</w>
Sc i</w>
stress- related</w>
pa yments</w>
chol este
E US-
2 61</w>
parallel -
compu ters</w>
an ate</w>
B ost
IC P-
semin iferous</w>
disrup tive</w>
Mel atonin</w>
aqu educ
c- Fos</w>
Wil li
litter mates</w>
si lox
m old</w>
ri vers</w>
ann ul
propan ol</w>
n NOS</w>
W i
su ite</w>
pro myelocytic</w>
phyl ogenetically</w>
sporo zo
war d
inclin ation</w>
L os</w>
2 33</w>
scal e-
proto plasts</w>
transf ec
M eg
bur ied</w>
h um</w>
as ka</w>
sil denafil</w>
ke to</w>
occa sion</w>
B om
gr ac
amal gam</w>
ol -1
u an</w>
mal nourished</w>
novel ty</w>
post surgical</w>
LN CaP</w>
Epig en
thyl ak
FE V</w>
1. 50</w>
radi osensitivity</w>
quar tz</w>
Forty- two</w>
tetram er</w>
2 37</w>
peri stal
him bine</w>
Infra red</w>
stre am
alpha- D-
E osin
inten sively</w>
Epid ermal</w>
re generate</w>
dist res
Gi ardia</w>
coord inating</w>
Li po
non selective</w>
ful fill</w>
immunoprecip itated</w>
colo strum</w>
sol di
administr ations</w>
Mor ris</w>
osteocl ast
thir teen</w>
enzym ic</w>
S t</w>
p ou
M BC</w>
sulfon yl
ab used</w>
anes ulf
min ated</w>
g 1</w>
H az
2 98</w>
ca pro
infarc tions</w>
Aer omonas</w>
cap tive</w>
low- molecular-weight</w>
CT D</w>
lor dosis</w>
Ser ies</w>
Aberr ant</w>
phosph ot
Bal ance</w>
gl abr
Resi dual</w>
steroid ogenic</w>
ph acoemulsification</w>
fluor inated</w>
C PT
l pr</w>
Rev ision</w>
dis course</w>
electro physiology</w>
to- date</w>
cor ner
bio assays</w>
ota xime</w>
en ing
is otype</w>
g e-
Spectr al</w>
redund ancy</w>
rec alc
allodyn ia</w>
ceftazidi me</w>
bo ost
Agre ement</w>
ten sions</w>
physi o
not omy</w>
lo dipine</w>
assi gn</w>
Org anis
5 0.0</w>
Ab sorption</w>
o yl</w>
3 00-
s ay</w>
.00 3</w>
vox el</w>
diffusi vity</w>
Path ways</w>
O SAS</w>
nanoro ds</w>
50 s</w>
sub lingual</w>
CM V-
acc ru
transfer ring</w>
ym ph
Minim al</w>
util ised</w>
biom aterial</w>
pon der
erythropoie sis</w>
circum flex</w>
e ters</w>
hype remia</w>
perox ynitr
afford able</w>
A EDs</w>
non union</w>
T MP</w>
P ep
cytochal asin</w>
Al l-
rec alled</w>
L ess
men arche</w>
beta 3</w>
convinc ing</w>
e ders</w>
D DP</w>
cl oth
Penic illium</w>
tod d
non- human</w>
CH 2
2 44</w>
disc er
glucose- 6-phosphate</w>
inter im</w>
epti form</w>
pancre atectomy</w>
SD H</w>
break point</w>
ultrac entrifug
vir gin</w>
recip itation</w>
mening eal</w>
k d</w>
tent atively</w>
2 1.3</w>
quin ones</w>
ato hepatitis</w>
ob acillus</w>
man no
4- methyl
placent as</w>
ab ulary</w>
lymph oblastoid</w>
2 41</w>
pl otted</w>
Specific ity</w>
Hsp 90</w>
endoscop ically</w>
si le</w>
aug ments</w>
met all
pal pation</w>
cure ttage</w>
o to</w>
MC L</w>
earth qu
Radi ological</w>
oro usly</w>
es onide</w>
pre determined</w>
Recei ver</w>
end- systolic</w>
oscill ator</w>
glycosamin oglycan</w>
I 1</w>
Arc tic</w>
osahexa enoic</w>
ad her
sub retinal</w>
go al-
NH 3</w>
fac ul
Leng th</w>
S or
assum es</w>
g oblet</w>
SI K</w>
naphthal ene</w>
R A-
end ang
Meas ure</w>
wh it
sc ribed</w>
rop ic</w>
A H
N SE</w>
Con version</w>
in compatibility</w>
strat a</w>
advoc acy</w>
s ins</w>
ran i
casp ases</w>
C U</w>
lo zin</w>
15. 9</w>
orh inal</w>
stil b
1. 56</w>
AD T</w>
Contr ibution</w>
Mechanis tically</w>
muscul ature</w>
in- situ</w>
anox ia</w>
adel ph
b pm</w>
R S-
phen idate</w>
SM I</w>
Sem i-
issu ed</w>
CS P</w>
ju n</w>
calcium- dependent</w>
ger m-
T1 DM</w>
Beh ç
ar ic</w>
ell a-
administrat ors</w>
in activate</w>
Resear chers</w>
Coryne bacterium</w>
F ram
Pre ventive</w>
spous es</w>
1. 44</w>
edent ulous</w>
C ef
O pen
brom ocriptine</w>
Dem on
Par as
in gens</w>
An .</w>
allo -
multin ucle
neurolog y</w>
ESI- MS</w>
F LI
e igen
pal mitic</w>
sulf ur
Th al
Eth ics</w>
landscap es</w>
bath ing</w>
3T3- L1</w>
DE -
P orph
TK I</w>
hom osexual</w>
18 S</w>
lev el
andro gen-
hi m</w>
mis leading</w>
intra thoracic</w>
small- molecule</w>
Contr ast</w>
B H</w>
scop olamine</w>
Car bo
Rou x-
ent orhinal</w>
0.0 29</w>
g ents</w>
S ex
bo otstr
propos als</w>
ester ases</w>
glucone ogenesis</w>
imp acting</w>
ampl ing</w>
anteri or-
inter view
radi ologically</w>
V al-
occup ying</w>
entr al</w>
1. 41</w>
c Gy</w>
ri d</w>
dis infec
sil enced</w>
un defined</w>
AP I</w>
Re actions</w>
R SD</w>
in operable</w>
im olar</w>
lec ithin</w>
AP L</w>
Surve ys</w>
forc eps</w>
citi zens</w>
dec iding</w>
Lym ph</w>
ic ola</w>
mal adaptive</w>
Pre clinical</w>
stoichi ometric</w>
nost osis</w>
neur ites</w>
pediatr icians</w>
IN H</w>
Practi cal</w>
tetradec ano
P R-
Cor tico
phen e</w>
T MA</w>
vitil igo</w>
PL S</w>
biom imetic</w>
Behç et</w>
19 70s</w>
Con sumption</w>
hypo perfusion</w>
rever ses</w>
Col or</w>
Lew y</w>
ar ticul
IM POR
phot ocoagulation</w>
S MS</w>
W G</w>
GnR H-
H .
restric ting</w>
align ments</w>
Perc eption</w>
Gene tics</w>
b outs</w>
sh ire</w>
Diff use</w>
F und
f ting</w>
H ippocamp
Q D</w>
nanot echn
cha otic</w>
MP V</w>
IMPOR TA
osin usitis</w>
cartil aginous</w>
obi ology</w>
phot oc
mark eted</w>
Ox ide</w>
long- lived</w>
deci sive</w>
heli x-
C Ps</w>
Le uc
pe l</w>
hem agglutination</w>
gr atings</w>
physi co-chemical</w>
gli osis</w>
w .</w>
Er ro
mode stly</w>
paran asal</w>
concer ted</w>
haem olytic</w>
CD 2</w>
Observ ation</w>
asparag ine</w>
fum arate</w>
overestim ated</w>
carbap enem
thyrotrop in</w>
2, 2-
homocy ste
Glc NA
tum or
SP C</w>
fundam entally</w>
Pro ducts</w>
per fr
L FA
le ar</w>
mat ters</w>
aff e
mag lob
cataly sed</w>
R en
Echocardi ography</w>
r uc
1. 55</w>
rot ated</w>
mol-ec ule</w>
bom b
ur ve
ocat alytic</w>
non- obese</w>
Larg e-
Ch lo
em py
atin -
can opy</w>
sl aughter</w>
Simult aneously</w>
Aneur ys
pre valences</w>
intra vesical</w>
PD R</w>
Streng th</w>
2 500</w>
18 ,
s oma</w>
p c
T 0</w>
CD 56</w>
discrimin atory</w>
roc k</w>
amphib ian</w>
a 2</w>
9 3
Ex tra
2 63</w>
dosi metric</w>
clau dication</w>
K aw
av al
epsil on-
neutr alized</w>
ophysi ological</w>
J i
li ps</w>
post graduate</w>
cav itation</w>
De pl
organis ations</w>
intr atr
CH B</w>
LA K</w>
intim a</w>
En d-
nip ple</w>
RA NT
rhabdomy osarcoma</w>
enthal py</w>
biop sy-
clim bing</w>
DQ B1</w>
B owel</w>
collag en-
trade- off</w>
patient- centered</w>
protr usion</w>
e ze</w>
Im mediately</w>
chro tron</w>
p K</w>
t -1</w>
sal ping
- .
Inj uries</w>
metallothione in</w>
G AP</w>
rhiz osphere</w>
A bl
odynam ically</w>
miR- 21</w>
post- intervention</w>
3, 3</w>
GI ST</w>
inter costal</w>
rem if
or ib
M ari
1. 4-
core- shell</w>
C p</w>
Ex tended</w>
DM N</w>
Mob ile</w>
osup pression</w>
inten sification</w>
b ach
PAC AP</w>
AD Rs</w>
l ement</w>
NT s</w>
con val
C el
C CD</w>
multi component</w>
H ipp
90- day</w>
mit ogens</w>
edi tion</w>
toxic osis</w>
Star ting</w>
proto- oncogene</w>
er -induced</w>
regres sed</w>
E K</w>
ta vid
H ind
1. 48</w>
sti r
spac e-
pre mat
ster ility</w>
manifest s</w>
RANT ES</w>
ca dic</w>
F OR
R e</w>
O mp
re positioning</w>
man ometry</w>
pren atally</w>
cohe sion</w>
MD s</w>
Q S</w>
1. 47</w>
N i-
Suppl ementation</w>
1. 46</w>
mono valent</w>
P ai
dis sections</w>
AT RA</w>
foot ball</w>
A NA</w>
neuro pathological</w>
17. 8</w>
HCO 3-</w>
le ach
rel ying</w>
sol vation</w>
vacu ole</w>
Ps ori
com positional</w>
thorac olumbar</w>
2 1.5</w>
T olerance</w>
O ry
z ip
Ap gar</w>
side- chain</w>
Per spective</w>
th emia</w>
TA VI</w>
Con f
ML R</w>
GLUT 4</w>
satis factor
cap ita</w>
propag ating</w>
in ning</w>
Metast asis</w>
Consider able</w>
phot oluminescence</w>
Mac aca</w>
fav ors</w>
Phil adelph
P PS</w>
bl ank</w>
tain able</w>
T ro
st ands</w>
aspec ific</w>
isot op
pyl ori
plethys mography</w>
bin omial</w>
cry o-
tri vial</w>
ds RNA</w>
aggra vated</w>
vi bri
1, 5-
NK T</w>
Ox idation</w>
con serving</w>
PD MS</w>
carbox yp
ph entolamine</w>
A 9</w>
cys tine</w>
ventro medial</w>
A r</w>
1.0 2-
S et
uro dynamic</w>
AC -
sup pressors</w>
Elig ible</w>
Uter ine</w>
ur chin</w>
toler able</w>
un available</w>
F ru
un trained</w>
preced e</w>
Off ice</w>
thym oma</w>
must ard</w>
exc i
thi op
teen agers</w>
2 1.1</w>
passi vely</w>
obliter ation</w>
0.0 36</w>
Mar kers</w>
L MP
E SI</w>
F UN
M CP</w>
ver tically</w>
blo c</w>
inc entive</w>
PG A</w>
Com plexes</w>
LA SIK</w>
peri or</w>
us et
Cyto chrome</w>
chel ator</w>
Fib rosis</w>
septic emia</w>
n ations</w>
p ubic</w>
ph aryng
cal ories</w>
Particip ation</w>
ap entin</w>
institu ted</w>
av al</w>
suppl ying</w>
aver sion</w>
volu tional</w>
substrat e-
EXP ERI
bodi ly</w>
Bost on</w>
at oxin</w>
re visions</w>
Val idity</w>
exhaus tive</w>
A RE
th inner</w>
mo ves</w>
Cz ech</w>
G DNF</w>
acyl transferase</w>
Ch E</w>
gu est</w>
at opy</w>
I PC</w>
poly urethane</w>
hyn chus</w>
S MR</w>
par adox</w>
gl os
n omenclature</w>
ello femoral</w>
Burkit t</w>
E TS</w>
AN ES</w>
computer- aided</w>
AM -
PI C</w>
angi ograms</w>
40 5</w>
Controll ing</w>
satisfactor ily</w>
in ulin</w>
phen olate</w>
F ish</w>
Immun ological</w>
-1 20</w>
chem o-
neur itis</w>
CRISP R-
2 7.5</w>
up per-
ant oin</w>
ofib rate</w>
later alis</w>
fruct ose-
on ite</w>
20 ,000</w>
fem oro
Ep o</w>
S ystolic</w>
W R</w>
conjunctiv a</w>
amin obenz
IMPORTA NCE</w>
mal absorption</w>
tur key</w>
prop yl-
thrombo plastin</w>
philosoph y</w>
bot tle</w>
priv ileg
In jec
Alg orith
pur ulent</w>
anter ograde</w>
Contr ib
kn ife</w>
P 6</w>
Str ong
do ors</w>
wit nessed</w>
metamorph osis</w>
hypo plastic</w>
su turing</w>
17. 3</w>
In activation</w>
19 6
Gre en
broncho constriction</w>
T CC</w>
ton ian</w>
pheny ls</w>
py ogenes</w>
TB ARS</w>
Nic oti
Al ong</w>
o a</w>
y n</w>
Phy s</w>
scre en
19. 4</w>
tri azole</w>
disease- related</w>
Isl ands</w>
inter genic</w>
CP C</w>
s n-
Nur se</w>
acros ome</w>
sens ations</w>
V WF</w>
W el
ec top
Po oled</w>
Squ amous</w>
SI R</w>
inqu iry</w>
GPC Rs</w>
ch oc
1. 54</w>
B i</w>
bi oc
post transplant</w>
PC V</w>
histopath ologically</w>
F 1-
organ ize</w>
Aff airs</w>
inhe rently</w>
Determin ing</w>
investig ator</w>
preser v
30 6</w>
Sep sis</w>
Cul tured</w>
ne ocortical</w>
atr an</w>
Gol d
mTOR C1</w>
I R-
2 49</w>
ig ence</w>
D CA</w>
pom be</w>
- cyclic</w>
org hum</w>
pen sion</w>
Con ference</w>
2 71</w>
lab el-free</w>
oglut arate</w>
E GFP</w>
expan ds</w>
Mal aw
od en
Al ber
M IN
bre ad
inter ing</w>
var us</w>
vinbl astine</w>
O v
fel low</w>
St res
D MAR
200 9-
is tin</w>
two- year</w>
intern alizing</w>
piezo electric</w>
broad ening</w>
ap noea</w>
cor ti
Trans forming</w>
Hol ter</w>
anc iclovir</w>
fl ank</w>
tumorig enicity</w>
sulfameth oxazole</w>
mal occlusion</w>
nur se-
30 9</w>
Her pes</w>
Uniqu e</w>
Dend ritic</w>
yl on</w>
Di vision</w>
Per itoneal</w>
I x
parv um</w>
ur ing
17. 1</w>
compart mental</w>
1. 65</w>
Du al-
oc ked</w>
parti te</w>
co variate</w>
N- ethyl
AF 1</w>
achiev ements</w>
X anth
16. 8</w>
wavel et</w>
F TD</w>
E U
60 s</w>
volu me-
f ats</w>
V enti
ocycl ine</w>
an ian</w>
Enzym atic</w>
refuge es</w>
el min
In sec
ster notomy</w>
Electro chemical</w>
Enter obacter</w>
ost elium</w>
ri ol</w>
ge ts</w>
bar bit
telev ision</w>
vers ati
Ec topic</w>
hear t
Uni versal</w>
U se
di ous</w>
ex pres
bl ad
reli eving</w>
anter olateral</w>
K ing</w>
E ti
mat ured</w>
β- cell</w>
on- based</w>
Chang ing</w>
disper sions</w>
prot amine</w>
Profes sional</w>
acet am</w>
bu terol</w>
ga g</w>
oint ment</w>
radi ographically</w>
profes sions</w>
retin oids</w>
relax ing</w>
ultra thin</w>
p ill</w>
bi ogenic</w>
fl utter</w>
cell-to- cell</w>
sum mation</w>
O CT
re wards</w>
ex ogenously</w>
E TH
controver sies</w>
pseud om
sphingomyel in</w>
p ine
sal va</w>
lif lozin</w>
t- related</w>
bio char</w>
pro tracted</w>
mono oxygenase</w>
Buil ding</w>
corne um</w>
IM A</w>
0.0 45</w>
administr ated</w>
G e</w>
abol ish</w>
cat abol
thyro id-
disp osable</w>
box es</w>
OR R</w>
B il
ob a</w>
pr ison</w>
Infarc tion</w>
di p
Y el
gl ibenclamide</w>
T AT
I ON</w>
W O
1, 8
inv aded</w>
deuter ium</w>
CTLA- 4</w>
A udi
Struc tured</w>
os amine</w>
ach uset
diam ond</w>
it ted</w>
pro active</w>
cross- reactive</w>
miR- 3
renew ed</w>
TC GA</w>
tezom ib</w>
S 1
d P</w>
gastro stomy</w>
2 57</w>
0.0 32</w>
ns 0</w>
angi ogram</w>
Anti gen</w>
8 th</w>
m ex
parapl egia</w>
chloro -
two- hybrid</w>
ur anium</w>
inc ial</w>
single- strand</w>
nanoc arri
cere al</w>
phospho protein</w>
Auto immune</w>
ac ar
minim ization</w>
tic k-
se ated</w>
vec tor-
dilu tions</w>
2 73</w>
transep ithelial</w>
ref used</w>
Cost s</w>
B 7</w>
home ob
wr ong</w>
SHB G</w>
K -1</w>
fasc icul
Mass achuset
hypogon adism</w>
ad or</w>
p ockets</w>
18 F</w>
Al tman</w>
C itr
H p</w>
3 15</w>
bronchi ectasis</w>
thermophil us</w>
v ign
intr as
thym ine</w>
un intended</w>
ow ners</w>
IP 3</w>
adju stable</w>
MD R1</w>
l ing
AR E</w>
HP C</w>
past ure</w>
loc alizes</w>
Pro fil
stradi ol</w>
rom e</w>
Ultrason ography</w>
immuno chemical</w>
pericardi tis</w>
2 62</w>
car trid
rec ession</w>
co arctation</w>
single- molecule</w>
epig astric</w>
Pa CO2</w>
Conserv ative</w>
chel ation</w>
expos e</w>
lit azone</w>
chlor promazine</w>
pil ocar
MD P</w>
lamin ae</w>
A chi
al falfa</w>
di butyr
drug- related</w>
Lymph oma</w>
E FS</w>
shor ten</w>
hex adec
hydro static</w>
Su icide</w>
amoun ted</w>
intern ationally</w>
1. 49</w>
12 10</w>
ester ification</w>
Dist al</w>
tin ine</w>
verm ectin</w>
ME M</w>
phag ocyt
perfr ingens</w>
juven iles</w>
V alley</w>
N SS</w>
or d</w>
str ipping</w>
sto ols</w>
satell ites</w>
reticul ocyte</w>
-1, 2-
un protected</w>
ocor tin</w>
os ting</w>
cl ick</w>
extern alizing</w>
2 88</w>
carbo hydrate-
r ine-
permeabil ized</w>
estim ator</w>
E I
ant -negative</w>
dos e-</w>
sensiti zing</w>
sa ved</w>
pecul i
exam eth
SB RT</w>
AG Es</w>
itu itary</w>
chori o
hyper uric
S AT</w>
econ omics</w>
ab users</w>
he at
opon tin</w>
Feder ation</w>
2 53</w>
virtu e</w>
mini atur
40 L</w>
19. 2</w>
sk inf
GM P-
Anat omical</w>
14. 0</w>
PO -
ende av
y fish</w>
d n
6- week</w>
50 8</w>
opr amide</w>
T UR
tri angular</w>
MD CT</w>
FK 506</w>
Abnormal ities</w>
Massachuset ts</w>
under stand
MV PA</w>
r ust</w>
Acc ept
al asia</w>
melan ocytic</w>
epil eptiform</w>
mic elle</w>
pericardi um</w>
Wh o</w>
pyro lysis</w>
synthesi sed</w>
de ath
Dicty ostelium</w>
aqu ap
m ated</w>
comp action</w>
E T-
ad y</w>
Ble eding</w>
mas ticatory</w>
echocardi ogram</w>
cyto chromes</w>
Bet a</w>
neutrop enic</w>
phot ography</w>
docum enting</w>
resear cher</w>
TRPV 1</w>
Emp ir
b id
2 1st</w>
br an</w>
resi stive</w>
Attemp ts</w>
Typh imurium</w>
- 8
H arr
MD MA</w>
ometr ics</w>
2 72</w>
fe red</w>
A J
wa king</w>
Viv o</w>
P SII</w>
tumor- specific</w>
ul inic</w>
T Fs</w>
electro poration</w>
maneu vers</w>
L ine</w>
ath ymic</w>
at ever</w>
stret ched</w>
III B</w>
coumar in</w>
deter gents</w>
multi forme</w>
Electroph ore
E r</w>
NA T</w>
gon ads</w>
ses qu
k V</w>
anc erous</w>
curren t-
Adap tation</w>
resist ances</w>
II IA</w>
lin ic</w>
Minim ally</w>
ul ovirus</w>
inev itable</w>
irin otecan</w>
a j
hem opoietic</w>
penic ill
clinic o-
Hierarch ical</w>
Font an</w>
versati lity</w>
2 3.1</w>
yog a</w>
Z P</w>
olig omer</w>
clear ing</w>
mol es</w>
C ase-
D ex
hom os
CO LL
B ud
&# 124
function alities</w>
&#124 ;</w>
Bi ology</w>
osmol arity</w>
F AP</w>
G ab
S an
B O</w>
ero sive</w>
3 11</w>
G ar
de dness</w>
con e-
child bearing</w>
SP S</w>
enter itis</w>
non toxic</w>
ultraf ast</w>
new s</w>
Inf ected</w>
Lang mu
r an</w>
tr ies</w>
Par k</w>
hepat obiliary</w>
sp ora</w>
High- resolution</w>
disc ern
P PAR</w>
S OS</w>
athi one-
necess itates</w>
Non invasive</w>
S till</w>
17. 9</w>
im pressive</w>
keratin s</w>
Educ ational</w>
-14 C</w>
pur ple</w>
Lim itations</w>
0.0 31</w>
gar lic</w>
lign ocellul
or -1</w>
con idia</w>
Re fl
fe eds</w>
200 8-
May o</w>
G ross</w>
ste ep</w>
hydro peroxide</w>
anc illary</w>
rac em
low- affinity</w>
in ol</w>
18. 6</w>
myofibro blasts</w>
nig er</w>
ne ovascular</w>
AT L</w>
vol vulus</w>
six teen</w>
recommend s</w>
p en</w>
R UN
eth oxy
SY 5Y</w>
16. 9</w>
ACh Rs</w>
19 71</w>
non responders</w>
Don or</w>
0.0 37</w>
tend encies</w>
se aling</w>
ce ased</w>
S PO
p t
ic ing</w>
sw im</w>
C ross</w>
en etetra
RE E</w>
andro genic</w>
parall els</w>
spectr in</w>
thi o</w>
r as
B m
Ad ding</w>
TK Is</w>
Di ver
per ip
inst all
ocl opramide</w>
ha y</w>
E W
duc k</w>
p end
aqu at</w>
Sp ir
youn gest</w>
2 3.3</w>
agre ements</w>
apo B</w>
CH C</w>
real- life</w>
viro logic</w>
al arm</w>
are r</w>
follicle- stimulating</w>
s ong</w>
ome dial</w>
ar is
but yric</w>
diver si
al ex
PP P</w>
chromatography- tandem</w>
a o</w>
Wh ilst</w>
periodic ity</w>
O V</w>
SU V</w>
electro retin
chemopre ventive</w>
asymmetr ies</w>
on ism</w>
PE F</w>
mas cul
C5 a</w>
od ystrophy</w>
hir su
G EN
Struc tures</w>
ch able</w>
A 2-
ud in</w>
L H
Gam ma</w>
P el
othre itol</w>
or chi
st ar</w>
ol gus</w>
G RA
vir idae</w>
stitu ted</w>
scler otherapy</w>
dis advantaged</w>
ER α</w>
mill is
ure teric</w>
plas mid-
dres sings</w>
Adequ ate</w>
Me V</w>
fro gs</w>
E SC</w>
Oc ean</w>
gros sly</w>
ri v
hin der</w>
CCl 4</w>
linol enic</w>
t RNAs</w>
A SCs</w>
famil y-
Puer to</w>
ab sol
occur rences</w>
for th</w>
T EN
uni directional</w>
ubiquit ously</w>
opol ysaccharide</w>
11 1
Check list</w>
PCR- based</w>
N OR</w>
abund antly</w>
at e-</w>
APAC HE</w>
par a</w>
iz z
ste atohepatitis</w>
TA VR</w>
4 S</w>
lu tide</w>
charg ing</w>
peri apical</w>
M ec
erg ometer</w>
plas ties</w>
P g
nano structured</w>
sudden ly</w>
cross- talk</w>
t les</w>
in breeding</w>
end ogenously</w>
trimethop rim</w>
Subst antial</w>
lo s</w>
1. 52</w>
on- site</w>
Melan oma</w>
B atter
colli sions</w>
J .
mass -
Li pos
Pro ton</w>
200 5-
enteroc occi</w>
Tum our</w>
L eptin</w>
NA s</w>
emin ence</w>
Ver o</w>
0.0 38</w>
equ imolar</w>
DE P</w>
depress ant</w>
S As</w>
r ons</w>
lon eliness</w>
intracerebro ventricular</w>
tel em
troph oblastic</w>
ch ord
cef otaxime</w>
FGF- 2</w>
Aut ologous</w>
Tox ic
antigen icity</w>
PR S</w>
enteroc olitis</w>
conn ex
kerat oconus</w>
endor sed</w>
Through out</w>
assembl ages</w>
t ang
micro vessel</w>
E OC</w>
ron utri
rifamp in</w>
ab ies</w>
precip itating</w>
disc ectomy</w>
Sequ ences</w>
spec ts</w>
agon istic</w>
scin til
t at
0.0 34</w>
muc o
vibr ations</w>
Wil son</w>
byst ander</w>
organ ophosph
3 β</w>
half- maximal</w>
assembl ing</w>
Cryp tococcus</w>
ten sion-
Mend elian</w>
R oles</w>
um ps</w>
2 67</w>
G la
Pro duc
be ings</w>
phorb ol-1
aneu ploid</w>
oci ous</w>
fam ide</w>
microm eter</w>
bl ur
rip tyline</w>
tob ramycin</w>
18. 3</w>
lax ity</w>
ren e-
SP T</w>
R -</w>
S ource</w>
We e
un acceptable</w>
hy aline</w>
occupati ons</w>
a kers</w>
AC D</w>
C- 2</w>
agend a</w>
P PAR-
3 42</w>
corpor a</w>
Mut ant</w>
AM A</w>
et an
co de
Cy clos
leaf lets</w>
un detected</w>
CH S</w>
strep tavid
de ad
Fung al</w>
1. 53</w>
normo xic</w>
In fusion</w>
t RNA
Su stained</w>
extrapol ation</w>
en one</w>
resi des</w>
isothi ocyanate</w>
HIV-1- infected</w>
7 20</w>
nucle ophilic</w>
18. 4</w>
200 7-
Def ects</w>
Compon ent</w>
nanoshe ets</w>
z idovudine</w>
incub ating</w>
oviduc t</w>
Out patient</w>
fill er</w>
glauc omatous</w>
allevi ating</w>
2,3- di
coerul eus</w>
FUN DING</w>
artem is
4 E</w>
hystere sis</w>
telangi ectasia</w>
mut h</w>
th uring
Pers ons</w>
plu g</w>
hematoxyl in</w>
inv ag
p ads</w>
4 32</w>
ver y-
practi c</w>
ynchron ization</w>
rel ay</w>
intram uscul
Palli ative</w>
Estim ated</w>
Hormon e</w>
pall adium</w>
atell ite</w>
TH -
Sensi tive</w>
ameli oration</w>
AZ T</w>
amb ulation</w>
MCA O</w>
S O2</w>
2 85</w>
cl ipping</w>
continu ous-
CYP 1A1</w>
mening itidis</w>
se aled</w>
gall stone</w>
narrati ves</w>
T .
obstetr ics</w>
A UC
ovari ectomy</w>
n AChR</w>
dy nor
A ph
for tified</w>
cycl o-
phal an</w>
oz ol
2 0.8</w>
R 0</w>
Bioin formatics</w>
Govern ment</w>
nich es</w>
L CA</w>
us en</w>
On set</w>
recru its</w>
19. 6</w>
Polym er</w>
MD CK</w>
hydrol ases</w>
P SD</w>
Perin atal</w>
im eter</w>
two- way</w>
my o-
overl apped</w>
peren nial</w>
classi fiers</w>
Par allel</w>
PI s</w>
OR F
str ain
Dru g-
Ri o</w>
2 7.3</w>
h l
M U</w>
um -</w>
Ox ford</w>
ero sions</w>
L ep
pro ves</w>
pup ils</w>
ec tic</w>
metab otropic</w>
diff us
centrifug al</w>
B est</w>
Min or</w>
c iliated</w>
stere oselective</w>
PV C</w>
16. 0</w>
pursu ed</w>
pre formed</w>
OR T</w>
dissec ting</w>
constitu ting</w>
aur a</w>
er ism</w>
miR -19
deci ph
b out</w>
dop amine-
5- 7</w>
mesoth elial</w>
Ad -
Comm erc
know ing</w>
aspir ate</w>
school -based</w>
Ab solute</w>
Ara b</w>
P U</w>
neighbo ur
th ings</w>
cap ped</w>
bat ches</w>
1. 00
micro liter</w>
po ro
ocyt openia</w>
empir ic</w>
reg rowth</w>
primor dial</w>
H ym
an am
om as
met am
solv ent-
SB s</w>
Thirty- eight</w>
ul ators</w>
ta -
3 8.5</w>
pal mar</w>
6-OHD A</w>
x i</w>
Haw ai
DM F</w>
m PFC</w>
2 76</w>
ti ma-
od al
reser ves</w>
end onucle
my corrhizal</w>
un ve
tex ts</w>
phosph oglyc
Per spectives</w>
bruc ellosis</w>
18 0
urg ical</w>
ma y
fem oris</w>
vide ot
ide ally</w>
bic uc
CD H</w>
PA L</w>
astrocyt omas</w>
clinical trials.gov</w>
ten e</w>
flav in</w>
C ot
Ad sorption</w>
V TA</w>
tour niqu
hs- CRP</w>
eth i
bio inform
tonsill ectomy</w>
S ib
cont ag
ine- containing</w>
acul ture</w>
tram adol</w>
Pag et</w>
s way</w>
9 80
not eworthy</w>
peptid yl</w>
Con sist
A spir
MR s</w>
legi tim
G CT</w>
anti angiogenic</w>
ab -
C ann
C W</w>
em oral</w>
inst ar</w>
19 66</w>
A stro
fi tinib</w>
calc it
Typ ical</w>
Fri ed
T able</w>
I MP</w>
all yl</w>
AT R</w>
al- induced</w>
vascular isation</w>
neighbo uring</w>
T un
R P-
Electro physiological</w>
oblig atory</w>
de polarized</w>
entan il</w>
Exc essive</w>
Cong o</w>
Hy al
cach exia</w>
C CA
As n</w>
p ons</w>
elev ate</w>
omy ositis</w>
Opi oid</w>
co exist</w>
ultracentrifug ation</w>
p asses</w>
di oxin</w>
3 93</w>
lap s</w>
HIV- negative</w>
Gu ided</w>
f ight</w>
inv ade</w>
Micro scopy</w>
aver ages</w>
cyan o
deser ves</w>
fluoro scopic</w>
commens al</w>
2 95</w>
PD I</w>
ind ole-
kinet och
col ors</w>
dig its</w>
immun isation</w>
MV C</w>
Mechanis tic</w>
B lin
enke phal
C lear
ple ura</w>
hemat omas</w>
Alph a</w>
S cler
Resi dents</w>
sphing osine</w>
HTL V-1</w>
A e.</w>
as matic</w>
bi phenyls</w>
intramuscul arly</w>
lam ivudine</w>
mel t</w>
Wa als</w>
Roux- en-
W E</w>
L 1-
k ins</w>
PC -3</w>
dehydro epiandrosterone</w>
domin ant-negative</w>
S m</w>
T AT</w>
uc k</w>
2, 0
Cycl o
exempl ified</w>
tri am
Mach ine</w>
Sub cutaneous</w>
s lip</w>
ap enta
tubercul in</w>
X PS</w>
mamm ographic</w>
AN C</w>
gonadotroph in</w>
rat ers</w>
petro leum</w>
L an
y- 1</w>
Ob ese</w>
l one</w>
sub luxation</w>
t- based</w>
decompens ated</w>
2 59</w>
yo himbine</w>
cy nom
Brit ain</w>
me sial</w>
An th
pul mon
gre l</w>
R- TB</w>
benth ic</w>
nucle oli</w>
ase- negative</w>
granul omatosis</w>
tan k</w>
tric eps</w>
E PCs</w>
Isol ates</w>
epox y</w>
myri sto
b os
c- erb
inf ested</w>
1- phosphate</w>
appreci ably</w>
cholangi opancre
E ur
ath ic</w>
pa ste
e sional</w>
sacrific e</w>
archa eal</w>
4 6-
for ty</w>
inter -</w>
wor n</w>
circ RNAs</w>
relax ations</w>
dis similar</w>
T etr
wheel chair</w>
cuti cle</w>
ne sts</w>
Ar tem
L up
aut ophosphorylation</w>
PA 1</w>
2 6.7</w>
beet le</w>
n .
k ening</w>
1. 58</w>
Se iz
consul ted</w>
ooph o
4 3.
empy ema</w>
on ych
pos itory</w>
distor tions</w>
s els</w>
2 4.5</w>
17. 7</w>
B 6
os sy
1. 51</w>
otox ic
se tron</w>
Krusk al-
ser osal</w>
Anes thesia</w>
rs 10
conve x</w>
Com position</w>
Up date</w>
Y AP</w>
alpha- helical</w>
arox aban</w>
D exameth
medi ate-
det ached</w>
CM E</w>
up- to-date</w>
thuring iensis</w>
Syn ech
adip ogenesis</w>
Alph a-
recur ring</w>
VO Cs</w>
gil ts</w>
2 74</w>
avid ity</w>
H 5</w>
antagon ize</w>
tetr afluoro
il ic</w>
-1 8
parag angli
B CI</w>
Al ex
trunc ation</w>
rhin osinusitis</w>
nois y</w>
quin idine</w>
TA G</w>
un reliable</w>
ke V</w>
pre molars</w>
c- kit</w>
Epigen etic</w>
N .
co expression</w>
arg in</w>
Ver sion</w>
ri tical</w>
beta- glucuronidase</w>
peri kary
G PS</w>
0.0 33</w>
di bular</w>
7 1.4</w>
cre ative</w>
bis phosphonates</w>
cot yled
D NP</w>
af ter-
Ps A</w>
Ju ven
MEN TAL</w>
l ice</w>
il o
acr idine</w>
Prote in-
8- week</w>
ation- specific</w>
Here ditary</w>
P2 X
Bioch em</w>
affor ds</w>
S H2</w>
en v</w>
anti apoptotic</w>
ant o
hypno tic</w>
C igaret
prog est
ather ogenesis</w>
30 7</w>
Rel ap
im mobility</w>
Pot enti
O k
V K
ter ro
X L</w>
ac k-
P c</w>
re dness</w>
qu is
Gly co
N ow</w>
St abil
en forcement</w>
1,2- di
effec ted</w>
redox in</w>
dihydro testosterone</w>
C GH</w>
os tin</w>
he ur
8 5.7</w>
odi a</w>
T al
un reported</w>
AL D
offic in
5 00-
anti cholinergic</w>
in- stimulated</w>
TT R</w>
ne ts</w>
whe el</w>
dimin ishes</w>
purch ase</w>
E uc
de fer
est u
approxim ated</w>
NH2- terminal</w>
st ories</w>
fat alities</w>
compan ion</w>
S ed
3 9.
Reg ular</w>
quality- of-life</w>
I le</w>
ne eding</w>
hypoxia- induced</w>
Müll er</w>
sper mati
M ir
CL S</w>
recombin ants</w>
Z h
vast us</w>
sol it
pris on
Aqu eous</w>
tetrach loro
Val salva</w>
Effici ency</w>
st ut
two- photon</w>
intenti on-
Depl etion</w>
per oxidase-
EC C</w>
N W</w>
Percep tions</w>
mosa icism</w>
des min</w>
pol is</w>
CR PC</w>
Struc ture-
G ib
nucle ocap
Nicoti ana</w>
S pr
tr iterpen
Ill ness</w>
disul ph
laun ched</w>
Ch arg
spati o-temporal</w>
obarbit uric</w>
op t
nas oph
hypertriglyceri demia</w>
al d
extra ordinary</w>
exp ired</w>
per ine
under line</w>
B CR-
Mam malian</w>
phot otherapy</w>
prox en</w>
bet aine</w>
therapeu tical</w>
logarith mic</w>
il in
hyph ae</w>
al ar
quin ine</w>
c idin</w>
leuk openia</w>
1, 1-
ble ph
pyrid inium</w>
F ecal</w>
β- lactam
papill ae</w>
ph le
p 24</w>
8- 10</w>
Cul tures</w>
rewar ding</w>
az ines</w>
40 7</w>
Expl oratory</w>
opac ities</w>
Sp A</w>
musi cal</w>
T b
Web -based</w>
SH- SY5Y</w>
pl aqu
inten sely</w>
incub ations</w>
T uni
etr on</w>
ambul ance</w>
ar ab
X I</w>
ha plo
y ls</w>
U D</w>
el ap
eigh ty-
ap sig
e ut
CH 2</w>
Ag ents</w>
co iling</w>
job s</w>
Concer ning</w>
peroxynitr ite</w>
- 30</w>
ob tur
ME R
erb erine</w>
gonadotrop in-releasing</w>
Sper m</w>
un familiar</w>
retro viruses</w>
cross- validation</w>
Recor ds</w>
plas tic
enol pyruvate</w>
8 5-
gol d-
monoph y
sec tomy</w>
non- toxic</w>
sta urospor
cyto protective</w>
intra- operative</w>
N-acetyl cysteine</w>
un exposed</w>
Scal es</w>
F ACS</w>
fa una</w>
pack ages</w>
finger prints</w>
T ATA</w>
GR P
g A</w>
carboxyl- terminal</w>
IL I</w>
feat uring</w>
moderate-to- severe</w>
R v
ne o-
ag u
T 8</w>
il e-
fl or
ellul ose</w>
E X</w>
alk yn
C- 3</w>
An der
sin ogen</w>
Kruskal- Wallis</w>
as king</w>
co incidence</w>
semi- quantitative</w>
P PA</w>
fertil izer</w>
B e</w>
in let</w>
Inter leukin</w>
call ing</w>
computer -based</w>
Roux-en- Y</w>
N SCs</w>
T SP
rect angular</w>
2 77</w>
E lim
later alization</w>
Nitro gen</w>
ind ole
cu ts</w>
is ogenic</w>
1- induced</w>
TR P</w>
dimin ution</w>
compl ement
2- methyl
varic ose</w>
arith metic</w>
0.0 48</w>
PS 1</w>
cy r
aryn go
hex yl</w>
L ib
induc tively</w>
oz ygotic</w>
post- stroke</w>
Val ve</w>
um or</w>
un suitable</w>
ure ment</w>
soci al-
valid ating</w>
fuc ose</w>
neuro behavioral</w>
ket oconazole</w>
H NF
predisp osed</w>
amput ations</w>
- alpha</w>
ub ular</w>
N K1</w>
hospit alised</w>
SA C</w>
to thec
eti r
human ized</w>
J ord
om ies</w>
mon ocular</w>
pup illary</w>
1. 57</w>
eng ine</w>
consul tant</w>
L i-
night time</w>
non parametric</w>
impair ing</w>
HCO 3</w>
mal le
D 2-
fluoro quinolones</w>
pter yg
I SI</w>
RE D</w>
visu ospatial</w>
In ser
R af
rup tures</w>
cocul ture</w>
t age</w>
ham string</w>
mor tal
beha ved</w>
K appa</w>
fun do
PU FAs</w>
ph r
hepat ocarcin
cf u</w>
basoph ils</w>
t ently</w>
n ails</w>
ing ham</w>
aut ofluorescence</w>
ss DNA</w>
on ous</w>
weak ened</w>
intestin es</w>
pos tis
h inge</w>
U su
electr icity</w>
consist encies</w>
vacc inations</w>
Gu ill
non- selective</w>
test -
bud esonide</w>
under way</w>
PE -
fur n
Ambul atory</w>
neuro filament</w>
exec uted</w>
autoradi ographic</w>
en ig
rop ivacaine</w>
DR S</w>
clo ac
polysomn ography</w>
am lodipine</w>
rom atic</w>
ion omer</w>
pene trance</w>
ti zing</w>
complic ate</w>
oryz ae</w>
0. 4-
tun g
peripher ally</w>
con son
P NS</w>
br ight
stimul ants</w>
molyb denum</w>
di polar</w>
sal es</w>
immunos tim
s arc
2 6.5</w>
CD 5</w>
infin ite</w>
unc ul
babo ons</w>
Ve si
xenobi otics</w>
E di
entr apped</w>
absol utely</w>
- 4.
F BS</w>
ay a</w>
Hist one</w>
Mar ked</w>
discord ance</w>
H ed
Fi g</w>
biotechn ological</w>
extrapol ated</w>
herbic ides</w>
N oc
og litazone</w>
Anes thesi
F el
n owadays</w>
Q L
peri plasmic</w>
20 12-
quantit ate</w>
transfer ase-
Op portun
RA DS</w>
pac k</w>
at o-
acter ium</w>
but ter
gol d
G PCR</w>
Polymorph isms</w>
pre malignant</w>
HDL- cholesterol</w>
bac ulovirus</w>
so as</w>
frag ilis</w>
once- daily</w>
5 B</w>
Sch ed
recalc itr
c ow
exam s</w>
2 1.7</w>
3 98</w>
li ve-
1.0 3-
ir reversibly</w>
raz ine</w>
fore head</w>
2 1.2</w>
ven ting</w>
histor ic</w>
Philadelph ia</w>
des mo
appl iance</w>
F ig
B 19</w>
am ant
F ur
ici ous</w>
intram ural</w>
COLL ECTION</w>
A ED</w>
osse o
parv ovirus</w>
20 13-
un employment</w>
igen es</w>
Wa ve</w>
CD 4-
genit alia</w>
amylo id
pre test</w>
conf ident</w>
O il</w>
il ization</w>
trop ism</w>
ec oxib</w>
Portu gal</w>
un aware</w>
overwhel ming</w>
V AP</w>
8 4
othor acic</w>
os al
tail oring</w>
spon s
Meth ylation</w>
supra -
v imetric</w>
Cyt otoxicity</w>
Hb A</w>
Liker t</w>
s u</w>
con genit
mat h</w>
Sto kes</w>
illustr ating</w>
refr ig
sp aw
CH 3
lamin ectomy</w>
di op
collag ens</w>
diabet es
F ever</w>
post test</w>
phosph oro
B IS</w>
regul arities</w>
hemangi omas</w>
hypos padias</w>
D ox
floc ks</w>
ylo xy
2 2.7</w>
clar ification</w>
preclud e</w>
spind les</w>
Bal b</w>
in sensitivity</w>
it arian</w>
ob vi
Kaw asaki</w>
CT N
thi o-
vis cer
tibi alis</w>
encephal y</w>
lo tinib</w>
particip atory</w>
Investig ating</w>
hydroxy urea</w>
g anciclovir</w>
hist ogram</w>
Cyto kine</w>
pres cho
se at</w>
antinoc iception</w>
μ -
7 T</w>
E volution
excre tory</w>
2 69</w>
conform al</w>
disrup tions</w>
pall idum</w>
eigh th</w>
ar res
forelim b</w>
3- day</w>
PR F</w>
LFA -1</w>
s onic</w>
2 78</w>
conf used</w>
Men ing
nig ro
Forty- one</w>
tun e</w>
V ul
B am
cor n
non operative</w>
carb amo
contrain dicated</w>
5 1-
tail -
dis agreement</w>
4 60</w>
se af
doc osahexaenoic</w>
di peptide</w>
0.0 46</w>
hype rex
ar tum</w>
investig ational</w>
log 10</w>
Bur k
Morph ology</w>
narco tic</w>
bl ends</w>
fin ished</w>
crystall ized</w>
inter fered</w>
classi cally</w>
pre ponder
HT- 29</w>
repres s</w>
anth elmin
HMG- CoA</w>
U s
no tification</w>
ner i</w>
si li
Res ting</w>
8- OH-
flow ing</w>
co tinine</w>
neuro tensin</w>
HA M</w>
p it</w>
ys tic</w>
light- induced</w>
allop urinol</w>
perfec tly</w>
V HL</w>
con tainment</w>
ag lutide</w>
photo thermal</w>
t actic</w>
ph lo
mis diagnosis</w>
abl ated</w>
T -</w>
A AV
rip tan</w>
hom e-based</w>
satis fy</w>
Enh ancing</w>
perv asive</w>
im pulses</w>
af il
ar ra
op ic
IL-1 5</w>
dis assembly</w>
I r</w>
disease- modifying</w>
dithi othreitol</w>
hyper prolactin
MM P-1</w>
g all</w>
HI AA</w>
sam ine</w>
kil odal
radionuc lides</w>
m ogenic</w>
S ic
ter in</w>
poly phenol</w>
biop olym
B SI</w>
rs 2
r um</w>
P TS</w>
sist ence</w>
hypox anthine</w>
crystallin ity</w>
extrac table</w>
genotyp e-
fasci itis</w>
choleste atoma</w>
prog estin</w>
concentr ating</w>
SS B</w>
ch a</w>
sin k</w>
W R
constitu tional</w>
MUC 1</w>
low- energy</w>
time- course</w>
kilob ase</w>
R DS</w>
two- phase</w>
regi str
IU D</w>
Restric tion</w>
CB S</w>
cl aud
n ights</w>
Sp ace</w>
b all
d war
voc abulary</w>
ad d-
substanti ated</w>
D ogs</w>
MA L
it ant</w>
pemphig us</w>
E l</w>
Cys -
0.0 1-
bis exual</w>
ver b
TA A</w>
phyto plankton</w>
between- group</w>
PO AG</w>
electroencephal ographic</w>
mon as</w>
bene f
enteroc oli
S Q</w>
PM I</w>
leiomy osarcoma</w>
Dom ain</w>
X A</w>
rati a</w>
Su pr
spermati ds</w>
c ub
G Hz</w>
eradic ate</w>
N al
tem s</w>
Suc cess</w>
regist ers</w>
cle fts</w>
foun der</w>
LMW H</w>
S anger</w>
ech inoc
educ ate</w>
rot ary</w>
oc tion</w>
dy e-
beta- cells</w>
S 100</w>
-1 50</w>
non- surgical</w>
thi ol-
rhod amine</w>
B ran
prim i
immuno regulatory</w>
H2 S</w>
complex ities</w>
Sal ivary</w>
PPAR gamma</w>
prevent ative</w>
R- 2</w>
Y east</w>
monol ith
renew able</w>
in noc
occup y</w>
Minim um</w>
neutrophil ic</w>
bottom -up</w>
resc ence</w>
anten n
si RNAs</w>
99mT c</w>
cuc umber</w>
Con ver
PO C</w>
sp otted</w>
a- 5p</w>
M orbidity</w>
O LT</w>
wo od
T s
m ev
yr amidal</w>
Sil ver</w>
C PS</w>
expl ant</w>
pul l-
6 7-
tw e
obi ological</w>
e at
0.0 5-
in ized</w>
dis appear</w>
Self- reported</w>
e ther
4 7-
preser ves</w>
new- onset</w>
astig otes</w>
O TC</w>
micro algae</w>
glob us</w>
photo volta
vor tex</w>
dis integration</w>
anticip ation</w>
ven ules</w>
1. 66</w>
D TH</w>
pro line-
anti social</w>
micro structural</w>
acc ent
decre ment</w>
imp rec
18. 9</w>
A U</w>
PC 3</w>
por cel
mat ur
if olia</w>
iP SCs</w>
haem ophilia</w>
R CA</w>
40 4</w>
GP x</w>
MD V</w>
chec king</w>
2 1.6</w>
su tured</w>
prote ase-
argin ine-
F CM</w>
trans gender</w>
PL R</w>
in adver
Sph ing
1. 63</w>
Ca uses</w>
N as
S omatic</w>
M ang
cal end
ric kett
M d
tetrach lor
adhe sives</w>
m 1</w>
ap ed</w>
Nor mal
aqu aculture</w>
above- mentioned</w>
An k
in arily</w>
MD I</w>
CI D</w>
H ab
X -1</w>
ath ion</w>
micro vasculature</w>
cyto kinesis</w>
Per fusion</w>
Co ul
2 86</w>
odon tics</w>
cis- acting</w>
A Ps</w>
pol yc
my ositis</w>
CO MT</w>
sapon ins</w>
ful filling</w>
weight- bearing</w>
temperature -dependent</w>
one -</w>
Bio chemistry</w>
l i</w>
vi z</w>
col ytic</w>
CB Z</w>
Prophyl actic</w>
bio feedback</w>
PA O</w>
autom ation</w>
decont amination</w>
A sh
ambigu ity</w>
L en
oro facial</w>
Eth ical</w>
Z uc
tim olol</w>
-1 25</w>
la red</w>
centrom ere</w>
peroxis omes</w>
Adhe sion</w>
at ory-
- monophosphate</w>
multicentr ic</w>
ceram ics</w>
Victor ia</w>
short- chain</w>
phot olysis</w>
IF A</w>
α- synuclein</w>
plas tid</w>
rectom ized</w>
kg- 1.
ch ain-
enti tled</w>
man ag
13 0
nes tic</w>
G ir
ig nor
CD 20</w>
Bi op
6 19</w>
bag s</w>
oste osynthesis</w>
B Ps</w>
on ian</w>
tele ost</w>
k is
eri ous</w>
R up
pul sed-
2- mediated</w>
lab ial</w>
RA W
che ap</w>
spin ach</w>
icon azole</w>
3 12</w>
Youn ger</w>
2 3.8</w>
W T1</w>
on olactone</w>
mil est
Con form
Cyt otoxic</w>
S par
H and
W H</w>
post al</w>
d f</w>
IgG 4-
anti- CD3</w>
- 7
Chi ari</w>
T ST</w>
addic ts</w>
Angel es</w>
gen t-
18. 7</w>
b ench</w>
ó n</w>
M g-
ov an
em mas</w>
chloro thiazide</w>
he al</w>
ach alasia</w>
stre et</w>
4 4.
en yl
ad in</w>
wor sen</w>
alim umab</w>
resus cit
6 -12</w>
1. 64</w>
beta- lact
inst alled</w>
an ting</w>
benef ited</w>
qu es</w>
ster n
premat urely</w>
wh is
g ic</w>
om -
0.0 39</w>
guar ante
if ery</w>
experim entation</w>
Cha in</w>
micro graphs</w>
promo ter-
H a</w>
inter body</w>
can is</w>
dec oding</w>
Im plant</w>
PP Is</w>
Thirty- seven</w>
caud a</w>
fin ishing</w>
catast roph
d um
z umab</w>
N G-
post- test</w>
CS F-
amin ophen
l acc
K LF
satis fying</w>
18. 1</w>
TR AP</w>
work shops</w>
ulf an</w>
P osi
it orial</w>
ser ologically</w>
alph ab
Tradi tionally</w>
is cent</w>
ribonucle otide</w>
z wit
in- A</w>
ud inal</w>
200 6-
lipid- lowering</w>
n ymph
Pl anning</w>
ging iva</w>
turbul ence</w>
M n-
fluoro -
Ultim ately</w>
temper ament</w>
1, 9
CN N</w>
C -</w>
al fa</w>
cl ed</w>
enterocoli tica</w>
anhydr ide</w>
radi opharmac
GS K3
am ps</w>
hyper bilirubin
food borne</w>
over use</w>
poly propylene</w>
hypocalc emia</w>
in- 4</w>
Random ised</w>
maxim izing</w>
allo t</w>
2 0.6</w>
well- documented</w>
de -induced</w>
6 R</w>
sphen oidal</w>
I ris
bronch i</w>
hair s</w>
Agro bacterium</w>
acycl ic</w>
al o
glut athione-
ist ed</w>
pul l</w>
cou gh
sp ans</w>
MA O-
SO CS
pack aged</w>
a etiological</w>
A GA</w>
hyper glycaemia</w>
cat fish</w>
Hist ology</w>
To oth</w>
micro RNA-
pop ulated</w>
D SB</w>
el eph
Autom atic</w>
CO P</w>
Glut athione</w>
secre tag
For m
uve al</w>
ca ught</w>
IL s</w>
forc ing</w>
N it
mal e-
K an
aminoglyco sides</w>
crust ace
ey e
Trans formation</w>
syst ole</w>
scop ing</w>
TR AF
co- morbidities</w>
MP I</w>
im oto</w>
0.0 47</w>
sci sic</w>
K IT</w>
spec tac
eg al</w>
abut ment</w>
endang ered</w>
G ut</w>
eg o</w>
B ic
ch ase</w>
one- pot</w>
19. 3</w>
pheny leth
ym ia</w>
mel phalan</w>
clea ve</w>
Dexameth asone</w>
calcul us</w>
remo ves</w>
cr ush</w>
dr illing</w>
pige ons</w>
sati lity</w>
Scat chard</w>
D enti
chem ic</w>
SU D</w>
ow ned</w>
meth ox
P eptides</w>
homeob ox</w>
c on</w>
c ation-
cann ulated</w>
Practi ces</w>
de regulation</w>
aden osyl
Orth opaedic</w>
20 ,
Ch i</w>
intr icate</w>
d T</w>
de stabilization</w>
12- O-
carboxy- terminal</w>
re mic</w>
D ON</w>
cl ock
op elvic</w>
time- varying</w>
wet land</w>
p add
ul ans</w>
tro pic
chromat osis</w>
post- operatively</w>
low- temperature</w>
in atus</w>
LIN C
W ild
el aboration</w>
Ch ondro
EV AR</w>
advis able</w>
PC M</w>
S olution</w>
j udge</w>
speci es-
AV R</w>
2 4,
B 7-
loc alizing</w>
5- methyl
analog y</w>
sug ar
choled och
genu ine</w>
2 82</w>
4 2.
gener alised</w>
ATP- binding</w>
2 5.5</w>
w ol
us sions</w>
bar s</w>
Cap e</w>
Pen n
unra vel</w>
avul sion</w>
ph ox</w>
SP L</w>
amin ol
assist ants</w>
xen o
sil age</w>
V SD</w>
de generated</w>
prec ocious</w>
apenta enoic</w>
comm enced</w>
pat ellofemoral</w>
pall idus</w>
4 6.
in tima-
densit ometry</w>
am ended</w>
Un its</w>
A- treated</w>
acceler ometer</w>
alpha- amylase</w>
Si O</w>
Rec ru
-- -
c ecum</w>
fruc to
asympto tic</w>
re visited</w>
Ac -
DE N
circum scribed</w>
pu tida</w>
thi ol
plan us</w>
k no
uro logy</w>
He avy</w>
termin ate</w>
cobal amin</w>
potenti ating</w>
Met al-
H ard
H ous
oste openia</w>
Su gg
NCT 00
C CC</w>
mal tose</w>
HLA- DR
govern mental</w>
interferon- alpha</w>
EXPERI MENTAL</w>
1. 85</w>
Egyp tian</w>
U E</w>
un characterized</w>
ejac ulation</w>
examin er</w>
ozol omide</w>
el u
sub chondral</w>
rever sion</w>
equilib ration</w>
CD 38</w>
NU MB
five fold</w>
ninet y-
mass eter</w>
ET P</w>
Osteopo rosis</w>
w ay
corner stone</w>
aldoster onism</w>
tyros ine-
Cu 2</w>
Ah R</w>
B 16</w>
2- 6</w>
PO MC</w>
Forty- four</w>
S U</w>
r po
NA -
thi obarbituric</w>
s- related</w>
lumin escent</w>
2 0.4</w>
G ST-
ante grade</w>
pa stor
anti- human</w>
Phil ipp
por ter</w>
fi l</w>
bread th</w>
medullo blastoma</w>
B- cells</w>
FF R</w>
P CD
fil ls</w>
prefer ably</w>
bin d
AM R</w>
indol ent</w>
dimension ality</w>
infec tion-
de par
EC A</w>
Ar teri
kynu ren
adnex al</w>
og el</w>
hol der
2 2.3</w>
fibros arcoma</w>
cholangiopancre atography</w>
P la
uro logic</w>
cynom olgus</w>
80 3</w>
financ ing</w>
amer ic
pos ting</w>
strepto kinase</w>
et -based</w>
min orities</w>
Apo E</w>
Ric kett
cel ecoxib</w>
Ad ri
Adv ant
tur bin
o rest</w>
polic y
oro logical</w>
spong es</w>
dyne in</w>
abstr acted</w>
micronucle i</w>
B -</w>
ab ig
ga ther</w>
phosphor ib
incur red</w>
intention- to-treat</w>
dec lared</w>
CD C
coloc alized</w>
Reas ons</w>
T SP</w>
ass ure</w>
L ight-
di vor
angi o
15 N</w>
cra ft</w>
Com p
matrix- assisted</w>
institution alized</w>
ab a</w>
et a-
rein nerv
op ene</w>
ont ally</w>
alumin a</w>
N owadays</w>
4 40</w>
Compu terized</w>
HT N</w>
azol amide</w>
H VA</w>
rec to
tw ard</w>
mar mos
Ch it
ex pedi
IN S</w>
stake holder</w>
LO X</w>
g ain
et an</w>
sub merged</w>
exerc ising</w>
na ked</w>
a plasia</w>
methyl phenidate</w>
tor sional</w>
f usc
end o-
P Q</w>
U B
am ib
tor ch
fundo plication</w>
Ar gin
RA PD</w>
SR T</w>
m s
D PAT</w>
en closed</w>
Nig erian</w>
dys ph
AU D</w>
19. 8</w>
remin iscent</w>
G au
TH F</w>
epig ene
G rowing</w>
am pull
L 1210</w>
sac cadic</w>
vascul opathy</w>
HPV 16</w>
abra sion</w>
Tur ner</w>
de pot</w>
lipopol ysacchari
dehydrogen ases</w>
V eg
pluripot ency</w>
wor ry</w>
gra ined</w>
0.000 3</w>
than ks</w>
costim ulatory</w>
tis ed</w>
bre asts</w>
manif esting</w>
chimpanze es</w>
cryp t
Regi stration</w>
ore tin
reser pine</w>
myocl onus</w>
U M</w>
Thirty- nine</w>
tor tu
Compl iance</w>
hemi paresis</w>
mac ula</w>
.00 4</w>
magnet o
D AS</w>
E u</w>
en ema</w>
SC R</w>
nerv e-
after noon</w>
1. 62</w>
phen anthro
myelo proliferative</w>
bra sili
fast est</w>
Pai red</w>
under take</w>
CD 16</w>
hex okinase</w>
entr ant</w>
PP 1</w>
noc ic
Spe ech</w>
pK a</w>
ediatr ics</w>
Juven ile</w>
T ME</w>
per pet
GA PDH</w>
structure- function</w>
bi ting</w>
opi oid
Cat alyzed</w>
Chrom osomal</w>
p ests</w>
V ision</w>
po oling</w>
Sho uld</w>
ad mixture</w>
non- insulin-dependent</w>
Interfer on</w>
s noring</w>
thal idomide</w>
pre- mRNA</w>
ambly opia</w>
amenor rhea</w>
psych ophysical</w>
stac ked</w>
o viruses</w>
P MS</w>
cel lo
ho id</w>
al ty</w>
PP E</w>
MT B</w>
-1 5
y me
k led</w>
PT P
J IA</w>
le ptom
Cat al
est yle</w>
polyaden ylation</w>
co- infection</w>
silox ane</w>
Malaw i</w>
Per u</w>
accep ting</w>
glomerul osclerosis</w>
decid uous</w>
gingi vitis</w>
heav y-
con sortium</w>
CO OH-
lenti viral</w>
sh eds</w>
4 10</w>
re presses</w>
al dol
PP 2A</w>
err on
PS G</w>
Con st
t ances</w>
supr as
oplas min</w>
commerc i
st ent-
sun flower</w>
r p
B ow
in o-
alpha- helix</w>
cra b</w>
T ris
4 5.
bur sting</w>
re medi
off ici
short- lived</w>
M CD</w>
po re-
T rim
1.0 4-
eclamp tic</w>
SI DS</w>
P ut
ag liflozin</w>
I GT</w>
non fatal</w>
PRI SMA</w>
dec o
CO M</w>
van adate</w>
ot- assisted</w>
te tras
SC O
D ex</w>
ca vit
plex iform</w>
C 2-
dec ap
beta- amyloid</w>
prospec t</w>
Cycl in</w>
AT s</w>
thi ophene</w>
dimin ishing</w>
T ot
h TERT</w>
resist ance-
My D
m IU</w>
he ard</w>
ag glomer
th aw</w>
Ar m</w>
cellul itis</w>
open- ended</w>
standar d-
CD 36</w>
Func tioning</w>
met oclopramide</w>
CM T</w>
form ally</w>
iso kinetic</w>
com et</w>
Con text</w>
hr an</w>
p 21
helmin th</w>
cinti graphy</w>
glass -
amit riptyline</w>
hem agglutin
an ks</w>
mon osacchar
plas mal
sequ ence-
Pro mo
Cir cular</w>
led -
age- associated</w>
2 4.3</w>
san itation</w>
er ations</w>
cell ence</w>
metal- organic</w>
F C
or f
ca val</w>
polym er-
mic tur
2 84</w>
war ts</w>
P c
EZ H2</w>
erron eous</w>
og al
Cr -
per chlor
DD D</w>
CD 133</w>
TB S</w>
retur ns</w>
ore tinal</w>
chim erism</w>
glo ves</w>
Establ ishment</w>
D RE
d amp
le ast-
rec al
li kewise</w>
meth oxy</w>
magne t</w>
Austr ia</w>
micro electrode</w>
append age</w>
gal anin</w>
tetr ap
ens or</w>
cas e
underestim ate</w>
9 -</w>
hist olytica</w>
2 0.3</w>
CT Ls</w>
PCR- RFLP</w>
AS M</w>
front otemporal</w>
V ene
exp enses</w>
transmis sible</w>
T a</w>
imped e</w>
moun ting</w>
un paired</w>
U tility</w>
4 70</w>
CN P</w>
zol id</w>
opter in</w>
D in
ophthalm ology</w>
C old</w>
xy lem</w>
et ch</w>
post ures</w>
3 1P</w>
os in-
til l
Collabor ation</w>
2 92</w>
Z im
gyna ecological</w>
og old</w>
STAT 1</w>
sati ety</w>
ensu ing</w>
ill ation</w>
lo oks</w>
extr actions</w>
custom -
R ice</w>
fluoresc ence-
abstr action</w>
micro gravity</w>
SP M</w>
Con duc
dissec t</w>
o il
cyto chemical</w>
tac kle</w>
Issu es</w>
inhibit or-
t oglobin</w>
vari able-
ligh ts</w>
2- h</w>
counter acted</w>
qu ery</w>
Cy an
Estim ating</w>
Sup por
in homogeneous</w>
N os
trans rectal</w>
mon os
sh ore</w>
al ign</w>
rib b
par aneoplastic</w>
sc arc
main stream</w>
i vermectin</w>
coll ar</w>
scaveng ers</w>
P HC</w>
un fractionated</w>
BU N</w>
pyre thro
2 6.3</w>
19. 7</w>
transplant ations</w>
2 83</w>
k new</w>
lip oma</w>
C oupling</w>
abol ishes</w>
Ser ratia</w>
acylglycer ols</w>
succ essively</w>
bronchodi lator</w>
T 6</w>
osph eres</w>
holder ia</w>
K P</w>
S pati
conver sions</w>
anthocyan in</w>
nitr ide</w>
ET A</w>
thermod ynamics</w>
FIT C</w>
Con sul
pre load</w>
D- 2</w>
her tz</w>
expan sions</w>
dimorph ic</w>
calcit riol</w>
l anding</w>
hydrogen ation</w>
d augh
efflu ents</w>
con doms</w>
y m</w>
im pressions</w>
131 I</w>
2 2.6</w>
A cr
ag enic</w>
terat ogenic</w>
faec ium</w>
E MENT</w>
sub surface</w>
DO M</w>
prolong ing</w>
Con stitu
Que bec</w>
osph ing
ept or-
AN N</w>
catch ment</w>
ther mos
non ionic</w>
tas k
trans glutaminase</w>
1- like</w>
succe eded</w>
Endome trial</w>
de hydr
em es</w>
PO P</w>
rib ozyme</w>
Tc- 99m</w>
gonadotrop ins</w>
la w
fusi form</w>
Gla uc
paste ur
2 81</w>
5 40</w>
ec itabine</w>
ad al</w>
col or-
micro cephaly</w>
iner tial</w>
b arely</w>
R ana</w>
U preg
6-hydroxy dopamine</w>
Evolution ary</w>
sl ing</w>
decompens ation</w>
K 4</w>
OR S</w>
HLA- B</w>
ste aro
Rec tal</w>
type- 1</w>
end-to- end</w>
SP EC
T -1</w>
V P1</w>
syn chrotron</w>
0.0 42</w>
5- day</w>
Stro op</w>
cin olone</w>
or ub
aven ue</w>
duc ks</w>
hy oid</w>
tion ary</w>
al ists</w>
M yc
-1 000</w>
2- deoxy-
lim e</w>
prolifer ated</w>
LA TION</w>
haemat opoietic</w>
chem osensitivity</w>
there of</w>
macro lide</w>
M ST</w>
2 0.7</w>
2. 25</w>
sou theastern</w>
ozo ites</w>
PA N</w>
2 96</w>
F- 2</w>
T as
phil a</w>
respec ts</w>
Tre ating</w>
cTn I</w>
R ich
A tomic</w>
C- type</w>
cortic ospinal</w>
or hin
tr is</w>
G .
B DI</w>
not ch</w>
noc iception</w>
F AB
p ic</w>
contrac tures</w>
P 7</w>
lep rae</w>
L BW</w>
Na F</w>
Cam ero
lati tude</w>
micronucle us</w>
D AP</w>
os clerotic</w>
fluoro deoxyglucose</w>
All ergic</w>
Rever sible</w>
Angi ography</w>
cm -1</w>
an emic</w>
comput ations</w>
ESB L</w>
com ment</w>
Por cine</w>
Practi tion
un it-
ore activity</w>
nucle ated</w>
semi structured</w>
ogran in</w>
and able</w>
PL L</w>
Bi ofil
Bloc kade</w>
L epid
miti gated</w>
H PS</w>
met azo
nulli parous</w>
D TC</w>
hybri disation</w>
fasc ial</w>
L ec
dispens ing</w>
cytokin e-
Chic ago</w>
T ou
chol angiography</w>
chondro sarcoma</w>
Fo ot</w>
Jew ish</w>
hypo vol
Cigaret te</w>
Obstetr ics</w>
in osine</w>
ord inate</w>
Pro ximal</w>
intr aspecific</w>
2 99</w>
w rin
Sr i</w>
after wards</w>
t k</w>
ed ited</w>
psych ologists</w>
0.0 43</w>
verte bro
bi um</w>
ile oc
Ophthal m
NUMB ER</w>
di hydroxy-
lev ofloxacin</w>
ori enting</w>
125I- labeled</w>
P Z
spin- echo</w>
W o
N ation
RA R</w>
myri ad</w>
man ic</w>
decor ated</w>
- untranslated</w>
N MDA-
1 -19
apo A-I</w>
cardio plegia</w>
Impro ve</w>
inter section</w>
neurolep tics</w>
ane diol</w>
cour t</w>
propor tionally</w>
gastro duodenal</w>
dis close</w>
posi um</w>
or amic</w>
c aly
E OR
AT E</w>
tetram ethyl
an yl</w>
impl ant-
CV C</w>
hand led</w>
psycho active</w>
ther mot
Pre -</w>
RA W</w>
transcriptase- polymerase</w>
alpha 2</w>
H S-
G a-
ain ide</w>
ci vil</w>
trac ks</w>
D engue</w>
Z O
associ ating</w>
haemat oma</w>
D U</w>
W id
un corrected</w>
contin ental</w>
Agr icul
L ank
gen in</w>
anxi ety-
inv alu
am y</w>
T on
Qu in
U 1</w>
1. 68</w>
still birth</w>
K -12</w>
me 3</w>
secretag og
under scores</w>
mot or-
Ex tr
12 th</w>
cellul ase</w>
hypoxia- inducible</w>
B land-
Compl ementary</w>
2 94</w>
1. 61</w>
drain ed</w>
phosph ine</w>
ATP ases</w>
f atigu
th apsig
coinc ides</w>
brevi ated</w>
bicuc ulline</w>
En rich
Newcast le</w>
m oth</w>
illu sion</w>
Questionn aires</w>
1. 59</w>
28- day</w>
ro oted</w>
wid ening</w>
orp tive</w>
an aph
fron to-
intima- media</w>
invalu able</w>
Par is</w>
SAR S</w>
right- handed</w>
enter ocytes</w>
sp ared</w>
CI A</w>
CP E</w>
Descrip tion</w>
op enem</w>
Na OH</w>
ni x</w>
fo ot-
Eco RI</w>
affin ity-
U P</w>
oste olysis</w>
nic k</w>
buff alo</w>
ther mol
yl ates</w>
TO F-
spec kle</w>
cul tur
0.0 49</w>
anis m</w>
adip ogenic</w>
el ic</w>
pec tomy</w>
spons ored</w>
epiphy seal</w>
u ts</w>
D un
spiro ch
de formations</w>
1. 60</w>
posi tive-
pneum atic</w>
Sub stitution</w>
T yrosine</w>
am ents</w>
Con cep
allo x
endo derm</w>
ER O</w>
F 5</w>
high- sensitivity</w>
mo tives</w>
plasm apheresis</w>
eth idium</w>
19. 1</w>
cystic er
c enter
K al
Q s</w>
opto electronic</w>
ation- associated</w>
van adium</w>
heterodi mers</w>
mod el-based</w>
remo vable</w>
t elec
trabecul ectomy</w>
-to- day</w>
2 79</w>
pro viral</w>
impul sive</w>
1 20-
proof-of- concept</w>
H K</w>
contro l
k o</w>
Re plication</w>
L ES</w>
ver a</w>
scen es</w>
CEN TR
2 91</w>
dermat ological</w>
Car ri
normo xia</w>
Repe at</w>
M ell
es cul
gal ectin
plan in</w>
electrocardi ography</w>
laryng oscopy</w>
nanotechn ology</w>
2 2.4</w>
em et
em atical</w>
sul fo
uni tinib</w>
supr ag
industri alized</w>
C E-
14 0
na proxen</w>
domain- containing</w>
- 80</w>
is os
kind ling</w>
O f
ess or</w>
coloc alization</w>
str ation-
form ic</w>
benz othi
co- occurrence</w>
Tr p-
T ME
exha ust</w>
T i-
cap tures</w>
pediatr ics</w>
firm ly</w>
re tail</w>
it ching</w>
c- jun</w>
cas ual
C e</w>
Taiw anese</w>
3 2.5</w>
vir als</w>
lip ogenesis</w>
sal ience</w>
breast- feeding</w>
inter viewing</w>
ot onin</w>
V aginal</w>
ure -related</w>
diver ged</w>
T m</w>
domin ate</w>
ind ocyanine</w>
9 4
immun olab
assi sting</w>
omen ing
ac t-
clear -
w ives</w>
rel s</w>
30- min</w>
carc asses</w>
1. 6-
hydro ps</w>
antibio tic
allergen ic</w>
1- month</w>
drop out</w>
min ocycline</w>
simpl ify</w>
Includ ed</w>
ol is
Pre term</w>
repor tedly</w>
2. 00</w>
G eriatric</w>
f allopian</w>
haem olyticus</w>
cannabin oids</w>
str on
PC 1</w>
Pas sive</w>
op razole</w>
video- assisted</w>
M 4</w>
pat ern
Pl an</w>
che ek</w>
sprin t</w>
glabr ata</w>
bright ness</w>
calmodul in-dependent</w>
og e
e- cigarette</w>
C os
V a
- flanking</w>
par aquat</w>
stimul ations</w>
2 8.5</w>
tax on</w>
protop orphyrin</w>
on idine</w>
Trans fection</w>
out-of- hospital</w>
P 0</w>
HP G</w>
ven om
Ar sen
sl ur
ethan ol-induced</w>
R 5</w>
chlor ite</w>
Forty- three</w>
soldi ers</w>
CD 31</w>
SE C</w>
UV- B</w>
cardiover sion</w>
DM BA</w>
Synerg istic</w>
15 0-
underestim ation</w>
X 4</w>
rel uc
ph obia</w>
1. 72</w>
SSR Is</w>
S Z</w>
S- D</w>
in sti
lipi demic</w>
appl i
PI K3
dal ton</w>
fem al
attention- deficit</w>
op sin</w>
IL-1 7A</w>
etr ic</w>
ali qu
Test osterone</w>
F ent
platelet- rich</w>
N av
17. 0</w>
intrad uctal</w>
ex t
hepar in-
pos th
disc ol
6- year</w>
ol uc
oc ine</w>
1, 25-dihydroxyvitamin</w>
protein emia</w>
dil emmas</w>
scinti graphic</w>
Burk holderia</w>
solu tion-
Bac k</w>
later ality</w>
F allot</w>
Mar ine</w>
pro coagulant</w>
Flex ible</w>
S impl
Fem oral</w>
P ICU</w>
dorm ancy</w>
1 S</w>
de gre
tin gu
neuro p
TR IM
GR F</w>
dom onas</w>
As n
provo ke</w>
ro ll</w>
interfer ons</w>
ribonucle oprotein</w>
BL M</w>
li um-
on yl
Accum ulating</w>
8 3
U PR</w>
CO OH</w>
dor si
pat chy</w>
non obese</w>
histo chemically</w>
endotox emia</w>
un equal</w>
Spi ro
h ot-
30- 40</w>
H US</w>
PC SK
organis ational</w>
IL 6</w>
macro globulin</w>
g ills</w>
de duc
otyp ical</w>
trop omyosin</w>
sphinc ter
MR D</w>
co- cultured</w>
Maj ority</w>
pos it
2 97</w>
mas ks</w>
perin uclear</w>
o acetate</w>
xenobi otic</w>
gab apentin</w>
- 2-</w>
no thing</w>
Con struc
Fol l
opac ification</w>
pix els</w>
conc e
ograph ed</w>
intr onic</w>
vit ality</w>
bi tis</w>
ev es</w>
cross- links</w>
V AD</w>
open- angle</w>
ar a-
ren s</w>
contain ers</w>
m econ
sec tioning</w>
y- -
prec ancerous</w>
normal ize</w>
bor tezomib</w>
de alt</w>
CD 40L</w>
RNA- Seq</w>
pneumon ectomy</w>
foot print</w>
cancer- associated</w>
fem in
gold fish</w>
M ol</w>
iso propyl</w>
6 3-
CA H</w>
idi otypic</w>
tex tile</w>
Cyt ogenetic</w>
remif entanil</w>
ond an
cr ises</w>
on wards</w>
di -</w>
un published</w>
Me Hg</w>
op al
bo ur
B 5</w>
bil s</w>
schizophren ics</w>
Path ologic</w>
cholest atic</w>
0.0 41</w>
g ris
kerat o
Micro -
Mon o
H ETE</w>
ca uter
bi ob
hist ograms</w>
D HF
X X
G US</w>
Co he
ac ylated</w>
on om
multi ply</w>
Neutroph il</w>
beta- sheet</w>
LP O</w>
denitr ification</w>
9 29</w>
ud ing</w>
AM Ps</w>
Si O2</w>
trim er</w>
H ash
4 01</w>
1. 76</w>
eno humeral</w>
c up
AP 2</w>
1. 78</w>
olim us</w>
ti st</w>
2 89</w>
ot o
PC E</w>
tal ar</w>
Pr inci
prescrib e</w>
precip itates</w>
We ek</w>
B ile</w>
P- 450
Isra eli</w>
Te hran</w>
Scal e-
up dating</w>
nan o</w>
He aling</w>
sw ing</w>
advertis ing</w>
micro extraction</w>
Ser otonin</w>
FIT C-
Institu tional</w>
therm ogenesis</w>
cephalospor in</w>
ap ia</w>
poly genic</w>
point -
phosphoryl ates</w>
ag al</w>
cl i
govern ments</w>
SYN THESIS</w>
standardi ze</w>
Bene fits</w>
top ographical</w>
euthan ized</w>
ov aginal</w>
Pa ediatric</w>
t apping</w>
5 2-
TL Rs</w>
Smal l-
mineral ocorticoid</w>
John son</w>
- H</w>
u d</w>
on itis</w>
fav oured</w>
r Hu
lute um</w>
inhal er</w>
quasi- experimental</w>
lipoly tic</w>
re missions</w>
oste ochondral</w>
980 59</w>
Tran sp
- bi
intercal ated</w>
TM Z</w>
ap arin</w>
0. 6-
og els</w>
sli t</w>
2 87</w>
asp ing</w>
Bur den</w>
penetr ated</w>
ent ails</w>
sum ing</w>
2 4.1</w>
inten sity-
Cir cadian</w>
Guill ain-
angi ographically</w>
-1- yl</w>
opres sin</w>
i red-
tap ered</w>
n ailing</w>
endoc annabin
laryng ectomy</w>
foramin al</w>
G ri
On -
Dis sem
G SSG</w>
p 75</w>
pol yl
ed rine</w>
cul min
spo ken</w>
D SBs</w>
immun odom
Child -
ine ous</w>
18 F-
voc ational</w>
mc g</w>
Er r
apoli po
fl ushing</w>
dor si</w>
att ach</w>
Integr ating</w>
radiolab elled</w>
oopho rectomy</w>
depend encies</w>
tou gh
pip ette</w>
syl van
dis cour
meth rin</w>
P v
20 1
SE D</w>
mac ronutri
Post natal</w>
pa ins</w>
biop sied</w>
unra vel
1. 69</w>
spo use</w>
EQ-5 D</w>
um inated</w>
phospho enolpyruvate</w>
U NA
ph i
brac kets</w>
exp iration</w>
Mo roc
biog e
CM A</w>
poli o</w>
Chlamy domonas</w>
P Y</w>
at roph
ile ostomy</w>
transpos ons</w>
Ant arctic</w>
re folding</w>
lat or-
suic ides</w>
obstetr ical</w>
dec entr
KE GG</w>
ad an</w>
co operate</w>
1. 95</w>
hom e-
immuno deficient</w>
12-O- tetradecano
F as-
En cephal
32 P-
Bif id
oper ant</w>
ing rowth</w>
fol ia</w>
le f
euthan asia</w>
0. 8-
medium- sized</w>
r il
0.0 20</w>
pal in
con ferences</w>
monoph asic</w>
2 3.4</w>
compl aining</w>
si ds</w>
war d-
Cardi ology</w>
tourniqu et</w>
ve g
pseud op
reg ressive</w>
Rec eptors</w>
Path ogenesis</w>
Bland- Altman</w>
r hom
son ication</w>
us s</w>
prop idium</w>
cl ips</w>
ut z
CT GF</w>
Per ox
om ata</w>
DE NV</w>
propo s</w>
Fre und</w>
TR PM
AD CC</w>
hemat ology</w>
pursu e</w>
pigment osa</w>
Cyt os
light- emitting</w>
gel ation</w>
ap o-
re ven
Cor on
N RS</w>
reg ained</w>
19 ,
oval e</w>
Nico tine</w>
ambi a</w>
R RT</w>
contrain dication</w>
si ll
cu ps</w>
U K
2 2.1</w>
Ar my</w>
Jan us</w>
ur onate</w>
cyan obacterial</w>
n m
g or
cl amped</w>
- L
encomp ass</w>
H ome
-1 6
3 D
in ium-
12 9
GI P</w>
satur ating</w>
Impl antation</w>
Q M</w>
rin se</w>
sil yl</w>
proprioc eptive</w>
- 40</w>
hyper ventilation</w>
NC S</w>
japon icum</w>
end obronchial</w>
nor theastern</w>
war m
f .</w>
PC Ps</w>
TR AC
endop eptidase</w>
F ABP</w>
re use</w>
st -</w>
Pul se</w>
S 9</w>
hy men
lipo protein-
TE s</w>
beta 1-
oth yro
AN IMA
mill il
Amaz on</w>
p S</w>
bo ards</w>
CD 18</w>
ax on
G V</w>
ast e</w>
my enteric</w>
ovi position</w>
see ing</w>
Extrac ts</w>
4 7.
grac ilis</w>
P r</w>
NO T
aband oned</w>
car ds</w>
parti cle-
rec eption</w>
trib ut
quer ied</w>
K- ras</w>
repeti tions</w>
mon om
-1 a</w>
Met formin</w>
AO M</w>
Z r
activ eness</w>
PL C-MS</w>
intrap artum</w>
penicill amine</w>
I tems</w>
d A</w>
per if
b ore</w>
Hy dr
duoden ectomy</w>
S SCP</w>
pro ving</w>
cre tion</w>
ed -type</w>
ondan setron</w>
v owel</w>
co il
H ES</w>
ge fitinib</w>
MI BG</w>
MR L</w>
distingu ishes</w>
Gr ad
an ec
drug- drug</w>
Guillain- Barr
non invasively</w>
sil ane</w>
y- specific</w>
phyto hemagglutinin</w>
Ra f</w>
Tor onto</w>
Issu e</w>
om uc
1, 2</w>
deriv atized</w>
di alogue</w>
ad ural</w>
analy tically</w>
nucle osomes</w>
elev ating</w>
scarc ity</w>
ac tom
pi rosis</w>
4 8.
Pre v
relap se-
pH- dependent</w>
F g
si i</w>
oxif ylline</w>
Ga g</w>
9 8.
en i
SR P</w>
circum vent</w>
Wor kers</w>
sam pl
op exy</w>
chondro genic</w>
im mediate-
miti gating</w>
2. 0-
protozo a</w>
phenol ics</w>
6- keto-
B- type</w>
C er</w>
M é
ir o</w>
valpro ic</w>
I SH</w>
ependym al</w>
P ha
bis phenol</w>
dysp noea</w>
A 1-
cryp torch
porphyr ins</w>
ox ins</w>
In nov
sen i
mit ogen
CYP2 E1</w>
p -</w>
si as</w>
diarrhe al</w>
asci tic</w>
dish es</w>
W AT</w>
s tick</w>
ron ous</w>
up dates</w>
TT X</w>
mum ps</w>
par g
entr ain
spe ech
cell- associated</w>
sp end</w>
ari etal</w>
varic ocele</w>
C JD</w>
an nel</w>
collo ids</w>
ligand- binding</w>
ech oic</w>
pow ers</w>
robu stly</w>
intellig ent</w>
tin in</w>
A cous
typh oid</w>
Tes ticular</w>
li ver-
flu ence</w>
3. 0
Str ati
MB q</w>
pl us-
bl a
tr uth</w>
40 3</w>
Lymph ocyte</w>
antr one</w>
C SE</w>
micro gram
un ity</w>
uro graphy</w>
quad ri
aptam ers</w>
pre molar</w>
ICD -10</w>
veter in
by- products</w>
diffus ely</w>
identi fier</w>
hand grip</w>
Cat alytic</w>
anaphy lactic</w>
Macroph age</w>
in hab
anticip atory</w>
0 -19
in i
extram edullary</w>
de regulated</w>
15- 20</w>
cyt opathic</w>
fib ula</w>
au er</w>
9 5-
inter position</w>
CH 4</w>
HR CT</w>
aph th
inter- rater</w>
4 00-
Tok yo</w>
o estrus</w>
lep tos
op us</w>
osp ond
follow- ups</w>
b in</w>
oper ation
pep per</w>
hop ed</w>
calend ar</w>
H c
X i
sug ar-
RE s</w>
emb rane</w>
ST 2</w>
tuber cle</w>
dre w</w>
d og
riv aroxaban</w>
ne omycin</w>
br ace</w>
accred itation</w>
dist ally</w>
oc h</w>
Gen otyping</w>
J AK</w>
secre tase</w>
gall ate</w>
Agg ressive</w>
CYP2C 19</w>
cyclo addition</w>
co infection</w>
fer ron
DM I</w>
bio tin-
a head</w>
3 33</w>
granul ocytic</w>
quality- adjusted</w>
abig atran</w>
liquid- liquid</w>
me ant</w>
horiz on</w>
Lin kage</w>
F CS</w>
s orbent</w>
4 18</w>
beta- blocker</w>
i eld</w>
A ge
DA SH</w>
p its</w>
G N
hyper thyroid</w>
ben z</w>
inv al
out performed</w>
lat tices</w>
intra renal</w>
kine tically</w>
Fifty- two</w>
DO T</w>
fl avi
Immun oglobulin</w>
pilocar pine</w>
- deficient</w>
on ase</w>
pe tic</w>
L Ns</w>
ol .
fi de-
step ping</w>
col leg
ro ad
atr ic
MT D</w>
Pro per</w>
water shed</w>
s 1</w>
O DI</w>
micro sphere</w>
at tract</w>
val vul
Prote omic</w>
in suff
gam bi
pancre at
aug menting</w>
New ly</w>
D 5</w>
ur ge</w>
X II</w>
tet anic</w>
perc ritical</w>
STAT EMENT</w>
anthocyan ins</w>
fin ite-
CD 1</w>
IMP ACT</w>
mal arial</w>
c un
ev asion</w>
dis ap
non- neoplastic</w>
estradi ol
osper mic</w>
In take</w>
neointim al</w>
disast ers</w>
neighbor hoods</w>
transfec tants</w>
poly pharmacy</w>
Perc ent
P yro
neuro fibrillary</w>
Pharmac eutical</w>
im umab</w>
1. 74</w>
F M
2 1.8</w>
pacem akers</w>
nitro samine</w>
pollin ation</w>
N ear-
anti-HB s</w>
dynor phin</w>
add- on</w>
3 45</w>
o- associated</w>
M aster</w>
Gl c</w>
S ons</w>
Par ticular</w>
basi cally</w>
lam ellae</w>
seg ment
sh ade</w>
X yl
Th resh
gu il
cle aves</w>
col istin</w>
child -
aspir ated</w>
acin i</w>
anti- angiogenic</w>
m Health</w>
p ant
E PC</w>
4 30</w>
clav icle</w>
bul king</w>
volt ages</w>
NMD AR</w>
om itted</w>
et ched</w>
coupl ings</w>
2, 7
employ ers</w>
U bi
am idine</w>
P x</w>
hypot onic</w>
- shaped</w>
insulin- stimulated</w>
blin k</w>
steril ized</w>
high- volume</w>
29 400
econ ds</w>
pre incubated</w>
we ap
cycl op
aden oid</w>
6 B</w>
Th r-
An omal
moder ating</w>
aort as</w>
CENTR AL</w>
entr ies</w>
const ell
peculi arities</w>
PO IN
L ind
E ither</w>
un supervised</w>
ent om
g ym
ER alpha</w>
Radi ology</w>
NT P</w>
corticotrop in-releasing</w>
f ost
1. 71</w>
hydro -
5- HIAA</w>
200 4-
specific ations</w>
chi sis</w>
pleth ora</w>
cere als</w>
well ness</w>
asynchron ous</w>
Res ource</w>
ed- chain</w>
ali ke</w>
s ort</w>
mus cim
Yel low</w>
S c</w>
ib izumab</w>
Syn chron
e fully</w>
ra p</w>
p idus</w>
tur tle</w>
immunost ained</w>
Endoc rine</w>
un balanced</w>
AR I</w>
pedi grees</w>
alk anes</w>
mill ig
SNA P</w>
in forming</w>
multi system</w>
Prostagland in</w>
hal ide</w>
tick- borne</w>
Forty- six</w>
life times</w>
14-3- 3</w>
p 38
ro d
CR E</w>
atic ity</w>
MB L</w>
D K
W MD</w>
clu sively</w>
bor ate</w>
Cur cumin</w>
ic ks</w>
PD L</w>
Le af</w>
oguan idine</w>
out performs</w>
som ata</w>
SC Cs</w>
Rob ust</w>
Glut amate</w>
archa ea</w>
onco protein</w>
plas ti
stor m</w>
pell ucid
adher ing</w>
S ham</w>
self- harm</w>
C3 b</w>
Bloc king</w>
A uro
immuno diffusion</w>
CN Vs</w>
U. S.
mutag ens</w>
p esti
3 13</w>
metabol omic</w>
Por tal</w>
o v</w>
Per man
bis phosphonate</w>
ou re
F ro
cc RCC</w>
G -1</w>
ab at
HIV- 2</w>
flow metry</w>
Clim ate</w>
P ure</w>
deri ving</w>
beet les</w>
IFN- beta</w>
phosphatidyl inositol-
redox -
lar va</w>
hypothalamic- pituitary-adrenal</w>
Examin ing</w>
co transporter</w>
galactos amine</w>
urban ization</w>
Fram ingham</w>
digit orum</w>
ub a</w>
quin tile</w>
Pu gh</w>
pro apoptotic</w>
me ticul
kary otypes</w>
ethan olic</w>
of emoral</w>
B iliary</w>
mig ra
recalcitr ant</w>
am ed</w>
poly vinyl</w>
PP H</w>
1.0 5-
R -1</w>
diff usive</w>
visu al-
scann ers</w>
daugh ters</w>
5 7.1</w>
Cerebro spinal</w>
HIV- related</w>
par si
Bloc k</w>
contu sion</w>
an ders</w>
A- II</w>
confron ted</w>
postis chemic</w>
resear ched</w>
eth ing</w>
Wh ites</w>
time- to-
Inter sti
lipid aemia</w>
dac tyly</w>
E -1</w>
Con focal</w>
psych o-
coinc ide</w>
U m
lin kers</w>
resembl ance</w>
event- free</w>
fac i
caus ation</w>
swe ating</w>
bod y
recogn izable</w>
two- component</w>
hum ic</w>
PC V
anti- proliferative</w>
leuk ocytosis</w>
Bon ferron
p ies</w>
centrom eric</w>
foun ded</w>
Ful l-
stem ness</w>
HC Cs</w>
NH ANES</w>
Mitochond ria</w>
amplic on</w>
MA A</w>
IT H</w>
tw isted</w>
suff ers</w>
mess engers</w>
happ y</w>
LU TS</w>
chiro practic</w>
kain ic</w>
et allic</w>
Col or
ex o
perim etry</w>
motiv ations</w>
relig ion</w>
2 4.2</w>
AT G
phospho transferase</w>
3 17</w>
azol e-
extrem es</w>
alpha- adrenergic</w>
miR- 34
day -to-day</w>
t agging</w>
sh ell
re pairing</w>
Tr acking</w>
O Cs</w>
staurospor ine</w>
idi al</w>
beha ves</w>
Inten sity</w>
vari ances</w>
mes encephalic</w>
bac illus</w>
fib ular</w>
k A</w>
dibutyr yl</w>
di phenyl</w>
achi asmatic</w>
assist ant</w>
A symmetric</w>
un described</w>
sc Fv</w>
end osperm</w>
biolog ics</w>
ar athyro
fl un
cle aving</w>
megakary ocytes</w>
hed gehog</w>
infiltr ative</w>
Wist ar-
flan ked</w>
Lith ium</w>
defl ection</w>
e ism</w>
ul ph
electro spun</w>
P ast</w>
PR s</w>
se baceous</w>
ind olol</w>
0- 2</w>
Sy d
Less ons</w>
carboxyp eptidase</w>
o chr
yn ess</w>
tub ulo
A Y
psych ologic</w>
Cryst all
D AG</w>
di lol</w>
1. 82</w>
DE HP</w>
plant arum</w>
An emia</w>
2 0.2</w>
vehicle- treated</w>
1, 2,
Rab bit</w>
flatten ed</w>
oste otomies</w>
Doc um
5 b</w>
t mann
inf lated</w>
ith ymia</w>
aer ation</w>
r iton
Arti cles</w>
phosphor ylate</w>
well- designed</w>
ospor ium</w>
Me dia</w>
intersti tium</w>
Al aska</w>
oste opontin</w>
one- treated</w>
flex ural</w>
NS 1</w>
IT C</w>
gang rene</w>
loc alities</w>
GTP- binding</w>
hem optysis</w>
Tu key</w>
2 1.9</w>
Hist opathology</w>
Peri od
emb odi
pow er-
AD D</w>
ML H1</w>
Wh ich</w>
succ ession</w>
Su perior</w>
Qu erc
9- fold</w>
nic oti
p c</w>
beta- globin</w>
Mo tion</w>
ow a</w>
Gl n
n ong
de g</w>
al- type</w>
FI GO</w>
Alber ta</w>
2 5.6</w>
NT G</w>
n ylon</w>
Spectro metry</w>
turb idity</w>
at rist</w>
ocyt omas</w>
CD 68</w>
4 4.4</w>
bl astom
pul satility</w>
Ga it</w>
HD V</w>
prov incial</w>
single- photon</w>
ve dilol</w>
annot ations</w>
a ked</w>
exp andable</w>
SB S</w>
Tum or-
Ischem ia</w>
A As</w>
1. 96</w>
conver ge</w>
diverticul itis</w>
D W</w>
bis muth</w>
cock ro
Frequ ent</w>
2- adrenergic</w>
aris en</w>
success es</w>
Typ es</w>
rhabdomy olysis</w>
at entorial</w>
equ atorial</w>
Regi stered</w>
r icin</w>
lifest yles</w>
histi ocytic</w>
S ection</w>
Col e
hypog los
s ine</w>
K L</w>
an -induced</w>
ic ho
2 2.8</w>
2 7.8</w>
sing le-</w>
E 1A</w>
Casp ase-
b low
A SP</w>
bran ds</w>
ambigu ously</w>
marc escens</w>
erec tion</w>
spor um</w>
LDL- cholesterol</w>
re hydration</w>
neur amin
mill ing</w>
exud ative</w>
m r
ec o-
Dec om
F 6</w>
CE M</w>
I DA</w>
chim era</w>
MO Fs</w>
a plasma</w>
ore sistant</w>
resc rip
micro capsules</w>
ad versity</w>
itu ality</w>
13 C-
Pres enting</w>
exce ed
phospho choline</w>
Cros s
I CT</w>
mat eri
mis s</w>
SP F</w>
eigh teen</w>
moll us
ver ruc
p. i.</w>
natur alistic</w>
Meth an
metacar pal</w>
gen ol</w>
Man ip
Interpre tation</w>
appli ances</w>
En z
M im
L AB
co done</w>
19 60</w>
olig o</w>
skew ed</w>
h its</w>
C oma</w>
glycolip id</w>
dig est</w>
Suppl ementary</w>
R PA</w>
ST A</w>
B W
G- quadru
onc ogenesis</w>
P ituitary</w>
bl a</w>
neur on
lec ture</w>
Intersti tial</w>
Sm ith</w>
V erbal</w>
minim izes</w>
Harr is</w>
C CS</w>
r yp
di ving</w>
F 0</w>
ger bils</w>
k el-
diast ole</w>
T CD</w>
Bor det
C rani
L AP</w>
ser y</w>
tan gen
Prog esterone</w>
ros ette</w>
eg u
z u
Sud den</w>
p ub
P EC
Pro grams</w>
En v</w>
spermat ocytes</w>
D ur
nigro striatal</w>
C 9</w>
Physi ology</w>
foll icul
cist er
phon on</w>
stem ic</w>
accoun tability</w>
ed- release</w>
ylox y</w>
pod ocytes</w>
Anti bacterial</w>
ex onuclease</w>
o- p-
ensu red</w>
3 14</w>
anti hist
PR IN
F PG</w>
mod ulations</w>
H2 AX</w>
Immun otherapy</w>
ation -</w>
W er
eb a</w>
bif ida</w>
titr ated</w>
bioinform atic</w>
4 5.5</w>
og ram
kan amycin</w>
s ocket</w>
6 20</w>
Famil ies</w>
4 2.9</w>
w ounding</w>
resum ption</w>
py ran
cry otherapy</w>
29. 4</w>
19 69</w>
SC RIP
Rel ax
im balances</w>
2 0.9</w>
j er
phyto chemical</w>
CDK N
Empir ical</w>
carb amate</w>
Vide o</w>
pres sur
MR C</w>
cl ots</w>
bo ar</w>
2- microglobulin</w>
deoxy cholate</w>
subjec tively</w>
IL- 7</w>
lit ters</w>
p f
od on</w>
peri prosthetic</w>
H3 N2</w>
AS L</w>
Ampl ification</w>
pa ired-
tox oid</w>
AC E-
n ine-
7 2
plank tonic</w>
capro lactone</w>
in t</w>
al og</w>
estro l</w>
gyn ecology</w>
corrobor ate</w>
1, 4,5-
chron otropic</w>
arthro plasties</w>
jum ping</w>
t on-
amni ocentesis</w>
Sud an</w>
N-acetyl glucosamine</w>
rectom ies</w>
fluoroph ore</w>
build ings</w>
CE US</w>
plasm atic</w>
neg ative-
Cyto kines</w>
os an-
inter cept</w>
direc ts</w>
C affe
lam b</w>
fo reg
Ad j
b am
ation .</w>
sched uling</w>
des ert</w>
flag ella</w>
RG Cs</w>
F MS</w>
el y-
P ND</w>
compl ements</w>
anti- HIV</w>
micronutri ent</w>
ir a</w>
ho ok
Ne ed
- UTR</w>
SU Vmax</w>
hydro lysate</w>
mel it
neurolog ically</w>
Sens or</w>
l af
1. 70</w>
myc otoxins</w>
triple- negative</w>
Bordet ella</w>
C DS</w>
gra vid
icillin -
calcium- binding</w>
perpe tr
J H</w>
sw allow</w>
mil d-to-
intr af
H F-
qu e
Psori asis</w>
SR s</w>
triam cinolone</w>
SH 3</w>
lithi um-
S SA
first- time</w>
peric ytes</w>
mon ozygotic</w>
cataly zing</w>
un loading</w>
inter ictal</w>
expon ent</w>
H all</w>
pe el</w>
V el
indic a</w>
Secre tion</w>
C I-
diag rams</w>
pre diabetes</w>
Ser ological</w>
C Z
ot us</w>
PP G</w>
PW S</w>
scap hoid</w>
5 12</w>
inter- molecular</w>
hydra zone</w>
radi ative</w>
hot spots</w>
otrop ia</w>
igen in</w>
p 62</w>
3 19</w>
Conf idence</w>
Syd ney</w>
3 43</w>
id ines</w>
sub threshold</w>
hem olymph</w>
SO M</w>
transl ating</w>
olis thesis</w>
oc al
eas y-to-
o at</w>
ch ore
col ostomy</w>
gri ef</w>
percenti les</w>
Cardi omy
neighb or</w>
w in</w>
C uc
9 7.
ar as
19. 9</w>
45 0-
municip alities</w>
sh op
amid o
Compu ter-
G CA</w>
I PD</w>
rib s</w>
parox etine</w>
hypothesi sed</w>
ta u
of luoro
deform ability</w>
3 16</w>
ven oms</w>
y- associated</w>
calib er</w>
hun ger</w>
tw ice-
CL E</w>
multi step</w>
50 5</w>
code ine</w>
hybrid omas</w>
cent uries</w>
Sol anum</w>
Cop ing</w>
problem- solving</w>
dwar f</w>
b out
G PA</w>
cet uximab</w>
un conscious</w>
continu ally</w>
Tr ac
SW I</w>
im migration</w>
2 4.4</w>
AI D</w>
virus- like</w>
t angles</w>
ep ri
gl ing</w>
draw s</w>
Neuro spora</w>
TD F</w>
Mell itus</w>
o ide
bl ade</w>
π- π</w>
d na
0 -1</w>
immuno electrophoresis</w>
breath -
yl and</w>
V AT</w>
am isol
Ch AT</w>
transmit ting</w>
fo als</w>
provi sional</w>
o frontal</w>
extrap yramidal</w>
streptozotoc in-induced</w>
GI T</w>
3 6.4</w>
Character istic</w>
excit on</w>
seas onality</w>
Mar fan</w>
glucag on-like</w>
Polymorph ism</w>
id ylate</w>
Al ve
al ising</w>
exc imer</w>
mev al
fi ref
ill uminated</w>
4- 8</w>
mean ings</w>
HEK 293</w>
myo- inositol</w>
cysticer cosis</w>
numer ary</w>
B ipolar</w>
oc ally</w>
tab ac
ospir a</w>
N b
am per
Abl ation</w>
B eli
1. 86</w>
oid ectomy</w>
chyl omic
electron ically</w>
Que ens
po ts</w>
oph obia</w>
PT V</w>
tail or</w>
om ental</w>
eb all</w>
tec tum</w>
pp ing</w>
S and
preponder ance</w>
s orghum</w>
200 1-
inf inity</w>
6. 25</w>
Re produc
ward ship</w>
S ST</w>
W NV</w>
mal function</w>
retri eve</w>
Georg ia</w>
Prec ision</w>
disproportion ate</w>
A Q</w>
sing ular</w>
lyc opene</w>
interleukin -8</w>
Or b
chemo embolization</w>
postin ter
Amylo id</w>
un specific</w>
dipl opia</w>
me ets</w>
nat ally</w>
UV- vis</w>
1- dependent</w>
Ex ec
pu zz
biom olecular</w>
2 2.9</w>
T Z</w>
C ER
L amin
porcel ain</w>
por phy
hydro genase</w>
consul tants</w>
Cro ati
2- adrenoceptor</w>
Col on</w>
E mission</w>
arom a</w>
Lat ent</w>
j aws</w>
Av oid
1. 77</w>
aph id</w>
resum ed</w>
pre medication</w>
L- DOPA</w>
aldol ase</w>
i g</w>
un ate</w>
nasoph arynx</w>
steroid -
ord inal</w>
Ga N</w>
G K</w>
1. 8-
H ox
f ishing</w>
QAL Ys</w>
ifer ol</w>
R od
PD C</w>
yl- tRNA</w>
O sc
ampull ary</w>
- 0.5</w>
P p
micro -</w>
4 9-
dic tion</w>
pro insulin</w>
pu st
ST ATI
radic ular</w>
digiti zed</w>
no s</w>
Aspir in</w>
i qu
A1 C</w>
ocul tural</w>
gen ome-
diap hor
13 7
Cl ose</w>
X S</w>
p. m.</w>
S tra
G i</w>
single- blind</w>
C ast
ec ologically</w>
1. 83</w>
4- nitro
lys osome</w>
pip e</w>
rep ell
29400 2</w>
oc king</w>
ref usal</w>
si gh
con vol
ni volum
diag onal</w>
sol -
mis matches</w>
ad aic</w>
pre motor</w>
ush ed</w>
allevi ates</w>
re infection</w>
Ep ith
parathyro idectomy</w>
Transcrip tome</w>
hydro chlorothiazide</w>
techn icians</w>
40 8</w>
ti ed</w>
ag og
Ray n
CT X-
enter pr
gl enohumeral</w>
suscepti bilities</w>
amelior ating</w>
I ra
multi stage</w>
exud ates</w>
T b</w>
end- tidal</w>
O D
ad alimumab</w>
pige on</w>
ter y</w>
synth ases</w>
com ycin
no dos
psych osomatic</w>
brasili ensis</w>
T end
St ent</w>
volati les</w>
inter related</w>
H 7
pea king</w>
mictur ition</w>
Hippocamp al</w>
home odom
ifos famide</w>
1 B1</w>
Z .</w>
sc r
Hep arin</w>
Matr ig
Pop ulations</w>
con volutional</w>
Differen ce</w>
Proced ures</w>
doub ly</w>
D ry</w>
II -induced</w>
lyophil ized</w>
over laps</w>
I PA</w>
ac s</w>
PP C</w>
miR- 5
P GF</w>
K L
piper azine</w>
chemopre vention</w>
zwit teri
T ab
con versely</w>
applic ants</w>
Sma d</w>
tom ized</w>
deoxynucle oti
N SC</w>
ad duction</w>
chir ality</w>
dorm ant</w>
6 8-
pur pos
load ings</w>
Gest ational</w>
A AC</w>
neuro ticism</w>
mac ul
patient- derived</w>
homin is</w>
H5 N1</w>
Mus cul
entrain ment</w>
id ality</w>
0.0 44</w>
TGF- alpha</w>
CA R
Hash imoto</w>
Queens land</w>
un -
health ier</w>
MC H</w>
- 50</w>
PV I</w>
conn exin</w>
Glyc ine</w>
bromo -
read out</w>
supr achiasmatic</w>
Demon stration</w>
t uce</w>
parasi tism</w>
fin ds</w>
Paste u
accompan ies</w>
monocyte- derived</w>
k les</w>
18. 0</w>
j uris
M ot
1, 25-</w>
mist ak
O TA</w>
w af
flu i
micro circulatory</w>
microtubule- associated</w>
X en
under taking</w>
MR P</w>
blad ders</w>
Langmu ir</w>
sh ru
PE s</w>
F 10</w>
P W</w>
dist ention</w>
discern ible</w>
arachid onate</w>
ANIMA LS</w>
5 3.
in ner-
GI S</w>
T V
defin itively</w>
ni an</w>
sig ma
LD A</w>
MAPK s</w>
k not</w>
func tioned</w>
Pit ts
st oring</w>
LA M</w>
di odes</w>
Micro array</w>
J ones</w>
pro -</w>
Bas in</w>
mast oid</w>
Elev ation</w>
sel f
cock tail</w>
ph obic</w>
nucleoti dase</w>
implic ates</w>
acr on</w>
- 70</w>
H AP</w>
As suming</w>
hap toglobin</w>
oxygenase- 1</w>
3 35</w>
end ophytic</w>
cardi ologists</w>
ex otic</w>
2. 15</w>
morb idly</w>
adi ene</w>
cross- section</w>
biopsy- proven</w>
2 3.6</w>
A HA</w>
adi ab
degrad ability</w>
L AS</w>
in- containing</w>
An kle</w>
prokary otes</w>
ogn athic</w>
Hist opathologic</w>
19 60s</w>
C PD</w>
O vid</w>
5- az
Pro c</w>
Saf e</w>
m ally</w>
P article</w>
wh atever</w>
den oted</w>
decid ual</w>
N PS</w>
TI PS</w>
ici an-
platelet- activating</w>
spas ms</w>
i ers</w>
e dics</w>
G p
gl um
ga thering</w>
AI P</w>
199 9-
30 ,000</w>
D V
t ably</w>
is omer
pyraz ol
tri angle</w>
Com pet
chol ine-
Tox ic</w>
shad ow</w>
a ul
organ ochlor
at elec
sub tropical</w>
bulim ia</w>
gu ide
2 3.2</w>
6 000</w>
addic tive</w>
d l
stri ate</w>
six ty</w>
pi oglitazone</w>
Cis platin</w>
i osity</w>
Iris h</w>
pneum operitoneum</w>
ond yl
AB C
mon ophosph
alpha- hydroxy
3 36</w>
anc e-based</w>
Jer sey</w>
E AC</w>
SN S</w>
COX -1</w>
actinomyc et
b ounded</w>
examin ers</w>
inter mit
transp eptidase</w>
symbi osis</w>
re at
ff -
co- occurring</w>
12- myristate</w>
Vari able</w>
arsen ite</w>
pun ishment</w>
efficac ies</w>
baro receptor</w>
Fifty- one</w>
NG AL</w>
symb olic</w>
multinucle ated</w>
end ronate</w>
aver ine</w>
Platel et-
fas cin
Head ache</w>
S ti
ex pressive</w>
TGF- β
Z EB
sp ina</w>
attr activeness</w>
er lotinib</w>
las er-induced</w>
muscim ol</w>
A y
re activities</w>
Al li
cl onic</w>
I RE
del inqu
bro minated</w>
nar col
amy cin
2 9.5</w>
str aw
min ent</w>
mag na</w>
judg ement</w>
happ iness</w>
cler k
ket on
Reve als</w>
conc ise</w>
thal lium</w>
glycer o-
glycolip ids</w>
Glauc oma</w>
2 4.6</w>
5 6-
path ogen-
cloth ing</w>
ogen omics</w>
perfor ator</w>
babo on</w>
atech in</w>
L AA</w>
tur keys</w>
beta- subunit</w>
ti vel
cist ern
el o
ta sis</w>
Ran kin</w>
ofib rosis</w>
T CS</w>
NS 3</w>
GLUT 1</w>
D eg
N od
PC O</w>
Cle ar</w>
epilept ogenic</w>
3 0.0</w>
N ocardi
Typ ically</w>
t- tests</w>
n r
H 1-
f ear
beta-D- glucopyran
dichotom ous</w>
Cl ar
mon t
car d
glycol ic</w>
invari ance</w>
D ST</w>
tr aline</w>
invol ution</w>
Func tion
LT D</w>
Magne sium</w>
4 90</w>
un ambiguously</w>
ro unded</w>
fact ual</w>
EN aC</w>
anti- TNF</w>
alli ed</w>
at razine</w>
de formed</w>
Cul ex</w>
isth mus</w>
strati fy</w>
Deriv atives</w>
allo on</w>
Classi cal</w>
tor iness</w>
defec ation</w>
C 16</w>
Ar cha
Dist urb
ab scisic</w>
gu st
Ac ids</w>
leptom ening
relapse- free</w>
Bi g</w>
dor s
Camero on</w>
ost osis</w>
ze in</w>
e ably</w>
un intentional</w>
ede matous</w>
routin es</w>
chem i
circum cision</w>
pres ent
DE SCRIP
P ip
Ehrl ich</w>
C en
tr y
main land</w>
5-HT 2</w>
19. 0</w>
dissoci ative</w>
Fox p3</w>
s -</w>
low- fat</w>
fluoro metric</w>
C Y</w>
fr active</w>
PG C-1
R U</w>
pyrid ine-
caver nos
phorbol-1 3-
z hou</w>
19 68</w>
x ylo
is otypes</w>
end ole
som ething</w>
it i</w>
under served</w>
Ste p
Rep eti
cri st
surro und</w>
AC I</w>
Profil ing</w>
3 18</w>
arch i
virus- mediated</w>
M r
chemo therapy-induced</w>
Nation wide</w>
- phosphate</w>
si r
Mini- Mental</w>
explo sive</w>
An nexin</w>
adap tability</w>
promin ently</w>
Cap illary</w>
ar d-
but yl-
in ella</w>
3 4.5</w>
A poli
hypercholesterol emic</w>
Res .</w>
imp eded</w>
IL- 33</w>
2, 4,6-
cryp ts</w>
Ory za</w>
10 -12</w>
CF s</w>
arbox ylate</w>
plaqu e-
q 13</w>
mas tig
earthqu ake</w>
Z o
equiv ocally</w>
D AS
CP M</w>
AN G
alim entary</w>
lymph ocyte-
edi a</w>
p CR</w>
Ig AN</w>
gras p</w>
or der
pan oramic</w>
hep cidin</w>
SH V</w>
di amine</w>
heter otrophic</w>
consul ting</w>
arathyro idism</w>
f ears</w>
inf l
worth while</w>
a- based</w>
inser ting</w>
t ography</w>
neuro pathology</w>
stere ois
azol- 2-yl</w>
elap sed</w>
u tional</w>
ide um</w>
tent ative</w>
cat en
c occidi
D s
ba ic
branch ed-chain</w>
todd lers</w>
K Y
transpos able</w>
PCSK 9</w>
Sp ine</w>
decel eration</w>
cu ed</w>
TIV E</w>
Rayn aud</w>
c rop
micro surgery</w>
PM T</w>
p O2</w>
Lif estyle</w>
cm H2O</w>
L B
2 0.1</w>
nor th-
P rescrip
3 1.5</w>
pec ific</w>
2 3.7</w>
small- scale</w>
sarcol emmal</w>
sh all</w>
CL D</w>
ex changed</w>
sin onasal</w>
uni ons</w>
Fe wer</w>
3 84</w>
amphib ians</w>
S ampling</w>
R ange</w>
ation .
F an
pro drom
on- related</w>
resorb able</w>
M un
in correctly</w>
install ation</w>
5 20</w>
at oes</w>
neurolog ists</w>
RY GB</w>
m ative</w>
1. 81</w>
sou th-
hat ch
H NE</w>
pro st</w>
Ret ention</w>
W u
ation- -
rex ia</w>
Hum ans</w>
lav icular</w>
aff iliation</w>
p im
f ox
D ro
peri anal</w>
ech o-
deter gent-
mar sup
Sprag ue</w>
20 14-
cap ecitabine</w>
3 0.8</w>
FF M</w>
Porph yro
1. 79</w>
in- 3-
herbiv ores</w>
I d
re treatment</w>
Fe ed
chori ocarcinoma</w>
Franc isco</w>
sub epithelial</w>
1. 87</w>
40 6</w>
menstr uation</w>
destro y</w>
4 b</w>
ur ally</w>
1. 89</w>
PL T</w>
dose- limiting</w>
Qu estions</w>
PP T</w>
opi ates</w>
micro electrodes</w>
Bl ast
de an</w>
ang led</w>
Nor theast</w>
IV US</w>
V is</w>
S- adenosyl
cryst allo
p 63</w>
mer openem</w>
PR RSV</w>
2 5.8</w>
LY P</w>
bul l</w>
dermat ologic</w>
glucose- induced</w>
otom ized</w>
uro lithiasis</w>
intim ately</w>
Gau cher</w>
am id</w>
Intell igence</w>
ace us</w>
aeros ol
Lei den</w>
aphy sis</w>
yel low
anthrac ycline</w>
al um</w>
sh ik
image- guided</w>
bomb esin</w>
os ylated</w>
Man aging</w>
b es
in ding</w>
1. 88</w>
emo tionally</w>
att achments</w>
Ep is
pare tic</w>
Hormon al</w>
Hung ary</w>
longer- term</w>
organ ogenesis</w>
0.9 9
postin fection</w>
man o
a- specific</w>
L Q
T CE</w>
be er</w>
DT T</w>
immunodom inant</w>
1. 84</w>
lay er-
2.0 5</w>
fi x</w>
PO A</w>
HC Ws</w>
Lig and</w>
3 55</w>
m ere</w>
pro drugs</w>
targ et
Reg ions</w>
emp tive</w>
A AT</w>
IC M</w>
isother ms</w>
func tion-
40 9</w>
POIN TS</w>
par val
Ch im
Sk ills</w>
R ig
D rin
sub si
Dec i
enanti omeric</w>
N ex
pur ify</w>
irrit ability</w>
en er</w>
pl akia</w>
Af ter
VI D</w>
tonsill ar</w>
conc ept
Re ad
SD B</w>
Te am</w>
synovi um</w>
integr ase</w>
Ca Cl2</w>
sl er</w>
U F</w>
f owl</w>
extrav ascular</w>
team work</w>
EC L</w>
off ices</w>
Ul tr
P NP</w>
hap ten</w>
co activator</w>
heat- shock</w>
re ef</w>
Syn aptic</w>
alpha- L-
chel ate</w>
Alter ation</w>
M Z</w>
pl ana</w>
benzo yl</w>
N- cadherin</w>
sal is</w>
Bi osynthesis</w>
oscill ators</w>
il legal</w>
fa ult</w>
Muc osal</w>
spra ying</w>
congru ence</w>
Cal met
turbul ent</w>
G em
Neu rom
sub mucosa</w>
desatur ase</w>
facul tative</w>
y co
G al-
multi modality</w>
factor- I</w>
0 6
iod ine-
AV Ms</w>
PT s</w>
abor tus</w>
tent h</w>
Conform ational</w>
5 4.
5 01</w>
delib erate</w>
cy pro
ic ed</w>
Inter mittent</w>
macro -
U RES</w>
in opathy</w>
upreg ulate</w>
tu me
1.0 6-
c occus</w>
A AS</w>
am pu
equ il
HR QL</w>
special ised</w>
Pseud o
fron t-
2,4- dinitro
amin ases</w>
prop ion</w>
glucos aminidase</w>
0. 1
On going</w>
sar tan</w>
per il
tur tles</w>
single- crystal</w>
cari ous</w>
nivolum ab</w>
St orage</w>
transi tion-
confoun ded</w>
mus cl
s- old</w>
Mo Ab</w>
transist ors</w>
1. 80</w>
Transc ranial</w>
carrageen an</w>
mete orological</w>
al en</w>
ou b
HM G</w>
polyn omial</w>
intratr acheal</w>
0. 125</w>
rin one</w>
cyan obacterium</w>
dibenz o-p-
clinic al-
ze olite</w>
El ucid
DPP C</w>
nur sery</w>
metagen omic</w>
tw ist</w>
el ement-
1. 92</w>
can ines</w>
CM P</w>
Hist amine</w>
pyridox al</w>
metach ronous</w>
2 O
meth y
atis simus</w>
collap sed</w>
m Sv</w>
Ch l</w>
CA 125</w>
fiber optic</w>
T PP</w>
glyc opeptides</w>
cross- cultural</w>
trig ine</w>
sub families</w>
k cat</w>
Mem orial</w>
abdomin is</w>
p 40</w>
ph leb
lute us</w>
Coll ection</w>
Immunocyto chemical</w>
I -</w>
keto acidosis</w>
p 300</w>
3 G</w>
enumer ation</w>
in adequately</w>
policy makers</w>
co aching</w>
min ip
wet lands</w>
p ill
mus sels</w>
bac tam</w>
O HD</w>
st at</w>
perikary a</w>
un im
per methrin</w>
SE T</w>
200 3-
Of ten</w>
M NC</w>
ampl ifier</w>
suppur ative</w>
STATI STI
y an
k -1</w>
self- regulation</w>
F AM
imp utation</w>
awa kening</w>
EOR TC</w>
ofur an
5 5.
surviv or</w>
C Q</w>
ec centr
over flow</w>
bic ycl
sn akes</w>
CFU- GM</w>
form ulae</w>
Dist ress</w>
rig orously</w>
CD 44
MP M</w>
fimbri ae</w>
Mas sive</w>
Fabr ication</w>
acute- phase</w>
pastor is</w>
gon i
Tra it</w>
CK 2</w>
hygi enic</w>
PA F-
H 6</w>
meth anesulf
ber ries</w>
PRO SP
ag us</w>
Penn sylvan
4 35</w>
Transc atheter</w>
halogen ated</w>
ext ents</w>
L AMP</w>
4 9.
Le ad
phosphatidyl glycerol</w>
III- R</w>
Plac ental</w>
hypo physi
Cdc 42</w>
5 7.
stre ptococcus</w>
visu alizing</w>
Sal v
Michael is-
in consistencies</w>
intro g
ped al</w>
Consist ently</w>
S erious</w>
A symptomatic</w>
ar mam
peri- implant</w>
12 -</w>
ante l</w>
9 5.
IgG 2a</w>
W HR</w>
hel ium</w>
pa res
En anti
Competi tion</w>
y amo
v r
TT E</w>
g eal</w>
microm etast
radio iodine</w>
M J</w>
ch s</w>
Exp anded</w>
N- oxide</w>
s s</w>
z en-
fe eder</w>
handic ap</w>
CK- MB</w>
asp inatus</w>
Chrom atin</w>
pemphig oid</w>
Sub strate</w>
T DI</w>
os accharomyces</w>
centros ome</w>
H 19</w>
d C</w>
un equivocally</w>
midw ifery</w>
3 1.3</w>
wor e</w>
dihydro pyridine</w>
selen ite</w>
recir culation</w>
aminol ev
B LA
en ec
il age</w>
intra abdominal</w>
second arily</w>
CYP 1A2</w>
imp action</w>
sil k
2 6.6</w>
Color ado</w>
en ni
Zuc ker</w>
GR ADE</w>
hex ose</w>
Pitts burgh</w>
C AT
di ethyl</w>
hem odynamically</w>
Cob b</w>
CR s</w>
NI HSS</w>
Ex cellent</w>
Ag ed</w>
PROSP ERO</w>
N IV</w>
oc eles</w>
Arthro plasty</w>
amisol e</w>
f unds</w>
1. 7-
freeze- dried</w>
5 60</w>
abil ity-
spir onolactone</w>
transduc ing</w>
endometri oid</w>
Acous tic</w>
3 5.7</w>
m ural</w>
L Y</w>
amid o</w>
H a-
cont acting</w>
Ir radiation</w>
sugar cane</w>
2- dependent</w>
prost atitis</w>
dyslex ia</w>
UD CA</w>
artemis inin</w>
a hertz</w>
d otal</w>
de pressor</w>
double- blinded</w>
ou ght</w>
ari ae</w>
trache obronchial</w>
Hem oglobin</w>
Ad renal</w>
acet azolamide</w>
del im
conform ers</w>
VEGF- A</w>
Zim bab
un insured</w>
ag on</w>
alc iferol</w>
m C</w>
under nutrition</w>
ml .
phosphati dic</w>
separ able</w>
SR BC</w>
quen ched</w>
Prom otes</w>
conflu ence</w>
q 21</w>
consangu ineous</w>
semic ir
N ag
CA N</w>
PE A</w>
Math ematical</w>
ha em</w>
li ties</w>
piper az
tem ozolomide</w>
CR D4
AF B1</w>
hypop nea</w>
aggreg ating</w>
4 88</w>
appe aling</w>
T BP</w>
9 6.
pap ain</w>
I- III</w>
LE T</w>
ox antrone</w>
hormone- releasing</w>
c n
mur m
gn ath
nucle olus</w>
myx oma</w>
si rolimus</w>
ec t
Rhiz obium</w>
S et</w>
v us</w>
re forms</w>
osyl ceramide</w>
Provid ing</w>
neur on-specific</w>
leukotri enes</w>
grass land</w>
L 6</w>
G SE
phyl um</w>
Radi x</w>
optim ism</w>
ethyl ene
ji ang</w>
2 c</w>
ul ls</w>
dihydro folate</w>
inter ventricular</w>
citr ulline</w>
sphen oid</w>
o on</w>
per sic
dom ain
PI A</w>
Em bol
16 0
Hor iz
Elim ination</w>
NA S</w>
fil arial</w>
DM 1</w>
Pot assium</w>
QU ES
endos ym
SI P</w>
neg atives</w>
Fifty- four</w>
Di alysis</w>
str ide</w>
tri phosphatase</w>
non linearity</w>
full- time</w>
after load</w>
NI S</w>
anterior- posterior</w>
multi parous</w>
fil tr
excur sion</w>
eicos apentaenoic</w>
asc ial</w>
bromo deoxyuridine</w>
phosphoglyc erate</w>
CO I</w>
p ann
desi pramine</w>
anch orage</w>
Aca d</w>
y osin</w>
cam eras</w>
incur able</w>
Visu alization</w>
- I</w>
- D
T SS</w>
5 4.5</w>
post transcriptional</w>
Func tions</w>
extran odal</w>
DESCRIP TION</w>
transl uc
Contin ued</w>
commit tees</w>
2 5.3</w>
aut ocor
lipos arcoma</w>
coil ed-
- terminal</w>
2 5.4</w>
Z r</w>
ar ism</w>
il ine</w>
vacc ine-
SP- A</w>
cyste ines</w>
no ro
bacterioph ages</w>
ban ks</w>
- end</w>
Dev ices</w>
regi on
Ar ray</w>
bir th-
fellow ship</w>
d ul
ap position</w>
ak ic</w>
sph aer
caspase- 8</w>
underpin ning</w>
Taq Man</w>
d ane</w>
trans itory</w>
pod ocyte</w>
seal ant</w>
ti tu
A- 2</w>
Ho ech
ho p</w>
CI C</w>
cum ulus</w>
phyto chemicals</w>
3 26</w>
en esulf
ca ine</w>
ase- positive</w>
oreduc tive</w>
3 73</w>
bi valent</w>
cr assa</w>
Re generation</w>
angi osarcoma</w>
CCL 2</w>
3 23</w>
pot assi
Ch er
skinf old</w>
3 32</w>
w is
acetyl salicylic</w>
Hir sch
ag ro
4- hydroxy-
5-H T3</w>
3 24</w>
bin der</w>
5 HT</w>
tin -1</w>
aden itis</w>
extra ocular</w>
Porphyro monas</w>
b age</w>
Br id
EB NA
HA I</w>
dermat ologists</w>
S SS</w>
2.0 4</w>
3 0.5</w>
8 50</w>
ker n
My x
Rel atively</w>
anch ors</w>
mild-to- moderate</w>
ou mar
EC Gs</w>
Con taining</w>
Promo ting</w>
C ut
expl anted</w>
Defin ing</w>
Cole optera</w>
E im
el ithiasis</w>
sp r
ucle otides</w>
mecon ium</w>
D AL
inter- individual</w>
zym osan</w>
tom ies</w>
argin ase</w>
- 5.
mon etary</w>
med itation</w>
prol yl</w>
osulf ate</w>
6 6.
trans genes</w>
exc itable</w>
H P-
De sign
Tr ust</w>
Vir gin
tur n-
Caregi vers</w>
hypertroph ied</w>
thermo stable</w>
hypo phosphat
clear ances</w>
semin oma</w>
Arthro scopic</w>
h p
P ichia</w>
bl ack
explo sion</w>
MCF 7</w>
ep ine</w>
Ab l</w>
el ders</w>
B- mode</w>
in s
isother m</w>
laf ax
contribut ory</w>
MG MT</w>
user- friendly</w>
ent a</w>
Mod elling</w>
op tom
b 5</w>
-1 R</w>
tetra ploid</w>
RI F</w>
endonucle ases</w>
ol ium</w>
su is</w>
co- administration</w>
myofibr illar</w>
condi tion
chrom ogenic</w>
tumour -
M itral</w>
vis itors</w>
anti- oxidant</w>
alge sic</w>
Err atum</w>
IL ITY</w>
U AE</w>
long- distance</w>
Commun ities</w>
b w</w>
bio available</w>
hs a-
self- assessment</w>
Jo h
immuno therapeutic</w>
trans forms</w>
non randomized</w>
holog raph
F ts
MM T</w>
Intr aperitoneal</w>
Method ology</w>
em comit
ESW L</w>
L os
ocyt otic</w>
exc itations</w>
enhanc ements</w>
Char l
V p</w>
ac cord</w>
insi pidus</w>
tetrachlor ide</w>
K g</w>
bo osting</w>
e- cigarettes</w>
ax y</w>
metast able</w>
dermat omyositis</w>
V V</w>
und oub
MA s</w>
6 30</w>
11 C</w>
Intr insic</w>
sn ap
stun ting</w>
unil aterally</w>
motoneur on</w>
CDK 4</w>
glucon ate</w>
hyperuric emia</w>
ico tin
em e</w>
2 6.8</w>
K M</w>
PK 1</w>
Period ontal</w>
P 1-
st ayed</w>
non competitive</w>
Acanth amoeba</w>
Angi ogenesis</w>
bott les</w>
W ell
cardi olipin</w>
DL S</w>
Pharmac y</w>
em ia-
pi -
upreg ulating</w>
ebo ok</w>
Lup us</w>
ut most</w>
ing ival</w>
numb ness</w>
HI F-1</w>
Pennsylvan ia</w>
han dedness</w>
ADAM TS
8-OH- DPAT</w>
re rs</w>
Parkin son
cycl ists</w>
situ ational</w>
pil i</w>
Cou pled</w>
confidenti ality</w>
rec ep
exfoli ation</w>
Behavi our</w>
heterozyg ote</w>
Use fulness</w>
Th in</w>
end o</w>
bach ia</w>
2 5.7</w>
ib ration</w>
estim ators</w>
O 6-
Oc t
cephal ometric</w>
receptor- positive</w>
Forty- seven</w>
Extrac orporeal</w>
Bonferron i</w>
P DS</w>
e k
L RP</w>
bi l</w>
Lim b</w>
5 8.
land fill</w>
Cor relates</w>
hypo chlorite</w>
3 28</w>
em al</w>
gg ed</w>
COOH- terminal</w>
PO PU
sil ence</w>
co erc
ran ibizumab</w>
nan of
Cl 3</w>
Aden ocarcinoma</w>
e wide</w>
b olic</w>
P ene
SU MO
necess itate</w>
u alized</w>
regi onally</w>
hal ation</w>
low- intensity</w>
PG D</w>
BM P-
fel d
al- specific</w>
Ap parent</w>
A PAP</w>
ON O
clu e</w>
2- induced</w>
ens embl
l end</w>
I de
5 4-
pro peptide</w>
RB F</w>
0. 7-
ME LD</w>
post- partum</w>
Vis c
methan olic</w>
boost ed</w>
etan ercept</w>
gen ation</w>
lo th
sep ta</w>
actinomycet emcomit
Ab use</w>
n itro</w>
St an
AP PRO
Em ph
oroph arynx</w>
D DS</w>
em ide</w>
3. 75</w>
Neu tr
ir us</w>
0- 10</w>
H s
A ro
yr -old</w>
2 6.2</w>
Sh h</w>
fibrobl ast
ol ers</w>
su pers
sn ow
audi o</w>
recycl ed</w>
mon ensin</w>
ho ok</w>
50 3</w>
sulfon yl</w>
CRD4 20
t arily</w>
opoie tin</w>
E -</w>
un answered</w>
diff using</w>
45 Ca</w>
fat -free</w>
0.000 4</w>
in competence</w>
pro mastig
star ter</w>
caus ally</w>
tic -like</w>
are rs</w>
sper sed</w>
IR S-1</w>
centro id</w>
demethyl ase</w>
ag A</w>
Fifty- five</w>
bit ter</w>
Ster oid</w>
p icro
om entum</w>
squir rel</w>
perim eter</w>
domin antly</w>
ofil tration</w>
RAW 264.7</w>
2 10
S PAR
c s
mam mal</w>
DHF R</w>
cul in</w>
hyaluron idase</w>
hem olysin</w>
pain- related</w>
h oma</w>
psychi atrist</w>
thylak oid</w>
postinter vention</w>
nan ob
male ate</w>
hy pol
te dness</w>
yamo ya</w>
CA F</w>
fix ator</w>
Gli oblastoma</w>
man ager</w>
Rest oration</w>
G DF
comm and</w>
Resi d
M WT</w>
An tic
spermatog onia</w>
G m
pl en
alk enes</w>
egg -
S olar</w>
plo ids</w>
mir abilis</w>
Ax is</w>
third- generation</w>
lati t
Matrig el</w>
K 5</w>
on ics</w>
un ambiguous</w>
nitro x
photosensiti zer</w>
reg ain</w>
1 L</w>
R K2</w>
Ig G2</w>
Ont ology</w>
Discrim ination</w>
2 6.1</w>
Anti biotics</w>
apo protein</w>
gun shot</w>
R al
ore x
tic ally-
fibrobl astic</w>
50 2</w>
bacteri uria</w>
itu it
Pro l
flo od</w>
4 2.5</w>
engine er</w>
Bab esia</w>
organ -
3 5.5</w>
D er</w>
ent arium</w>
B SE</w>
Sens ing</w>
o eba</w>
ne o</w>
co- expressed</w>
Rickett sia</w>
T CR-
R XR</w>
plas mosis</w>
p ills</w>
NO S-
catar rh
su p</w>
ap hor
e ful</w>
le es</w>
m itis</w>
Histor ically</w>
hyperbilirubin emia</w>
MI BI</w>
m TBI</w>
haem odynamics</w>
multiplex ed</w>
methyl cellulose</w>
dithi ocarb
polymy xin</w>
ad h
bi ologists</w>
multi locus</w>
adren o
viol ations</w>
Hemat opoietic</w>
general izability</w>
enth usi
HI S</w>
pr ud
Michaelis- Ment
m es</w>
three- year</w>
out- patient</w>
2- ox
4- chloro
isoc itrate</w>
l op
phenyl alan
0. 25-
civ ilian</w>
aval ent</w>
bio accumulation</w>
sarcom ere</w>
lot tic</w>
b p
irradi ance</w>
Transl ational</w>
exceed ingly</w>
a HR</w>
inter sec
MA LT</w>
Vari ants</w>
multi potent</w>
C2 C12</w>
glyox al</w>
n i</w>
to tic</w>
opro st</w>
AC 1</w>
pyr ine</w>
techne tium-
S ources</w>
2 7.6</w>
high- temperature</w>
re bleeding</w>
et om
TH z</w>
tetr alogy</w>
Cd 2</w>
al d</w>
28. 8</w>
enol one</w>
P 8</w>
P 53</w>
cr acks</w>
pris tine</w>
HI P</w>
intermedi ary</w>
F uc
MC V</w>
if loxacin</w>
audi ometry</w>
myco phenolate</w>
un conventional</w>
te tran
om ission</w>
gr amin
dys men
cyst oscopy</w>
CYP2C 9</w>
mat uring</w>
contin gency</w>
min i</w>
bre vis</w>
Prote obacteria</w>
P edi
fl ashes</w>
lam in</w>
Cor responding</w>
TA R</w>
du plexes</w>
2 -19
achi an</w>
plat e-
mon op
1. 98</w>
TF II
fluoroph ores</w>
CB V</w>
tri phenyl
are sis</w>
L- cysteine</w>
cri ti
Tricho derma</w>
ul ant</w>
prioriti ze</w>
Compon ents</w>
bi refr
semiconduc tors</w>
aqueduc tal</w>
S e-
der gar
post- infection</w>
over comes</w>
TA S</w>
cur able</w>
tuber ous</w>
narrow er</w>
trin itro
tothec in</w>
4 T</w>
dis accharide</w>
poly ke
an them
Con sum
overestim ation</w>
AD PKD</w>
re perfused</w>
un pleasant</w>
tub ing</w>
Anthrop ometric</w>
29. 6</w>
E Ps</w>
PI N</w>
inform ants</w>
Neuro psychological</w>
im pose</w>
oxif ene</w>
F A-
aut oreactive</w>
inoc occus</w>
Sil encing</w>
intercal ation</w>
Fent on</w>
fri end</w>
pir ide</w>
mil king</w>
electron- dense</w>
p ush</w>
AD SCs</w>
-0. 2</w>
Cap acity</w>
b py</w>
4 .</w>
Ch ip</w>
mo fe
3 0.4</w>
inter media</w>
quit ting</w>
allevi ation</w>
simpl est</w>
H B-
N Ws</w>
re ts</w>
m RS</w>
vasodi lators</w>
nucleocap sid</w>
G- protein-coupled</w>
MP T</w>
d iterpen
har sh</w>
sens u</w>
Tran spor
Ba P</w>
prolong s</w>
incap able</w>
ac -
Bifid obacterium</w>
o is</w>
k at
gamma-glutam yl</w>
azol in</w>
miR-1 8
B lacks</w>
agre es</w>
mycel ium</w>
sal ine-
termin ating</w>
Loc alized</w>
S LI
Scot tish</w>
C in
1. 94</w>
Chrom at
19 65</w>
nic ardi
phorbol-13- acetate</w>
ess ay</w>
hyper coagul
ER s</w>
G v
Li ve</w>
orth o-
CC M</w>
innerv ating</w>
sigmo id
- 60</w>
glutam ate-
azol ine</w>
T ube</w>
pre ovulatory</w>
mot ors</w>
L- dopa</w>
2 6.4</w>
lib eration</w>
Wol bachia</w>
s unitinib</w>
CA R-
SE ER</w>
N ox
jour ney</w>
Termin al</w>
CM I</w>
gradi ent-
6- 7</w>
Fe 2</w>
2.0 3</w>
monolith ic</w>
S low</w>
encephal ography</w>
A spects</w>
Fib er</w>
un safe</w>
sub sample</w>
HB O</w>
hyph al</w>
so il-
Mut ants</w>
matern al-
lact obac
she aths</w>
60 2</w>
tachy cardi
sol- gel</w>
form ative</w>
1. 93</w>
heter ogenous</w>
ov orin</w>
Philipp ines</w>
2 6.9</w>
Ex cit
hip pur
scr atch</w>
D AR
Lact ate</w>
lafax ine</w>
s ore</w>
D W
cin ere
ig ilance</w>
psych opathological</w>
DM E</w>
Adi pose</w>
o h
as exual</w>
tex t
escal ating</w>
2 5.9</w>
hymen a</w>
3 9.5</w>
Chem istry</w>
posteri orly</w>
kynuren ine</w>
Pasteu rella</w>
5 6.
a ea</w>
ND V</w>
4 0.0</w>
Behavi ors</w>
C t
immun e-related</w>
Long er</w>
2 3.9</w>
osi ties</w>
flo oding</w>
morph ol
rob ot-assisted</w>
28. 3</w>
Bi omedical</w>
L yn
scienti fic
supr atentorial</w>
p ial</w>
g y
st al</w>
instruc tional</w>
ap re
disap pointing</w>
un conjugated</w>
A 10</w>
Electro cardi
3H- thymidine</w>
extrap ulmonary</w>
oph ora</w>
3. 5-
17 0
thyro idal</w>
reat ment</w>
U sed</w>
train ee</w>
trade- offs</w>
CaMK II</w>
3 ,000</w>
B os
thapsig argin</w>
M TS</w>
f lip
3 21</w>
SI RS</w>
P2 Y
HC Ps</w>
one- stage</w>
cohe sive</w>
hypop arathyroidism</w>
B 7
α 1</w>
hal ogen</w>
acceler ator</w>
I PS</w>
phenanthro line</w>
th al</w>
angi oedema</w>
PE D</w>
mano eu
2 2.0</w>
DO PAC</w>
micronutri ents</w>
adiab atic</w>
g st</w>
li ers</w>
Ec ological</w>
a- 3p</w>
Pos itron</w>
holo enzyme</w>
ir one</w>
En tam
29. 2</w>
mesenter y</w>
CD R</w>
nitr ates</w>
compar ability</w>
si zing</w>
S ite-
gu ard</w>
CH X</w>
oxygen ases</w>
eth nic
2 4.7</w>
optim ised</w>
toph ysin</w>
ten ofovir</w>
let tuce</w>
mimic ry</w>
STI s</w>
ot er</w>
C C-
O x</w>
thri ve</w>
am pul
og on
lear n
calcane al</w>
S f
toxic ants</w>
MD R-TB</w>
proteas omal</w>
extr uded</w>
SIGN ED</w>
hepatocarcin ogenesis</w>
I ON
L- glutamate</w>
zwitteri onic</w>
actinomycetemcomit ans</w>
vasodil atory</w>
pur inergic</w>
induc ibility</w>
radic ulopathy</w>
papill omas</w>
Cho ice</w>
4 73</w>
B t</w>
el der</w>
splin t</w>
spondyl olisthesis</w>
H AT</w>
W ITH</w>
ogen omic</w>
CD 30</w>
Biom echanical</w>
tetrafluoro ethylene</w>
od ors</w>
ori ous</w>
thalass aemia</w>
om imetic</w>
hyper active</w>
phyl a</w>
c GMP-
d abigatran</w>
asi an</w>
nanop arti
remedi es</w>
leg ume</w>
a rene</w>
anteced ent</w>
X O</w>
en rich</w>
ro ads</w>
adi um-
dor some
acclim ated</w>
- triphosphate</w>
e IF-
del icate</w>
Recru itment</w>
inf un
Alve olar</w>
Hous e
HC T1
super numerary</w>
neutr alize</w>
blast omas</w>
sulfat ase</w>
ensembl es</w>
flav us</w>
Mod e</w>
6 8.
proc urement</w>
CD 86</w>
Pro files</w>
intox icated</w>
L ati
IC Cs</w>
anaph ase</w>
Virgin ia</w>
A bo
P ress</w>
Al ign
dys biosis</w>
SR C</w>
Am mon
Dra wing</w>
3 41</w>
B CN
inter hemispheric</w>
2 4.8</w>
altern ation</w>
AD MA</w>
R eal</w>
post- menopausal</w>
ensi bility</w>
disease- associated</w>
P2 X</w>
o yl-
posi tion-
programm able</w>
-of- function</w>
H TS</w>
ful l
Depend ence</w>
I owa</w>
microscop ical</w>
b end</w>
A bility</w>
In sp
armam entarium</w>
of er
loop -
vul va</w>
T SC</w>
d -</w>
Cul tural</w>
PGF 1</w>
in- person</w>
un employed</w>
album in-
F resh</w>
B q</w>
mes o-
orbit als</w>
hypoglos sal</w>
T ween</w>
neuro anatomical</w>
Neuro imaging</w>
a 3</w>
fact ant</w>
L- lysine</w>
for k</w>
hal lux</w>
rever ted</w>
piper acillin</w>
deuter ated</w>
E gr
bo iling</w>
go od
LH- RH</w>
Entam oeba</w>
du p</w>
Orig in</w>
bi oluminescence</w>
exer ting</w>
ide- sensitive</w>
C ause</w>
7 a</w>
derang ement</w>
revolution ized</w>
platin um-based</w>
cra yfish</w>
HI F</w>
L aw</w>
c itation</w>
Th y-1</w>
ag g</w>
electro philic</w>
aw aiting</w>
olip oma</w>
Embry onic</w>
radi oluc
CO -
aor to
rheumat ology</w>
omod ulin</w>
in accessible</w>
care ers</w>
H o</w>
ar rests</w>
elic itation</w>
abro ad</w>
A PCs</w>
Aer obic</w>
Guillain-Barr é</w>
bi ocat
adult- onset</w>
B ET</w>
tal us</w>
I kappa
pent ag
riton avir</w>
fol k</w>
win ding</w>
dihydro -
GIST s</w>
photovolta ic</w>
lacc ase</w>
P od
is omeric</w>
infec ts</w>
-1 00
mos sy</w>
MALD I</w>
bl ack-
not -
under studied</w>
ICP- MS</w>
D raft</w>
tis ol</w>
happ ens</w>
O AB</w>
3 38</w>
3 1.6</w>
characteris tically</w>
n ight-
1, 500</w>
HD R</w>
Vi olence</w>
Vas cul
CD 95</w>
hyd ati
multim orbidity</w>
3 6.5</w>
K O
min s</w>
wo ol</w>
type- 2</w>
nid ulans</w>
struc ture-based</w>
NC I-
conform ity</w>
L amb
di fluoro
sulf onic</w>
end- point</w>
S SC</w>
su percritical</w>
gg le</w>
super conducting</w>
K at
or ized</w>
Ha pl
3 27</w>
necess itated</w>
certific ates</w>
T ar
5- 8</w>
macro scopically</w>
pl ague</w>
protein- 2</w>
F r</w>
Par ac
chron icity</w>
alli ance</w>
cul turation</w>
eti apine</w>
5 .</w>
5 8-
cit alopram</w>
Fifty- six</w>
4 1.7</w>
Nor dic</w>
Sec urity</w>
irrit ant</w>
tmann in</w>
RO S-
t- specific</w>
off ending</w>
B rug
Su stain
Provid ers</w>
homogene ously</w>
lute in</w>
phosphot yrosine</w>
O le
Step wise</w>
compar ator</w>
Can ine</w>
matern ally</w>
Tetra hymena</w>
3 48</w>
fic ient</w>
C SD</w>
L- carnitine</w>
deli vers</w>
Ca T</w>
O Cl</w>
in- plane</w>
log MAR</w>
1.0 7-
mul toc
P o</w>
wh ol
arteri osclerosis</w>
T y
vesi cou
ass ment</w>
diaphor ase</w>
oc re
co- ord
sulph ur</w>
PRIN CIPA
bacter aemia</w>
2.0 2</w>
CV S</w>
react ants</w>
de ma</w>
Ar ach
aggra v
disco vering</w>
Gyn ecology</w>
a den</w>
M ood</w>
un equivocal</w>
ro ot
bl ended</w>
phil es</w>
V R
optim isation</w>
Sal t</w>
HC P</w>
squ am
Under going</w>
Morph ine</w>
p si
out look</w>
hi o</w>
hypophy sis</w>
AI s</w>
sex -</w>
SAM PLE</w>
tangen tial</w>
S p</w>
3 39</w>
reson ator</w>
xyl anase</w>
cal ifor
TGF β</w>
non- fatal</w>
suic idality</w>
expect ancies</w>
ifor ms</w>
2.0 8</w>
fa ith
m assi
5 5.6</w>
arch ival</w>
fluor ine</w>
T PS</w>
serov ars</w>
lob ule</w>
wo ven</w>
ren ovascular</w>
feat ured</w>
c r</w>
x L</w>
detec tability</w>
GST M1</w>
L AR</w>
B LE
end owed</w>
legis l
o c</w>
ar m
Amon gst</w>
Gal NAc</w>
PRINCIPA L</w>
C as</w>
3 S</w>
Cul ic
depolar izations</w>
obesity- related</w>
inclin ed</w>
e w</w>
colon ize</w>
predisp oses</w>
olim bic</w>
n ate</w>
attrib ution</w>
Lepid optera</w>
alpha- MSH</w>
HCT1 16</w>
stand point</w>
Cd k
bleph aro
p ens</w>
radi i</w>
squ e
justi fication</w>
chel ators</w>
fellow s</w>
at ories</w>
ir aglutide</w>
predomin ate</w>
D oses</w>
HLA- DRB1</w>
base- pair</w>
vari ably</w>
imid azo</w>
s one</w>
PE O</w>
erythemat ous</w>
HHV- 6</w>
Sched ule</w>
R 1
fl um
Car til
F ES</w>
OR E</w>
R Rs</w>
mat ch
ST E
heter ocy
atic -
W alker</w>
J A
pea k-
antibio tic-
anteri orly</w>
tropic alis</w>
Assess ments</w>
mu M</w>
Fix ation</w>
P is
syn dro
Mon tre
UNA S
p 50</w>
electro convulsive</w>
HC O</w>
TX A</w>
UNAS SIGNED</w>
S FA</w>
sub stratum</w>
s-- a</w>
val erate</w>
I SR</w>
3 -19
schwann omas</w>
logarith m</w>
m t</w>
V SV</w>
anis h
Transl ation</w>
r udi
arri ved</w>
Mn SOD</w>
filari asis</w>
P X
de hydrated</w>
Fu k
H -1</w>
4 G</w>
be rel
des erve</w>
bu oy
fin s</w>
ste wardship</w>
Inte rest</w>
refrac toriness</w>
pedi cled</w>
A pl
Ga As</w>
bottlen eck</w>
intr a</w>
S ites</w>
micro satellites</w>
end- expiratory</w>
kin ins</w>
nov ice</w>
Hemorrh age</w>
Haz ard</w>
col or
l ane</w>
7- 10</w>
transl ationally</w>
APPRO ACH</w>
am acrine</w>
re pulsion</w>
g ate
V 4</w>
al ise</w>
hem e-
H ox</w>
audi ence</w>
as i</w>
ocl avicular</w>
SB A</w>
star s</w>
ic ations</w>
my oblast</w>
gly phos
wild type</w>
sub urban</w>
1. 97</w>
Nat l</w>
3,4- dihydroxy
Cad mium</w>
apr ide</w>
mortal ities</w>
as sion</w>
mid point</w>
anat om
Michaelis-Ment en</w>
Seventy- five</w>
S PA</w>
valu ation</w>
50 4</w>
r ul
SI T</w>
Com mon
MM N</w>
F NAC</w>
post natally</w>
IB M</w>
convers ations</w>
nicardi pine</w>
air craft</w>
Dis charge</w>
accum ulations</w>
IL 2</w>
scaff olding</w>
U U
viol et-
irrig ated</w>
multoc ida</w>
her m
arthro pods</w>
branch ial</w>
reverse- phase</w>
tot al-
Tib etan</w>
loc alizations</w>
Apoli poprotein</w>
fir st-</w>
nu ts</w>
fulle rene</w>
b .</w>
im perfect</w>
ME N</w>
arte facts</w>
w iring</w>
replic ation-
T Z
0- 3</w>
gam etes</w>
RB D</w>
E o
F luoresc
phyl lo
mol .
DL B</w>
ofl ag
un even</w>
oph ore
14- day</w>
bi ventricular</w>
bl es
autop sies</w>
ag ly
dr ill</w>
3 29</w>
Z ea</w>
dec oction</w>
exam ic</w>
azo ospermia</w>
gener ators</w>
ment oring</w>
pector alis</w>
S HP
p ed-
V an</w>
est rel</w>
tyr amine</w>
Notch 1</w>
mofe til</w>
pa ve</w>
oscill ating</w>
disulph ide</w>
2 1.0</w>
J s</w>
sup ran
conduc tances</w>
ap ath
fol iar</w>
drug- eluting</w>
guinea- pigs</w>
2 R
abs orb</w>
comp assion</w>
non verbal</w>
e h
L ine
2 n</w>
tachy arrhythmias</w>
age able</w>
Fifty- three</w>
phen ol-
degrad es</w>
azol es</w>
olym phatic</w>
POPU LATION</w>
H NC</w>
G d
aff ection</w>
process or</w>
VL BW</w>
Rac ial</w>
CH O-
L- selectin</w>
la den</w>
heur istic</w>
fo il</w>
fabr ic</w>
Cy cle</w>
S HR
M ess
gelatin ase</w>
p o</w>
ang inal</w>
issu res</w>
var ial</w>
STATISTI CAL</w>
bootstr ap</w>
igh ted</w>
29. 9</w>
DSM- III-R</w>
meticul ous</w>
b anded</w>
incarcer ated</w>
on itoring</w>
Gen otype</w>
Int act</w>
ic als</w>
High- dose</w>
hal o
K el
200 2-
A 8</w>
sou thwestern</w>
b ent</w>
G PI
osyn aptic</w>
us tine</w>
AI H</w>
20- 40</w>
6 1.5</w>
co expressed</w>
system -
C atheter</w>
2 5.2</w>
N S-
ro of</w>
ol ian</w>
desi c
sett lement</w>
Res ult</w>
aph y</w>
anti- VEGF</w>
thyro toxicosis</w>
p EF</w>
μ l</w>
Vene zu
in coming</w>
inter spersed</w>
O hio</w>
Eim eria</w>
elec ted</w>
Ch ir
data- driven</w>
ever olimus</w>
od in</w>
Smad 3</w>
Charl son</w>
loth o</w>
CS M</w>
b erberine</w>
alk ylated</w>
gon ad</w>
Sec tional</w>
em an
envelop ed</w>
HI F
oro lac</w>
Ver tical</w>
17 beta-estradiol</w>
substanti ate</w>
but aline</w>
SSR I</w>
ilin ear</w>
M P-
hal ves</w>
G 1-
dec ol
Heal th-
2.0 6</w>
Hoech st</w>
6 1-
1. 90</w>
hydro quinone</w>
aren a</w>
non- malignant</w>
six- month</w>
for tification</w>
l atissimus</w>
4 25</w>
form amide</w>
LY 294002</w>
con genic</w>
MI P-1
prison ers</w>
under lines</w>
somat ost
sphincter otomy</w>
str ings</w>
ech in
oste oblast
caspase- 9</w>
Stri kingly</w>
l .</w>
o plankton</w>
2 7.7</w>
ad ductor</w>
1. 91</w>
eti opathogenesis</w>
nucleotide- binding</w>
w ines</w>
2.0 7</w>
G Y
comp ly</w>
amni on</w>
oc tam
allel e-specific</w>
emp fer
scintil lation</w>
ble m</w>
v ille</w>
ul lin
form alism</w>
ran ks</w>
injur ious</w>
We in
E t</w>
w all-
tonsi l</w>
N if
trans ected</w>
Pre ferred</w>
Plat form</w>
calcin osis</w>
Di verse</w>
Nan os
dec tomy</w>
MA M</w>
chlamy dia</w>
lactobac illi</w>
T- helper</w>
erro r-
25 0-
Calmet te-
1- week</w>
interpol ation</w>
v end
ren z
TI L</w>
Cd S</w>
intellig ibility</w>
6 6-
homogen ization</w>
sap onin</w>
mesh work</w>
pulsed- field</w>
dig ests</w>
ever sion</w>
inform ational</w>
hyper reactivity</w>
aden omy
Morph ometric</w>
big ger</w>
hos tility</w>
mercapto ethanol</w>
V in
high- income</w>
Over view</w>
tis ation</w>
insul ator</w>
glycin e-
cerul oplasmin</w>
SI M</w>
F RA
closed- loop</w>
apolipo proteins</w>
rec ur</w>
Ex cess</w>
Initi ation</w>
6 32</w>
Sep arate</w>
par af
mon oton
10 9
Pro blem</w>
adren om
Forty- nine</w>
q i</w>
er s-
oc iliary</w>
L MICs</w>
ut a</w>
sc ant</w>
id ers</w>
sub thalamic</w>
ven e
uro logists</w>
ampl ifying</w>
E2 F</w>
ase- producing</w>
Inter val</w>
relax in</w>
nano structure</w>
Fabr y</w>
knock -out</w>
tonsi ls</w>
N- glycosylation</w>
-0. 3</w>
00 2</w>
flic k</w>
l agged</w>
L AC</w>
R ome</w>
B MS</w>
hyper thermic</w>
clar ifying</w>
C ode</w>
Mar row</w>
Over weight</w>
T 4
te thering</w>
parallel- group</w>
enter ovirus</w>
Orth op
m um</w>
5 9.
Stud ying</w>
repl en
obac tam</w>
rap id-
aden o-associated</w>
ich thy
den uded</w>
imidazol ium</w>
U TIs</w>
pec toral</w>
eradic ated</w>
Mob ility</w>
symb ol</w>
Method ological</w>
s k</w>
Au -
pancreatico duodenectomy</w>
Algorith m</w>
electro mechanical</w>
down regulating</w>
ket anserin</w>
C AC
P un
ed r
DD E</w>
protr usions</w>
6 -19
poly electrolyte</w>
R- mediated</w>
pre- treated</w>
Schiz osaccharomyces</w>
per col
mang ro
- and</w>
ro si
propag ate</w>
contro l-
mod el
amni os</w>
antin uclear</w>
B3 LYP</w>
fibrom atosis</w>
Montre al</w>
al pine</w>
ent -based</w>
Tim ing</w>
id inium</w>
growth- promoting</w>
Calmette- Gu
3 37</w>
anaesthe tics</w>
00 01</w>
eph edrine</w>
CP 2</w>
MB F</w>
later alized</w>
handic apped</w>
s wee
in born</w>
di zation</w>
uc k
tum orous</w>
5 30</w>
ma ys</w>
all ant
N RT</w>
os ine-
gro oming</w>
PA -induced</w>
Gen omes</w>
conve y</w>
B AF
un ya</w>
EB RT</w>
Mer cur
self- reports</w>
CF C</w>
caspase- 1</w>
astr in</w>
an icol
og astro
hot spot</w>
oph aryn
NA G</w>
SO FA</w>
chrom ogranin</w>
normal ity</w>
refuge e</w>
double t</w>
nymph s</w>
hem in</w>
Mech an
Muscul oskeletal</w>
un structured</w>
av ement</w>
Br -
t all</w>
ophyl l</w>
Aff inity</w>
para haemolyticus</w>
condu its</w>
PET- CT</w>
Z NF
0.0 30</w>
f o</w>
ent angl
PD B</w>
til apia</w>
Vir uses</w>
IGFB P-1</w>
big gest</w>
recti fier</w>
CD 80</w>
P ed
NA L</w>
CO RT</w>
Ob served</w>
neurop il</w>
sympath ectomy</w>
In trig
Ex change</w>
Child- Pugh</w>
C W
hom ologies</w>
phosphor ic</w>
B eng
enc ycl
19 th</w>
NC C</w>
Ba 2</w>
osteoclast ogenesis</w>
conduc tor</w>
set -up</w>
Meas ured</w>
teen age</w>
M arg
put atively</w>
ph a
rot um</w>
f use</w>
3 O4</w>
is oxazol
9 4.
Impro ves</w>
g luteal</w>
4 54</w>
chol elithiasis</w>
deriv es</w>
iod ination</w>
communic ative</w>
atelec tasis</w>
Fibr illation</w>
Appl ied</w>
L C3</w>
3 51</w>
re med
destin ation</w>
epir ubicin</w>
S ear
hypo kalemia</w>
ign -
hydr alazine</w>
Fi el
H ur
extr adural</w>
w ing
NA B</w>
1.0 8-
28. 9</w>
purch ased</w>
Kre bs</w>
re inst
F asci
25 ,
di aries</w>
transcriptom es</w>
u PAR</w>
N- acetyl</w>
photo acoustic</w>
stear ic</w>
sub regions</w>
phen -yl</w>
50 ,
alc ogen
R BP</w>
az en
gon ococcal</w>
least- squares</w>
Exec utive</w>
ADP-rib osylation</w>
8 -12</w>
att a</w>
organis ed</w>
Inc id
A gon
G M-
multi valent</w>
wal ked</w>
aff ec
Re fer
shell fish</w>
T rib
inter chang
benz imidazole</w>
Cr uc
ness ing</w>
ster ically</w>
AM F</w>
dox orub
natri uresis</w>
Usu ally</w>
prognos es</w>
Adju stment</w>
oste oid</w>
angiotens inogen</w>
car bodi
1- --
T SC
muc ins</w>
apro tinin</w>
nanocarri ers</w>
ox acillin</w>
spir ituality</w>
9, 10-
ill ic</w>
opon tine</w>
micro structures</w>
corti co-
SD A</w>
e ed</w>
N -1</w>
experi ential</w>
ger man
contamin ating</w>
L yt
chrom osom
dil ection</w>
8 -19
ED SS</w>
lo vastatin</w>
RO Is</w>
nucle oprotein</w>
re entrant</w>
macro cyclic</w>
Pneum onia</w>
cTn T</w>
i demic</w>
re entry</w>
surviv als</w>
HIF-1 alpha</w>
L ayer</w>
O PD</w>
N ations</w>
ren es</w>
micro angiopathy</w>
novi al</w>
plat e
Compl ement</w>
H es
2 4.9</w>
immuno therapies</w>
pyr if
re volution</w>
Mo tiv
acchar ides</w>
Al umin
Vec tor</w>
ann els</w>
os pores</w>
fibro ids</w>
amb er</w>
en g</w>
ev al</w>
some one</w>
Micha el</w>
pro ficient</w>
antibody- mediated</w>
St ate-
high- molecular-weight</w>
ci ans</w>
late- stage</w>
tetram eric</w>
spaw ning</w>
s now</w>
3 58</w>
ser traline</w>
prov oc
decon volution</w>
1 G</w>
anti emetic</w>
Ber lin</w>
Tes la</w>
2 7.2</w>
3 88</w>
1- 42</w>
osy nostosis</w>
punc tate</w>
L T-
3 34</w>
rop in</w>
adren als</w>
rid ges</w>
O reg
4 -19
om ni
dro p-
3- week</w>
fluoresc ently</w>
enop tera</w>
narrow ed</w>
Socio economic</w>
C ETP</w>
AF S</w>
Mut ational</w>
HF pEF</w>
A SE</w>
ibr ated</w>
Asc aris</w>
minim ise</w>
swim mers</w>
L MA</w>
arch es</w>
vor iconazole</w>
W heat</w>
on colytic</w>
ab alin</w>
23 S</w>
prot otypical</w>
stru ggle</w>
in- related</w>
immunoglob ul
labyrin th
MyD 88</w>
Con flic
advoc ates</w>
ep in</w>
Ex clusion</w>
reproduc ibly</w>
PA X
low- quality</w>
som n
Five- year</w>
Quanti tation</w>
interven e</w>
mis folded</w>
iform es</w>
inter rater</w>
lymph atics</w>
AR B</w>
fluoresc e
Sar co
Th o
GP a</w>
Lank a</w>
con cave</w>
mit ophagy</w>
top yran
inform ation-
anaerob es</w>
str ained</w>
An ten
promis cu
chec ks</w>
conven i
osyl -</w>
K V</w>
undoub tedly</w>
colpos copy</w>
syn tactic</w>
open ings</w>
O E</w>
M- mode</w>
on- induced</w>
beta- oxidation</w>
CT G</w>
enox aparin</w>
Pre mature</w>
S b
IgG 3</w>
Mil itary</w>
H air</w>
I tem</w>
su it</w>
multi channel</w>
scre en-
md x</w>
prioriti zation</w>
immun ogold</w>
bur sa</w>
DSM -5</w>
sub division</w>
one- based</w>
PK U</w>
crani oc
V NS</w>
ven ography</w>
d UTP</w>
poly g
P 1
un itary</w>
P- value</w>
60 9</w>
On cor
ser ine-
inter ferences</w>
GI C</w>
Path ogenic</w>
A do
al endronate</w>
2. 1-
CD T</w>
antigen ically</w>
upreg ulates</w>
Non- invasive</w>
3 56</w>
os e
pre mise</w>
i- squared</w>
ion omycin</w>
D aph
ren z</w>
prefer ring</w>
w alk
IC F</w>
B ed
inter group</w>
stabil izer</w>
Mu LV</w>
deoxynucleoti dyl</w>
S cor
Emplo ying</w>
T F-
v ault</w>
J C</w>
ro ten
to ad</w>
sem is
TI MI</w>
para ox
VL Ps</w>
leach ate</w>
h s</w>
B I-
aster ide</w>
chi 2</w>
ver tex</w>
loc ating</w>
comp eted</w>
Al u</w>
monophy letic</w>
Down regulation</w>
t 2</w>
O HCA</w>
Questionn ai
ung unya</w>
tung sten</w>
Fibro blast</w>
O FF</w>
restr aints</w>
Sle ep
pyrro l
tough ness</w>
vir al-
MP H</w>
pra vastatin</w>
embran ous</w>
c anti
D PI</w>
acces sion</w>
n um
oc aly
ther anos
hyperpolar izing</w>
carri er-
Dise ase-
T OR</w>
pap averine</w>
Y ou
A PR
per ineural</w>
Hed gehog</w>
T issues</w>
RA ST</w>
all- trans</w>
vol ar</w>
Pub med</w>
E PSPs</w>
6 3.
T in
L SD</w>
K it
weigh t
PF O</w>
Intr al
leptos pirosis</w>
et uses</w>
inter species</w>
yp yr
resi stin</w>
coron a</w>
amib i</w>
wo ody</w>
well- controlled</w>
oli pos
men th
nanoc lu
Echocardi ographic</w>
dorsome dial</w>
oph ot
interleukin -10</w>
repeat able</w>
convers ation</w>
6 4.
17 β-
homocyste inemia</w>
ophil in</w>
squ are-
osy stemic</w>
C GP</w>
oth rom
English- language</w>
lim bal</w>
SE -
chie fly</w>
Establ ishing</w>
3 0.6</w>
mm -
s ong
U k
mes ylate</w>
6 40</w>
non polar</w>
CO S-
spac ers</w>
Tot ally</w>
glut en-
propi on
Att achment</w>
desic cation</w>
alpha- induced</w>
pren eo
pri t</w>
seque stered</w>
stimul ators</w>
Mer kel</w>
M ant
vo rous</w>
rest aur
gal lium</w>
nephro toxic</w>
8 8.
un coated</w>
NE P</w>
j ury</w>
Ex tract</w>
Fr uc
nas ogastric</w>
yl -</w>
ca red</w>
gl acial</w>
disco ideum</w>
bot anical</w>
coiled- coil</w>
c in</w>
sev enteen</w>
restric ts</w>
sti ff</w>
optim ise</w>
glyco si
tryp tase</w>
st ock
gr ant</w>
correl ative</w>
ac ked</w>
V NTR</w>
N CAM</w>
re feeding</w>
cyt ogenetics</w>
fec ture</w>
d u</w>
pre dilection</w>
sensiti ze</w>
robo ts</w>
attrac ting</w>
S SD</w>
3 31</w>
PC r</w>
bro aden</w>
G U
tic ula</w>
Surviv ors</w>
ag am
stereotyp ed</w>
t yro
NT M</w>
oc tap
r umination</w>
al oric</w>
par ties</w>
W GA</w>
2- macroglobulin</w>
overex press</w>
Pap anicol
cough ing</w>
s d</w>
chromo phore
oc entric</w>
ari ous</w>
tit les</w>
ophthalm ologic</w>
ta ut
Pa rent</w>
V RE</w>
re operations</w>
ch al</w>
enc ement</w>
PL s</w>
Mar yland</w>
polypo id</w>
underpin nings</w>
ethyl amine</w>
RD W</w>
canal icular</w>
S taining</w>
fl ud
Immun op
Emph asis</w>
ra emia</w>
ophysi ology</w>
chin ensis</w>
thyroid- stimulating</w>
obtur ator</w>
Eth nic</w>
non- B</w>
lubr ic
A spar
W AF1</w>
AD G</w>
single- chain</w>
nutri ent-
promin ence</w>
osensi tive</w>
4 68</w>
em ig
cf DNA</w>
correl ational</w>
recti fying</w>
de afferen
sp inous</w>
phy sis</w>
ar med</w>
40 ,000</w>
deoxynucle otides</w>
An atomic</w>
mel on</w>
Ab bot
spind le-
pyrif os</w>
por tr
ov ani</w>
EM F</w>
Tri ticum</w>
Lymph ocytes</w>
morph ine-
hal o</w>
macro lides</w>
adsorb ents</w>
trans well</w>
5 3.3</w>
pent oxifylline</w>
Cy A</w>
scru tiny</w>
n y</w>
Me eting</w>
dendrim ers</w>
ot gun</w>
Medi um</w>
b ell</w>
L L-
be am
NO x</w>
remin der</w>
spec ifying</w>
tuber cular</w>
3 85</w>
5 8.3</w>
neuro development</w>
spe aker</w>
Sol id-
dysmorph ic</w>
ear um</w>
Com orbidity</w>
bor reli
aph thal
sett led</w>
insuff lation</w>
5 10</w>
5 2.
ath on</w>
St ages</w>
leg umes</w>
short ness</w>
str ia</w>
PS M</w>
hsp 70</w>
manoeu v
Ne igh
alve oli</w>
decom posed</w>
5 alpha-
5 9-
flav one</w>
alc ium</w>
P inus</w>
N erv
G angli
B 1-
micro cos
ethyl ammonium</w>
cy t</w>
multi scale</w>
dic arboxylic</w>
epist axis</w>
dec ellul
multi plic
oyst er</w>
1 p
w ound-
28. 2</w>
self- control</w>
UV -induced</w>
Batter y</w>
Re activity</w>
otox igenic</w>
dy sen
di o
Ch o</w>
L AM
I K</w>
S tom
D AA</w>
br it
inte restingly</w>
idi zed</w>
LOG ICAL</w>
disc arded</w>
glyco conjugates</w>
exchang eable</w>
stereo chemistry</w>
3 1.8</w>
substitu ting</w>
depl eting</w>
osseo integration</w>
8 A</w>
com man
Anesthesi ologists</w>
mannos e-
ME -
A- mediated</w>
reconstruc ting</w>
p ond</w>
C US</w>
d amping</w>
no ti
amplic ons</w>
Commerc ial</w>
6 5.
spher oid</w>
Viet nam
ED L</w>
lute a</w>
Contr ast-
f r</w>
mus sel</w>
psych ogenic</w>
nim odipine</w>
Re ading</w>
alpha- synuclein</w>
ca u
.00 6</w>
gas- phase</w>
pa yer</w>
om ectomy</w>
hyper secretion</w>
Cr ude</w>
carbox y</w>
S un
al together</w>
pon ds</w>
digesti ble</w>
- catalyzed</w>
X pert</w>
BM s</w>
viol ation</w>
aminopyr idine</w>
semicir cular</w>
2- amino
ophil es</w>
Det ecting</w>
hin dr
inter s</w>
Pro duct</w>
psych ic</w>
glass y</w>
un remarkable</w>
daun orubicin</w>
SC G</w>
Bel gian</w>
ure mia</w>
P et
in ator</w>
ed o</w>
angi omy
mid- term</w>
cereb ell
Abo ve</w>
G HD</w>
perfec ta</w>
resur facing</w>
er ol</w>
thromb ospond
Fac ebook</w>
inev itably</w>
synap tophysin</w>
Br agg</w>
E ll
Tr kB</w>
metabol ize</w>
fo etus</w>
SR H</w>
IV M</w>
IP SS</w>
tab ulated</w>
pre pro
Proced ure</w>
Upreg ulation</w>
anti pyrine</w>
co t</w>
CT R</w>
ve d-
Ca used</w>
Chr on
CO 3</w>
hind brain</w>
is er</w>
29. 3</w>
CI P</w>
III- IV</w>
knowled ge
insti lled</w>
gr asping</w>
van comycin
pro polis</w>
line zolid</w>
piper idine</w>
I cel
R equi
pl antation</w>
bin ders</w>
hydro chlor
imp ending</w>
HSP 90</w>
t s-
mo ul
ram us</w>
J ac
don ovani</w>
9 7.5</w>
2. 5-fold</w>
agg rec
disul fide-
did n</w>
S HS</w>
per id
rhe ology</w>
arrhyth mogenic</w>
repeat ed-
av itary</w>
000- fold</w>
TRAI L-
F -</w>
radic al-
Ur d</w>
3 46</w>
con i</w>
pati c</w>
Cyt omegalovirus</w>
1. 99</w>
reduc ed-
reticul ocytes</w>
co administration</w>
lec tures</w>
G ER</w>
ysi a</w>
single- channel</w>
glucuron idation</w>
myot onic</w>
3 68</w>
respon dent</w>
Per for
Difficul ties</w>
rele as
TUR P</w>
F atal</w>
9 3.
TIM P-2</w>
D ox</w>
run g</w>
A- 4</w>
hom icide</w>
head -to-
a ena</w>
Psych ometric</w>
12-O-tetradecano yl
lab s</w>
-0. 4</w>
pum ped</w>
Rob otic</w>
U N</w>
4 12</w>
por a</w>
hydr amnios</w>
preclud ed</w>
R GC</w>
un ruptured</w>
ver si
glyc osphing
aer o
hyp nosis</w>
fluoro quinolone</w>
Trans well</w>
anesthesi ologists</w>
Ix odes</w>
B -induced</w>
re implantation</w>
normo thermic</w>
pro pen
AC TH
scop ies</w>
aqu ine</w>
600 E</w>
Oncor hynchus</w>
de w</w>
psych oses</w>
tol l-like</w>
K ol
mal ic</w>
eli i</w>
Par adox
lib erated</w>
9 th</w>
fove a</w>
c i</w>
hydro lysates</w>
triti um</w>
PH B</w>
agonist -induced</w>
New born</w>
S PA
az osin</w>
grad ely</w>
immun izations</w>
myo epithelial</w>
N PH</w>
re pository</w>
mis classification</w>
MMP 9</w>
des -
neighb ors</w>
occip it
hel met</w>
S- nitros
stabil isation</w>
Su peroxide</w>
coagul ase-negative</w>
out liers</w>
St aff</w>
SV C</w>
injec t</w>
intran uclear</w>
- 0.1</w>
J os
Fer mi</w>
M 2-
py ogenic</w>
N ST</w>
vol can
rs 1
28. 4</w>
zip per</w>
organ ophosphate</w>
m -2</w>
mening o
28. 1</w>
a ison</w>
Zimbab we</w>
umb ers</w>
FK BP
2 7.1</w>
sen esc
NH 4
anch or
impro per</w>
Intra ocular</w>
ind oles</w>
on er</w>
ST EM</w>
atr e</w>
co transport</w>
relap sing
e Health</w>
ex tir
hydrogen- bonding</w>
3 52</w>
s ory</w>
M SC
8 9.
mat a</w>
sulf ation</w>
repar ative</w>
remed y</w>
ir amate</w>
5- year-old</w>
S tern
par alyzed</w>
A- 3</w>
Sixty- four</w>
goal- directed</w>
8 5.
q -
com post</w>
contain er</w>
3 96</w>
oc la
par ab
oper ons</w>
bor onic</w>
je op
c p</w>
epox y
Adri amycin</w>
h aptic</w>
op neum
T f</w>
Rec ogn
PR K</w>
Inser tion</w>
i vir</w>
2 7.4</w>
wet tability</w>
Consider ations</w>
til ted</w>
time- series</w>
act yl
1, 3,
Decre ase</w>
Dri ven</w>
ro und
2. 10</w>
stro ke-
Ne eds</w>
8 4.
mor i</w>
Modi fications</w>
str onic</w>
dr y-
Thrombo sis</w>
fl ying</w>
lac eration</w>
ur so
dec ayed</w>
to es</w>
resi s
astro glial</w>
ortholog s</w>
3 62</w>
3 5.3</w>
A GS</w>
gu ai
I onic</w>
3 6.8</w>
B IA</w>
eri atr
but ton</w>
rein hard
par then
ros ettes</w>
3 47</w>
A propos</w>
ul na</w>
r iding</w>
T n</w>
ometr ical</w>
otrop h</w>
cas ual</w>
Phot odynamic</w>
peptide -1</w>
if ts</w>
lev ator</w>
EM D</w>
DN R</w>
7 7.8</w>
Op tic</w>
RNA- mediated</w>
Aff ect</w>
dor sum</w>
5, 7-
SI V
correspond ingly</w>
mon ogenic</w>
car vedilol</w>
chimpanze e</w>
p illar</w>
RO CK</w>
Predic t</w>
fibrom a</w>
L TA</w>
organ -specific</w>
2, 6
Nem at
o chrom
Pre incubation</w>
approxim ations</w>
tob ac
miR- 29
kil ogram</w>
lacun ar</w>
T AL
om p
Per sian</w>
cry oglob
cd c
M CT
com min
hyper kalemia</w>
epitheli alization</w>
Smad 2</w>
oph ile</w>
Ca esarean</w>
26 ,
muscul aris</w>
f id
Res veratrol</w>
2. 75</w>
alb opic
NAD H-
otroph oblast</w>
ec ologic</w>
ob liqu
Plas tic</w>
ana x</w>
homeodom ain</w>
kern els</w>
Per sistence</w>
carbox amide</w>
Rheum atology</w>
cyt arabine</w>
lam eness</w>
Ig M-
LD LR</w>
leuc ovorin</w>
Jord an</w>
whole- brain</w>
ag rel
sc rat
li pot
pr ism</w>
Chr ys
IK K
adeno viruses</w>
m -based</w>
dist antly</w>
fer redoxin</w>
don ia</w>
recogn ise</w>
Ha CaT</w>
Sol utions</w>
lipopol ysaccharides</w>
excit otoxicity</w>
best- corrected</w>
a uro
acti le</w>
surro gates</w>
Caffe ine</w>
SL T</w>
IO Ls</w>
S Ps</w>
J E</w>
gastr ulation</w>
E K
K ATP</w>
happ ened</w>
l .
I MS</w>
is ob
mit oxantrone</w>
s. d.</w>
Wistar- Kyoto</w>
T RO
col l</w>
all ylic</w>
random isation</w>
scientific ally</w>
neuro ectodermal</w>
concentration- response</w>
D CD</w>
S- R</w>
DE A</w>
12- year-old</w>
DN s</w>
Stro mal</w>
immunosuppress ant</w>
Papanicol a
K ur
Ap o</w>
re activated</w>
lipo philicity</w>
S 1-
E gg
B eg
AC E2</w>
lam o
4 3.5</w>
3, 0
arthro pod</w>
cycl ical</w>
icul i</w>
leuk aemic</w>
DB T</w>
SR IF</w>
abor ted</w>
tubulo interstitial</w>
10 8
clock wise</w>
rin us</w>
C CP</w>
3 54</w>
Fra ilty</w>
C G-
7 8.
posit ories</w>
3 0.3</w>
es thesia</w>
2. 13</w>
long standing</w>
immunop ositive</w>
cd c2</w>
0- 4</w>
V- 3</w>
dissoci ate</w>
Gu ide</w>
Po rous</w>
P2 Y</w>
ligh ter</w>
numer ic</w>
S ports</w>
R X
saf egu
fro zen-
magn ocellular</w>
ond -
Com plex
vibri o</w>
S ab
beta-hydroxy steroid</w>
G HR
Mt b</w>
scho oling</w>
Metast ases</w>
intrap ulmonary</w>
dorsi flexion</w>
rec A</w>
chor dom
M MS</w>
ig s</w>
f ighting</w>
D r</w>
E 1
atr ac
resol utions</w>
synapt osomal</w>
g B</w>
4 0.5</w>
distr actor</w>
Psychi atry</w>
J 2</w>
Phosph ate</w>
co infected</w>
mobil ities</w>
hs CRP</w>
ophag ocytic</w>
Immun ost
Therap ies</w>
Rh in
- and-
s ell</w>
over active</w>
withdraw ing</w>
conduc ive</w>
Tre pon
- nucleotidase</w>
L PC</w>
al ene</w>
ac ade
specific s</w>
Ther mod
streptavid in</w>
cardio protection</w>
in- patient</w>
benz yl-
wean ling</w>
ophthalm ological</w>
tar sal</w>
rh ab
clos ures</w>
iso prost
PON 1</w>
a is</w>
Endos copy</w>
parent- child</w>
neurotroph in</w>
19 50</w>
IC V</w>
commis sural</w>
ch ur
comm encement</w>
PD D</w>
four th-
MV s</w>
coar se-
hum idi
2. 14</w>
categor ised</w>
sub fractions</w>
E stradiol</w>
s in-like</w>
3 2.4</w>
pa use</w>
parti tioned</w>
Instrum ent</w>
e pers</w>
lin s</w>
anil ide</w>
g hosts</w>
P ec
non- parametric</w>
-re mitting</w>
opson ized</w>
um ent</w>
cu ticular</w>
homodi mer</w>
omet allic</w>
flatten ing</w>
9 3.3</w>
respon d
V OR</w>
LD s</w>
R equ
D J
un suspected</w>
3 1.4</w>
ure as</w>
syn ten
Al bumin</w>
IC a</w>
oly tics</w>
I VA</w>
Sou th-
3 1.2</w>
w ounded</w>
ain flu
pol yt
loc ality</w>
ation al-
ESB L-
Q O
bur ne
Post traumatic</w>
individu al-level</w>
purch asing</w>
or -induced</w>
reinnerv ation</w>
mamm ograms</w>
ellip s
clu b</w>
nutri tive</w>
evol ves</w>
St ock
D a
DE R</w>
neighbour hood</w>
SC M</w>
er- like</w>
erythro cytic</w>
B asi
ic idin</w>
MI M</w>
horiz ontally</w>
active- site</w>
Veter inary</w>
O u
c ush
thre ad</w>
coag ulated</w>
Le sion</w>
Sixty- two</w>
Biop sies</w>
8 3.
ir -
syn dec
dispens ed</w>
Ass ays</w>
Lept ospira</w>
albopic tus</w>
R ac</w>
A F-
cl en
ow els</w>
equ i</w>
icardi um</w>
harb ors</w>
orbit ofrontal</w>
F T4</w>
H ib</w>
ut ter
electro spinning</w>
insuffici ently</w>
p v.</w>
os molar</w>
osteo arthritic</w>
poly ester</w>
cle arer</w>
Analy zing</w>
N N
8 8.9</w>
In domethacin</w>
0 9
men tion</w>
14 th</w>
Reg ulates</w>
F ear</w>
U p-
or tical</w>
tax ol</w>
cholec alciferol</w>
cel y</w>
sc ram
oz on
ind entation</w>
typh i</w>
C 3-
kin dergar
Sh ock</w>
min k</w>
sens ory-
yt openia</w>
ocy steine</w>
categor ize</w>
Z one</w>
co ol</w>
1. 00-
ubi quinone</w>
un ia</w>
pres urgical</w>
anti diuretic</w>
ret te</w>
keto profen</w>
found ations</w>
gambi ae</w>
man ageable</w>
N KG
6 3.6</w>
SL Ns</w>
y rene</w>
N CI</w>
con form</w>
40- 50</w>
Cour se</w>
mac ros
Cost a</w>
avi d</w>
equilib ria</w>
As n-
SE R</w>
acetab ulum</w>
herm aph
CI T</w>
Orb ital</w>
8 6.
2. 12</w>
IP L</w>
PH A-
co d</w>
Me dial</w>
2, 5
insulin- induced</w>
understand ings</w>
M PC</w>
ven lafaxine</w>
Ac upuncture</w>
Citr us</w>
Advant ages</w>
4 6.7</w>
ann a</w>
AN T</w>
Lif e
po unds</w>
rati onally</w>
pal at
A 7</w>
sum med</w>
antibody- dependent</w>
bom bar
epiphy sis</w>
pharmac ophore</w>
Syn ap
resili ent</w>
Intrig u
re trac
di eti
micro environments</w>
tri valent</w>
PE M</w>
assembl age</w>
scler a</w>
myofibr ils</w>
di peptidyl</w>
CYP 3A</w>
Intrigu ingly</w>
S DM</w>
fluoro uracil</w>
5 -19
re ject</w>
surg er
Tel e
Hym enoptera</w>
ec dys
thym idylate</w>
spi ke-
pressure- volume</w>
ME L</w>
millim eter</w>
P HT</w>
com posting</w>
DI s</w>
TD P-43</w>
sulfon amide</w>
F RC</w>
ab breviated</w>
immunomod ulation</w>
forec ast</w>
hamartom a</w>
M VA</w>
L Cs</w>
s- induced</w>
catech in</w>
ut um</w>
cal varial</w>
rham n
3 6.7</w>
manif old</w>
Low- dose</w>
hyster oscopy</w>
amend ment</w>
U PD
RA D</w>
unic ellular</w>
omel an
t old</w>
Cyto plasmic</w>
V isi
dr yness</w>
liz ards</w>
F SS</w>
P d-
Feed back</w>
GRP 78</w>
ATP- sensitive</w>
Prec ise</w>
sist ers</w>
permeabil ization</w>
oc ulation</w>
Labor atories</w>
insectic idal</w>
r ide</w>
3 66</w>
G ad
bu propion</w>
officin alis</w>
ro mo
ane ph
trunc al</w>
nev er-
e utroph
M ap</w>
ö r
inter relationships</w>
- off</w>
CA I</w>
immuno electron</w>
candi d
gender -specific</w>
non covalent</w>
AB S</w>
GA Gs</w>
CD A</w>
denti fr
2.0 9</w>
H h</w>
post- surgery</w>
non adherence</w>
f using</w>
end plate</w>
Andro gen</w>
Aneurys m</w>
cul prit</w>
TI Ls</w>
traum atized</w>
myel ofibrosis</w>
syring ae</w>
Electrophore tic</w>
v est</w>
caus e-specific</w>
cal vari
acquisi tions</w>
complement arity</w>
Gl omerular</w>
MMP- 3</w>
apoptosis- inducing</w>
no b
fil trate</w>
dec lar
MD SCs</w>
IT T</w>
qui escence</w>
cylin ders</w>
Ath l
autocor relation</w>
op ril</w>
Pro bing</w>
Immun ob
whe eze</w>
β 2</w>
CH A</w>
HM O</w>
cannabin ol</w>
sal i
phot ob
Sim ulated</w>
Seventy- two</w>
Platel ets</w>
carcin omatosis</w>
biore mediation</w>
beta-lactam ases</w>
SU I</w>
termin alis</w>
devi ant</w>
flur amine</w>
gain -of-function</w>
a the
ME A</w>
radi ation-
Optim izing</w>
prioriti zed</w>
gener alize</w>
B rom
ul ence</w>
am eric</w>
non malignant</w>
ge o
MT P</w>
AG T</w>
2,3, 7,8-
Sca ff
relapsing -remitting</w>
S end
p enc
ic in-induced</w>
symbi onts</w>
d b
6 7.
sc rotum</w>
7- year</w>
disturb ing</w>
forec asting</w>
dict ated</w>
F BG</w>
den ied</w>
uro xime</w>
connec ts</w>
u ity</w>
at taining</w>
del usions</w>
P- treated</w>
Inter face</w>
trabec ulae</w>
TOF- MS</w>
G K
sm ell</w>
I le-
sp rings</w>
dem enti
ar bor
po sive</w>
motiv ate</w>
ter butaline</w>
2 -1</w>
us -specific</w>
sc orp
micro filaments</w>
Ha ve</w>
Phen yl
mal -
2. 01</w>
cat ch</w>
under water</w>
hypo -
hydroly ze</w>
transplant able</w>
am idase</w>
heterodi meric</w>
constell ation</w>
an em
id ins</w>
fer r
18 F-FDG</w>
laparo scopically</w>
n AChRs</w>
ap ing</w>
ne opterin</w>
te t</w>
CD K</w>
1.0 9-
Mi R-
- II</w>
Inter mediate</w>
IP P</w>
seni ors</w>
C d-
S V-
M ast</w>
ab duc
meth em
hepat oprotective</w>
AP N</w>
Princi ples</w>
F ST</w>
mon grel</w>
decre ments</w>
st age-specific</w>
Qu ad
FI M</w>
Re in
ogran ul
f -1</w>
micro be</w>
prog es
los a</w>
orth ologous</w>
oll is</w>
3 61</w>
me si
LT C</w>
protr uding</w>
S edi
3 0.2</w>
O meg
poly tetrafluoroethylene</w>
edull in</w>
kilodal ton</w>
Const ant</w>
multi loc
cell aneous</w>
Cat ar
lact ones</w>
un dec
neuro secretory</w>
Cat ech
6, 7-
scorp ion</w>
or al-
IF Ns</w>
leiomy omas</w>
3 2.3</w>
ventricul ography</w>
kilob ases</w>
r us</w>
P 4
AT C</w>
heter ot
Inter ference</w>
D OR</w>
β 3</w>
educ ating</w>
append ages</w>
GSH- Px</w>
P Q
bet amethasone</w>
end omy
Lif e-
29. 7</w>
k head</w>
sub gingival</w>
Pl ain</w>
Nan oc
Rem ote</w>
L nc
ulf ite</w>
Ris ks</w>
m ock</w>
L n</w>
A A-
tap er</w>
60- year-old</w>
AS s</w>
Insi ght</w>
CXCL 12</w>
ometh ylation</w>
remin ders</w>
porphy ria</w>
ur on</w>
19 67</w>
thermo stability</w>
endothelium- derived</w>
Bol tz
G ray</w>
angi omas</w>
miR-1 46
gust atory</w>
ren yl</w>
venti lator-
week end</w>
L ast</w>
C- 5</w>
Li poprotein</w>
Peri od</w>
Cong ress</w>
lun g-
K SHV</w>
non- treated</w>
T et
ere rs</w>
Ultras onic</w>
Aut onomic</w>
wel ding</w>
meso dermal</w>
FL AIR</w>
Dis per
cardio plegic</w>
oc ratic</w>
oph y
hypot onia</w>
Dow n-
fl ash
SC L</w>
stri ol</w>
chi tinase</w>
in consistency</w>
7 6.
5 51</w>
benzo yl
centr alized</w>
Cross- Sectional</w>
alar ming</w>
U SD</w>
trans abdominal</w>
Pro pi
ger bil</w>
Argin ine</w>
at em
de generating</w>
read mitted</w>
cisplatin -induced</w>
R AB
con vec
phen anthrene</w>
V UR</w>
B ER</w>
rac ing</w>
surroun dings</w>
tr il
prote obacteria</w>
thym ectomy</w>
i ation</w>
Ne f</w>
fluoresc ens</w>
BH 4</w>
grap ev
helmin ths</w>
W GS</w>
em atous</w>
Fer tility</w>
6 2-
homozyg osity</w>
C EC</w>
I d</w>
travel ing</w>
AC F</w>
preneo plastic</w>
og los
bi otype</w>
abrup tly</w>
anthelmin tic</w>
lamo trigine</w>
lo ad-
ISR CTN
No ise</w>
homogen ized</w>
decarbox ylation</w>
S NA</w>
4 1.5</w>
lymph oblasts</w>
micro- organisms</w>
O 2
Per me
haemat ocrit</w>
o proteins</w>
Ch annel</w>
Di arr
rhin oplasty</w>
dendr ite</w>
Insul in-like</w>
Bac k
L V-
2. 50</w>
ardi ve</w>
isoflav ones</w>
ech ogenicity</w>
Epid ural</w>
Alk aline</w>
retic ulin</w>
sul piride</w>
28. 7</w>
strong ylus</w>
ur b</w>
treatment- resistant</w>
collim ator</w>
S Y</w>
P gp</w>
clu b
sacchar in</w>
e tically</w>
lymph otropic</w>
pres en
hex os
m Gy</w>
PT E</w>
ate- based</w>
pari et
ogrou p</w>
tele health</w>
exci sional</w>
constitu tion</w>
G E-
tic al-
Con temporary</w>
pregn enolone</w>
g yp
D 3
Pro be</w>
angi itis</w>
EX TRAC
harbo uring</w>
G il
- 3-</w>
non equilibrium</w>
rim -
Reli able</w>
Cost- effectiveness</w>
thiop ental</w>
epti de-
CD 23</w>
multi- center</w>
sed ated</w>
N 1-
4 7.5</w>
hol m</w>
guil t</w>
glyc ogen
omon ocytic</w>
2 4.0</w>
Aut opsy</w>
nucle ar-
decid ua</w>
cognitive- behavioral</w>
dis appears</w>
raz epam</w>
fru it
Se e
N 0
am ellar</w>
3 95</w>
dis organization</w>
Me tr
frac tory</w>
self- monitoring</w>
CM D</w>
stret ches</w>
Biomar ker</w>
hemo chromatosis</w>
st ack</w>
conv ection</w>
An alog
E ver
or ia</w>
by- product</w>
v anish
de es</w>
Oc ca
PV L</w>
PS s</w>
hemipl egia</w>
O GD</w>
6 60</w>
dr um</w>
ophen one</w>
2 7.9</w>
N PCs</w>
IF G</w>
3 2.1</w>
SET TI
an ual</w>
GP I-
LPS- stimulated</w>
catechol aminergic</w>
h MSCs</w>
on azole</w>
HLA- G</w>
oxyt oc
Ptd Ins</w>
volun tarily</w>
L X
ter tiles</w>
acetyl ene</w>
Bra in-
re member</w>
net working</w>
nem atic</w>
recapit ulate</w>
primi parous</w>
card inal</w>
S chem
D PD</w>
gen .</w>
extrac apsular</w>
phlo em</w>
stron tium</w>
8 7.
Min i
si lo
con ical</w>
rap h</w>
β- D-
bronch ogenic</w>
loos ely</w>
m dr
hydro phila</w>
arri ve</w>
shi eld</w>
atidyl choline</w>
Pla que</w>
n ica</w>
Ch el
Pig s</w>
T CF
hel p-
Inter ventional</w>
acrom ial</w>
ore duction</w>
Ph ase
sign al
hyper stimulation</w>
MI A</w>
inos us</w>
miniatur ized</w>
2, 8
spermat ogenic</w>
Repeti tive</w>
all ogenic</w>
ach s</w>
PM s</w>
o uring</w>
se st
ric kets</w>
5- min</w>
AMP- activated</w>
meth icillin</w>
pr un
-1 .</w>
Com pens
L is
suc king</w>
flex ors</w>
aler ts</w>
microgram s.
D -1</w>
po orest</w>
voc alizations</w>
rep tiles</w>
adrenocortic otropic</w>
R IN
3 72</w>
lympho kine</w>
Arsen ic</w>
Cartil age</w>
F W</w>
E yes</w>
ul ants</w>
envel opes</w>
ry e</w>
post- injury</w>
phosphate- buffered</w>
Sel enium</w>
MW CNTs</w>
6- 10</w>
cha os</w>
enucle ated</w>
travel ers</w>
c-erb B-2</w>
sup er</w>
soci ocultural</w>
3 53</w>
miR-1 55</w>
c eph
J ust</w>
under graduates</w>
PI3 K-
Sem i
biog eo
C F-
alpha- hydroxylase</w>
myel osuppression</w>
9 5th</w>
ex pulsion</w>
parame ter
tun ica</w>
dermat oses</w>
spra yed</w>
E J</w>
Oper ation</w>
san itary</w>
I DS</w>
3 1.7</w>
K L-
C oc
are a-
myx oid</w>
Oreg on</w>
Par athyro
16 00</w>
q 22</w>
oc top
ho od-
An aes
TN P-
Gi em
p 70</w>
7 3.
if ting</w>
off- label</w>
N is
2. 35</w>
Cor tisol</w>
anti-HB c</w>
R b
multi organ</w>
LT C4</w>
B 10</w>
pa e</w>
consen ted</w>
peg ylated</w>
id in-
SNA RE</w>
cryptoc occal</w>
millis econds</w>
M FS</w>
bl ight</w>
extrac ellularly</w>
u st
PIK3 CA</w>
3 1.1</w>
be fore
Re present
29. 8</w>
aquap or
Te ach
assign ing</w>
gravit ational</w>
Abbot t</w>
be agle</w>
reinhard tii</w>
as ally</w>
arc is
nic kel-
inve stments</w>
flui dics</w>
3 82</w>
Impl ementing</w>
trypan osomes</w>
stu ffs</w>
seaf ood</w>
Fan coni</w>
P av
mixed- methods</w>
W all</w>
oxidi ze</w>
m Ci</w>
29. 1</w>
polycy themia</w>
acti ae</w>
sen te
1- 8</w>
Radi al</w>
The il
Br un
Vietnam ese</w>
I ST</w>
D -induced</w>
util ising</w>
or nam
sp rung</w>
ey er</w>
Bi oph
Non linear</w>
meri stem</w>
at etra
organ ic-
alk yl-
SR F</w>
glycer ophosph
Lin ked</w>
curv ilinear</w>
if lor
micro bubbles</w>
sin ess</w>
im eth
rhyth micity</w>
phen azine</w>
PT G</w>
x- rays</w>
Hybri dization</w>
V .
4- induced</w>
happ en</w>
D CP</w>
E cu
par ities</w>
Ch ris
Amer ic
an odic</w>
id ine
gen er</w>
stern um</w>
endoc ervical</w>
Inhib its</w>
AIDS- related</w>
tr un
Meth yl</w>
i ol</w>
hyper lipidemic</w>
troph y</w>
ram p</w>
H2 O2-
Enz yme-
an ion-exchange</w>
caveol in-1</w>
B IO
ou l</w>
ass uring</w>
bil ingual</w>
three- fold</w>
O .
ir regularity</w>
T issu
PD 98059</w>
arabin ose</w>
on ensis</w>
port osystemic</w>
Res ources</w>
slaugh tered</w>
P II</w>
F ab
r uling</w>
p soas</w>
non- pharmacological</w>
Su ff
A AD</w>
se als</w>
CA 19-9</w>
supr ap
PRO BLE
myocl onic</w>
u ates</w>
m olysis</w>
6 9.
the l</w>
my ogenesis</w>
assi stive</w>
den om
Mo S2</w>
neutr ons</w>
genotype- phenotype</w>
k g
CF R</w>
mathem atics</w>
S 5</w>
str ian</w>
blin ding</w>
Abstr act</w>
3&apos; UTR</w>
Calcul ations</w>
SETTI NGS</w>
t max</w>
Interfer on-
oste olytic</w>
scar cely</w>
immunophen otype</w>
vitr onectin</w>
enrol lees</w>
f ates</w>
is ome</w>
vap our</w>
All ergy</w>
Nocardi a</w>
I RS</w>
ox i
self- help</w>
pil ots</w>
nitro cellulose</w>
Mac ular</w>
Ultras ound-
Q X</w>
serogrou ps</w>
3 78</w>
3 92</w>
str ug
2. 17</w>
she patic</w>
Cam bodi
bout ons</w>
id yl</w>
kin e-
phot ographic</w>
Neuro logic</w>
N-ethyl maleimide</w>
Trepon ema</w>
I RT</w>
micro titer</w>
Fin ding</w>
thor a</w>
orh odopsin</w>
lem an</w>
5 32</w>
LINC 00
re appraisal</w>
me dro
suc ro
centr i
45 Ca2</w>
h t
O TU
pre morbid</w>
til in</w>
ondyl ar</w>
trans sphenoidal</w>
oscop ies</w>
cri ticism</w>
GL S</w>
monoc linic</w>
adenos ine-
Practition ers</w>
Sc and
FD A-
adrenal ectomized</w>
liter atures</w>
trim oxazole</w>
acidi fied</w>
strip e</w>
organochlor ine</w>
perchlor ate</w>
S ap
H Q</w>
PV s</w>
cluster -
P 2-
HIV- associated</w>
od d</w>
2. 11</w>
complic ates</w>
entangl ement</w>
as tin
D ich
A round</w>
Ad op
opharyn gi
- beta</w>
oretin opathy</w>
6 a</w>
vit ro-
PS V</w>
l ays</w>
Nor thwest</w>
P X</w>
K a</w>
he i</w>
normal- weight</w>
on ym</w>
el astom
mem ory-
M e-
0 -</w>
B ID</w>
pa ying</w>
mycel ial</w>
D 1-
bi ota</w>
haem olysis</w>
ascer tainment</w>
P all
N 4</w>
neuro biology</w>
glyc opeptide</w>
PB DEs</w>
eth yn
ak in</w>
illumin ate</w>
8 8-
sente eism</w>
O thers</w>
oc idal</w>
organ o
B SP</w>
on i</w>
sem an
diver ticula</w>
er ial</w>
20 35
sit tac
norm oglyc
syndro me-
glycos ylase</w>
cef azolin</w>
lev amisole</w>
2. 45</w>
ster ase</w>
nan ospheres</w>
histi ocytes</w>
com promises</w>
PM 10</w>
pyr role</w>
cathe ter-
disease- causing</w>
tauro cholate</w>
antihist amines</w>
2 m</w>
4 11</w>
emb rol
sw ell
dra ins</w>
dimethyl thi
Tou rette</w>
T C-
az ocine</w>
Min i</w>
To ols</w>
Includ ing</w>
pro caine</w>
depres sion-
fin ely</w>
y an</w>
I -1
im perfecta</w>
lim b-
AS O</w>
3 beta</w>
D ir
è re</w>
kin umab</w>
Fifty- eight</w>
TX B2</w>
mon d</w>
bre eders</w>
chrom osome-
Sixty- five</w>
potassi um-
HI E</w>
osom al-
beta- cyclodextrin</w>
1, 3</w>
pellucid a</w>
in congruent</w>
character izations</w>
cyt oreductive</w>
Hamil tonian</w>
eicos anoids</w>
cre ativity</w>
DI S</w>
ent an</w>
2. 16</w>
Thor ac
Coul om
N 9</w>
ap ar
sub sid
mes ophilic</w>
evid ently</w>
m J</w>
7 5.
18- month</w>
neurom a</w>
hid rosis</w>
s ob
micro dilution</w>
hydro peroxides</w>
Dis section</w>
indu str
spre ads</w>
Fil ms</w>
orchi ectomy</w>
design ation</w>
amphi pathic</w>
Open -
P t-
re pressing</w>
ep i-
groo ves</w>
L p
V FA</w>
Re tri
suffici ency</w>
Sign s</w>
Bay es</w>
S N-
Veg et
7 5.0</w>
bin aural</w>
mono hydrate</w>
Ev ent</w>
z ygotic</w>
w ide
SD F-1</w>
constric tor</w>
foot printing</w>
Expan sion</w>
3 74</w>
un restricted</w>
po ison</w>
cre w</w>
IL- 23</w>
liz ard</w>
cyr rhiz
3 89</w>
qu etiapine</w>
ble ed</w>
aren es</w>
CS s</w>
skin ned</w>
Br ad
pip razole</w>
syring es</w>
pteryg ium</w>
convol uted</w>
illustr ative</w>
Evid ence-based</w>
T OC</w>
intra observer</w>
k bp</w>
Physi ol</w>
millim olar</w>
C ocaine</w>
B l</w>
im pedi
my opathies</w>
Georg e</w>
6 25</w>
tradi tion</w>
ib acterium</w>
inc ipient</w>
distrib ute</w>
CL 1</w>
DN MT
N ear</w>
di alytic</w>
mo tive</w>
ore xin</w>
hist ogenesis</w>
well- studied</w>
segreg ating</w>
ce iling</w>
distres sing</w>
M ast
M ature</w>
7 2.7</w>
3 76</w>
Ad dressing</w>
thermo -
CT- guided</w>
b. w.</w>
en ius</w>
non structural</w>
k ur
agon ism</w>
dose- rate</w>
Malay sian</w>
Percent age</w>
in omycin</w>
path way
impl em
- linked</w>
brush es</w>
apath y</w>
T empor
α -</w>
mes oc
incarcer ation</w>
Indu stry</w>
aggra vation</w>
a esti
p 13</w>
co operatively</w>
B erg